 AGREEMENT AND PLAN OF MERGER,
DATED AS OF OCTOBER 20, 2020      

Exhibit 2.1

  



  

 _Execution Version_

  

  



  

  

 _ _

  

AGREEMENT AND PLAN OF MERGER 
  
 by and among 
  
 PANACEA ACQUISITION CORP., 
  
 PANACEA MERGER SUBSIDIARY CORP, 
  
 and 
  
 NUVATION BIO INC. 
  
 dated as of 
  
 October 20, 2020

  



  

  



  



    



 



    



  

 _TABLE OF CONTENTS_

  



       |   | Page 
---|---|--- 
   Article I 
   DEFINITIONS 
   
   Article II 
   THE MERGER 
   
   2.1  | The Merger  | 22 
   2.2  | Effective Time  | 22 
   2.3  | Effect of the Merger  | 23 
   2.4  | Pre-Closing Recapitalization  | 23 
   2.5  | Governing Documents  | 23 
   2.6  | Closing  | 23 
   2.7  | Payment of Expenses  | 24 
   2.8  | Directors and Officers of the Surviving Corporation  | 24 
   2.9  | Taking of Necessary Action; Further Action  | 24 
     |   | 
   Article III 
   CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES 
   
   3.1  | Conversion of Securities; Assumption of Company Options  | 24 
   3.2  | Exchange of Certificates.  | 26 
   3.3  | Stock Transfer Books  | 29 
   3.4  | Appraisal Rights  | 29 
     |   | 
   Article IV 
   REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
   
   4.1  | Corporate Existence and Power  | 30 
   4.2  | Authorization  | 30 
   4.3  | Governmental Authorization  | 30 
   4.4  | Non-Contravention  | 30 
   4.5  | Capitalization  | 31 
   4.6  | Charter Documents  | 33 
   4.7  | Corporate Records  | 33 
   4.8  | Third Parties  | 33 
   4.9  | Subsidiaries  | 33 
   4.10  | Financial Statements  | 33 
   4.11  | Absence of Certain Changes  | 34 
   4.12  | Properties; Title to the Company's Assets  | 35 
   4.13  | Litigation  | 35 
   4.14  | Contracts  | 35 
   4.15  | Insurance  | 37 
   



    

1

 



    



     4.16  | Licenses and Permits  | 37 
---|---|--- 
   4.17  | Compliance with Laws  | 37 
   4.18  | Intellectual Property  | 38 
   4.19  | Employees  | 40 
   4.20  | Withholding  | 41 
   4.21  | Employee Benefits and Compensation  | 42 
   4.22  | Real Property  | 43 
   4.23  | Tax Matters  | 44 
   4.24  | Environmental Laws  | 45 
   4.25  | Finders' Fees  | 45 
   4.26  | Preclinical Development and Clinical Trials  | 46 
   4.27  | Regulatory Filings and Data Integrity  | 46 
   4.28  | FDA Approvals  | 47 
   4.29  | Healthcare Laws  | 47 
   4.30  | Board Approval; Vote Required  | 47 
   4.31  | Information Supplied  | 48 
   4.32  | No Other Representations  | 48 
     |   | 
   Article V 
   REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND MERGER SUB 
   
   5.1  | Corporate Existence and Power  | 49 
   5.2  | Authorization  | 49 
   5.3  | Governmental Authorization  | 49 
   5.4  | Non-Contravention  | 50 
   5.5  | Finders' Fees  | 50 
   5.6  | Capitalization  | 50 
   5.7  | Information Supplied  | 51 
   5.8  | Trust Fund  | 52 
   5.9  | Listing  | 52 
   5.10  | Board Approval  | 53 
   5.11  | Purchaser SEC Documents and Financial Statements  | 53 
   5.12  | Compliance with Laws  | 54 
   5.13  | OFAC  | 54 
   5.14  | Litigation  | 55 
   5.15  | Absence of Certain Changes  | 55 
   5.16  | Employees and Employee Benefit Plans  | 55 
   5.17  | Properties  | 55 
   5.18  | Contracts  | 56 
   5.19  | No Undisclosed Liabilities  | 56 
   5.20  | Affiliate Transactions  | 56 
   5.21  | Forward Purchase Agreement  | 57 
   5.22  | Tax Matters  | 57 
   5.23  | PIPE Investment  | 58 
   5.24  | Independent Investigation  | 59 
   



    

2

 



    



     Article VI 
--- 
   COVENANTS OF THE PARTIES PENDING CLOSING 
   
   6.1  | Conduct of the Business  | 59 
   6.2  | Annual and Interim Financial Statements  | 65 
   6.3  | Trust Account  | 65 
   6.4  | Purchaser Public Filings  | 65 
   6.5  | Form 8-K; Press Releases  | 65 
   6.6  | Section 16 of the Exchange Act  | 65 
   6.7  | No Solicitation  | 66 
   6.8  | Tax Matters  | 66 
   6.9  | Regulatory Compliance  | 67 
   6.10  | Employment Agreements  | 68 
   6.11  | Registration Rights Agreement.  | 68 
     |   | 
   Article VII 
   COVENANTS OF THE COMPANY AND THE PURCHASER 
   
   7.1  | Access to Information  | 69 
   7.2  | Notices of Certain Events  | 69 
   7.3  | Company IP Maintenance Filings and Payments  | 70 
     |   | 
   Article VIII 
   COVENANTS OF ALL PARTIES HERETO 
   
   8.1  | Registration Statement  | 71 
   8.2  | Purchaser Stockholder Meeting; Board Recommendation  | 73 
   8.3  | Further Assurances  | 73 
   8.4  | Company Stockholder Approval  | 73 
   8.5  | Compliance with SPAC Agreements  | 75 
   8.6  | Confidentiality  | 75 
   8.7  | Indemnification; Insurance  | 75 
   8.8  | PIPE Investment  | 76 
   8.9  | Additional Purchase Right  | 76 
   8.10  | Equity Incentive Plan  | 77 
   8.11  | Continuing Employees.  | 77 
   8.12  | Post-Closing Directors  | 78 
     |   | 
   Article IX 
   CONDITIONS TO CLOSING 
   
   9.1  | Condition to the Obligations of the Parties  | 78 
   9.2  | Conditions to Obligations of the Purchaser  | 79 
   9.3  | Conditions to Obligations of the Company  | 80 
   



    

3

 



    



     Article X 
--- 
   TERMINATION 
   
   10.1  | Termination Without Default  | 81 
   10.2  | Termination Upon Default  | 82 
   10.3  | Termination for Triggering Event  | 83 
   10.4  | Effect of Termination  | 83 
     |   | 
   Article XI 
   MISCELLANEOUS 
     |   | 
   11.1  | Notices  | 83 
   11.2  | Amendments; No Waivers; Remedies.  | 84 
   11.3  | Arm's Length Bargaining; No Presumption Against Drafter  | 84 
   11.4  | Publicity  | 85 
   11.5  | Expenses  | 85 
   11.6  | No Assignment or Delegation  | 85 
   11.7  | Governing Law  | 85 
   11.8  | Counterparts; Signatures  | 85 
   11.9  | Entire Agreement  | 85 
   11.10  | Severability  | 86 
   11.11  | Construction of Certain Terms and References; Captions  | 86 
   11.12  | Third Party Beneficiaries  | 87 
   11.13  | Waiver  | 87 
   11.14  | Non-Recourse  | 87 
   11.15  | Jurisdiction; Waiver of Trial by Jury  | 88 
   11.16  | Specific Performance  | 88 
   11.17  | Acknowledgement; Waiver of Conflicts; Retention of Privilege 
| 88 
   11.18  | No Survival  | 90 
   



  

 _EXHIBITS_

     Exhibit A  | -  | Form of the Purchaser Charter 
---|---|--- 
   Exhibit B  | -  | Form of the Purchaser Bylaws 
   Exhibit C  | -  | Form of Stockholder Support Agreement 
   Exhibit D  | -  | Form of Sponsor Support Agreement 
   Exhibit E  | -  | Form of Sponsor and Founder Lock-up Agreement 
   Exhibit F  | -  | Form of FPA Lock-up Agreement 
   Exhibit G  | -  | Form of Stockholder Lock-Up Agreement 
   Exhibit H  | -  | Form of Certificate of Merger 
   Exhibit I  | -  | Form of New Company Certificate of Incorporation 
   Exhibit J  | -  | Share Exchange Agreement 
   



    

4

 



    



  

 _AGREEMENT AND PLAN OF MERGER_

  



  

This AGREEMENT AND PLAN OF MERGER (the " _Agreement_ "), dated as of October
20, 2020, by and among Panacea Acquisition Corp., a Delaware corporation (the
" _Purchaser_ "), Panacea Merger Subsidiary Corp, a Delaware corporation and
direct, wholly owned subsidiary of the Purchaser (" _Merger Sub_ ") and
Nuvation Bio Inc., a Delaware corporation (the " _Company_ "). The Purchaser,
Merger Sub and the Company are collectively referred to herein as the "
_Parties_ " and individually as a " _Party_."

  



  

 _RECITALS_

  



  

A. The Company and its Subsidiaries (the " _Company Group_ ") are in the
business of researching, discovering, developing (including non-clinical and
clinical development activities and all regulatory-related activities related
thereto) and manufacturing pharmaceutical products (the " _Business_ ");

  



  

B. The Purchaser is a blank check company formed for the sole purpose of
entering into a merger, share exchange, asset acquisition, share purchase,
recapitalization, reorganization or other similar business combination with
one (1) or more businesses or entities;

  



  

C. On the terms and subject to the conditions of this Agreement and in
accordance with the General Corporation Law of the State of Delaware (the "
_DGCL_ ") and other applicable Laws, the Parties intend to enter into a
business combination transaction by which: (i) Merger Sub will merge with and
into the Company (the " _Merger_ "), with the Company being the
surviving corporation of the Merger (the Company, in its capacity as the
surviving corporation of the Merger, is sometimes referred to as the "
_Surviving Corporation_ ");

  



  

D. The boards of directors of the Company, the Purchaser and Merger Sub, have
each (i) determined that the Merger is fair, advisable and in the best
interests of their respective companies and stockholders and (ii) approved
this Agreement and the Transactions, including the Merger, upon the terms and
subject to the conditions set forth herein;

  



  

E The boards of directors of each of the Company, the Purchaser and Merger
Sub have determined to recommend to their respective stockholders the
approval and adoption of this Agreement and the Transactions, including the
Merger;

  



  

F. Prior to the Effective Time and the closing of the PIPE Investment, the
Purchaser shall (i) subject to obtaining the approval of the Purchaser
Stockholder Matters, amend and restate the certificate of incorporation of the
Purchaser to be substantially in the form of _Exhibit A_ attached hereto
(the " _Purchaser Charter_ ") and (ii) amend and restate the bylaws of the
Purchaser to be substantially in the form of _Exhibit B_ attached hereto (the
" _Purchaser Bylaws_ ");

  



  

G. Within twenty-four (24) hours of the execution and delivery of this
Agreement, stockholders of the Company (each, a " _Stockholder_ " and,
collectively, the " _Stockholders_ ") sufficient to approve the adoption of
this Agreement, the Merger and the other Transactions shall enter into one
(1) or more Support Agreements substantially in the form of _Exhibit C_
attached hereto (each, a " _Stockholder Support Agreement_ ") which will
provide that as promptly as practicable following the time at which the
Registration Statement shall have been declared effective and made available
to Stockholders, such Stockholders will approve and adopt this Agreement, the
Merger and the other Transactions in accordance with Section 251 of the DGCL
(the " _Company Stockholder Approval_ ") and agree to be bound by all of the
terms of this Agreement through a written consent pursuant to Section 228 of
the DGCL;

  



    

5

 



    



  

H. Concurrently with the execution and delivery of this Agreement, EcoR1
Panacea Holdings, LLC (" _Sponsor_ "), PA Co-Investment LLC, the Company and
the Purchaser, have entered into one (1) or more support agreements
substantially in the form of _Exhibit D_ attached hereto (each, a " _Sponsor
Support Agreement_ ");

  



  

I. Concurrently with the execution and delivery of this Agreement, the
Company has entered into a lock-up agreement with each of the Sponsor and PA
Co-Investment LLC substantially in the form of _Exhibit E_ attached hereto
(each, a " _Sponsor and Founder Lock-Up Agreement_ ");

  



  

J. Concurrently with the execution and delivery of this Agreement, the
Company has entered into a lock-up agreement with each of the
purchasers under the Forward Purchase Agreement substantially in the form of
_Exhibit F_ attached hereto (each, a " _FPA Lock-Up Agreement_ ");

  



  

K. Concurrently with the execution and delivery of this Agreement, the
Company has entered into a lock-up agreement with each officer, director and
owner of one percent (1%) or more of the outstanding equity of the Company (as
of the date hereof), among other Stockholders,] substantially in the form of
_Exhibit G_ attached hereto (each, a " _Stockholder Lock-Up Agreement_ ");

  



  

L. On or prior to the date hereof, the Purchaser has obtained commitments
from certain investors for a private placement of shares of the Purchaser
Class A Common Stock (the " _PIPE Investment_ ") pursuant to the terms of one
(1) or more subscription agreements (each, a " _Subscription Agreement_ "),
such private placements to be consummated prior to the consummation of the
Transactions; and

  



  

M. The Parties intend that (a) the Merger will qualify for U.S. federal
income tax purposes as a "reorganization" within the meaning of Section
368(a) of the Code and the Treasury Regulations promulgated thereunder and (b)
this Agreement is, and is hereby adopted as, a "plan of reorganization"
within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3.

  



  

The Parties accordingly agree as follows:

  



  

Article I _ 
 DEFINITIONS_

  



  

The following terms, as used herein, have the following meanings:

  



  

1.1 " _2019  Equity Incentive Plan_" means the Company's 2019 Equity
Incentive Plan.

  



    

6

 



    



  

1.2 " _Acquisition Proposal_ " means any agreement, offer, proposal or
indication of interest (other than the Pre-Closing Recapitalization, this
Agreement and the Transactions), or any public announcement of intention to
enter into any such agreement or of (or intention to make) any offer,
proposal or indication of interest, relating to, or involving: (a) any
acquisition or purchase by any Person or Group, directly or indirectly, of
ten percent (10%) or more securities of the Purchaser or any member of the
Company Group, or any tender offer or exchange offer, (b) any merger,
consolidation, business combination, share exchange or similar
transaction involving ten percent (10%) or more of the securities of the
Purchaser or any member of the Company Group, (c) any sale,
acquisition, disposition, mortgage, pledge or other transfer (other than a
license) of any of ten percent (10%) or more of the assets of the Purchaser
or any member of the Company Group, (d) any strategic joint ventures,
partnership, joint development, exclusive out-license or similar transaction
or (e) any liquidation or dissolution of the Purchaser or any member of the
Company Group, or any extraordinary dividend, whether of cash or other
property, in each case of the foregoing clauses, in any single transaction or
series of related transactions; provided, for the avoidance of doubt, that in
no event shall (i) any equity issuance pursuant to _Section 3.1(a)(v)_, (ii)
any other bona fide financing by the Company (subject to the Purchaser's
consent, not to be unreasonably withheld, conditioned or delayed), (iii) the
sale or transfer of immaterial assets in the Ordinary Course of Business, or
(iv) the issuance of Company Options or Company Common Stock upon the
exercise of Company Options in the Ordinary Course of Business, be deemed an
Acquisition Proposal.

  



  

1.3 " _Action_ " means any legal action, suit, claim, investigation, hearing
or proceeding, including any audit, claim or assessment for Taxes
or otherwise, by or before any Authority.

  



  

1.4 " _Additional Agreements_ " means the FPA Lock-Up Agreement, the
Stockholder Lock-Up Agreements, the Subscription Agreements, the Registration
Rights Agreement, the Stockholder Support Agreements, the Sponsor Support
Agreement, the Indemnification Agreements, and all the agreements, documents,
instruments and certificates entered into in connection herewith or therewith
and any and all exhibits and schedules thereto.

  



  

1.5 " _Affiliate_ " means, with respect to any Person, any other Person
directly or indirectly Controlling, Controlled by, or under common
Control with such Person (but excluding, with respect to the Company, any
portfolio companies of venture capital or investment funds that are, or
otherwise affiliated with, Stockholders, which portfolio companies may
otherwise be deemed to be under common Control with the Company).

  



  

1.6 " _Agreement_ " has the meaning set forth in the Preamble.

  



  

1.7 " _Aggregate Merger Consideration Shares_ " means the aggregate number of
shares of the Purchaser Class A Common Stock and the Purchaser Class B Common
Stock issued pursuant to _Section 3.1(a)(i)_ and _Section 3.1(a)(ii)_.

  



  

1.8 " _Audited Financial Statements_ " has the meaning set forth in _Section
4.10(a)_.

  



    

7

 



    



  

1.9 " _Authority_ " means any governmental, quasi-governmental, regulatory or
administrative body, agency, instrumentality, department or authority, any
court, tribunal, judicial authority, administrative hearing body, arbitrator,
commission or other similar dispute-resolving panel or body, or any public,
private or industry regulatory authority, whether international, national,
Federal, state, or local.

  



  

1.10 " _Available Closing Purchaser Cash_ " means amount equal to (i) all
amounts remaining in the Purchaser's Trust Account (net of any redemptions of
the Purchaser Common Stock (the " _Redemptions_ "), any unpaid or contingent
liabilities of the Purchaser (including transaction expenses incurred,
accrued, paid or payable by the Purchaser's Affiliates on the Purchaser's
behalf and any Deferred Underwriting Amount)), _plus_ (ii) the
aggregate amount of cash that has been funded to and remains with the
Purchaser pursuant to the Forward Purchase Agreement, _plus_ (iii) the
aggregate amount of cash that has been funded to and remains with the
Purchaser pursuant to the Subscription Agreements as of immediately prior to
the Closing.

  



  

1.11 " _Balance Sheet_ " has the meaning set forth in _Section 4.10(a)_.

  



  

1.12 " _Balance Sheet Date_ " has the meaning set forth in _Section
4.10(a)_.

  



  

1.13 " _Books and Records_ " means all books and records, ledgers, employee
records, files, correspondence, and other records of every kind (whether
written, electronic, or otherwise embodied) owned or controlled by a Person in
which a Person's assets, the business or its transactions are otherwise
reflected, other than stock books and minute books.

  



  

1.14 " _Business_ " has the meaning set forth in the Recitals.

  



  

1.15 " _Business Combination_ " has the meaning set forth in _Section 5.10_.

  



  

1.16 " _Business Day_ " means any day other than a Saturday, Sunday or a
legal holiday on which commercial banking institutions in Wilmington,
Delaware, New York, New York and San Francisco, California, are authorized to
close for business.

  



  

1.17 " _CARES Act_ " means the Coronavirus Aid, Relief, and Economic Security
Act.

  



  

1.18 " _Cash Closing Requirement_ " means an amount in cash equal to
$500,000,000 million; _provided_ that to the extent the Founder has not
funded at least $20.0 million of the PIPE Investment Amount, then the Cash
Closing Requirement shall be reduced dollar for dollar by the amount of such
shortfall.

  



  

1.19 " _Certificate of Merger_ " has the meaning set forth in _Section 2.2_.

  



  

1.20 " _Certificates_ " has the meaning set forth in _Section 3.2(b)_.

  



  

1.21 " _Change of Recommendation_ " has the meaning set forth in _Section
6.7_.

  



  

1.22 " _Closing_ " has the meaning set forth in _Section 2.6_.

  



    

8

 



    



  

1.23 " _Closing Date_ " has the meaning set forth in _Section 2.6_.

  



  

1.24 " _Closing Indebtedness_ " means, as of the close of business on the
Closing Date (and treating any Indebtedness for borrowed money as then
currently due and payable), the aggregate amount of all Indebtedness for
borrowed money of the Company Group, on a consolidated basis, determined in
accordance with GAAP.

  



  

1.25 " _Closing Press Release_ " has the meaning set forth in _Section
6.5(b)_.

  



  

1.26 " _COBRA_ " means collectively, the requirements of Sections 601 through
608 of ERISA and Section 4980B of the Code.

  



  

1.27 " _Code_ " means the Internal Revenue Code of 1986, as amended.

  



  

1.28 " _Company  Advised Parties_" has the meaning set forth in _Section
11.17(b)_.

  



  

1.29 " _Company Board_ " has the meaning set forth in _Section 6.7_.

  



  

1.30 " _Company Capital Stock_ " means the Company Common Stock and the
Company Series A Preferred Stock.

  



  

1.31 " _Company Certificate_ " has the meaning set forth in _Section
9.2(d)_.

  



  

1.32 " _Company  Charter Documents_" has the meaning set forth in _Section
4.6_.

  



  

1.33 " _Company Class A Common Stock_ " means the Class A common stock, par
value $0.0001 per share, of the Company, which as of immediately after the
Pre-Closing Recapitalization will have one (1) vote per share on all voting
matters.

  



  

1.34  " _Company Class B Common Stock_ " means the Class B common stock, par
value $0.0001 per share, of the Company, which as of immediately after the
Pre-Closing Recapitalization will have (a) ten (10) votes per share on any
proposed change in control transaction, (b) one (1) vote per share on all
other voting matters and (c) the right to appoint and remove three (3)
directors to the Company Board plus at least fifty (50%) of any directors
appointed beyond seven (seven) directors (as will be described in the Company
Charter Documents following the Pre-Closing Recapitalization).

  



  

1.35 " _Company Common Stock_ " has the meaning set forth in _Section 4.5(a)
_which shall, for the avoidance of doubt, following the Pre-Closing
Recapitalization include Company Class A Common Stock and Company Class B
Common Stock.

  



  

1.36 " _Company D andO Policy_" has the meaning set forth in _Section 8.7(a)_.

  



  

1.37 " _Company Employees_ " means the current employees of the Company.

  



  

1.38 " _Company_ " has the meaning set forth in the Preamble.

  



  

1.39 " _Company  Deal Communications_" has the meaning set forth in _Section
11.17(c)_.

  



    

9

 



    



  

1.40 " _Company Group_ " has the meaning set forth in the Recitals.

  



  

1.41 " _Company Group Product Candidates_ " means the Company's pre-clinical
and clinical product candidates, which are set forth on _Schedule 1(a)_.

  



  

1.42 " _Company IP_ " means all Intellectual Property Rights owned or
purported to be owned, or licensed, by any member of Company Group, or used
or held for use in the Business whether registered or unregistered or domestic
or foreign.

  



  

1.43 " _Company Option_ " has the meaning set forth in _Section 3.1(a)(v)_.

  



  

1.44  " _Company Plan_" has the meaning set forth in _Section 4.21(a)_.

  



  

1.45  " _Company Series A Preferred Stock_ " has the meaning set forth in
_Section 4.5(a)_.

  



  

1.46 " _Company Stockholder Approval_ " has the meaning set forth in the
Recitals.

  



  

1.47 " _Confidentiality Agreement_ " means that certain Mutual Non-Disclosure
Agreement by and between the Company and EcoR1 Capital, LLC dated August 12,
2020.

  



  

1.48 " _Continuing Employee_ " means each employee of the Company or any of
its Subsidiaries who will continue to be employed by the
Surviving Corporation or any subsidiary or Affiliate thereof after the
Closing Date.

  



  

1.49 " _Contracts_ " means the Leases and all other contracts, agreements,
leases (including equipment leases, car leases and capital leases),
licenses, commitments, client contracts, statements of work (SOWs), oral or
written, to which any member of the Company Group is a party or by which any
of its respective assets are bound, and all rights and benefits thereunder,
including all rights and benefits thereunder with respect to all cash and
other property of third parties under the Company Group's dominion or control.

  



  

1.50 " _Control_ " of a Person means the possession, directly or indirectly,
of the power to direct or cause the direction of the management and
policies of such Person, whether through the ownership of voting securities,
by contract, or otherwise. " _Controlled_ ", " _Controlling_ " and "
_under common Control with_ " have correlative meanings. Without limiting the
foregoing, a Person (the " _Controlled Person_ ") shall be deemed Controlled
by (a) any other Person (the " _10% Owner_ ") (i) owning beneficially, as
meant in Rule 13d-3 under the Exchange Act, securities entitling such
Person to cast 10% or more of the votes for election of directors or
equivalent governing authority of the Controlled Person or (ii) entitled to
be allocated or receive 10% or more of the profits, losses, or distributions
of the Controlled Person; (b) an officer, director, general partner, partner
(other than a limited partner), manager, or member (other than a member having
no management authority that is not a 10% Owner) of the Controlled Person; or
(c) a spouse, parent, lineal descendant, sibling, aunt, uncle, niece,
nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an
Affiliate of the Controlled Person or a trust for the benefit of an Affiliate
of the Controlled Person or of which an Affiliate of the Controlled Person is
a trustee.

  



    

10

 



    



  

1.51 " _Converted Option_ " has the meaning set forth in _Section 3.1(a)(v)_.

  



  

1.52 " _COVID-19_ " means SARS-CoV-2 or COVID-19, and any evolutions thereof
or any other related or associated epidemics, pandemics or disease outbreaks.

  



  

1.53 " _COVID-19 Measures_ " means any quarantine, "shelter in place," "stay
at home," workforce reduction, social distancing, shut down, closure,
sequester or any other Law, directive, guidelines or recommendations by any
Authority in each case in connection with or in response to COVID-19,
including, the CARES Act.

  



  

1.54 " _COVID-19 Response Measures_ " means any reasonable action, taken or
omitted to be taken after the date of this Agreement that is reasonably
determined to be necessary or prudent to be taken in response to COVID-19 or
any of the measures described in the definition of "COVID-19 Measures",
including the establishment of any policy, procedure or protocol; _provided_ ,
that, unless such action is immaterial, nether the Company nor the Purchaser
shall undertake any COVID-19 Response Measure after the date hereof unless
the Company or the Purchaser, as applicable, has informed, in reasonable
detail, the Purchaser or the Company, as applicable, of the necessity to take
such action; _provided_ , that no such notice shall be required to be provided
in advance of taking such action if it shall be impracticable for the Company
to provide such advance notice.

  



  

1.55 " _Data Protection Laws_ " means any applicable Laws governing the
collection, retention, protection, security, use and other processing of
Personal Information.

  



  

1.56 " _Deferred Underwriting Amount_ " means the portion of the underwriting
discounts and commissions held in the Trust Account, which the underwriters
of the IPO are entitled to receive upon the Closing in accordance with the
Trust Agreement, which shall not exceed $5,031,250.

  



  

1.57 " _DGCL_ " has the meaning set forth in the Recitals.

  



  

1.58 " _Disclosure Schedule_ " means the disclosure schedule that has been
prepared by the Company in accordance with the requirements of this Agreement
and that has been delivered by the Company to the Purchaser on the date of
this Agreement.

  



  

1.59 " _EDGAR_ " has the meaning set forth in _Section 5.1_.

  



  

1.60 " _Effective Time_ " has the meaning set forth in _Section 2.2_.

  



  

1.61 " _Environmental Laws_ " means all Laws that prohibit, regulate or
control any Hazardous Material or any Hazardous Material Activity, including
the Comprehensive Environmental Response, Compensation, and Liability Act of
1980, the Resource Recovery and Conservation Act of 1976, the Federal Water
Pollution Control Act, the Clean Air Act, the Hazardous Materials
Transportation Act and the Clean Water Act.

  



  

1.62 " _Equity Incentive Plan_ " has the meaning set forth in _Section
8.10_.

  



    

11

 



    



  

1.63 " _ERISA_ " means the Employee Retirement Income Security Act of 1974,
as amended.

  



  

1.64 " _Exchange Act_ " means the Securities Exchange Act of 1934, as
amended.

  



  

1.65 " _Exchange Agent_ " has the meaning set forth in _Section 3.2(a)_.

  



  

1.66 " _Exchange Fund_ " has the meaning set forth in _Section 3.2(a)_.

  



  

1.67 " _Exchange Ratio_ " means the quotient obtained by _dividing_ (x) the
Target Share Amount, _by_ (y) the number of Fully-Diluted Company Shares.

  



  

1.68 " _Excluded Share_ " has the meaning set forth in _Section
3.1(a)(iii)_.

  



  

1.69 " _FDA_ " has the meaning set forth in _Section 4.28_.

  



  

1.70 " _FDA Application Integrity Policy_ " has the meaning set forth in
_Section 4.28_.

  



  

1.71 " _FFCRA_ " means the Families First Coronavirus Response Act.

  



  

1.72 " _Financial Statements_ " has the meaning set forth in _Section
4.10(a)_.

  



  

1.73 " _Foreign Corrupt Practices Act_ " has the meaning set forth in
_Section 4.17(b)(ii)_.

  



  

1.74 " _Forward Purchase Agreement_ " means the Forward Purchase Agreement
entered into by and among the Purchaser, EcoR1 Panacea Holdings, LLC and each
of the purchasers listed on the signature pages thereto executed as of June
30, 2020.

  



  

1.75 " _Founder_ " means David Hung, M.D.

  



  

1.76 " _Founder Shares_ " means the Class B common stock, par value $0.0001
per share, of the Purchaser prior to amendment and restatement of the
Purchaser Charter.

  



  

1.77 " _Fraud_ " means actual common law fraud under the Laws of the State of
Delaware in the making of a specific representation or warranty set forth in
this Agreement.

  



  

1.78 " _Fully-Diluted Company Shares_ " means an amount equal to the
aggregate number of outstanding shares of Company Capital Stock plus
the number of shares of Company Capital Stock issuable pursuant to the vested
Company Options, calculated using the treasury method of accounting as of
immediately prior to the Effective Time.

  



  

1.79 " _Fully-Diluted Purchaser Common Stock_ " has the meaning set forth in
_Section 8.10_.

  



  

1.80 " _Fundamental Representations_ " means the representations and
warranties contained in _Section 4.1_ (Corporate Existence and Power), 
_Section 4.2_ (Authorization), _Section 4.5(a), (b), (c), (f), (g), and (h)_
(Capitalization) and _Section 4.25_  (Finders' Fees).

  



    

12

 



    



  

1.81 " _FPA Lock-Up Agreement_ " has the meaning set forth in the Recitals.

  



  

1.82 " _GAAP_ " means United States generally accepted accounting principles,
consistently applied.

  



  

1.83 " _Governmental Approval_ " has the meaning set forth in _Section 4.3_.

  



  

1.84 " _Government Shutdown_ " means any shutdown of or material interruption
to, prior to the Outside Closing Date, the Authorities providing, approving
or reviewing the applicable consents, authorizations, orders and approvals of
(or filings or registrations with) relating to the Transactions, in each case
that relates to the ongoing COVID-19 pandemic.

  



  

1.85  " _Group_ " means any two (2) more Persons acting as a group, and all
Affiliates of such Person or Persons.

  



  

1.86 " _Hazardous Material_ " shall mean any material, emission, chemical,
substance or waste that has been designated by any Authority to be
radioactive, toxic, hazardous, a pollutant or a contaminant.

  



  

1.87 " _Hazardous Material Activity_ " shall mean the transportation,
transfer, recycling, storage, use, treatment, manufacture,
removal, remediation, release, exposure of others to, sale, labeling, or
distribution of any Hazardous Material or any product or waste containing a
Hazardous Material, or product manufactured with ozone depleting substances,
including, any required labeling, payment of waste fees or charges (including
so-called e-waste fees) and compliance with any recycling, product take-back
or product content requirements.

  



  

1.88 " _HSR Act_ " shall mean the Hart-Scott-Rodino Antitrust Improvements
Act of 1976, as amended, and the rules and regulations promulgated
thereunder.

  



  

1.89  " _Indebtedness_ " means with respect to any Person, (a) all
obligations of such Person for borrowed money, or with respect to deposits or
advances of any kind (including amounts by reason of overdrafts and amounts
owed by reason of letter of credit reimbursement agreements), including with
respect thereto, all interests, fees and costs, (b) all obligations of such
Person evidenced by bonds, debentures, notes or similar instruments, (c) all
obligations of such Person under conditional sale or other title retention
agreements relating to property purchased by such Person, (d) all
Indebtedness of others secured by (or for which the holder of such
Indebtedness has an existing right, contingent or otherwise, to be
secured by) any lien or security interest on property owned or acquired by
such Person, whether or not the obligations secured thereby have been
assumed, (e) all guarantees by such Person and (f) any agreement to incur any
of the same. For the avoidance of doubt, Indebtedness shall not include
Taxes.

  



  

1.90 " _Indemnification Agreements_ " has the meaning set forth in _Section
8.7(f)_.

  



  

1.91 " _Insured Parties_ " has the meaning set forth in _Section 8.7(a)_.

  



    

13

 



    



  

1.92 " _Intellectual Property Right_ " means all intellectual property and
industrial property rights and rights in confidential information of every
kind and description throughout the world, including all U.S. and foreign (a)
trademarks, service marks, names, corporate names, trade names, domain names,
URLs, logos, slogans, trade dress, design rights, and other similar
designations of source or origin, together with the goodwill symbolized by
any of the foregoing (" _Trademarks_ "), (b) patents and patent applications,
including any provisionals, non-provisionals, continuations, continuations-in-
part, divisionals, reissues, re-examinations, substitutions and extensions
thereof, and any invention disclosures (" _Patents_ "), (c) copyrights,
copyrightable materials, copyright registration, applications for copyright
registration, and copyrightable subject matter (" _Copyrights_ "), (d) rights
in software programs (whether in source code, object code, or other form),
algorithms, databases, compilations and data, technology supporting the
foregoing, and all documentation, including user manuals and training
materials, related to any of the foregoing (" _Software_ "), (e) trade
secrets and all other confidential information, ideas, know-how,
inventions, proprietary processes, formulas, models and methodologies ("
_Trade Secrets_ "), (f) all rights in the foregoing and in other similar
intangible assets and (g) all applications and registrations, and any
renewals, extensions and reversions, for the foregoing.

  



  

1.93 " _Interim Period_ " has the meaning set forth in _Section 6.1_.

  



  

1.94  " _IPO_ " means the initial public offering of the Purchaser pursuant
to a prospectus dated July 2, 2020.

  



  

1.95 " _IRS_ " means the U.S. Internal Revenue Service.

  



  

1.96 " _Key Company Employee_ " has the meaning set forth in _Section
11.11(g)_.

  



  

1.97 " _Law_ " means any domestic or foreign, federal, state, municipality or
local law, statute, ordinance, code, rule, regulation, legislation, principle
of common law, edict, decree, treaty, or Order that is or has been issued,
enacted, adopted, passed, approved, promulgated, made, implemented or
otherwise put into effect by or under the authority of any Authority.

  



  

1.98 " _Leases_ " means the leases set forth on _Schedule 4.22_ of the
Disclosure Schedule, together with all fixtures and improvements erected on
the premises leased thereby.

  



  

1.99 " _Letter of Transmittal_ " has the meaning set forth in _Section
3.2(b)_.

  



  

1.100 " _Lien_ " means, with respect to any property or asset, any mortgage,
lien, pledge, charge, security interest or encumbrance of any kind in respect
of such property or asset, and any conditional sale or voting agreement or
proxy, including any agreement to give any of the foregoing.

  



    

14

 



    



  

1.101 " _Material Adverse Effect_ " means a material adverse change or a
material adverse effect, individually or in the aggregate, upon on the
assets, financial condition, business or operations of the Company Group,
taken as a whole; provided, however, that none of the following shall be
deemed in and of themselves, either alone or in combination, to constitute,
and none of the following shall be taken into account in determining whether
there is, or would reasonably likely to be, a Material Adverse Effect on
the Company Group: (i) any event, occurrence, violation, inaccuracy,
circumstance or other matter directly resulting from the announcement or
pendency of the Transactions (other than for purposes of any representation or
warranty contained in _Section 4.4_ but subject to disclosures in _Schedule
4.4_ of the Disclosure Schedule); (ii) any event, occurrence, circumstance,
change or effect in the industries in which the Company Group operates or in
the economy generally or other general business, economic, currency,
financial or market conditions, except to the extent that the Company Group is
adversely affected materially disproportionately relative to the other
participants in such industries or the economy generally, as applicable; (iii)
any event, circumstance, change or effect arising directly or indirectly from
or otherwise relating to any act of terrorism, war, national or international
calamity, pandemic (including the COVID-19 pandemic), epidemic, earthquake,
hurricane, tsunami, tornado, flood, mudslide, wild fire or other natural
disaster, act of God or other force majeure event or any other similar event,
except to the extent that such event, circumstance, change or effect
materially disproportionately affects the Company Group relative to other
participants in the industries in which the Company Group operates or the
economy generally, as applicable; (iv) the failure of the Company to meet
internal expectations or projections or the results of operations of the
Company Group; (v) any event, occurrence, circumstance, change or effect
resulting or arising from the Purchaser's material breach of this Agreement
that is not subsequently cured within 30 days; (vi) any event, occurrence,
circumstance, change or effect arising directly or indirectly from or
otherwise relating to any change in, or any compliance with or action taken
for the purpose of complying with, any Law (including COVID-19 Measures) or
GAAP; (vii) the compliance with the express terms of this Agreement, or
(viii) any matters disclosed in the Registration Statement; it being
understood that the exception in clause "(iv)" shall not prevent or otherwise
affect a determination that the underlying cause of any such decline or
failure referred to therein (if not otherwise falling within any of the
exceptions provided by clauses "(i)" through "(iii)" or "(v)" through
"(viii)" hereof) is or would be reasonably likely to be a Material Adverse
Effect.

  



  

1.102 " _Material Contracts_ " has the meaning set forth in _Section
4.14(a)_.

  



  

1.103 " _Merger_ " has the meaning set forth in the Recitals.

  



  

1.104 " _Merger Sub_ " has the meaning set forth in the Preamble.

  



  

1.105 " _Merger Sub Common Stock_ " has the meaning set forth in _Section
5.6(c)_.

  



  

1.106 " _New Plans_ " has the meaning set forth in _Section 8.11(a)_.

  



  

1.107 " _Non-Recourse Party_ " means, with respect to a Party, any of such
Party's former, current and future equity holders, controlling persons,
directors, officers, employees, agents, representatives, Affiliates, members,
managers, general or limited partners, or assignees (or any former, current
or future equity holder, controlling person, director, officer, employee,
agent, representative, Affiliate, member, manager, general or limited
partner, or assignee of any of the foregoing); _provided_ that for the
avoidance of doubt, no Party will be considered a Non-Recourse Party.

  



  

1.108  " _NYSE_ " means the New York Stock Exchange.

  



  

1.109 " _NYSE Listing Application_ " has the meaning set forth in _Section
6.4_.

  



  

1.110 " _OFAC_ " has the meaning set forth in _Section 4.17(c)_.

  



    

15

 



    



  

1.111 " _Offer Documents_ " has the meaning set forth in _Section 8.1(a)_.

  



  

1.112 " _Old Plans_ " has the meaning set forth in _Section 8.11(a)_.

  



  

1.113 " _Order_ " means any decree, order, judgment, writ, award, injunction,
rule or consent of or by an Authority.

  



  

1.114 " _Ordinary Course of Business_ " means, at any given time, the
ordinary and usual course of operations of the business of the Company and
its Subsidiaries (as applicable), consistent with past practice, subject to
any reasonable changes required to address any then current facts and
circumstances (including requirements to comply with applicable Law) and, in
the case of an action taken by the Company or its Subsidiaries, a COVID-19
Response Measure taken to reasonably preserve the health and safety of current
Company Employees and independent contractors of the Company who are natural
persons).

  



  

1.115 " _Outside Closing Date_ " has the meaning set forth in _Section
10.1(a)_.

  



  

1.116 " _Party_ " has the meaning set forth in the Preamble.

  



  

1.117 " _Per Share Merger Consideration_ " means, (a) with respect to shares
of Company Class A Common Stock and shares of Company Series A Preferred
Stock issued and outstanding immediately prior to the Effective Time, the
right to receive the number of shares of the Purchaser Class A Common Stock
set forth in _Section 3.1(a)(i)_ and (b) with respect to shares of Company
Class B Common Stock issued and outstanding immediately prior to the
Effective Time, the right to receive the number of shares of the
Purchaser Class B Common Stock set forth in _Section 3.1(a)(ii)_.

  



  

1.118 " _Permits_ " has the meaning set forth in _Section 4.16_.

  



  

1.119 " _Permitted Liens_ " means (a) all defects, exceptions, restrictions,
easements, rights of way and encumbrances affecting Real Property that are
not, individually or in the aggregate material to the Business; (b)
mechanics', carriers', workers', repairers' and similar statutory Liens
arising or incurred in the Ordinary Course of Business for amounts (i) that
are not delinquent, (ii) that are not material to the business, operations
and financial condition of the Company so encumbered, either individually or
in the aggregate, and (iii) not resulting from a breach, default or violation
by the Company Group of any Contract or Law; (c) liens for Taxes or
assessments and similar governmental charges or levies, which either are (i)
not delinquent or (ii) being contested in good faith and by appropriate
proceedings, and adequate reserves have been established with respect
thereto; (d) non-exclusive licenses of Intellectual Property Rights (other
than with respect to Patents or Trade Secrets) granted in the Ordinary Course
of Business consistent with past practice; (e) other liens arising in the
Ordinary Course of Business and not incurred in connection and on a basis
consistent with past practice in connection with workers' compensation,
unemployment insurance or other types of social security; (f) other liens
that that do not, individually or in the aggregate, materially impair the
use, occupancy or value of the applicable assets of the Company Group; and
(g) the Liens set forth on _Schedule 1(b)_.

  



  

1.120 " _Person_ " means an individual, corporation, partnership (including a
general partnership, limited partnership or limited liability
partnership), limited liability company, association, trust or other entity
or organization, including a government, domestic or foreign, or political
subdivision thereof, or an agency or instrumentality thereof.

  



    

16

 



    



  

1.121 " _Personal Information_ " means data or information that identifies or
can identify a particular natural person and includes "personal data",
"protected health information", "personally identifiable information",
"personal information" or similar terms under applicable Law.

  



  

1.122 " _PIPE Investment_ " has the meaning set forth in the Recitals.

  



  

1.123 " _PIPE Investment Amount_ " has the meaning set forth in _Section
5.23(a)_.

  



  

1.124 " _PIPE Investor_ " means an investor party to a Subscription
Agreement.

  



  

1.125 " _Plan_ " means each "employee benefit plan" (as defined in Section
3(3) of ERISA), bonus, deferred compensation, equity-based or non-equity-
based incentive, employment, severance or other material plan or agreement
relating to employee or director employment, compensation or benefits.

  



  

1.126 " _Pre-Closing Recapitalization_ " has the meaning set forth in
_Section 2.4._

  



  

1.127 " _Prior Company Counsel_ " has the meaning set forth in _Section
11.17(a)_.

  



  

1.128 " _Prior Purchaser Counsel_ " has the meaning set forth in _Section
11.17(a)_.

  



  

1.129 " _Privileged Company Deal Communications_ " has the meaning set forth
in _Section 11.17(c)_.

  



  

1.130 " _Privileged Purchaser Deal Communications_ " has the meaning set
forth in _Section 11.17(c)_.

  



  

1.131 " _Prospectus_ " has the meaning set forth in _Section 11.13_.

  



  

1.132 " _Purchase Plan_ " has the meaning set forth in _Section 8.10_.

  



  

1.133 " _Purchaser_ " has the meaning set forth in the Preamble.

  



  

1.134 " _Purchaser  Advised Parties_" has the meaning set forth in _Section
11.17(b)_.

  



  

1.135 " _Purchaser Board_ " has the meaning set forth in _Section 5.10_.

  



  

1.136 " _Purchaser Board Recommendation_ " has the meaning set forth in
_Section 5.10_.

  



  

1.137 " _Purchaser Bylaws_ " has the meaning set forth in the Recitals.

  



  

1.138 " _Purchaser Charter_ " has the meaning set forth in the Recitals.

  



    

17

 



    



  

1.139 " _Purchaser Charter Amendment_ " has the meaning set forth in _Section
8.1(a)_.

  



  

1.140 " _Purchaser Class A Common Stock_ " means the Class A common stock,
par value $0.0001 per share, of the Purchaser.

  



  

1.141 " _Purchaser Class B Common Stock_ " means the Class B common stock,
par value $0.0001 per share, of the Purchaser following amendment and
restatement of the Purchaser Charter.

  



  

1.142 " _Purchaser Common Stock_ " means the Purchaser Class A Common Stock
and the Purchaser Class B Common Stock.

  



  

1.143 " _Purchaser  Deal Communications_" has the meaning set forth in
_Section 11.17(c)_.

  



  

1.144 " _Purchaser D andO Policy_" has the meaning set forth in _Section
8.7(b)_.

  



  

1.145 " _Purchaser Financials_ " has the meaning set forth in _Section
5.11(b)_.

  



  

1.146 " _Purchaser  Insured Parties_" has the meaning set forth in _Section
8.7(b)_.

  



  

1.147 " _Purchaser Material Adverse Effect_ " means (a) a material adverse
change or a material adverse effect, individually or in the aggregate, upon
on the assets, financial condition, business or operations of the Purchaser,
taken as a whole, or (b) any effect, change, event or occurrence that would
individually or in the aggregate, prevent, materially delay or materially
impair the ability of the Purchaser to consummate the Transactions.

  



  

1.148 " _Purchaser Material Contract_ " has the meaning set forth in _Section
5.18(a)_.

  



  

1.149 " _Purchaser Preferred Stock_ " means the preferred stock, par value
$0.0001 per share, of the Purchaser.

  



  

1.150 " _Purchaser Private Warrant_ " means each redeemable warrant issued in
the private placement at the time of the consummation of the IPO, entitling
the holder thereof to purchase one-third (1/3) of one (1) share of the
Purchaser Common Stock at an exercise price of $11.50 per share.

  



  

1.151 " _Purchaser Public Warrant_ " means each redeemable warrant that was
included as part of each Purchaser Unit in the IPO, entitling the holder
thereof to purchase one-third (1/3) of one share of the Purchaser Common Stock
at an exercise price of $11.50 per share.

  



  

1.152 " _Purchaser SEC Documents_ " has the meaning set forth in _Section
5.11(a)_.

  



  

1.153 " _Purchaser Securities_ " has the meaning set forth in _Section 5.9_.

  



    

18

 



    



  

1.154 " _Purchaser Stockholder Approval_ " has the meaning set forth in
_Section 8.2(a)_.

  



  

1.155 " _Purchaser Stockholder Matters_ " has the meaning set forth in
_Section 8.1(a)_.

  



  

1.156 " _Purchaser Stockholder Meeting_ " has the meaning set forth in
_Section 8.2(a)_.

  



  

1.157 " _Purchaser Unit_ " means a unit of the Purchaser comprised of (a) one
share of the Purchaser Common Stock, and (b) one (1) redeemable warrant to
purchase one-third (1/3) of one (1) share of the Purchaser Common Stock at an
exercise price of $11.50 per share.

  



  

1.158 " _Purchaser Warrants_ " means the Purchaser Private Warrants and the
Purchaser Public Warrants.

  



  

1.159 " _Real Property_ " means, collectively, all real properties and
interests therein (including the right to use), together with all buildings,
fixtures, trade fixtures, plant and other improvements located thereon or
attached thereto; all rights arising out of use thereof (including air,
water, oil and mineral rights); and all subleases, franchises, licenses,
permits, easements and rights-of-way which are appurtenant thereto.

  



  

1.160 " _Redemptions_ " has the meaning set forth in _Section 1.10_.

  



  

1.161 " _Registered Company IP_ " means all Company IP that is (a) owned,
exclusively licensed to, or purported to be owned by or exclusively licensed
to, a member of the Company Group and (b) registered, filed or issued under
the authority of any Authority, including all Patents, registered Copyrights,
registered Trademarks, domain names, and all applications for registration of
any of the foregoing.

  



  

1.162 " _Registration Rights Agreement_ " means the agreement between the
Purchaser and certain Stockholders to be entered into on or prior to the
Closing in a form that is mutually acceptable to the Company and the
Purchaser.

  



  

1.163 " _Registration Statement_ " means the Registration Statement on Form
S-4, or another appropriate form, including any pre-effective or post-
effective amendments or supplements thereto, to be filed with the SEC by the
Purchaser under the Securities Act with respect to the shares of the
Purchaser Common Stock to be issued to stockholders of the Company pursuant to
this Agreement.

  



  

1.164 " _Rejection Recommendation_ " has the meaning set forth in _Section
1.192_.

  



  

1.165 " _Representatives_ " means, collectively, with respect to any Person,
such Person's officers, directors, Affiliates, employees, agents or
advisors, including any investment banker, broker, attorney, accountant,
consultant or other authorized representative of such Person.

  



    

19

 



    



  

1.166 " _Sarbanes-Oxley Act_ " means the Sarbanes-Oxley Act of 2002, as
amended.

  



  

1.167 " _SEC_ " means the U.S. Securities and Exchange Commission.

  



  

1.168 " _Section 16_ " has the meaning set forth in _Section 6.6_.

  



  

1.169 " _Securities Act_ " means the Securities Act of 1933, as amended.

  



  

1.170 " _Sponsor_ " has the meaning set forth in the Recitals.

  



  

1.171 " _Sponsor and Founder Lock-Up Agreement_ " has the meaning set forth
in the Recitals.

  



  

1.172 " _Sponsor Support Agreement_ " has the meaning set forth in the
Recitals.

  



  

1.173 " _Standard Contracts_ " means (a) "shrink wrap" or other licenses for
generally commercially available software (including open source software) or
hosted services and (b) Contracts with the employees or contractors of a
member of the Company Group substantially on the Company Group's standard
forms.

  



  

1.174 " _Stockholder Lock-Up Agreement_ " has the meaning set forth in the
Recitals.

  



  

1.175 " _Stockholder Support Agreement_ " has the meaning set forth in the
Recitals.

  



  

1.176 " _Stockholders_ " has the meaning set forth in the Recitals.

  



  

1.177 " _Subscription Agreement_ " has the meaning set forth in the Recitals.

  



  

1.178  " _Subsidiary_ " means each entity of which at least fifty percent
(50%) of the capital stock or other equity or voting securities are
Controlled or owned, directly or indirectly, by the Company.

  



  

1.179 " _Support Agreements_ " means collectively, the Stockholder Support
Agreements and the Sponsor Support Agreements.

  



  

1.180 " _Surviving Corporation_ " has the meaning set forth in the Recitals.

  



  

1.181 " _Target Share Amount_ " means one-hundred fifty million
(150,000,000).

  



  

1.182 " _Tax Return_ " means any return, information return, declaration,
claim for refund or credit, report or any similar statement, and any
amendment thereto, including any attached schedule and supporting information,
whether on a separate, consolidated, combined, unitary or other basis, that
is filed or required to be filed with any Taxing Authority in connection with
the determination, assessment, collection or payment of a Tax or the
administration of any Law relating to any Tax.

  



    

20

 



    



  

1.183 " _Tax(es)_ " means any federal, state, local or foreign tax, charge,
fee, levy, custom, duty, deficiency, or other assessment in the nature of a
tax imposed by any Taxing Authority (including any income (net or gross),
gross receipts, profits, windfall profit, sales, use, goods and services, ad
valorem, franchise, license, withholding, employment, social security, workers
compensation, unemployment compensation, employment, payroll, transfer,
excise, import, real property, personal property, intangible property,
occupancy, recording, minimum, alternative minimum, environmental or
estimated tax), together with any interest, penalty, additions to tax or
additional amount imposed with respect thereto.

  



  

1.184 " _Taxing Authority_ " means the IRS and any other Authority
responsible for the administration, imposition, regulation,
enforcement, assessment, determination or collection of any Tax.

  



  

1.185 " _Transaction Expenses_ " of a Person means, without duplication, the
aggregate expenses, fees and disbursements of all attorneys, accountants and
investment bankers for which a Person is liable in connection with the
negotiation, execution, delivery and performance of this Agreement through
the Closing that remain unpaid or outstanding as of the Closing. Except for
the repayment of any loans to Sponsor, none of the Purchaser, the Purchaser's
equityholders, Sponsor or any of their Affiliates shall receive any
transaction, monitoring, management or other fees in connection with the
Transactions.

  



  

1.186 " _Transaction Litigation_ " shall have the meaning set forth in
_Section 7.2(c)_.

  



  

1.187 " _Transaction Securities_ " means the shares of the Purchaser Common
Stock issued as consideration for the Merger, shares of the Purchaser Class A
Common Stock issued pursuant to the Subscription Agreements, and the shares of
the Purchaser Class A Common Stock issued pursuant to the Forward Purchase
Agreement.

  



  

1.188 " _Transactions_ " means the transactions contemplated by this
Agreement, including the Merger, and the Additional Agreements.

  



  

1.189 " _Transfer Agent Cancellation_ " shall have the meaning set forth in
_Section 3.2(b)_.

  



  

1.190 " _Transfer Taxes_ " means all transfer, documentary, sales, use,
stamp, registration, value-added (to the extent irrecoverable), excise, stock
transfer, filing, real property transfer, recording, and other similar Taxes
and fees (including any penalties and interest) applicable to or incurred in
connection with the Transactions.

  



    

21

 



    



  

1.191  " _Triggering Event_ " shall be deemed to have occurred if: (a) a
Change of Recommendation shall have been effected or occurred for any reason;
(b) the Purchaser shall have failed to convene or hold the Purchaser
Stockholder Meeting in accordance with _Section 8.2_; (c) the Purchaser or
the Company shall have breached any of the provisions of _Section 6.7_ in
any material respect; (d) the Purchaser Board fails to reaffirm the
Purchaser Board Recommendation within 10 Business Days after the Company
requests in writing that such recommendation be reaffirmed in response to an
Acquisition Proposal or material modification to an Acquisition Proposal that
has been publicly announced or otherwise becomes publicly known (or if such
request is delivered less than 10 Business Days prior to the Purchaser
Stockholder Meeting, no later than one (1) Business Day prior to the
Purchaser Stockholder Meeting; _provided_ that if such Acquisition Proposal is
subsequently modified within such period, then the Purchaser Board shall be
required to reaffirm such recommendation no later than one (1) Business Day
prior to the Purchaser Stockholder Meeting); or (e) a tender or exchange offer
relating to securities of the Purchaser shall have been commenced by a Person
unaffiliated with the Company and the Purchaser fails to send to its
stockholders pursuant to Rule 14e-2 promulgated under the Securities Act,
within 10 Business Days after such tender or exchange offer is first
published, sent or given, a statement disclosing that the Purchaser
unconditionally recommends rejection of such tender or exchange offer (the "
_Rejection Recommendation_ ") and reaffirms the Purchaser Board
Recommendation or fails to reaffirm the Rejection Recommendation in any press
release published by the Purchaser (or by any of its Affiliates or
Representatives) or in any Schedule 14D-9 filed by the Purchaser with the SEC,
in each case relating to such tender offer or exchange offer, at any time
after the foregoing 10 Business Day period.

  



  

1.192 " _Trust Account_ " has the meaning set forth in _Section 5.8_.

  



  

1.193 " _Trust Agreement_ " has the meaning set forth in _Section 5.8_.

  



  

1.194 " _Trust Fund_ " has the meaning set forth in _Section 5.8_.

  



  

1.195 " _Trustee_ " has the meaning set forth in _Section 5.8_.

  



  

1.196 " _Unaudited Financial Statements_ " has the meaning set forth in
_Section 4.10(a)_.

  



  

1.197 " _Written Consent_ " has the meaning set forth in _Section 8.4_.

  



  

1.198 " _10% Owner_ " has the meaning set forth in _Section 1.51_.

  



  

Article II _ 
 THE MERGER_

  



  

2.1 _The Merger_. At the Effective Time, on the terms and subject to the
conditions set forth herein and in accordance with the applicable provisions
of the DGCL, Merger Sub and the Company shall consummate the Merger,
following which the separate corporate existence of Merger Sub shall
cease and the Company shall continue as the Surviving Corporation after the
Merger and as a direct, wholly owned subsidiary of the Purchaser.

  



  

2.2 _Effective Time_. On the terms and subject to the conditions set forth
herein, on the Closing Date, the Company and Merger Sub shall cause the Merger
to be consummated by filing the certificate of merger in substantially the
form of _Exhibit H_ attached hereto (the " _Certificate of Merger_ ") with
the Secretary of State of the State of Delaware in accordance with the
applicable provisions of the DGCL (the time of such filing, or such later
time as may be agreed in writing by the Company and the Purchaser and
specified in the Certificate of Merger, being the " _Effective Time_ ").

  



    

22

 



    



  

2.3 _Effect of the Merger_. At the Effective Time, the effect of the Merger
shall be as provided in this Agreement, the Certificate of Merger and the
applicable provisions of the DGCL. Without limiting the generality of the
foregoing, and subject thereto, at the Effective Time, all the property,
rights, privileges, agreements, powers and franchises, debts, liabilities,
duties and obligations of Merger Sub and the Company shall become the
property, rights, privileges, agreements, powers and franchises, debts,
liabilities, duties and obligations of the Surviving Corporation, which shall
include the assumption by the Surviving Corporation of any and all agreements,
covenants, duties and obligations of Merger Sub and the Company set forth in
this Agreement to be performed after the Effective Time.

  



  

2.4 _Pre-Closing Recapitalization_. At any time prior to the Closing Date,
without breach of any representation, warranty, covenant or agreement of the
Company under this Agreement and notwithstanding anything to the contrary
contained herein, the Company and the Founder shall be permitted to (i) file
an amended and restated certificate of incorporation in the form of _Exhibit
I_ attached hereto (the " _New Company Certificate of Incorporation_ "),
pursuant to which, among other things, each existing share of Company
Common Stock held by any Stockholder as of immediately prior to such
recapitalization will be exchanged for one (1) new share of Company Class A
Common Stock, (ii) effect the transactions contemplated by the Share Exchange
Agreement dated as of October 5, 2020 between the Company and the Founder, a
copy of which is attached hereto as _Exhibit J_ (or if so determined by the
Company and the Founder, effect such transactions with respect to a portion
of the Founder's existing shares), pursuant to which existing shares of
Company Common Stock and/or Company Series A Preferred Stock held by the
Founder as of immediately prior to such transactions will be exchanged for
new shares of Company Class B Common Stock, and (iii) effect the conversion of
any or all of the shares of Company Class B Common Stock held by the Founder
as a result of such transactions into shares of Company Class A Common
Stock in accordance with the provisions of the New Company Certificate of
Incorporation (the " _Pre-Closing Recapitalization_ ").

  



  

2.5 _Governing Documents_.

  



  

(a) Subject to _Section 8.7_, at the Effective Time, the certificate of
incorporation and bylaws of the Surviving Corporation shall be amended to
read the same as the certificate of incorporation and bylaws of Merger Sub as
in effect immediately prior to the Effective Time, except that the name of
the Surviving Corporation shall be "Nuvation Bio Inc.".

  



  

(b) At the Closing, the Purchaser shall amend and restate, immediately prior
to the Effective Time, its certificate of incorporation to be substantially
in the form of _Exhibit A_ attached hereto, pursuant to which the Purchaser
shall have a dual class structure consisting of Company Class A Common Stock
and Company Class B Common Stock.

  



  

2.6 _Closing_. Unless this Agreement is earlier terminated in accordance
with _Article 9.3(g)_, the closing of the Transactions (the " _Closing_
") (a) electronically by the mutual exchange of electronic signatures
(including portable document format (.PDF)) commencing as promptly as
practicable (and in any event no later than 10:00 a.m. Eastern Time on the
third (3rd) Business Day) following the satisfaction or, to the extent
permitted by applicable Law, waiver of the conditions set forth in _Article
IX_ other than those conditions that by their terms or nature are to be
satisfied at the Closing; _provided_ that such conditions are satisfied or, to
the extent permitted by applicable Law, waived at the Closing) or (b) at such
other place, time or date as the Purchaser and the Company may mutually agree
in writing. The date on which the Closing actually occurs is hereinafter
referred to as the " _Closing Date_ ".

  



    

23

 



    



  

2.7 _Payment of Expenses_.

  



  

(a) No later than two (2) Business Days prior to the Closing Date, the
Company shall provide to the Purchaser a written report setting forth a list
of all of the Company's Transaction Expenses as of the Closing Date. On the
Closing Date at or following the Closing, the Purchaser shall pay or cause to
be paid by wire transfer of immediately available funds all such Transaction
Expenses. For the avoidance of doubt, the Company's outstanding Transaction
Expenses shall not include any fees and expenses of the Stockholders.

  



  

(b) No later than two (2) Business Days prior to the Closing Date, the
Purchaser shall provide to the Company a written report setting forth a list
of all of the Purchaser's Transaction Expenses as of the Closing Date. On the
Closing Date at or following the Closing, the Purchaser shall pay or cause to
be paid by wire transfer of immediately available funds all such Transaction
Expenses.

  



  

2.8 _Directors and Officers of the Surviving Corporation_. The Parties shall
take all actions necessary such that immediately after the Effective Time, the
board of directors and officers of the Surviving Corporation shall be the
directors and executive officers set forth on _Schedule 2.8_.

  



  

2.9 _Taking of Necessary Action; Further Action_. If, at any time after the
Effective Time, any further action is necessary or desirable to carry out the
purposes of this Agreement and to vest the Surviving Corporation following
the Merger with full right, title and possession to all assets, property,
rights, privileges, powers and franchises of the Company and Merger Sub, the
applicable directors and officers of the Company and Merger Sub (or their
designees) are fully authorized in the name of their respective
corporations/companies or otherwise to take, and will take, all such lawful
and necessary action, so long as such action is not inconsistent with this
Agreement.

  



  

Article III _ 
 CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES_

  



  

3.1 _Conversion of Securities; Assumption of Company Options_.

  



  

(a)  At the Effective Time, by virtue of the Merger and without any action on
the part of the Purchaser, Merger Sub, the Company or the holders of any of
the following securities:

  



  

(i) each share of Company Class A Common Stock and each share of Company
Series A Preferred Stock issued and outstanding immediately prior to the
Effective Time shall be canceled and converted into the right to receive the
number of shares of the Purchaser Class A Common Stock equal to the Exchange
Ratio;

  



    

24

 



    



  

(ii) each share of Company Class B Common Stock issued and outstanding
immediately prior to the Effective Time shall be canceled and converted into
the right to receive the number of shares of the Purchaser Class B Common
Stock equal to the Exchange Ratio;

  



  

(iii) any shares of Company Capital Stock held in the treasury of the Company
or owned by the Purchaser, Merger Sub or the Company immediately prior to the
Effective Time (each, an " _Excluded Share_ ") shall be canceled without any
conversion thereof and no payment or distribution shall be made with respect
thereto;

  



  

(iv) each issued and outstanding share of common stock of Merger Sub shall be
converted into and become one (1) validly issued, fully paid and
nonassessable share of common stock, par value $0.0001 per share, of the
Surviving Corporation, which shall constitute the only outstanding shares of
capital stock of the Surviving Corporation. From and after the Effective Time,
all certificates representing the common stock of Merger Sub shall be deemed
for all purposes to represent the number of shares of common stock of the
Surviving Corporation into which they were converted in accordance with the
immediately preceding sentence; and

  



  

(v) each option to purchase Company Class A Common Stock (each, a " _Company
Option_ ") that is outstanding under the 2019 Equity Incentive Plan
immediately prior to the Closing, whether vested or unvested, shall
be assumed by the Purchaser and converted into an option to purchase shares
of the Purchaser Class A Common Stock (each, a " _Converted Option_ ") equal
to the product (rounded down to the nearest whole number) of (a) the number of
shares of Company Common Stock subject to such Company Option immediately
prior to the Effective Time and (b) the Exchange Ratio, at an exercise price
per share (rounded up to the nearest whole cent) equal to (i) the exercise
price per share of such Company Option immediately prior to the Effective
Time divided by (ii) the Exchange Ratio; _provided_ , _however_ , that the
exercise price and the number of shares of the Purchaser Common Stock
purchasable pursuant to the Converted Options shall be determined in a manner
consistent with the requirements of Section 409A of the Code; _provided_ ,
_further_ , _however_ , that in the case of any Converted Option to which
Section 422 of the Code applies, the exercise price and the number of shares
of the Purchaser Common Stock purchasable pursuant to such option shall be
determined in accordance with the foregoing, subject to such adjustments in a
manner consistent with Treasury Regulation Section 1.424-1, such that the
Converted Option will not constitute a modification of such Company
Option for purposes of Section 409A or Section 424 of the Code. Except as
specifically provided above, following the Effective Time, each Converted
Option shall continue to be governed by the same terms and conditions
(including vesting and exercisability terms) as were applicable to the
corresponding former Company Option immediately prior to the Effective Time.
At or prior to the Effective Time, the Company shall take any actions that
are necessary to effectuate the treatment of the Company Options pursuant to
this subsection.

  



  

(b) For purposes of calculating the aggregate amount of shares of the
Purchaser Class A Common Stock or the Purchaser Class B Common Stock, as the
case may be, issuable to each holder of shares of Company Capital Stock
pursuant to the terms of this _Section 3.1_ , all shares of Company Class A
Common Stock, Company Class B Company Stock and all shares of Company Series A
Preferred Stock held by such holder shall be aggregated amongst themselves,
and the aggregate number of shares of the Purchaser Class A Common Stock or
the Purchaser Class B Common Stock, as the case may be, to be issued in
respect of such aggregate number of shares held by such holder shall be
rounded down to the nearest whole number.

  



    

25

 



    



  

(c) At the Closing, the Purchaser shall assume all of the obligations of the
Company under the 2019 Equity Incentive Plan in respect of Company Options,
and shall, subject to and in accordance with _Section 3.1(a)(v)_ , assume such
outstanding awards and the obligations under the agreements evidencing such
awards. The Purchaser shall take all corporate action necessary to reserve
for issuance a number of authorized but unissued shares of the Purchaser
Class A Common Stock for delivery upon settlement of the assumed Company
Options in accordance with _Section 3.1(a)(v)_. Once permitted by applicable
Law, the Purchaser shall file or otherwise have available a registration
statement on Form S-8 with respect to the shares of the Purchaser Class A
Common Stock subject to the assumed Company Options to the extent available
for registration on Form S-8.

  



  

3.2 _Exchange of Certificates_.

  



  

(a) _Exchange Agent_. On the Closing Date, the Purchaser shall deposit, or
shall cause to be deposited, with a bank or trust company that shall be
designated by the Purchaser and is reasonably satisfactory to the Company (the
" _Exchange Agent_ "), (i) for the benefit of the holders of Company Class A
Common Stock and Company Series A Preferred Stock, for exchange in
accordance with this _Article III_ , the number of shares of the Purchaser
Class A Common Stock sufficient to deliver the aggregate Per Share Merger
Consideration payable with respect thereto pursuant to _Section 3.1(a)(i)_ of
this Agreement and (ii) for the benefit of the holders of Company Class B
Common Stock, for exchange in accordance with this _Article III_ , the number
of shares of the Purchaser Class B Common Stock sufficient to deliver the
aggregate Per Share Merger Consideration payable with respect thereto
pursuant to _Section 3.1(a)(ii)_ of this Agreement (such shares of the
Purchaser Class A Common Stock and the Purchaser Class B Common Stock, in
each case referred to in the preceding clauses (i) and (ii), together with any
dividends or distributions with respect thereto pursuant to _Section 3.1(c)_
, being hereinafter referred to as the " _Exchange Fund_ "). The Purchaser
shall cause the Exchange Agent pursuant to irrevocable instructions, to pay
the Per Share Merger Consideration out of the Exchange Fund in accordance
with this Agreement. Except as contemplated by _Section 3.1(c)_ , the Exchange
Fund shall not be used for any other purpose. All shares deposited hereunder
shall not be certificated.

  



    

26

 



    



  

(b) _Exchange Procedures_.

  



  

(i) As promptly as practicable after the Effective Time, the Purchaser shall
use its reasonable best efforts to cause the Exchange Agent to mail to each
holder of Company Capital Stock evidenced by certificates (the "
_Certificates_ ") entitled to receive the Per Share Merger Consideration
pursuant to _Section 3.1_ : a letter of transmittal, which shall be in a form
reasonably acceptable to the Purchaser and the Company (the " _Letter of
Transmittal_ ") and shall specify (a) that delivery shall be effected, and
risk of loss and title to the certificates evidencing such Certificates shall
pass, only upon proper delivery of the Certificates to the Exchange Agent or
confirmation of cancellation of such Certificates from the Company's
transfer agent, eShares, Inc. (DBA Carta, Inc.) (each, a " _Transfer Agent
Cancellation_ "); and (b) instructions for use in effecting the surrender of
the Certificates pursuant to the Letter of Transmittal. Within two (2)
Business Days (but in no event prior to the Effective Time) after the
surrender to the Exchange Agent of all Certificates held by such holder for
cancellation (or a Transfer Agent Cancellation), together with a Letter of
Transmittal, duly completed and validly executed in accordance with the
instructions thereto and such other documents as may be required pursuant to
such instructions, the holder of such Certificates shall be entitled to
receive in exchange therefore, and the Purchaser shall use commercially
reasonable efforts to cause the Exchange Agent to deliver, the applicable Per
Share Merger Consideration in accordance with the provisions of _Section 3.1_
, and the Certificate(s) so surrendered shall forthwith be cancelled. Until
surrendered as contemplated by this _Section 3.2_ , each Certificate entitled
to receive the applicable Per Share Merger Consideration in accordance with
_Section 3.1_ shall be deemed at all times after the Effective Time to
represent only the right to receive upon such surrender the applicable Per
Share Merger Consideration that such holder is entitled to receive in
accordance with the provisions of _Section 3.1_.

  



  

(ii) Within two (2) Business Days following receipt of a completed Letter of
Transmittal (but in no event prior to the Effective Time), the Purchaser
shall cause the Exchange Agent to deliver to each holder of Company Capital
Stock, as of immediately prior to the Effective Time, represented by book-
entry the Per Share Merger Consideration in accordance with the provisions of
_Section 3.1_ , and such Company Capital Stock shall forthwith be cancelled.

  



  

(c) _Distributions with Respect to Unexchanged Shares of the Purchaser
Common Stock_. No dividends or other distributions declared or made after the
Effective Time with respect to the Purchaser Common Stock with a record date
after the Effective Time shall be paid to the holder of any unsurrendered
Certificate with respect to the shares of the Purchaser Common Stock
represented thereby until the holder of such Certificate shall surrender such
Certificate in accordance with _Section 3.2(b)_. Subject to the effect
of escheat, tax or other applicable Laws, following surrender of any such
Certificate, the Purchaser shall use commercially reasonable efforts to pay
or cause to be paid to the holder of shares of the Purchaser Common Stock
issued in exchange therefore, without interest, (i) promptly, but in any
event within five (5) Business Days of such surrender, the amount of dividends
or other distributions with a record date after the Effective Time and
theretofore paid with respect to such shares of the Purchaser Common Stock,
and (ii) at the appropriate payment date, the amount of dividends or other
distributions, with a record date after the Effective Time but prior to
surrender and a payment date occurring after surrender, payable with respect
to such shares of the Purchaser Common Stock.

  



  

(d) _No Further Rights in Company Common Stock and Company Series A
Preferred Stock_. The Per Share Merger Consideration payable upon conversion
of the Company Capital Stock in accordance with the terms hereof shall be
deemed to have been paid and issued in full satisfaction of all rights
pertaining to such Company Capital Stock.

  



    

27

 



    



  

(e) _Adjustments to Per Share Merger Consideration_. The Per Share Merger
Consideration shall be adjusted to reflect appropriately the effect of any
stock split, reverse stock split, stock dividend, reorganization,
recapitalization, reclassification, combination, exchange of shares or other
like change with respect to the Purchaser Common Stock or the Purchaser
Preferred Stock occurring on or after the date of this Agreement and prior to
the Effective Time (but, for the avoidance of doubt, shall not be adjusted to
reflect any change in the capitalization of the Company, except to the extent
expressly set forth in the definition of "Exchange Ratio" and its
components).

  



  

(f) _Termination of Exchange Fund_. Any portion of the Exchange Fund that
remains undistributed to the holders of Company Capital Stock for one (1)
year after the Effective Time shall be delivered to the Purchaser, upon
demand, and any holders of Company Capital Stock who have not theretofore
complied with this _Section 3.2_ shall thereafter look only to the Purchaser
for the Per Share Merger Consideration. Any portion of the Exchange Fund
remaining unclaimed by holders of Company Capital Stock as of a date which is
immediately prior to such time as such amounts would otherwise escheat to or
become property of any government entity shall, to the extent permitted by
applicable law, become the property of the Purchaser free and clear of any
claims or interest of any person previously entitled thereto.

  



  

(g) _No Liability_. None of the Exchange Agent, the Purchaser or the
Surviving Corporation shall be liable to any holder of Company Capital Stock
for any such Company Capital Stock (or dividends or distributions with respect
thereto) or cash delivered to a public official pursuant to any abandoned
property, escheat or similar Law in accordance with this _Section 3.2_.

  



  

(h) _Withholding Rights_. Each of the Surviving Corporation and the
Purchaser shall be entitled to deduct and withhold from the
consideration otherwise payable pursuant to this Agreement to any holder of
Company Capital Stock such amounts as it is required to deduct and withhold
with respect to the making of such payment under the Code, or any provision of
state, local or foreign tax law. Each of the Surviving Corporation and the
Purchaser shall use commercially reasonable efforts to cooperate with any
holder of Company Capital Stock to reduce or eliminate such deduction and
withholding. To the extent that amounts are so withheld by the Surviving
Corporation or the Purchaser, as the case may be, such withheld amounts shall
be treated for all purposes of this Agreement as having been paid to the
holder of the Company Capital Stock (or intended recipients of compensatory
payments) in respect of which such deduction and withholding was made by the
Surviving Corporation or the Purchaser, as the case may be.

  



  

(i) _Lost Certificates_. If any Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact and related indemnity
by the person claiming such Certificate to be lost, stolen or destroyed (such
affidavit and indemnity to be in form and substance reasonably satisfactory
to the Purchaser and the Surviving Corporation but in any case to not require
the delivery of a bond), the Exchange Agent will issue in exchange for such
lost, stolen or destroyed Certificate, the applicable Per Share Merger
Consideration that such holder is otherwise entitled to receive pursuant to,
and in accordance with, the provisions of _Section 3.1_.

  



    

28

 



    



  

3.3 _Stock Transfer Books_. At the Effective Time, the stock transfer books
of the Company shall be closed and there shall be no further registration of
transfers of Company Capital Stock thereafter on the records of the Company.
From and after the Effective Time, the holders of Certificates representing
Company Capital Stock outstanding immediately prior to the Effective Time
shall cease to have any rights with respect to such Company Capital Stock,
except as otherwise provided in this Agreement or by Law. On or after the
Effective Time, any Certificates presented to the Exchange Agent or the
Purchaser for any reason shall be converted into the applicable Per Share
Merger Consideration in accordance with the applicable provisions of _Section
3.1_.

  



  

3.4 _Appraisal Rights_.

  



  

(a) Notwithstanding any provision of this Agreement to the contrary and to
the extent available under the DGCL, shares of Company Common Stock
and Company Series A Preferred Stock that are outstanding immediately prior
to the Effective Time and that are held by Stockholders who shall have
neither voted in favor of the Merger nor consented thereto in writing and who
shall have demanded properly in writing appraisal for such Company Common
Stock or Company Series A Preferred Stock in accordance with Section 262 of
the DGCL and otherwise complied with all of the provisions of the DGCL
relevant to the exercise and perfection of dissenters' rights shall not
be converted into, and such stockholders shall have no right to receive, the
applicable Per Share Merger Consideration unless and until such stockholder
fails to perfect or withdraws or otherwise loses his, her or its right to
appraisal and payment under the DGCL. Any stockholder of the Company who
fails to perfect or who effectively withdraws or otherwise loses his, her or
its rights to appraisal of such shares of Company Common Stock or Company
Series A Preferred Stock under Section 262 of the DGCL shall thereupon be
deemed to have been converted into, and to have become exchangeable for, as of
the Effective Time, the right to receive the applicable Per Share Merger
Consideration, without any interest thereon, upon surrender, in the manner
provided in this _Article III_ , of the Certificate or Certificates that
formerly evidenced such shares of Company Common Stock or Company Series A
Preferred Stock (as the case may be).

  



  

(b) Prior to the Closing, the Company shall give the Purchaser (i) prompt
notice of any demands for appraisal received by the Company and any
withdrawals of such demands, and (ii) the opportunity to participate in all
negotiations and proceedings with respect to demands for appraisal under the
DGCL. The Company shall not, except with the prior written consent of the
Purchaser (which consent shall not be unreasonably withheld, conditioned or
delayed), make any payment with respect to any demands for appraisal or offer
to settle or settle any such demands.

  



  

Article IV _ 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY_

  



  

Except as set forth in the Disclosure Schedule, the Company hereby represents
and warrants to the Purchaser that each of the following representations and
warranties are true, correct and complete as of the date of this Agreement
and as of the Closing Date (except to the extent expressly made as of
an earlier date, in which case such representations and warranties shall be
so true, correct and complete as of such earlier date).

  



    

29

 



    



  

4.1  _Corporate Existence and Power_. The Company is a corporation duly
incorporated, validly existing and in good standing under the Laws of the
State of Delaware. The Company has all power and authority, corporate and
otherwise, and all governmental licenses, franchises, Permits,
authorizations, consents and approvals required to own and operate its
properties and assets and to carry on the Business as presently conducted and
as proposed to be conducted. The Company is duly licensed or qualified to do
business and is in good standing in each jurisdiction in which the properties
owned or leased by it or the operation of its Business as currently conducted
makes such licensing or qualification necessary, except where the failure to
be so licensed, qualified or in good standing would not have a Material
Adverse Effect.

  



  

4.2  _Authorization_. The execution, delivery and performance by the Company
of this Agreement and the Additional Agreements to which the Company is a
party and the consummation by the Company of the Transactions are within the
corporate powers of the Company and, subject to receipt of the Company
Stockholder Approval, have been duly authorized by all necessary action on
the part of the Company. This Agreement has been duly executed and delivered
by the Company and, assuming due authorization, execution and delivery by
each other Party to this Agreement and by each other party to the Additional
Agreements, constitutes, and, upon their execution and delivery, each of the
Additional Agreements will constitute, a valid and legally binding agreement
of the Company enforceable against the Company in accordance with their
respective terms, except as may be limited by bankruptcy,
insolvency, reorganization or other similar laws affecting the enforcement of
creditors' rights generally and by general principles of equity.

  



  

4.3  _Governmental Authorization_. Except for filings under the HSR Act,
neither the execution, delivery nor performance by the Company of this
Agreement or any Additional Agreements to which the Company is a Party
requires any consent, approval, license, order or other action by or in
respect of, or registration, declaration or filing with, any Authority as a
result of the execution, delivery and performance of this Agreement or any of
the Additional Agreements or the consummation of the Transactions (each of
the foregoing, a " _Governmental Approval_ ").

  



  

4.4  _Non-Contravention_. Subject to the receipt of the Company Stockholder
Approval, none of the execution, delivery or performance by the Company of
this Agreement or any Additional Agreements does or will (a) contravene or
conflict with the organizational or constitutive documents of any member of
the Company Group, (b) contravene or conflict with or constitute a violation
of any provision of any Law or Order binding upon or applicable to the
Company Group, (c) constitute a default under or breach of (with or without
the giving of notice or the passage of time or both) or violate or give rise
to any right of termination, cancellation, amendment or acceleration of any
right or obligation of the Company Group or require any payment or
reimbursement or to a loss of any material benefit relating to the Business
to which the Company Group are entitled under any provision of any Material
Contract, (d) result in the creation or imposition of any Lien on any Company
Common Stock, or (e) result in the creation or imposition of any Lien (except
for Permitted Liens) on any of the Company Group's assets, except, in the case
of (b), (c), (d) and (e), as would not, individually or in the aggregate,
reasonably likely to have a Material Adverse Effect.

  



  

   

30

 



    



  

4.5  _Capitalization_.

  



  

(a) The Company is authorized to issue 880,000,000 shares of common stock,
par value $0.0001 per share (the " _Company Common Stock_ ") of which
400,000,000 shares are issued and outstanding as of the date hereof. The
Company is authorized to issue 360,500,000 shares of preferred stock, par
value $0.0001 per share of which 360,386,897 are issued and outstanding as of
the date hereof, all of which shares are designated as Series A Preferred
Stock (the " _Company _ _Series A Preferred Stock_"). The Company has
41,994,218 shares of Company Common Stock subject to outstanding Company
Options as of the date hereof, with another 11,737,347 shares of
Company Common Stock authorized for issuance under the 2019 Equity Incentive
Plan as of the date hereof. No Company Common Stock is held in its treasury.
All of the issued and outstanding shares of Company Common Stock and Company
Series A Preferred Stock have been duly authorized and validly issued, is
fully paid and non-assessable, have been issued and granted in compliance with
applicable securities laws and other applicable Laws, and have not been
issued in violation of any preemptive or similar rights of any Person.

  



  

(b) Immediately following the Pre-Closing Recapitalization, (i) each share of
Company Common Stock held by any Stockholder as of immediately prior to such
recapitalization shall have been exchanged for one (1) new share of Company
Class A Common Stock, following which (ii) the Founder shall have exchanged
281,130,898 shares of Company Common Stock and 12,963,780 shares of Company
Series A Preferred Stock for 294,094,678 shares of newly issued Company Class
B Common Stock. As of immediately following the Pre-Closing
Recapitalization, the Company will be authorized to issue (i) 880,000,000
shares of Company Class A Common Stock, (ii) 294,094,678 shares of
Company Class B Common Stock, of which 294,094,678 shares shall be issued and
outstanding (all of which shall be held of record by the Founder) (assuming
no exercise of Company Options), and 360,500,000 shares of Company Series A
Preferred Stock, of which 347,423,117 shares shall be issued and outstanding.
All of the issued and outstanding Company Common Stock and Company Series A
Preferred Stock shall have been duly authorized and validly issued, be fully
paid and non-assessable and shall not have been issued in violation of any
preemptive or similar rights of any Person. No outstanding Company Common
Stock or Company Series A Preferred Stock shall be subject to any right of
first refusal, right of first offer, preemptive right or similar restriction
other than as set forth in _Schedule 4.5(b)_.

  



  

(c) The only Company Common Stock that will be outstanding immediately after
the Closing will be the Company Common Stock owned by the Purchaser following
the consummation of the Merger. No other class of capital stock of the will be
authorized or outstanding at that time. After the Effective Time, all of the
shares of Company Series A Preferred Stock shall no longer be outstanding
and shall cease to exist, and each previous holder of Company Series A
Preferred Stock shall thereafter cease to have any rights with respect to
such securities. Each share of Company Series A Preferred Stock is convertible
into one (1) share of Company Series A Common Stock.

  



  

   

31

 



    



  

(d) _Schedule 4.5(d)_ sets forth, as of the date of this Agreement, the
following information with respect to each Company Option outstanding: (i)
whether the Company Option satisfies the requirements of Section 422 of the
Code; (ii) the name of the Company Option holder; (iii) whether the Company
Option holder is a Company Employee or a director of the Company; (iv) the
number of shares of Company Common Stock subject to such Company Option; (v)
the exercise price of such Company Option; (vi) the date on which such
Company Option was granted; (vii) the date on which such Company Option
expires; and (viii) the vesting schedule of the Company Option, including the
terms of any acceleration rights thereunder. The Company has prior to the date
of this Agreement made available to the Purchaser true, complete and correct
copies of the 2019 Equity Incentive Plan as in effect as of the date of this
Agreement pursuant to which the Company has granted the Company Options that
are currently outstanding and the form of all stock award
agreements evidencing such Company Options. No Company Option was granted
with an exercise price per share less than the fair market value as of the
date such Company Option was granted. All shares of the Company subject to
issuance as aforesaid, upon issuance on the terms and conditions specified in
the instruments pursuant to which they are issuable, will be duly authorized,
validly issued, fully paid and nonassessable. In addition, _Schedule 4.5(d)_
sets forth all commitments the Company has made to grant Company Options that
have not yet been granted as of the date of this Agreement, specifying: (i)
the name of the person to whom Company Options were promised by the Company;
(ii) the type of Company Option promised by the Company (i.e. whether such
Company Option is intended to satisfy the requirements of Section 422 of the
Code); and (iii) the number of each type of Company Option promised by the
Company.

  



  

(e) Immediately following the Pre-Closing Recapitalization, all of the issued
and outstanding Company Common Stock and Company Series A Preferred Stock
shall be owned of record by the Stockholders and in the amounts and classes as
set forth on _Schedule 4.5(e)_.

  



  

(f) Except as set forth in the Company's organizational documents, there are
no outstanding contractual obligations of the Company to repurchase, redeem
or otherwise acquire any shares of Company Common Stock, Company Series A
Preferred Stock or any capital equity of the Company. There are no
outstanding contractual obligations of the Company to provide funds to, or
make any investment (in the form of a loan, capital contribution or
otherwise) in, the equity of any other Person. There are no: (i) outstanding
subscriptions, options, warrants, rights (including "phantom stock rights"),
calls, commitments, understandings, conversion rights, rights of exchange,
plans or other agreements of any kind providing for the purchase, issuance or
sale of any shares of the Company or (ii) any agreement to which the Company
is a party, or to the knowledge of the Company or, any other agreements, with
respect to the Company Common Stock or Company Series A Preferred Stock,
including any voting trust, other voting agreement or proxy with respect
thereto.

  



  

(g) (i) There are no commitments or agreements of any character to which the
Company is bound obligating the Company to accelerate the vesting of any
Company Option as a result of the proposed Transactions herein and (ii) all
outstanding shares of the Company and all outstanding Company Options have
been issued and granted in compliance with (A) all applicable securities laws
and other applicable laws, (B) the terms of the 2019 Equity Incentive Plan
(if applicable) and (C) all pre-emptive rights and other requirements
set forth in applicable contracts to which the Company is a party. No
outstanding Company Common Stock is subject to any right of first refusal,
right of first offer, preemptive right or similar restriction other than as
set forth in _Schedule 4.5(b)_.

  



  

(h) Except for the shares of Company Common Stock and Company Series A
Preferred Stock held by the Stockholders and Company Options, no shares or
other equity or voting interest of the Company, or options, warrants or other
rights to acquire any such shares or other equity or voting interest, of the
Company is authorized or issued and outstanding.

  



   

32

 



    



  

4.6  _Charter Documents_. Copies of the certificate of incorporation and the
amended and restated bylaws of the Company (the " _Company Charter
Documents_") have heretofore been made available to the Purchaser, and such
copies are each true and complete copies of such instruments as amended and in
effect on the date hereof. The Company Charter Documents are in full force
and effect and the Company is not in violation of any of the provisions of
the Company Charter Documents.

  



  

4.7  _Corporate Records_. All proceedings occurring of the Company Board
since inception of the Company, including committees thereof, and all
consents to actions taken thereby, are accurately reflected in the minutes and
records contained in the corporate minute books of the Company in all
material respects, which are complete and have been maintained in accordance
with sound business practices.

  



  

4.8  _Third Parties_. Except as set forth on Schedule 4.8, to the knowledge
of the Company no Key Company Employee, is an employee of, or provides any
service for compensation to (other than as a board or advisory group member),
any other business concern. Other than offer letters for employment or
Company Option grant agreements or exercise notices, _Schedule 4.8 _lists
each Contract to which the Company, on the one hand, and any Stockholder, on
the other hand, is a party, including any such Contract pursuant to which a
Stockholder or any Affiliate of a Stockholder owns, directly or indirectly, in
whole or in part, any tangible or intangible property (including Intellectual
Property Rights) that is used or held for use by any member of the Company
Group or the use of which is necessary for the conduct of the Business or the
ownership or operation of the Company's assets. _Schedule 4.8_ sets forth a
complete and accurate list of the Affiliates of the Company and the ownership
interests in the Affiliate of the Company and each Stockholder.

  



  

4.9  _Subsidiaries_.

  



  

(a) _Schedule 4.9 _of the Disclosure Schedule sets forth each Subsidiary of
the Company on the date hereof, and, except as set forth in _Schedule
4.9_, the Company does not currently own, directly or indirectly, securities
or other ownership interests in any other entity. The Company owns 100% of
the issued and outstanding capital stock and securities of each Person listed
on _Schedule 4.9_.

  



  

(b) Each Subsidiary is a corporation or limited liability company duly
organized, validly existing and in good standing under and by virtue of the
Laws of the jurisdiction of its formation set forth by its name on _Schedule
4.9_. Each Subsidiary has all power and authority, corporate and otherwise,
required to own and operate its properties and assets and to carry on the
Business as presently conducted. Other than as would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect, each Subsidiary is duly qualified as a foreign corporation,
partnership or limited liability company, as applicable, to transact the
Business in each jurisdiction in which the character of the property owned or
leased by any Subsidiary or the nature of its activities make qualification
of such Subsidiary in any such jurisdiction necessary. No Subsidiary has
entered into any agreement in respect of any merger, consolidation, sale of
all or substantially all of its assets, reorganization,
recapitalization, dissolution or liquidation.

  



  

4.10  _Financial Statements_.

  



  

(a) True and correct copies of (i) the audited consolidated financial
statements of the Company as of December 31, 2019 and December 31, 2018 (the
" _Audited Financial Statements_ ") consisting of the audited consolidated
balance sheets as of such dates, and the audited consolidated statements of
operations, comprehensive loss, equity and cash flows for such periods and
(ii) unaudited financial statements (the " _Unaudited Financial Statements_
") from December 31, 2019 through June 30, 2020 (collectively, the "
_Financial Statements_ " and the unaudited consolidated balance sheet as of
June 30, 2020 (the " _Balance Sheet Date_ ") included therein, the " _Balance
Sheet_ "), have been provided to the Purchaser.

  



  

(b) The Financial Statements (i) were prepared in accordance with GAAP
consistently applied, (ii) comply with all applicable accounting requirements
under the Securities Act and the rules and regulations of the SEC thereunder
and (iii) fairly present in all material respects, in conformity with GAAP
applied on a consistent basis, the financial position of the Company Group as
of the dates thereof and the results of operations of the Company Group for
the periods reflected therein (subject to normal and recurring year-
end adjustments that are not, individually or in the aggregate, material).

  



  

(c) As of the date of this Agreement, the Company Group does not have any
liabilities of the type required to be disclosed in the liabilities column of
a consolidated balance sheet prepared in accordance with GAAP, except for: (i)
liabilities disclosed on the Balance Sheet; (ii) liabilities or obligations
incurred pursuant to the terms of this Agreement; (iii) liabilities for
performance of obligations of the Company Group under Contracts binding upon
the applicable member of the Company Group (other than resulting from any
breach or acceleration thereof) either delivered or made available to the
Purchaser or the Purchaser's Representatives prior to the date of this
Agreement or entered into in the Ordinary Course of Business ; (iv)
liabilities incurred in the Ordinary Course of Business since the date of the
Balance Sheet; and (v) liabilities that individually or in the aggregate have
not had and would not reasonably be expected to have a Material Adverse
Effect.

  



  

(d) The Company and each of its Subsidiaries make and keep accurate Books and
Records and maintain a system of internal accounting controls designed, and
which the Company believes is sufficient, to provide reasonable assurance
that: (i) transactions are executed in accordance with management's general
or specific authorization; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to
maintain accountability for assets; (iii) access to assets is permitted only
in accordance with management's general or specific authorization; and (iv)
the recorded accountability for assets is compared with existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences.

  



   

33

 



    



  

4.11  _Absence of Certain Changes_. Since the Balance Sheet Date through the
date of this Agreement, the Company Group has conducted the Business in the
Ordinary Course of Business. Without limiting the generality of the foregoing,
since the Balance Sheet Date through the date of this Agreement, there has
not been:

  



  

(a) any Material Adverse Effect;

  



  

(b) any declaration, setting aside or payment of any dividend on, or other
distribution in respect of, any of the Company Group's capital stock, or any
purchase, redemption or other acquisition by the Company Group of any of the
Company Group's capital stock or any other securities of the Company Group or
any options, warrants, calls or rights to acquire any such shares or
other securities;

  



  

(c) any split, combination or reclassification of any of the Company Group's
capital stock;

  



  

(d) any material change by the Company Group in its accounting methods,
principles or practices, except as required by concurrent changes in GAAP (or
any interpretation thereof) or applicable Law;

  



  

(e) any change in the auditors of the Company Group;

  



  

(f) any issuance of capital stock of the Company Group;

  



  

(g) any revaluation by the Company Group of any of its assets, including any
sale of assets of the Company Group other than in the Ordinary Course of
Business;

  



  

(h) (i) any material amendment to or termination of any Material Contract,
(ii) any material amendment to any material Permit from any Authority held by
the Company, and (iii) any receipt of notice of termination of any of the
items referenced in (i) and (ii);

  



  

(i) any material Tax election changed or revoked by the Company Group; any
claim, audit or assessment in respect of any income or other material Taxes
settled or compromised by the Company Group; or any Tax allocation agreement,
Tax sharing agreement, Tax indemnity agreement or closing agreement relating
to any Tax (other than an ordinary commercial agreement not primarily related
to Taxes) entered into by the Company Group;

  



  

(j) except as set forth on _Schedule 4.11(j)_ , any amendment to the Company
Group's organizational documents, or any engagement by the Company Group in
any merger, consolidation, reorganization, reclassification, liquidation,
dissolution or similar transaction;

  



  

(k) any action taken or agreed upon by the Company Group that would be
prohibited by _Section 6.1(a)_ if such action were taken on or after the date
hereof without the consent of the Purchaser; or

  



  

(l) any commitment or agreement to do any of the foregoing.

  



   

34

 



    



  

4.12  _Properties; Title to the Company 's Assets_. Except as would not be
individually or in the aggregate, reasonably likely to have a Material
Adverse Effect, the Company has good, valid and marketable title in and to, or
in the case of the Leases and the assets which are leased or licensed
pursuant to Contracts, a valid leasehold interest or license in or a right to
use, all of their assets reflected on the Balance Sheet. No such asset is
subject to any Liens other than Permitted Liens. Except as would not be,
individually or in the aggregate, reasonably likely to have a Material Adverse
Effect, the Company Group's assets constitute all of the assets of any kind
or description whatsoever, including goodwill, for the Company Group to
operate the Business immediately after the Closing in the same manner as the
Business is currently being conducted. This _Section 4.12 _shall not cover
Intellectual Property Rights, which is addressed in _Section 4.18_.

  



  

4.13  _Litigation_. As of the date of this Agreement, there is no Action
pending against, or to the knowledge of the Company threatened in writing
against or affecting, the Company Group, or to the knowledge of the Company,
any of its contract laboratories, contract research organizations, contract
manufacturers, officers or directors with respect to the Business, or any of
the Company's Group assets, or any Contract before any court, Authority or
official, or which in any manner challenges or seeks to prevent or enjoin the
Transactions or by the Additional Agreements. As of the date of this
Agreement, there are no outstanding judgments against the Company Group.

  



  

4.14  _Contracts_.

  



  

(a) _Schedule 4.14(a) _lists all Contracts (other than (i) Standard
Contracts, (ii) sales, purchase orders, and agreements that solely govern
the use and disclosure of confidential information entered in the Ordinary
Course of Business, or (iii) Plans, which shall be governed by _Section
4.21_) to which a member of the Company Group is a party and which are in
effect as of the date of this Agreement and constitute the following
(collectively, " _Material Contracts_ "):

  



  

(i) all Contracts that require annual cash payments to or from the Company
Group, taken as a whole, of $200,000 or more in the fiscal year ending
December 31, 2019;

  



  

(ii) all Contracts creating a joint venture, strategic alliance, limited
liability company and partnership agreements or collaboration agreements to
which a member of the Company Group is a party;

  



  

(iii) all Contracts relating to the research and development of
pharmaceutical products, including any consulting, service,
collaboration, sponsor or supplier agreements involving clinical and pre-
clinical studies, chemical analysis, biological screening, imaging, drug
formulation, process development, and the supply or storage of samples,
materials, and equipment related thereto;

  



  

(iv) all Contracts pursuant to which any member of the Company Group (1)
grants rights in or to use any Patents, except for Contracts with service
providers to which the Company grants a license solely for the purpose of
providing services to the Company, (2) receives rights in or to any
Intellectual Property Rights that is used or currently intended for use in, or
otherwise necessary to manufacture, any Company Group Product Candidates, and
(3) other than as identified in _Schedule 4.14(a)(iv)(1)-(2)_ , grants or
receives rights in or to any Intellectual Property Rights material to the
Business;

  



   

35

 



    



  

(v) all Contracts (1) pursuant to which any member of the Company Group
grants exclusive rights in or to any material Company IP or (2) materially
limiting the freedom of the Company Group to compete in any line of business
or with any Person or in any geographic area;

  



  

(vi) all Contracts providing for (a) guarantees or (b) as their primary
purpose, indemnification arrangements and other hold harmless
arrangements made or provided by the Company Group, including all ongoing
agreements for the primary purpose of indemnification or similar obligations,
other than any such Contracts entered into in the Ordinary Course of Business;

  



  

(vii) all Contracts with or pertaining to the Company Group to which any
Affiliate of the Company Group is a party, other than any
Contracts pertaining to such Affiliate's status as a Company securityholder;

  



  

(viii) all Contracts relating to property or assets (whether real or
personal, tangible or intangible) in which the Company Group holds
a leasehold interest (including the Leases) and which individually involve
payments to the lessor thereunder in excess of $100,000 per year;

  



  

(ix) all Contracts relating to outstanding Indebtedness for borrowed money,
including financial instruments of indenture or security
instruments (typically interest-bearing) such as notes, mortgages, loans and
lines of credit which involve amounts individually in excess of $100,000;

  



  

(x) any Contract relating to the voting or control of the equity interests of
the Company Group or the election of directors of the Company Group (other
than the organizational documents of the Company Group); and

  



  

(xi) any Contract providing for hedging obligations, including interest rate
or currency exchange swaps, collars, caps or similar hedging obligations, of
the Company.

  



  

(b) Each Material Contract is a valid and binding agreement, and is in full
force and effect, and neither the Company Group nor, to the knowledge of the
Company, any other party thereto, is in breach or default (whether with or
without the passage of time or the giving of notice or both) under the
material terms of any such Material Contract, and no event has occurred that
with the passage of time or giving of notice or both would constitute such a
breach or default by such other party, or permit termination or
acceleration by the Company under any Material Contract. The Company Group
has not assigned, delegated, or otherwise transferred any of its rights or
obligations with respect to any Material Contracts, or granted any power of
attorney with respect thereto or to any of the Company Group's assets.

  



  

(c) The Company has, prior to the date hereof, provided to the Purchaser true
and correct fully executed copies of each written Material Contract.

  



   

36

 



    



  

(d) The Company Group is in compliance with all material covenants, including
all financial covenants, in all notes, indentures, bonds and other
instruments or agreements evidencing any Indebtedness of the Company Group.

  



  

4.15  _Insurance_. Except as would not be material to the Company Group,
taken as a whole, the Company Group is insured by recognized, financially
sound and reputable institutions with policies in such amounts and with such
deductibles and covering such risks as are customarily carried by Persons
conducting a business similar to the Company Group, including, but not
limited to, policies covering real and personal property owned or leased by
the Company Group against theft, damage, destruction and acts of vandalism
and policies covering the Company Group for product liability claims and
clinical trial liability claims. To the knowledge of the Company, the Company
and its Subsidiaries will be able (a) to renew its existing insurance coverage
as and when such policies expire or (b) to obtain comparable coverage from
similar institutions as may be necessary or appropriate to conduct its
business as now conducted and at a cost that would not reasonably be expected
to have a Material Adverse Effect. Neither the Company nor its Subsidiaries
have been denied any insurance coverage which it has sought or for which it
has applied.

  



  

4.16  _Licenses and Permits_. As of the date of this Agreement (a) the
Company Group possesses all licenses, approvals, consents, registrations,
franchises and permits (the " _Permits_ ") that are required to own, lease or
operate its properties and assets and to conduct the Business, (b) the
Permits are valid and in full force and effect, and none of the Permits will
be terminated or impaired or become terminable as a result of the
Transactions and (c) the operation of the Business is not in
material violation of any material Permit, except where the failure to so
possess the same would not be material to the Company Group, taken as a
whole.

  



  

4.17  _Compliance with Laws_.

  



  

(a) The Company Group is not in violation of, has not violated, in each case
in any material respect, and to the knowledge of the Company, is neither
under investigation with respect to nor has been threatened in writing to be
charged with or given notice of any violation or alleged violation of, any
Law, or judgment, order or decree entered by any court, arbitrator or
Authority, domestic or foreign and since its formation, the Company Group has
not received any subpoenas from any Authority.

  



  

(b) Except as would not be material to the Company Group, taken as a whole,
without limiting the foregoing paragraph, the Company Group is not in
violation of, has not violated, and to the knowledge of the Company, is not
under investigation with respect to nor has been threatened in writing or
charged with or given notice of any violation of any provisions of:

  



  

(i) any Law applicable to the Company Group due to the specific nature of the
Business, including any Data Protection Laws and Laws applicable to lending
activities;

  



  

(ii) the Foreign Corrupt Practices Act of 1977 ( 78dd-1 et seq.), as
amended (the " _Foreign Corrupt Practices Act_ ");

  



  

(iii) any comparable or similar Law of any jurisdiction; or

  



   

37

 



    



  

(iv) any Law regulating or covering conduct in, or the nature of, the
workplace, including regarding sexual harassment or, on any
impermissible basis, a hostile work environment.

  



  

(c) Without limiting the foregoing paragraph, neither the Company Group nor,
to the knowledge of the Company, any director, officer, agent, employee,
Affiliate or Person acting on behalf of the Company is currently subject to
any U.S. sanctions administered by the Office of Foreign Assets Control of
the U.S. Treasury Department (" _OFAC_ "). The Company Group has not engaged
in transactions with, or exported any of its products or associated technical
data (i) into (or to a national or resident of) Cuba, Iran, Iraq, Libya,
North Korea, Syria or any other country to which the United States has
embargoed goods to or has proscribed economic transactions with or (ii) to the
knowledge of the Company, to any Person included on the United States
Treasury Department's list of Specially Designated Nationals or the U.S.
Commerce Department's Denied Persons List.

  



  

4.18  _Intellectual Property_.

  



  

(a) _Schedule 4.18(a)_ sets forth a true, correct and complete list of all
Registered Company IP as of the date of this Agreement, specifying as to
each, as applicable: (i) the registration or application number of such
Intellectual Property Right; (ii) the status of such Intellectual Property
Right ( _i_. _e_., whether registered or a pending application); (iii) the
owner(s) of such Intellectual Property Right; (iv) the date on which such
Intellectual Property Right was filed with the relevant Authority; and (v)
the jurisdictions by or in which such Intellectual Property Right has been
issued or registered or in which an application for such issuance or
registration has been filed.

  



  

(b) To the knowledge of the Company, the conduct of the Business does not
infringe, misappropriate, or otherwise violate, and has not infringed,
misappropriated, or otherwise violated, any Person's Intellectual Property
Rights. Since its formation, the Company Group has not been sued or charged
in writing with, or to the knowledge of the Company charged orally with, or
been a defendant in any Action that involves a claim of infringement,
misappropriation or other violation of any Intellectual Property Rights. No
member of the Company Group has received any opinion of counsel that the
planned operation of the Business (including the research, development,
manufacturing, sale or other commercialization of any Company Group Product
Candidates) will infringe, misappropriate, or otherwise violate any
Intellectual Property Right of any Person. To the knowledge of the Company, no
Person is infringing, misappropriating, or otherwise violating any Company IP
that is owned by or exclusively licensed to the Company.

  



  

(c) Any Intellectual Property Rights used by the Company Group in the
performance of any Contract (existing as of the date of this
Agreement), which are purported to be exclusively or jointly owned by any
member of the Company Group prior to initiation of such performance, will
remain exclusively or jointly owned, as applicable, by a member of the Company
Group upon the performance of such Contract by such member of the Company
Group, and, to the knowledge of the Company, no third party has any claim of
ownership with respect to any such Intellectual Property Rights, other than
any Permitted Liens.

  



   

38

 



    



  

(d) A member of the Company Group is the sole and exclusive beneficial and,
with respect to applications and registrations (including Patents), record
owner of all Company IP owned or purported to be owned by a member of the
Company Group, including all Registered Company IP set forth (or that are
obligated to be set forth) on _Schedule 4.18(a)_. All Registered Company IP is
subsisting and, except for pending applications, to the knowledge of the
Company, valid and enforceable. To the knowledge of the Company, there has
been no Action asserted or threatened challenging the ownership, scope,
validity or enforceability of any applications or registrations for Patents
or other material Intellectual Property Rights owned or purported to be owned
by a member of the Company Group, and, to the knowledge of the Company, there
are no facts, circumstances or conditions that could reasonably be expected
to form the basis for such an Action.

  



  

(e) Each employee, agent, consultant and contractor who has contributed to or
participated in the creation or development of any Company IP owned or
purported to be owned by a member of the Company Group (including Copyrights,
Patents, Trademarks, and Trade Secrets), on behalf or for the benefit of the
Company Group or any predecessor in interest thereto either: (i) is a party to
a "work-for-hire" Contract under which a member of the Company Group is
deemed to be the original owner/author of all Intellectual Property
Rights therein; or (ii) has executed a Contract in favor of a member of the
Company Group (or such predecessor in interest, as applicable) assigning to
such member of the Company Group all right, title and interest in such
Intellectual Property Rights. To the knowledge of the Company, all
compensation due under applicable Law and pursuant to such Contracts has been
paid. The Company has made available to the Purchaser all forms of Standard
Contracts other than "shrink wrap" or other licenses for generally
commercially available software (including open source software) or hosted
services.

  



  

(f) None of the execution, delivery or performance by the Company Group of
this Agreement or any of the Additional Agreements to which any member of the
Company Group is a party or the consummation by the Company Group of the
Transactions will cause any Patent or Trade Secret included in the Company IP
or any other material item of Company IP to not be owned, licensed or
available for use by the Company Group on the same terms and conditions
immediately following the Closing.

  



  

(g) The Company has taken commercially reasonable measures to safeguard and
maintain the confidentiality and value of all Trade Secrets and other items
of Intellectual Property Rights owned by or licensed to a member of the
Company Group that are confidential, including by requiring all Persons
having access thereto to execute written agreements containing obligations of
confidentiality. To the knowledge of the Company, there has not been any
disclosure of or access to any material Trade Secret included in the
Company IP to any Person in a manner that has resulted or is likely to result
in the loss of trade secret or other rights in and to such Trade Secret
(except for the filing of a patent application by a member of the Company
Group disclosing such Trade Secret).

  



  

(h) To the knowledge of the Company, no funding, facilities or personnel of
any Authority were used, directly or indirectly, to develop or create, in
whole or in part, (i) any Intellectual Property Rights owned by a member of
the Company Group that is used or currently intended for use in, or otherwise
necessary to manufacture in any material respect, any Company Group Product
Candidates or (ii) any other Company IP that is material to the Business.

  



   

39

 



    



  

(i) With respect to the use of Software in the Business, (i) no member of the
Company Group has experienced any defects in such Software that has adversely
affected the Business in any material respect and (ii) to the knowledge of the
Company, no such Software contains any device or feature designed to disrupt,
disable, or otherwise impair the functioning of any Software or any "back
door," "time bomb," "Trojan horse," "worm," "drop dead device," or other code
or routines that permit unauthorized access or the unauthorized disablement
or erasure of such Software or information or data (or all parts thereof) or
other Software of users. To the knowledge of the Company, there have been no
material security breaches in the information technology systems of the
Company Group or the information technology systems of other Persons to the
extent used by or on behalf of a member of the Company Group. There have been
no disruptions in any information technology systems that have adversely
affected the Business in any material respect.

  



  

(j) The Company Group has at all times materially complied with its own
written rules, policies and procedures relating to privacy, data protection,
and the collection, retention, protection, security, use and other processing
of Personal Information. No Action has been asserted or threatened against
any member of the Company Group alleging a violation of any Data Protection
Law and, to the knowledge of the Company, there does not exist any basis
therefor. Except as would not, individually or in the aggregate, be
reasonably likely to have a Material Adverse Effect, the Transactions will
not result in the violation of any (i) Data Protection Law or (ii) the
Company Group's written and publicly available rules, policies and procedures
relating to privacy, data protection, and the collection, retention,
protection, security, use and other processing of Personal Information.

  



  

4.19  _Employees_.

  



  

(a) As of the date of this Agreement, no director or executive officer of the
Company (i) is on leave, (ii) has given written notice of his or her intent
to terminate his or her relationship with the Company or (iii) has received
written notice of such termination from the Company. To the knowledge of the
Company, as of the date of this Agreement, no Company Employee or independent
contractor (but specifically excluding all executive officers) of the Company
that earned an aggregate amount of compensation in excess of $250,000 in the
past twelve (12) months, has communicated to Company his or her intention to
terminate his or her employment or the contractor relationship, as
applicable, with the Company.

  



  

(b) The Company is not a party to, subject to or bound by any collective
bargaining agreements or similar labor agreements. No labor union or other
collective bargaining unit represents or claims to represent any of the
Company Employees and, to the knowledge of the Company, there is no, and
since the Company's formation, there has not been any, labor organizing
activity with respect to any Company Employees or former employees of the
Company. Since the Company's formation, there has been no actual or, to the
knowledge of the Company, threatened unfair labor practice charges, material
grievances, material arbitrations, strikes, lockouts, work stoppages,
picketing, hand billing or other labor disputes against or affecting any
member of the Company Group.

  



    

40

 



    



  

(c) Except as provided on _Schedule 4.19(c)_ there are no pending or, to the
knowledge of the Company, threatened in writing, charges, claims, complaints,
demands, actions, investigations, arbitrations, mediations, litigations or
other proceedings against or otherwise involving the Company Group made by or
on behalf of any Company Employee, former employee of the Company or current
or former applicant, independent contractor or consultant of any member of
the Company Group or otherwise involving labor or employment-related matters,
in each case that has been or could be material.

  



  

(d) To the knowledge of the Company, no Company Employee is in any respect in
violation of any material term of any employment agreement, nondisclosure
agreement, common law nondisclosure obligation, fiduciary duty, non-
competition agreement, restrictive covenant or other obligation: (i) to any
member of the Company Group or (ii) to a former employer of any such employee
relating (A) to the right of any such employee to be employed by the Company
or (B) to the knowledge or use of trade secrets or proprietary information.

  



  

(e) Except as provided on _Schedule 4.19(e)_ , no member of the Company Group
is party to a settlement agreement with a current or former officer, employee
or independent contractor of any member of the Company Group that involves
allegations relating to sexual or racial harassment, discrimination or
misconduct by either (i) a director or officer of any member of the Company
Group or (ii) a Company Employee at the level of senior vice president or
above. As of the date of this Agreement, since the Company's formation, no
allegations of sexual or racial harassment, discrimination or misconduct have
been made against (i) any director or officer of any member of the Company
Group or (ii) a Company Employee at the level of vice president or above.

  



  

(f) The Company Group has complied in all material respects as applicable
with the requirements of (i) the FFCRA, (ii) any applicable federal, state or
local stay-at-home orders ( _i.e._ , directives that order residents to stay
at home unless performing certain essential activities) and (iii) any
applicable provisions of the Coronavirus Aid, Relief, and Economic Security
Act.

  



  

4.20  _Withholding_. All obligations of the Company applicable to its Company
Employees, whether arising by operation of Law or contract, or attributable
to payments by the Company to trusts or other funds or to any governmental
agency, with respect to unemployment compensation benefits, social security
benefits or any other benefits for Company Employees with respect to
the employment of Company Employees through the date hereof have been paid or
adequate accruals therefor have been made on the Financial Statements. All
reasonably anticipated material obligations of the Company with respect to
Company Employees (except for those related to wages during the pay period
immediately prior to the Closing Date and arising in the Ordinary Course of
Business ), whether arising by operation of Law or contract for accrued
salaries and holiday pay, earned bonuses and other earned forms
of compensation payable to Company Employees in respect of the services
rendered by any of them prior to the date hereof have been or will be paid by
the Company prior to the Closing Date.

  



   

41

 



    



  

4.21  _Employee Benefits and Compensation_.

  



  

(a) Each Plan maintained or contributed to by the Company Group and/or with
respect to which the Company Group is a party or has or may reasonably be
expected to have any liability (contingent or otherwise) (each a " _Company
Plan_" and collectively, the " _Company Plans_") is and has been
maintained in all material respects in compliance with all applicable laws,
including (if applicable) ERISA and the Code, and has been administered and
operated in all material respects in accordance with its terms.

  



  

(b) With respect to each Company Plan, the Company has made available to the
Purchaser copies of each of the following documents, as applicable: (i) the
Company Plan document (or, if not written, a written description thereof);
(ii) the most recent annual report and actuarial report, if required under
ERISA or the Code; (iii) the most recent Summary Plan Description if required
under ERISA; (iv) if the Company Plan is funded through a trust or any third
party funding vehicle, the trust or other funding agreement document and
the most recent financial statements thereof; and (v) the most recent
determination or opinion letter received from the Internal Revenue Service
with respect to each Company Plan that is intended to be "qualified" within
the meaning of Section 401(a) of the Code. Each Company Plan which is
intended to be "qualified" within the meaning of Section 401(a) of the
Code has received a favorable determination or opinion letter from the IRS
and, to the knowledge of the Company, no event has occurred and no condition
exists which could reasonably be expected to result in the revocation of any
such determination or opinion letter.

  



  

(c) Neither the Company nor to the knowledge of the Company, any other
"disqualified person" or "party in interest" (as defined in Section
4975(e)(2) of the Code and Section 3(14) of ERISA, respectively), has engaged
in any transaction in connection with any Plan that could reasonably be
expected to result in the imposition of a penalty pursuant to Section 502(i)
of ERISA, damages pursuant to Section 409 of ERISA or a tax pursuant to
Section 4975(a) of the Code for which any member of the Company Group could
reasonably expect to have material liability. Neither the Company nor any
member of the Company Group has ever maintained any Plan (other than a Plan
which is intended to be "qualified" within the meaning of Section 401(a) of
the Code) which provides benefits with respect to current or former employees
or directors following their termination of service with the Company (other
than as required pursuant to COBRA). Each Company Plan subject to the
requirements of COBRA has been operated in substantial compliance therewith.

  



  

(d) No Company Employee or director of the Company will accrue or receive
additional benefits, service or accelerated rights to payment of benefits as
a direct result of the Transactions (whether alone or together with any other
event). No material liability, claim, investigation, audit, action or
litigation has been incurred, made, commenced or, to the knowledge of the
Company, threatened, by or against any Company Plan or any member of the
Company Group with respect to any Company Plan (other than for benefits
payable in the Ordinary Course of Business ). No Company Plan or related
trust owns any securities in violation of Section 407 of ERISA.

  



   

42

 



    



  

(e) Neither the Company nor any entity treated as a single employer with the
Company pursuant to Section 4001(b) of ERISA and/or Section 414 (b), (c), (m)
or (o) of the Code maintains or contributes to or ever maintained was required
to contribute to (i) any plan or arrangement that is or was subject to Title
IV of ERISA or Section 412 of the Code, (ii) any plan or arrangement that is
or was a multiemployer plan within the meaning of Section 3(37) or 4001(a)(3)
of ERISA, (iii) any multiple employer welfare arrangement within the meaning
of Section 3(40) of ERISA, or (iv) any nonqualified deferred compensation plan
within the meaning of Section 409A of the Code.

  



  

(f) The Company has prior to the date of this Agreement made available to the
Purchaser true, complete and correct copies of the 2019 Equity Incentive Plan
as in effect as of the date of this Agreement pursuant to which the Company
has granted the Company Options that are currently outstanding and the form
of all stock award agreements evidencing such Company Options.

  



  

4.22  _Real Property_.

  



  

(a) The Company Group does not own, or otherwise have an interest in, any
Real Property, including under any Real Property lease, sublease, space
sharing, license or other occupancy agreement. The Company Group has good,
valid and subsisting title to its respective leasehold estates in the offices
described on _Schedule 4.22(a)_, free and clear of all Liens (other than
Permitted Liens). Other than as would not reasonably be expected to have a
Material Adverse Effect, the Company Group has not breached or violated any
local zoning ordinance, and no notice from any Person has been received by the
Company Group or served upon the Company Group claiming any violation of any
local zoning ordinance.

  



  

(b) With respect to each Lease: (i) it is valid, binding and in full force
and effect against the Company Group, except as may be limited by bankruptcy,
insolvency, reorganization or other similar laws affecting the enforcement of
creditors' rights generally and by general principles of equity; (ii) except
as would not be, individually or in the aggregate, reasonably likely to
have a Material Adverse Effect, all rents and additional rents and other
sums, expenses and charges due thereunder have been paid; (iii) the lessee
has been in peaceable possession since the commencement of the original term
thereof in all material respects; (iv) no waiver, indulgence or postponement
of the lessee's material obligations thereunder has been granted by the
lessor; (v) there exists no material default or event of default thereunder
by the Company Group or, to the knowledge of the Company, by any other party
thereto; (vi) there exists no occurrence, condition or act which, with the
giving of notice, the lapse of time or the happening of any further event or
condition, would become a material default or event of default by the Company
Group thereunder; and (vii) to the knowledge of the Company Group, there are
no outstanding claims of breach or indemnification or notice of default or
termination thereunder. The Real Property leased by the Company Group is in a
state of maintenance and repair adequate and suitable for the purposes for
which it is presently being used, and there are no repair or restoration works
likely to be required in connection with any of the leased Real Properties,
in each case except as would not be, individually or in the aggregate,
reasonably likely to have a Material Adverse Effect. The Company Group is in
physical possession and actual and exclusive occupation of the whole of the
leased property, none of which is subleased or assigned to another Person. To
the knowledge of the Company, the Company Group does not owe any brokerage
commission with respect to any Real Property.

  



   

43

 



    



  

4.23  _Tax Matters_.

  



  

(a) Each member of the Company Group has or will have timely filed, or caused
to be timely filed, (taking into account valid extensions) all income and
other material Tax Returns required to be filed by such member, which Tax
Returns are correct and complete in all material respects, and has paid (or
withheld and paid over to the appropriate Authority) all Taxes required to be
paid (or withheld and paid over) by it other than such Taxes for which
adequate reserves in the Financial Statements have been established.

  



  

(b) There are no Actions pending against any member of the Company Group in
respect of any material Tax, and no member of the Company Group has been
notified in writing of any proposed material Tax claims or assessments against
the Company Group (other than, in each case, claims or assessments that have
been settled or otherwise resolved in full).

  



  

(c) There are no material Liens with respect to any Taxes upon any of the
assets of any member of the Company Group, other than Permitted Liens.

  



  

(d) No member of the Company Group has outstanding waivers or extensions of
any applicable statute of limitations to assess any material amount of Taxes
that has not been paid, other than pursuant to customary extensions of the due
date for filing a Tax Return obtained in the Ordinary Course of Business.
There are no outstanding requests by any member of the Company Group for any
extension of time within which to file any Tax Return other than an extension
requested in the Ordinary Course of Business.

  



  

(e) No member of the Company Group is a party to any Tax indemnification or
Tax sharing or similar agreement (other than any such agreement solely
between the Company and its existing Subsidiaries and customary commercial
Contracts (or Contracts entered into in the Ordinary Course of Business) not
primarily related to Taxes).

  



  

(f) No member of the Company Group has been a party to any transaction
treated by the parties as a distribution of stock qualifying for Tax-free
treatment under Section 355 of the Code in the two (2) years prior to the date
of this Agreement.

  



  

(g) No member of the Company Group (i) is liable for Taxes of any other
Person (other than the Company and its Subsidiaries) under
Treasury Regulation Section 1.1502-6 or any similar provision of state, local
or foreign Tax Law or as a transferee or successor or by Contract (other than
customary commercial Contracts (or Contracts entered into in the Ordinary
Course of Business ) not primarily related to Taxes) or (ii) has ever been a
member of an affiliated, consolidated, combined or unitary group filing for
U.S. federal, state or local income Tax purposes, other than a group the
common parent of which was or is the Company or any of its Subsidiaries.

  



  

(h) No written claim has been made by any Taxing Authority where the Company
or any of its Subsidiaries does not file Tax Returns that it is or may be
subject to taxation in that jurisdiction.

  



  

(i) No member of the Company Group has participated in a "listed transaction"
within the meaning of Treasury Regulation 1.6011-4(b)(2).

  



   

44

 



    



  

(j) No member of the Company Group will be required to include any material
amount in taxable income, or exclude any material item of deduction or loss
from taxable income, for any taxable period (or portion thereof) ending after
the Closing Date as a result of any (i) installment sale, excess loss account
or deferred intercompany transaction described in the Treasury Regulations
under Section 1502 of the Code (or any similar provision of state, local or
foreign Law) or open transaction disposition made prior to the Closing
outside the Ordinary Course of Business, (ii) prepaid amount received or
deferred revenue recognized prior to the Closing outside the Ordinary Course
of Business, (iii) change in method of accounting or adjustment pursuant to
Section 481 of the Code (or any similar provision of state, local, or foreign
law) for a taxable period ending on or prior to the Closing Date, (iv)
"closing agreements" described in Section 7121 of the Code (or any similar
provision of state, local or foreign Law) executed prior to the Closing, or
(v) by reason of Section 965(a) of the Code or election pursuant to Section
965(h) of the Code (or any similar provision of state, local or foreign Law).

  



  

(k) No member of the Company Group has deferred the employer's share of any
"applicable employment taxes" under Section 2302 of the CARES Act, failed to
properly comply in all material respects with and duly account for all credits
received under Sections 7001 through 7005 of the FFCRA and Section 2301 of
the CARES Act, or sought, or intends to seek, a covered loan under paragraph
(36) of Section 7(a) of the Small Business Act (15 U.S.C. 636(a)).

  



  

(l) The Company has not been, is not, and immediately prior to the Effective
Time will not be, treated as an "investment company" within the meaning of
Section 368(a)(2)(F) of the Code.

  



  

(m) No member of the Company Group has taken any action, or has any knowledge
of any fact or circumstance, that could reasonably be expected to prevent the
Transactions from qualifying as a "reorganization" for U.S. federal income tax
purposes within the meaning of Section 368(a)(1) of the Code.

  



  

4.24  _Environmental Laws_. The Company Group has not (a) received any
written notice of any alleged claim, violation of or liability under any
Environmental Law which has not heretofore been cured or for which there is
any remaining liability; (b) disposed of, emitted, discharged, handled,
stored, transported, used or released any Hazardous Materials, arranged for
the disposal, discharge, storage or release of any Hazardous Materials, or
exposed any Company Employee or other individual to any Hazardous Materials
so as to give rise to any liability or corrective or remedial obligation under
any Environmental Laws; or (c) entered into any agreement that may require it
to guarantee, reimburse, pledge, defend, hold harmless or indemnify any other
Person with respect to liabilities arising out of Environmental Laws.

  



  

4.25  _Finders ' Fees_. There is no investment banker, broker, finder or
other intermediary which has been retained by or is authorized to act on
behalf of the Company Group or any of Affiliates who might be entitled to any
fee or commission from the Company, the Purchaser or any of their Affiliates
upon consummation of the Transactions.

  



   

45

 



    



  

4.26  _Preclinical Development and Clinical Trials_. The studies, tests,
preclinical development and clinical trials, if any, conducted by or on
behalf of the Company Group are being conducted in all material respects in
accordance with all protocols, procedures and controls pursuant to accepted
professional and scientific standards for products or product candidates
comparable to those being developed by the Company Group, and all applicable
Laws and regulations, including the Federal Food, Drug, and Cosmetic Act and
regulations and guidance documents promulgated thereunder. The descriptions
of, protocols for, and data and other results of, the studies, tests,
development and trials conducted by or on behalf of the Company Group that
have been furnished or made available to the Purchaser or as provided in the
Registration Statement are accurate and complete in all material
respects (other than to the extent certain portions thereof were redacted by
the Company). The Company Group is not aware of any facts, studies, tests,
development or trials the results of which reasonably call into question the
results of the studies, tests, development and trials conducted by or on
behalf of the Company Group or require that any Company Group Product
Candidates cannot be developed, investigated, tested, labeled, manufactured,
stored or distributed substantially in the manner presently performed by or on
behalf of the Company Group. The Company Group has not received any notices
or correspondence from the FDA or any other Authority or any Institutional
Review Board or comparable authority threatening to commence or requiring the
termination, suspension or material modification of any studies, tests,
preclinical development or clinical trials conducted by or on behalf of the
Company Group.

  



  

4.27  _Regulatory Filings and Data Integrity_. The Company Group has filed,
maintained or furnished all material applications, documents, amendments,
modifications, notices, declarations, reports and submissions, including but
not limited to Company Group Product Candidate investigational new drug
applications, required to be filed, maintained or furnished to the FDA or any
other Authority. All information, reports, statistics, and other data and
conclusions submitted to FDA or any similar Authority in connection with the
Business or Company Group Product Candidates were true, complete and correct
in all material respects as of the date of submission and no updates,
changes, corrections, supplements, amendments or modifications necessary to
such filing have failed to be submitted to the FDA or other applicable
Authority since such date. To the knowledge of the Company Group, no event
has occurred that has adversely affected the integrity, in the aggregate, of
data or other results collected or otherwise obtained in connection with
clinical trials, nonclinical research and manufacturing activities conducted
by or on behalf of the Company Group, on the overall conclusions in any such
trial or research with respect to Company Group Product Candidates.

  



   

46

 



    



  

4.28  _FDA Approvals_. Except as would not be, individually or in the
aggregate, reasonably likely to have a Material Adverse Effect, the Company
Group possesses all permits, licenses, registrations, certificates,
authorizations, orders and approvals from the appropriate federal, state or
foreign regulatory authorities necessary to conduct the Business as now
conducted, including all such permits, licenses, registrations, certificates,
authorizations, orders and approvals required by the U.S. Food and
Drug Administration (" _FDA_ ") or any other federal, state or foreign
agencies or bodies engaged in the regulation of drugs, pharmaceuticals,
medical devices or biohazardous materials. The Company Group has not received
any written notice of proceedings relating to the suspension, modification,
revocation or cancellation of any such permit, license, registration,
certificate, authorization, order or approval. Neither the Company Group nor,
to the Company Group's knowledge, any officer, employee, or agent of the
Company Group has been convicted of any crime or engaged in any conduct
that has caused or would reasonably be expected to result in (a)
disqualification or debarment by the FDA under 21 U.S.C. Sections 335(a) or
(b), or any similar law, rule or regulation of any other Governmental
Authorities, (b) debarment, suspension, or exclusion under any Federal
Healthcare Programs or by the General Services Administration or (c) exclusion
under 42 U.S.C. Section 1320a-7 or any similar law, rule or regulation of any
Governmental Authorities. Neither the Company Group nor to the knowledge of
the Company Group, any of its officers, employees, or agents, is the subject
of any investigation by FDA pursuant to its "Fraud, Untrue Statements of
Material Facts, Bribery, and Illegal Gratuities" policy as stated at 56 Fed.
Reg. 46191 (September 10, 1991) (the " _FDA Application Integrity Policy_ ")
and any amendments thereto, or by any other similar Authority pursuant to any
similar policy. Neither the Company Group nor, to the Company
Group's knowledge, any of its officers, employees, contractors, and agents
has (a) failed to disclose a material fact required to be disclosed to the
FDA or any other Authority, (b) made an untrue statement of a material fact or
fraudulent statement to the FDA or any other Authority, or (c) committed any
act, made any statement or failed to make any statement that would reasonably
be expected to provide a basis for FDA to invoke the FDA Application
Integrity Policy or for any similar Authority to invoke a similar policy.

  



  

4.29  _Healthcare Laws_. The Company Group has been in compliance with all
applicable Laws pertaining to the Company Group Business and all Company
Group Product Candidates, including (a) the Federal Food, Drug, and Cosmetic
Act and all regulations and FDA guidance documents promulgated thereunder,
including 21 C.F.R. Parts 50,54,56,58, and 312, (b) all other Laws
regarding the development, conduct, testing, manufacturing, marketing,
distributing, analysis, use, reporting or promoting of nonclinical research
data or the Company Group Product Candidates, (c) all Laws governing the
detection, assessment, and understanding of adverse events (including
pharmacovigilance and adverse event regulations and guidance of the FDA and
the International Council for Harmonization), (d) all Laws governing patient
informed consent and (e) all comparable state and non-U.S. Laws relating
to any of the foregoing, except as would not reasonably be expected to have a
Material Adverse Effect.

  



  

4.30  _Board Approval; Vote Required_. The Company Board, by resolutions duly
adopted by unanimous vote of those voting at a meeting duly called and held
and not subsequently rescinded or modified in any way, or by unanimous written
consent, has duly (a) determined that this Agreement and the Merger are fair
to and in the best interests of the Company and the Stockholders, (b)
approved and adopted this Agreement and the Merger and declared their
advisability, (c) approved the Transactions, including the Merger, in
accordance with the DGCL on the terms and subject to the conditions of this
Agreement, (d) recommended the approval and adoption of this Agreement and
the Merger by the Stockholders, and (e) directed that, unless this Agreement
has been terminated in accordance with _Article 9.3(g)_ , that this Agreement
and the Transactions (including the Merger) be submitted for consideration by
the Stockholders. The Company Stockholder Approval is the only vote of the
holders of any class or series of capital stock of the Company necessary to
adopt this Agreement and approve the Transactions. The Written Consent, if
executed and delivered, would qualify as the Company Stockholder Approval and
no additional approval or vote from any holders of any class or series
of capital stock of the Company would then be necessary to adopt this
Agreement and approve the Transactions.

  



   

47

 



    



  

4.31  _Information Supplied_. None of the information supplied or to be
supplied by Company at the request of the Purchaser for inclusion or
incorporation by reference: (a) in any current report of the Purchaser on Form
8-K, and any exhibits thereto or any other report, form, registration or
other filing made with any Authority with respect to the Transactions; (b) in
the Registration Statement; or (c) in the mailings or other distributions to
the Purchaser's stockholders and/or prospective investors with respect to the
consummation of the Transactions or in any amendment to any of documents
identified in clauses (a) through (c), will, when filed, made available,
mailed or distributed, as the case may be, contain any untrue statement of a
material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading, but in each case only
to the extent that the untrue statement or alleged untrue statement or
omission or alleged omission was made in reliance upon and in conformity with
the information provided by the Company for inclusion in such documents
identified in clauses (a) through (c) above to be publicly filed with
the SEC. Notwithstanding the foregoing, Company makes no representation,
warranty or covenant with respect to any information supplied by or on behalf
of the Purchaser or its Affiliates or any third-party, including any
Stockholders.

  



  

4.32  _No Other Representations_. The Company acknowledges and agrees that:
(a) the Company and its Affiliates and their respective Representatives have
been provided adequate access to the personnel, properties, assets, premises,
Books and Records, and other documents and data of the Purchaser; (b) in
making its decision to enter into this Agreement and to consummate the
Transactions, it has relied solely upon its own investigation and the express
representations and warranties of the Purchaser set forth in _Article
V _(including the related portions of the Disclosure Schedules); and (c) none
of the Purchaser, Merger Sub, their Affiliates nor their respective
Representatives have made any express or implied representation or warranty as
to the Purchaser, Merger Sub, or this Agreement, except as expressly set
forth in _Article V_ (including the related portions of the Disclosure
Schedules).

  



  

Article V _ 
 REPRESENTATIONS AND WARRANTIES OF THE PURCHASER AND MERGER SUB_

  



  

Except as disclosed in the Purchaser SEC Documents filed with or furnished to
the SEC prior to the date of this Agreement (other than disclosures in the "
_Risk Factors_ " or " _Forward Looking Statements_ " sections of any
Purchaser SEC Document and other disclosures to the extent that such
disclosure is predictive or forward-looking in nature), the Purchaser and
Merger Sub hereby represent and warrant to the Company that each of the
following representations and warranties are true, correct and complete as of
the date of this Agreement and as of the Closing Date (except to the extent
expressly made as of an earlier date, in which case such representations and
warranties shall be so true, correct and complete as of such earlier date):

  



   

48

 



    



  

5.1  _Corporate Existence and Power_. Each of the Purchaser and Merger Sub is
a corporation duly incorporated, validly existing and in good standing under
the Laws of the State of Delaware. Each of the Purchaser and Merger Sub have
all power and authority to own and operate its properties and assets and to
carry on its business as presently conducted. The Purchaser has either
delivered or made available to Company, including via the SEC's Electronic
Data Gathering Analysis and Retrieval (" _EDGAR_ ") system database, accurate
and complete copies of the certificate of incorporation, bylaws and other
charter and organizational documents of the Purchaser and Merger Sub,
including all amendments thereto. None of Purchaser and Merger Sub are in
violation of any of the provisions of their respective certificate of
incorporation, bylaws and other charter and organizational documents. Each of
the Purchaser and Merger Sub is duly licensed or qualified to do business and
is in good standing in each jurisdiction in which the properties owned or
leased by it or the operation of its business as currently conducted makes
such licensing or qualification necessary, except where the failure to be so
licensed, qualified or in good standing would not have a Material Adverse
Effect. The Purchaser has no subsidiaries other than Merger Sub and
neither the Purchaser nor Merger Sub own, directly or indirectly, any equity
interests or other interests or investments (whether equity or debt) in any
Person, whether incorporated or unincorporated, other than the Purchaser's
ownership of Merger Sub. Merger Sub does not have any assets or properties of
any kind, does not now conduct and has never conducted any business, and has
and will have at the Closing no obligations or liabilities of any nature
whatsoever, except for such obligations as are imposed under this Agreement.
Merger Sub has been formed solely for the purpose of engaging in the
Transactions.

  



  

5.2  _Authorization_. The execution, delivery and performance by the
Purchaser and Merger Sub of this Agreement and the Additional Agreements to
which Purchaser or Merger Sub is a party and the consummation by the Purchaser
and Merger Sub of the Transactions are within the corporate powers of the
Purchaser and Merger Sub and, subject to receipt of the Purchaser
Stockholder Approval, have been duly authorized by all necessary action on
the part of the Purchaser and Merger Sub. This Agreement has been duly
executed and delivered by the Purchaser and Merger Sub and, assuming due
authorization, execution and delivery by each other Party to this Agreement
and each other party to the Additional Agreements, constitutes, and upon their
execution and delivery, the Additional Agreements will constitute, a valid
and legally binding agreement of the Purchaser and Merger Sub,
enforceable against the Purchaser and Merger Sub in accordance with their
respective terms, except as may be limited by bankruptcy,
insolvency, reorganization or other similar laws affecting the enforcement of
creditors' rights generally and by general principles of equity. Assuming a
quorum is present at the Purchaser Stockholder Meeting, as adjourned or
postponed, (a) the affirmative vote of holders of a majority of the
outstanding shares of the Purchaser Common Stock entitled to vote at the
Purchaser Stockholder Meeting, assuming a quorum is present, for the approval
of the Purchaser Charter Amendment and (b) the affirmative vote of
the holders of a majority of the shares of the Purchaser Common Stock present
in person or by proxy and entitled to vote thereon at the Purchaser
Stockholder Meeting for the approval of the Purchaser Stockholder Matters
(other than the Purchaser Charter Amendment) are the only votes of any of the
Purchaser's capital stock necessary to adopt this Agreement and to consummate
the Business Combination and the other Transactions.

  



  

5.3  _Governmental Authorization_. Except for filings under the HSR Act,
neither the execution, delivery nor performance by the Purchaser or Merger
Sub of this Agreement or any Additional Agreements to which the Purchaser or
Merger Sub is a Party requires any Governmental Approval.

  



   

49

 



    



  

5.4  _Non-Contravention_. The execution, delivery and performance by the
Purchaser or Merger Sub of this Agreement and the Additional Agreements does
not and will not (a) _provided_ that holders of fewer than the number of the
Purchaser Common Stock specified in the Purchaser's organizational documents
exercise their redemption rights with respect to such transaction and
assuming approval of the Purchaser Stockholder Matters at the Purchaser
Stockholder Meeting, contravene or conflict with the organizational or
constitutive documents of the Purchaser, (b) contravene or conflict with or
constitute a violation of any Law or Order binding upon or applicable to the
Purchaser or Merger Sub, (c) constitute a default under or breach of (with or
without the giving of notice or the passage of time or both) or violate or
give rise to any right of termination, cancellation, amendment or
acceleration of any right or obligation of the Purchaser or Merger Sub or
require any payment or reimbursement or to a loss of any material benefit on
the part of the Purchaser or Merger Sub under provision of any Purchaser
Material Contract, (d) result in the creation or imposition of any Lien on
any of the Purchaser Securities or (e) result in the creation or imposition of
any Lien (except for Permitted Liens) on any of the Purchaser's or Merger
Sub's assets, except as would not, individually or in the aggregate,
reasonably likely to have a Purchaser Material Adverse Effect.

  



  

5.5  _Finders ' Fees_. Except for the Deferred Underwriting Amount, there is
no investment banker, broker, finder or other intermediary which has been
retained by or is authorized to act on behalf of the Purchaser or its
Affiliates who might be entitled to any fee or commission from the Purchaser
or any of its Affiliates upon consummation of the Transactions
contemplated by this Agreement or any of the Subscription Agreements.

  



  

5.6  _Capitalization_.

  



  

(a) The authorized capital stock of the Purchaser consists of 500,000,000
shares of the Purchaser Class A Common Stock, of which 14,862,500 are issued
and outstanding as of the date hereof (inclusive of the Purchaser Class A
Common Stock included in any outstanding the Purchaser Units), and 20,000,000
Founder Shares, of which 3,593,750 are issued and outstanding as of the date
hereof. In addition, 4,954,167 Purchaser Warrants (inclusive of the Purchaser
Private Warrants and the Purchaser Public Warrants included in any
outstanding the Purchaser Units) are issued and outstanding as of the date
hereof. No other shares of capital stock or other voting securities of the
Purchaser are issued, reserved for issuance or outstanding. All issued and
outstanding shares of the Purchaser Common Stock and the Purchaser Warrants
are duly authorized, validly issued, fully paid and nonassessable and not
subject to or issued in violation of any preemptive or similar rights of any
Person.

  



  

(b) Immediately prior to the closing of the Transactions contemplated by the
Subscription Agreements and the completion of the Merger, the
authorized capital stock of the Purchaser will consist of 525,000,000 shares
of capital stock, including (i) 500,000,000 shares of the Purchaser Class A
Common Stock, (ii) 20,000,000 shares of the Purchaser Class B Common Stock and
(iii) 5,000,000 shares of the Purchaser Preferred Stock, of which the
Purchaser has committed to issue 3,593,750 shares of the Purchaser Class A
Common Stock upon the conversion the Purchaser's Class B Common Stock to the
Sponsor and the Purchaser will have up to 4,954,167 Purchaser
Warrants (inclusive of the Purchaser Private Warrants and the Purchaser
Public Warrants included in any outstanding the Purchaser Units) issued and
outstanding, of which 4,791,666 will be Purchaser Public Warrants which will
entitle the holder thereof to purchase Purchaser Class A Common Stock at an
exercise price of $11.50 per share on the terms and conditions set forth in
the applicable warrant agreement.

  



   

50

 



    



  

(c) The authorized capital stock of Merger Sub consists of one-thousand
(1,000) shares of common stock, par value $0.0001 per share (the " _Merger
Sub Common Stock_ "). As of the date hereof, one-thousand (1,000) shares of
Merger Sub Common Stock are issued and outstanding. All outstanding shares of
Merger Sub Common Stock (i) have been duly authorized, validly issued,
fully paid and are non-assessable and are not subject to any preemptive or
similar rights of any Person, and (ii) are owned by the Purchaser, free and
clear of all Liens.

  



  

(d) Except as set forth in the Purchaser's organizational documents, there
are no outstanding contractual obligations of the Purchaser or Merger Sub to
repurchase, redeem or otherwise acquire any shares of the Purchaser Common
Stock, the Purchaser Preferred Stock, Merger Sub Common Stock or any capital
equity of the Purchaser or Merger Sub. There are no outstanding contractual
obligations of the Purchaser or Merger Sub to provide funds to, or make any
investment (in the form of a loan, capital contribution or otherwise) in, the
equity of any other Person. There are no: (a) outstanding subscriptions,
options, warrants, rights (including "phantom stock rights"); calls,
commitments, understandings, conversion rights, rights of exchange, plans or
other agreements of any kind providing for the purchase, issuance or sale of
any securities of the Purchaser or Merger Sub; or (b) any agreement to which
the Purchaser or Merger Sub is a party, or to the knowledge of the Purchaser,
any other agreements, with respect to the Purchaser Common Stock, the
Purchaser Preferred Stock or Merger Sub Common Stock or any securities
exercisable or convertible into the foregoing, including any voting trust,
other voting agreement or proxy with respect thereto.

  



  

(e) Each share of the Purchaser Common Stock, the Purchaser Preferred Stock,
Merger Sub Common Stock and each Purchaser Warrant has been duly authorized
and validly issued, is fully paid and non-assessable, have been issued and
granted in compliance with applicable securities laws and other applicable
Laws, and have not been issued in violation of any preemptive or similar
rights of any Person.

  



  

(f) The Aggregate Merger Consideration Shares, the shares of the Purchaser
Common Stock to be issued by the Purchaser in connection with the Forward
Purchase Agreement and _Section 8.9_ , when issued in accordance with the
terms of this Agreement, shall be duly authorized, validly issued, fully paid
and nonassessable, will be issued in compliance with applicable Law and not
subject to or issued in violation of any preemptive or similar rights of any
Person and will be capable of effectively vesting in the Stockholders title
to all such securities, free and clear of all Liens. There are no securities
or instruments issued by or to which the Purchaser is a party containing
anti-dilution or similar provisions that will be triggered by the consummation
of the Transactions or the transactions contemplated by the Forward Purchase
Agreement, in each case, that have not been or will be waived on or prior
to the Closing Date.

  



  

5.7  _Information Supplied_. None of the information supplied or to be
supplied by the Purchaser or Merger Sub for inclusion or incorporation by
reference in the filings with the SEC and mailings to the Purchaser's
stockholders with respect to the solicitation of proxies to approve the
Transactions, if applicable, or in any other the Purchaser SEC Documents,
will, when filed, made available, mailed or distributed, as the case may be,
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they are made,
not misleading (subject to the qualifications and limitations set forth in the
materials provided by the Purchaser or that is included in the Purchaser SEC
Documents).

  



   

51

 



    



  

5.8  _Trust Fund_. As of the date of this Agreement, the Purchaser has at
least $143,753,387 in the trust fund established by the Purchaser for the
benefit of its public stockholders (the " _Trust Fund_ ") in a trust account
maintained by Continental Stock Transfer and Trust Company (the " _Trustee_
") at J.P. Morgan Chase Bank, N.A. (the " _Trust Account_ "), and such
monies are invested in "government securities" (as such term is defined in
the Investment Company Act of 1940, as amended) and held in trust by the
Trustee pursuant to the Investment Management Trust Agreement, dated as of
June 30, 2020, between the Purchaser and the Trustee (the " _Trust Agreement_
"). The Trust Agreement is valid and in full force and effect and enforceable
in accordance with its terms, except as may be limited by bankruptcy,
insolvency, reorganization or other similar laws affecting the enforcement of
creditors' rights generally and by general principles of equity, and has not
been amended or modified. There are no separate agreements, side letters or
other agreements or understandings (whether written or unwritten, express or
implied) that would cause the description of the Trust Agreement in the
Purchaser SEC Documents to be inaccurate in any material respect and/or that
would entitle any Person (other than stockholders of the Purchaser holding
shares of the Purchaser Common Stock sold in the Purchaser's IPO who shall
have elected to redeem their shares of the Purchaser Common Stock pursuant to
the Purchaser's certificate of incorporation) to any portion of the proceeds
in the Trust Account. Prior to the Closing, none of the funds held in the
Trust Account may be released except in accordance with the Purchaser SEC
Documents, the Trust Agreement and the Purchaser's organizational documents.
The Purchaser has performed all material obligations required to be performed
by it to date under, and is not in material default or delinquent in
performance or any other respect (claimed or actual) in connection with, the
Trust Agreement, and, to the knowledge of the Purchaser, no event has
occurred which, with due notice or lapse of time or both, would constitute
such a material default thereunder. There are no claims or proceedings
pending with respect to the Trust Account.

  



  

5.9  _Listing_. The Purchaser Units, the Purchaser Class A Common Stock and
the Purchaser Warrants (collectively, the " _Purchaser Securities_ ") are
listed on the NYSE, with trading tickers PANA.U, PANA and PANA WS. As of the
date of this Agreement, (a) the Purchaser is in compliance with applicable
continued listing requirements of the NYSE, (b) the Purchaser has not
received any written deficiency notice from the NYSE relating to the
continued listing requirements of such Purchaser Securities, (c) there are no
Actions pending or, to the knowledge of the Purchaser, threatened against the
Purchaser by the Financial Industry Regulatory Authority or any other Person
with respect to the continued listing of the Purchaser Securities on the NYSE,
including any intention by such entity to suspend, prohibit or terminate the
quoting of such Purchaser Securities on the NYSE and (d) such Purchaser
Securities are in compliance with all of the applicable listing and corporate
governance rules of the NYSE. There is no action or proceeding pending or, to
the knowledge of the Purchaser, threatened in writing against the Purchaser by
NYSE or the SEC with respect to any intention by such entity to deregister
the Purchaser Units, the shares of the Purchaser Class A Common Stock, the
Purchaser Class B Common Stock or the Purchaser Warrants or to terminate the
listing of the Purchaser on NYSE. None of the Purchaser or any of its
Affiliates has taken any action in an attempt to terminate the registration of
the Purchaser Units, the Purchaser Class A Common Stock, the Purchaser Class
B Common Stock or the Purchaser Warrants under the Exchange Act.

  



   

52

 



    



  

5.10  _Board Approval_. The Purchaser's board of directors (including any
required committee or subgroup of such board) (the " _Purchaser Board_ ")
has, as of the date of this Agreement, unanimously (a) declared the
advisability of the Transactions, (b) determined that the Transactions are in
the best interests of the stockholders of the Purchaser, (c) determined that
the Transactions constitutes a "Business Combination" as such term is
defined in the Purchaser's amended and restated certificate of incorporation
and bylaws (a " _Business Combination_ ") and (d) recommended that the
Purchaser's stockholders approve the Purchaser Stockholder Matters (the "
_Purchaser Board Recommendation_ "). The Merger Sub's board of directors,
has, as of the date of this Agreement unanimously, by resolutions, unanimously
(a) declared the advisability of the Transactions, (b) determined that the
Transactions are in the best interests of the sole stockholder of the
Purchaser and (c) recommended that the sole stockholder of Merger Sub approve
and adopt this Agreement and approve the Merger. The only vote of the holders
of any class or series of capital stock of Merger Sub that is necessary to
approve this Agreement, the Merger and the other Transactions contemplated by
this Agreement is the affirmative vote of the holders of a majority of the
outstanding shares of Merger Sub Common Stock.

  



  

5.11  _Purchaser SEC Documents and Financial Statements_.

  



  

(a) The Purchaser has filed all forms, reports, schedules, statements and
other documents, including any exhibits thereto, required to be filed or
furnished by the Purchaser with the SEC through EDGAR since the Purchaser's
formation under the Exchange Act or the Securities Act, together with any
amendments, restatements or supplements thereto (the " _Purchaser SEC
Documents_ "). The Purchaser SEC Documents were prepared in all material
respects in accordance with the requirements of the Securities Act, the
Exchange Act, and the Sarbanes-Oxley Act, as the case may be, and the rules
and regulations thereunder. The Purchaser SEC Documents did not, at the time
they were filed with the SEC (except to the extent that information
contained in any Purchaser SEC Document or the Purchaser SEC Document has
been or is revised or superseded by a later filed the Purchaser SEC Document
then on the date of such filing) contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements made therein, in the light of the
circumstances under which they were made, not misleading. As used in this
_Section 5.11_, the term "file" shall be broadly construed to include any
manner in which a document or information is furnished, supplied or otherwise
made available to the SEC.

  



  

(b) The financial statements and notes contained or incorporated by reference
in the Purchaser SEC Documents (the " _Purchaser Financials_ "), (i) were
prepared in accordance with GAAP consistently applied, (ii) comply with all
applicable accounting requirements under the Securities Act and the rules and
regulations of the SEC thereunder, and (iii) fairly present in all material
respects, in conformity with GAAP applied on a consistent basis, the financial
position of the Purchaser as of the dates thereof and the results of
operations of the Purchaser for the periods reflected therein (subject to
normal and recurring year-end adjustments that are not, individually or in
the aggregate, material).

  



  

(c) The Purchaser makes and keeps accurate Books and Records and maintain a
system of internal accounting controls designed, and which the Purchaser
believes is sufficient, to provide reasonable assurance that: (i) transactions
are executed in accordance with management's general or specific
authorization; (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain
accountability for assets; (iii) access to assets is permitted only in
accordance with management's general or specific authorization; and (iv) the
recorded accountability for assets is compared with existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences.

  



   

53

 



    



  

(d) The Purchaser has established and maintains disclosure controls and
procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act),
which (i) are designed to ensure that material information relating to the
Purchaser is made known to the Purchaser's principal executive officer and
its principal financial officer by others and (ii) are effective in all
material respects to perform the functions for which they were established.
Since the Purchaser's formation, there have been no significant
deficiencies or material weakness in the Purchaser's internal control over
financial reporting (whether or not remediated) and no change in the
Purchaser's internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Purchaser's
internal control over financial reporting.

  



  

5.12  _Compliance with Laws_. Each of the Purchaser and Merger Sub is not in
violation of, has not violated, in each case in any material respect, and to
the Purchaser's knowledge, is neither under investigation with respect to nor
has been threatened in writing to be charged with or given notice of any
violation or alleged violation of, any Law, or judgment, order or
decree entered by any court, arbitrator or Authority, domestic or foreign,
and since its formation, neither the Purchaser nor Merger Sub has not
received any subpoenas from any Authority, in each case except as would not
be, individually or in the aggregate, reasonably likely to have a Purchaser
Material Adverse Effect. Except as would not be material to the Purchaser,
without limiting the foregoing, neither the Purchaser or Merger Sub is not in
violation of, has not violated, and to the knowledge of the Purchaser, is not
under investigation with respect to nor has been threatened in writing or
charged with or given notice of any violation of any provisions of:

  



  

(a) Data Protection Laws and Laws applicable to lending activities;

  



  

(b) the Foreign Corrupt Practices Act;

  



  

(c) any comparable or similar Law of any jurisdiction; or

  



  

(d) any Law regulating or covering conduct in, or the nature of, the
workplace, including regarding sexual harassment or, on any
impermissible basis, a hostile work environment.

  



  

5.13  _OFAC_. Neither the Purchaser nor, to the knowledge of the Purchaser,
any director, officer, agent, employee, Affiliate or Person acting on behalf
of the Purchaser is currently identified on the specially designated nationals
or other blocked person list or otherwise currently subject to any U.S.
sanctions administered by the OFAC. The Purchaser has not engaged in
transactions with, or exported any of its products or associated technical
data (i) into (or to a national or resident of) Cuba, Iran, Iraq, Libya,
North Korea, Syria or any other country to which the United States has
embargoed goods to or has proscribed economic transactions with or (ii) to
the knowledge of the Purchaser, to any Person included on the United States
Treasury Department's list of Specially Designated Nationals or the U.S.
Commerce Department's Denied Persons List.

  



   

54

 



    



  

5.14  _Litigation_. As of the date of this Agreement, there is no Action
pending against, or to the knowledge of the Purchaser, threatened in writing
against or affecting, the Purchaser or Merger Sub, or to the knowledge of the
Purchaser, any of their officers or directors with respect to the business of
the Purchaser or Merger Sub or any securities of the Purchaser or Merger Sub
or any of the Purchaser's or Merger Sub's assets or any material contract of
the Purchaser or Merger Sub before any court, Authority or official or which
in any manner challenges or seeks to prevent or enjoin the Transactions. As of
the date of this Agreement, there are no outstanding judgments or Orders
against the Purchaser or Merger Sub.

  



  

5.15  _Absence of Certain Changes_. Since its formation through the date of
this Agreement, neither the Purchaser nor Merger Sub has (a) conducted no
business other than its formation, the public offering of its securities (and
the related private offerings), public reporting and its search for an
initial Business Combination as described in the Prospectus (including the
investigation of the Company Group and the negotiation and execution of this
Agreement) and related activities and (b) not been subject to a Purchaser
Material Adverse Effect. Except as set forth in the Purchaser's SEC reports
filed prior to the date of this Agreement, and except as contemplated by this
Agreement, since December 31, 2019 through the date of this Agreement, there
has not been: (a) any declaration, setting aside or payment of any dividend
on, or other distribution in respect of, any of the Purchaser's capital
stock, or any purchase, redemption or other acquisition by the Purchaser of
any of the Purchaser's capital stock or any other securities of the Purchaser
or any options, warrants, calls or rights to acquire any such shares or other
securities; (b) any split, combination or reclassification of any of the
Purchaser's capital stock; (c) any material change by the Purchaser in its
accounting methods, principles or practices, except as required by concurrent
changes in GAAP (or any interpretation thereof) or applicable Law; (d) any
change in the auditors of the Purchaser; (e) any issuance of capital stock of
the Purchaser; (f) any revaluation by the Purchaser of any of its assets,
including any sale of assets of the Purchaser other than in the Ordinary
Course of Business; or (i) any action taken or agreed upon by the Purchaser
or any of its Subsidiaries that would be prohibited by Section 6.1(b) if such
action were taken on or after the date hereof without the consent of the
Company.

  



  

5.16  _Employees and Employee Benefit Plans_. Neither the Purchaser nor
Merger Sub (a) have any paid employees or (b) maintain, sponsor, contribute
to or otherwise have any liability under any Plans. Neither the execution and
delivery of this Agreement or the other Additional Agreements nor the
consummation of the Transactions will: (a) result in any payment (including
severance, unemployment compensation, golden parachute, bonus or otherwise)
becoming due to any director, officer or employee of the Purchaser; or (b)
result in the acceleration of the time of payment or vesting of any such
benefits. Other than reimbursement of any out-of-pocket expenses incurred by
the Purchaser's officers and directors in connection with activities on the
Purchaser's behalf in an aggregate amount not in excess of the amount of cash
held by the Purchaser outside of the Trust Account, the Purchaser has no
unsatisfied material liability with respect to any officer or director.

  



  

5.17  _Properties_. The Purchaser does not own, license or otherwise have any
right, title or interest in any material Intellectual Property Rights (other
than Trademarks). The Purchaser does not own, or otherwise have an interest
in, any Real Property, including under any Real Property lease, sublease,
space sharing, license or other occupancy agreement.

  



   

55

 



    



  

5.18  _Contracts_.

  



  

(a) Other than this Agreement and the Additional Agreements, there are no
Contracts to which the Purchaser or Merger Sub is a party or by which any of
its properties or assets may be bound, subject or affected, which (a) creates
or imposes a liability greater than $200,000, (b) may not be cancelled by the
Purchaser on less than sixty (60) calendar days' prior notice without
payment of a material penalty or termination fee or (c) prohibits, prevents,
restricts or impairs in any material respect any business practice of the
Purchaser or Merger Sub as its business is currently conducted, any
acquisition of material property by the Purchaser or Merger Sub, or restricts
in any material respect the ability of the Purchaser or Merger Sub from
engaging in business as currently conducted by it or from competing with any
other Person (each such contract, a " _Purchaser Material Contract_ "). All
Purchaser Material Contracts have been made available to the Company other
than those that are exhibits to the Purchaser SEC Documents.

  



  

(b) Each Purchaser Material Contract is a valid and binding agreement, and is
in full force and effect, and neither the Purchaser nor, to the knowledge of
the Purchaser, any other party thereto, is in breach or default (whether with
or without the passage of time or the giving of notice or both) under the
material terms of any such Purchaser Material Contract, and no event has
occurred that with the passage of time or giving of notice or both would
constitute such a breach or default by such other party, or
permit termination or acceleration by the Purchaser under any Purchaser
Material Contract.

  



  

5.19  _No Undisclosed Liabilities_. The Purchaser and Merger Sub have no
liabilities (whether direct or indirect, absolute, accrued, contingent or
otherwise) of a nature required to be disclosed on a balance sheet in
accordance with GAAP, except for liabilities: (a) provided for in, or
otherwise disclosed or reflected in the most recent balance sheet included in
the Purchaser's quarterly report on Form 10-Q for the quarterly period ended
June 30, 2020; (b) arising in the Ordinary Course of Business since June 30,
2020; (c) incurred since June 30, 2020 pursuant to or in connection with this
Agreement or the Transactions; (d) disclosed in this Agreement (or its
schedules); or (e) which would not reasonably be expected to be material to
the Purchaser and its Subsidiaries, taken as a whole.

  



  

5.20  _Affiliate Transactions_. Except for equity ownership or employment
relationships (including any employment or similar Contract) expressly
contemplated by this Agreement, any non-disclosure or confidentiality Contract
entered into in connection with the "wall-crossing" of the Purchaser's
stockholders, any Additional Agreement, (a) there are no transactions or
Contracts, or series of related transactions or Contracts, between the
Purchaser, on the one hand, and any related party of the Purchaser, Sponsor,
any beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of five
percent (5%) or more of the Purchaser Common Stock or, to the knowledge of
the Purchaser, any of their respective "associates" or "immediate family"
members (as such terms are defined in Rule 12b-2 and Rule 16a-1 of the
Exchange Act), on the other hand, nor is any Indebtedness owed by or to the
Purchaser, on the one hand, to or by Sponsor or any such related party,
beneficial owner, associate or immediate family member, and (b) none of the
officers or directors (or members of a similar governing body) of the
Purchaser, Sponsor, any beneficial owner of five percent (5%) or more of the
Purchaser Common Stock or, to the knowledge of the Purchaser, their
respective "associates" or "immediate family members" owns directly or
indirectly in whole or in part, or has any other material interest in, (i)
any material tangible or real property that the Purchaser or uses, owns or
leases (other than through any equity interest in the Purchaser) or (ii) any
customer, vendor or other material business relation of the Purchaser or
Sponsor.

  



   

56

 



    



  

5.21  _Forward Purchase Agreement_. The Purchaser has delivered to the
Company a true, accurate and complete copy of the Forward Purchase Agreement.
The Forward Purchase Agreement is in full force and effect and has not been
withdrawn, terminated, or otherwise amended or modified, in any respect, and
no withdrawal, termination, amendment or modification is contemplated by the
Purchaser, and the commitments contained in the Forward Purchase Agreement
have not been withdrawn, terminated or rescinded in any respect. The Forward
Purchase Agreement is a legal, valid and binding obligation enforceable in
accordance with its terms. No event has occurred that, with or without
notice, lapse of time or both, would constitute a default under any condition
precedent or material term of the Forward Purchase Agreement and, as of the
date hereof, the Purchaser has no reason to believe that any of the
conditions to the consummation of the Forward Purchase Agreement will not be
satisfied, and, as of the date hereof, the Purchaser is not aware of the
existence of any fact or event that would or would reasonably be expected to
cause such conditions not to be satisfied.

  



  

5.22  _Tax Matters_.

  



  

(a) The Purchaser and Merger Sub have or will have timely filed, or caused to
be timely filed (taking into account valid extensions), all income and other
material Tax Returns required to be filed by them, which Tax Returns are
correct and complete in all material respects, and have paid (or withheld and
paid over to the appropriate Authority) all Taxes required to be paid (or
withheld and paid over) by the Purchaser or Merger Sub other than such Taxes
for which adequate reserves in the Purchaser Financials have
been established.

  



  

(b) There are no Actions pending against the Purchaser or Merger Sub in
respect of any material Tax, and neither the Purchaser nor Merger sub has
been notified in writing of any proposed material Tax claims or assessments
against the Purchaser or Merger Sub (other than, in each case, claims or
assessments that have been settled or otherwise resolved in full).

  



  

(c) There are no Liens with respect to any Taxes upon any of the Purchaser's
assets, other than Permitted Liens.

  



  

(d) The Purchaser and Merger Sub have no outstanding waivers or extensions of
any applicable statute of limitations to assess any material amount of Taxes
that has not been paid, other than pursuant to customary extensions of the due
date for filing a Tax Return obtained in the ordinary course of business.
There are no outstanding requests by the Purchaser or Merger Sub for any
extension of time within which to file any Tax Return other than an extension
requested in the ordinary course of business.

  



   

57

 



    



  

(e) Neither the Purchaser nor the Merger Sub is a party to any Tax
indemnification or Tax sharing or similar agreement (other than any
such agreement solely between the Purchaser and Merger Sub and customary
commercial Contracts (or Contracts entered into in the ordinary course of
business) not primarily related to Taxes).

  



  

(f) No written claim has been made by any Taxing Authority where the
Purchaser does not file Tax Returns that it is or may be subject to taxation
in that jurisdiction.

  



  

(g) Neither the Purchaser nor the Merger Sub has participated in a "listed
transaction" within the meaning of Treasury Regulation 1.6011-4(b)(2).

  



  

(h) The Purchaser has not taken any action, and does not have any knowledge
of any fact or circumstance, that could reasonably be expected to prevent the
Transactions, including the Merger, from qualifying as a "reorganization" for
U.S. federal income tax purposes within the meaning of Section 368(a)(1) of
the Code.

  



  

5.23  _PIPE Investment_.

  



  

(a) The Purchaser has delivered to the Company true, correct and complete
copies of each of the Subscription Agreements entered into by the Purchaser
with the applicable PIPE Investors named therein, pursuant to which the PIPE
Investors have committed to provide equity financing to the Purchaser solely
for purposes of consummating the Transactions in the aggregate amount of all
of the Subscription Agreements (the " _PIPE Investment Amount_ "). To the
knowledge of the Purchaser, with respect to each PIPE Investor, the
Subscription Agreement with such PIPE Investor is in full force and effect and
has not been withdrawn or terminated, or otherwise amended or modified, in
any respect, and no withdrawal, termination, amendment or modification is
contemplated by the Purchaser. Each Subscription Agreement is a legal, valid
and binding obligation of the Purchaser and, to the knowledge of the
Purchaser, each PIPE Investor, and neither the execution or delivery by any
party thereto nor the performance of any party's obligations under any such
Subscription Agreement violates any Laws. The Subscription Agreements provide
that the Company is a party thereto and is entitled to enforce such
agreements against the PIPE Investor. There are no other agreements, side
letters, or arrangements between the Purchaser and any PIPE Investor relating
to any Subscription Agreement that could affect the obligation of such
PIPE Investors to contribute to the Purchaser the applicable portion of the
PIPE Investment Amount set forth in the Subscription Agreement of such PIPE
Investors, and, as of the date hereof, the Purchaser does not know of any
facts or circumstances that may reasonably be expected to result in any of
the conditions set forth in any Subscription Agreement not being satisfied, or
the PIPE Investment Amount not being available to the Purchaser, on the
Closing Date. No event has occurred that, with or without notice, lapse
of time or both, would constitute a default or breach on the part of the
Purchaser under any material term or condition of any Subscription Agreement
and, as of the date hereof, the Purchaser has no reason to believe that it
will be unable to satisfy in all material respects on a timely basis any term
or condition of closing to be satisfied by it contained in any Subscription
Agreement. The Subscription Agreements contain all of the conditions
precedent (other than the conditions contained in the other
Transaction Agreements) to the obligations of the PIPE Investors to
contribute to the Purchaser the applicable portion of the PIPE
Investment Amount set forth in the Subscription Agreements on the terms
therein.

  



   

58

 



    



  

(b) No fees, consideration or other discounts are payable or have been agreed
by the Purchaser or any of its Subsidiaries (including, from and after the
Closing, the Company and its Subsidiaries) to any PIPE Investor in respect of
its PIPE Investment or, except as set forth in the Subscription Agreements.

  



  

5.24 _Independent Investigation_. The Purchaser and its Affiliates and their
respective Representatives have conducted their own
independent investigation, review and analysis of the business, results of
operations, prospects, condition (financial or otherwise) or assets of the
Company Group, and the Purchaser acknowledges that it and they have been
provided adequate access to the personnel, properties, assets, premises,
books and records, and other documents and data of the Company Group for such
purpose. The Purchaser acknowledges and agrees that: (a) in making its
decision to enter into this Agreement and to consummate the Transactions, it
has relied solely upon its own investigation and the express representations
and warranties of the Company set forth in _Article IV_ (including the
related portions of the Disclosure Schedules); and (b) none of the Company,
its Affiliates nor their respective Representatives have made any express or
implied representation or warranty as to the Company Group, or this Agreement,
except as expressly set forth in _Article IV_ (including the related
portions of the Disclosure Schedules).

  



  

Article VI _ 
 COVENANTS OF THE PARTIES PENDING CLOSING_

  



  

6.1 _Conduct of the Business_. From the date hereof through the earlier of
the termination of this Agreement in accordance with _Article X_ or the
Closing Date (the " _Interim Period_ "), each of the Purchaser, Merger Sub
and the Company shall, except as required by this Agreement, as set forth on
_Schedule 6.1_ , as consented in writing by the other Party (which consent
shall not be unreasonably withheld, conditioned or delayed), or as required by
applicable law (including any COVID-19 Measures), use commercially reasonable
efforts to conduct their respective businesses only in the Ordinary Course of
Business in all material respects (including with respect to the payment of
accounts payable and the collection of accounts receivable), and shall use
its commercially reasonable efforts to preserve intact its business
relationships with key employees, material suppliers and other material third
parties ( _provided_ that the Company shall be under no obligation to enter
into retention agreements with employees in order to comply with the
foregoing).

  



  

(a) Without limiting the generality of the foregoing, except as set forth on
_Schedule 6.1(a)_ , during the Interim Period, without the Purchaser's prior
written consent (which shall not be unreasonably withheld, conditioned or
delayed), except as required by applicable Law or as contemplated by this
Agreement, no member of the Company Group shall:

  



  

(i) amend, modify or supplement its certificate of incorporation and bylaws
or other organizational or governing documents;

  



  

(ii) amend, waive any provision of, or terminate prior to its scheduled
expiration date any Material Contract;

  



  

   

59

 



    



  

(iii) (A) modify, amend or enter into any contract, agreement, lease, license
or commitment, which is with respect to Real Property, (B) enter into any
contract, agreement, lease, license or commitment that obligates the payment
of more than $2,000,000 individually (other than with respect to Real
Property or Company IP, or with respect to contract manufacturing contracts
with contract manufacturing organizations), or (C) enter into any contract
manufacturing contract with a contract manufacturing organization that
obligates the payment of more than $5,000,000 individually;

  



  

(iv) excluding Company IP, sell, lease, license or otherwise dispose of any
of the Company Group's material assets or assets that are worth $2,000,000
or more (individually or in the aggregate) covered by any Material Contract
except (A) pursuant to existing contracts or commitments disclosed herein,
and (B) in the Ordinary Course of Business;

  



  

(v) make any capital expenditures in excess of $2,000,000 (individually or in
the aggregate) outside of the capital expenditure plan made available to the
Purchaser on or prior to the date of this Agreement;

  



  

(vi) pay, declare or promise to pay any cash or other dividends or other
distributions with respect to its capital stock or other equity securities, or
pay, declare or promise to pay any other payments to any Stockholder (other
than payment of salary, benefits, leases, commissions, grants of Company
Options, Company Capital Stock issued upon exercise of Company Options and
similar payments in the Ordinary Course of Business);

  



  

(vii) obtain or incur any loan or other Indebtedness other than (A) accounts
payable, (B) accrued liabilities in the Ordinary Course of Business and (C)
Permitted Liens;

  



  

(viii) suffer or incur any Lien, except for Permitted Liens, on the Company
Group's assets;

  



  

(ix) acquire, lease, in-license, out-license, sublicense, pledge, sell or
otherwise dispose of, divest or spin-off, abandon, waive, covenant not to
assert, relinquish or permit to lapse any Company IP except (A) any Patent
expiring at the end of its statutory term and not capable of being
extended, (B) pursuant to a Standard Contract or (C) granting a non-exclusive
license for a Person to perform services for a member of the Company Group
pursuant to any contract research, contract manufacturing, molecular testing
or similar contracts entered into in the Ordinary Course of Business;

  



  

(x) delay, accelerate or cancel any material Indebtedness owed to the Company
Group or write off or make further reserves against the same, other than in
the Ordinary Course of Business ;

  



  

(xi) merge or consolidate with or acquire any other Person or be acquired by
any other Person;

  



  

   

60

 



    



  

(xii) permit any material insurance policy protecting any of the Company
Group's assets to lapse, other than in connection with such lapse a
replacement policy having comparable deductions and providing coverage equal
to or greater than the coverage under the lapsed policy for
substantially similar premiums or less is in full force and effect;

  



  

(xiii) except in the ordinary course of business and consistent with past
practice (A) adopt or amend any Company Plan, other than as required to
maintain the qualified status of such Company Plan under the Code, or to pay
a routine claim for health and welfare benefits or (B) increase
compensation or pay any special bonus or other remuneration to any current or
former employee, director or other natural person service provider of the
Company Group (other than annual or quarterly bonuses in the Ordinary Course
of Business, annual compensation increases in the Ordinary Course of Business
or in connection with new hires (in compliance with clause (xiv) in the
Ordinary Course of Business), but in any event only to the extent there
results no more than $3,500,000 in aggregate in cost to the Company;

  



  

(xiv) (A) hire any individual as a Company Employee with an annual cash
compensation of over $250,000, other than to (1) fill an open position listed
on Schedule 6.1(a)(xiv)or (2) replace a Company Employee whose employment
terminates after the date of this Agreement, in each case with
compensation and benefits that are no more favorable than similarly situated
Company Employees; or (B) terminate the employment of any Company Employee at
or above the level of Senior Vice President, other than for cause;

  



  

(xv) modify, extend, or enter into any labor agreement, collective bargaining
agreement or any other labor-related agreements or arrangements with any labor
union, labor organization or works council, or recognize or certify any labor
union, labor organization, works council, or group of employees as the
bargaining representative for any Company Employees;

  



  

(xvi) waive the restrictive covenant obligations of any Company Employee;

  



  

(xvii) institute, settle or agree to settle any litigation, action,
proceeding or investigation before any court or Authority in each case in
excess of $250,000 (exclusive of any amounts covered by insurance) or that
imposes injunctive or other non-monetary relief on the Company;

  



  

(xviii) make any change in its financial accounting principles or methods;

  



  

(xix) change the place of business or jurisdiction of organization of the
Company;

  



  

(xx) extend any material loans to employees other than travel or other
expense advances to employees in the ordinary course of business;

  



  

   

61

 



    



  

(xxi) issue, redeem or repurchase any capital stock, membership interests or
other securities, or issue any securities exchangeable for or convertible into
any shares of its capital stock or other securities except subject to (vi)
above, in connection with obtaining any loans or grants in the Ordinary
Course of Business or issuance of Company Options in the ordinary course of
business or Company Common Stock in connection with exercise of Company
Options;

  



  

(xxii) (A) make or change any material election in respect of material Taxes,
(B) materially amend, modify or otherwise change any filed material Tax
Return, (C) adopt or request permission of any taxing authority to change any
material accounting method in respect of Taxes, (D) enter into any closing
agreement in respect of material Taxes or enter into any Tax sharing or
similar agreement (other than any such agreement entered into in the Ordinary
Course of Business not primarily related to Taxes), (E) settle any claim or
assessment in respect of material Taxes, (F) surrender or allow to expire any
right to claim a refund of material Taxes (other than a refund resulting from
any Tax credit that may have been permitted to be but was not claimed under
the FFCRA or CARES Act) or (G) consent to any extension or waiver of the
limitation period applicable to any claim or assessment in respect of material
Taxes or in respect to any material Tax attribute that would give rise to any
claim or assessment of Taxes (other than in connection with a
customary extension of the due date for filing a Tax Return obtained in the
Ordinary Course of Business);

  



  

(xxiii) take any action, or knowingly fail to take any action, which action
or failure to act could reasonably be expected to prevent the Merger from
qualifying as a "reorganization" within the meaning of Section 368(a) of the
Code and the Treasury Regulations promulgated thereunder; or

  



  

(xxiv) agree to do any of the foregoing.

  



  

Nothing herein shall require the Company to obtain consent from the Purchaser
to do any of the foregoing if obtaining such consent might reasonably be
expected to violate applicable Law, and nothing contained in this _Section
6.1(a)_ shall give to the Purchaser, directly or indirectly, the right to
control or direct the ordinary course of business operations of the Company
prior to the Closing Date. Prior to the Closing Date, each of the Purchaser
and the Company shall exercise, consistent with the terms and conditions
hereof, complete control and supervision of its respective operations.

  



  

(b) Without limiting the generality of the foregoing, during the Interim
Period, without the Company's prior written consent (which shall not be
unreasonably withheld, conditioned or delayed), except as required by
applicable Law or as contemplated by this Agreement, the Purchaser and Merger
Sub shall not:

  



  

(i) amend, modify or supplement its certificate of incorporation and bylaws
or other organizational or governing documents;

  



  

(ii) amend, waive any provision or terminate prior to its scheduled
expiration date, or otherwise compromise in any way, any material contract or
any other material right or asset of the Purchaser or Merger Sub or any other
contract which (A) is with respect to Real Property, (B) extends for a term
of one (1) year or more or (C) obligates the payment of more than $500,000
(individually or in the aggregate);

  



  

   

62

 



    



  

(iii) make any capital expenditures;

  



  

(iv) pay, declare or promise to pay any dividends or other distributions with
respect to its capital stock or other equity securities;

  



  

(v) obtain or incur any loan or other Indebtedness other than (A) accounts
payable, (B) accrued liabilities in the ordinary course of business consistent
with past practice, (C) Permitted Liens and (D) working capital loans;

  



  

(vi) suffer or incur any Lien, except for Permitted Liens, on the Purchaser's
or Merger Sub's assets;

  



  

(vii) merge or consolidate with or acquire (by purchasing a substantial
portion of the assets of or equity in, or by any other manner) any other
Person or be acquired by any other Person;

  



  

(viii) liquidate, dissolve, reorganize or otherwise wind up the business or
operations of the Purchaser or Merger Sub;

  



  

(ix) permit any material insurance policy protecting any of the Purchaser's
or Merger Sub's assets to lapse, other than in connection with such lapse a
replacement policy having comparable deductions and providing coverage equal
to or greater than the coverage under the lapsed policy for substantially
similar premiums or less is in full force and effect;

  



  

(x) enter into, renew or amend in any material respect, any transaction or
Contract with an Affiliate of the Purchaser or Merger Sub (including, for the
avoidance of doubt, (A) the Sponsors or anyone related by blood, marriage or
adoption to any Sponsor and (B) any Person in which any Sponsor has a direct
or indirect legal, contractual or beneficial ownership interest of five
percent (5%) or greater);

  



  

(xi) institute, settle or agree to settle any litigation, action, proceeding
or investigation before any court or Authority in each case in excess of
$250,000 (exclusive of any amounts covered by insurance) or that imposes
injunctive or other non-monetary relief on the Purchaser or Merger Sub;

  



  

(xii) make any change in its financial accounting principles or methods;

  



  

(xiii) change its place of business or jurisdiction;

  



  

(xiv) issue, redeem or repurchase any capital stock, or other securities, or
issue any securities exchangeable for or convertible into any shares of its
capital stock or other securities;

  



  

   

63

 



    



  

(xv) amend, modify or waive any of the terms or rights set forth in, any
Purchaser Warrant or the applicable warrant agreement, including any
amendment, modification or reduction of the warrant exercise price set forth
therein;

  



  

(xvi) (A) make or change any material election in respect of material Taxes,
(B) materially amend, modify or otherwise change any filed material Tax
Return, (C) adopt or request permission of any taxing authority to change any
material accounting method in respect of Taxes, (D) enter into any closing
agreement in respect of material Taxes or enter into any Tax sharing or
similar agreement other than any such agreement entered into in the ordinary
course of business not primarily related to Taxes), (E) settle any claim or
assessment in respect of material Taxes, (F) surrender or allow to expire any
right to claim a refund of material Taxes (other than a refund resulting from
any Tax credit that may have been permitted to be but was not claimed under
the FFCRA or CARES Act) or (G) consent to any extension or waiver of the
limitation period applicable to any claim or assessment in respect of material
Taxes or in respect to any material Tax attribute that would give rise to any
claim or assessment of Taxes (other than in connection with a
customary extension of the due date for filing a Tax Return obtained in the
ordinary course of business);

  



  

(xvii) take any action, or knowingly fail to take any action, which action or
failure to act could reasonably be expected to prevent the Merger from
qualifying as a "reorganization" within the meaning of Section 368(a) of the
Code and the Treasury Regulations promulgated thereunder;

  



  

(xviii) amend, waive or otherwise change the Trust Agreement in any manner
adverse to the Purchaser; or

  



  

(xix) agree to do any of the foregoing.

  



  

Nothing herein shall require the Purchaser to obtain consent from the Company
to do any of the foregoing if obtaining such consent might reasonably be
expected to violate applicable Law, and nothing contained in this _Section
6.1(b)_ shall give to the Company, directly or indirectly, the right to
control or direct the ordinary course of business operations of the Purchaser
prior to the Closing Date. Prior to the Closing Date, each of the Company and
the Purchaser shall exercise, consistent with the terms and conditions hereof,
complete control and supervision of its respective operations.

  



  

(c) In the event that the Company seeks consent pursuant to _Section 6.1(a)_
or the Purchaser seeks consent pursuant to _Section 6.2(b)_ above, the Company
or the Purchaser, as applicable, shall (in lieu of _Section 11.1_ ) send a
written request via electronic mail to moses.makunje@nuvationbio.com or
oleg@ecor1cap.com, respectively. In the event that the Company or the
Purchaser, as the case may be, does not receive a response within five (5)
Business Days of such written request, the Purchaser or the Company, as
applicable, shall be deemed to have provided such consent.

  



  

   

64

 



    



  

6.2 _Annual and Interim Financial Statements_. Each of the Company Group and
the Purchaser shall provide the other Party with its consolidated balance
sheet, income statements, and other financial information necessary for
inclusion in any Purchaser SEC Document and/or the Registration Statement no
later than November 30, 2020, all prepared in accordance with GAAP and
compliant with SEC requirements, except as otherwise indicated in such
statements and subject to year-end audit adjustments and omission of notes.

  



  

6.3 _Trust Account_. The Purchaser covenants that it shall make appropriate
arrangements to cause the funds in the Trust Account to be disbursed
in accordance with the Trust Agreement and for the payment of (a) all amounts
payable to stockholders holding the Purchaser Units or shares of the
Purchaser Common Stock who shall have validly redeemed their the Purchaser
Units or shares of the Purchaser Common Stock upon acceptance by the
Purchaser of such Purchaser Units or shares of the Purchaser Common Stock, (b)
the expenses to the third parties to which they are owed, (c) the Deferred
Underwriting Amount to the underwriter in the IPO and (d) the
remaining monies in the Trust Account to the Purchaser.

  



  

6.4 _Purchaser Public Filings_. During the Interim Period, the Purchaser will
keep current and timely file all of its public filings with the SEC and
otherwise comply in all material respects with applicable securities Laws and
shall use reasonable best efforts to maintain the listing of the Purchaser
Securities on the NYSE. Prior to the Effective Time, the Purchaser shall (a)
to the extent required by the rules and regulations of the NYSE, prepare and
submit to the NYSE a notification form for the listing of the
Transaction Securities, and to cause such shares to be conditionally approved
for listing (subject to official notice of issuance and any requirement to
have a sufficient number of round lot holders of the Purchaser Class A Common
Stock) and (b) to the extent required under the rules and regulations of the
NYSE, to file an initial listing application for the Purchaser Class A Common
Stock on the NYSE (the " _NYSE Listing Application_ ") and to cause such NYSE
Listing Application to be approved prior to the Closing.

  



  

6.5 _Form 8-K; Press Releases_.

  



  

(a) As promptly as practicable after execution of this Agreement, the
Purchaser will prepare and file a "Current Report" on Form 8-K pursuant to the
Exchange Act to report the execution of this Agreement, which the Company may
review and comment upon prior to filing. Promptly after the execution of this
Agreement, the Purchaser and the Company shall also issue a joint press
release announcing the execution of this Agreement and shall file such joint
press release on a "Current Report" on Form 8-K.

  



  

(b) Prior to the Closing, the Purchaser and the Company shall prepare a
mutually agreeable press release announcing the consummation of the Merger
(the " _Closing Press Release_ "). Concurrently with the Closing, the
Purchaser shall distribute the Closing Press Release.

  



  

6.6 _Section 16 of the Exchange Act_. Prior to the Closing, the Purchaser
Board, or an appropriate committee thereof, shall adopt a
resolution consistent with the interpretive guidance of the SEC relating to
Rule 16b-3(d) under the Exchange Act, such that the acquisition of the
Purchaser Common Stock pursuant to this Agreement by any officer or director
of the Company who is expected to become a "covered person" of the Purchaser
for purposes of Section 16 of the Exchange Act (" _Section 16_ ") shall be
exempt acquisitions for purposes of Section 16.

  



  

   

65

 



    



  

6.7 _No Solicitation_. During the Interim Period, none of the Purchaser Board
or the Purchaser and Merger Sub, on the one hand, or the Company or any of
its Subsidiaries, or the Company's board of directors (the " _Company Board_
"), on the other hand, will, nor will they authorize or permit any of their
respective Representatives to, directly or indirectly, (a) solicit, initiate
or knowingly encourage, support, facilitate or induce the making, submission
or public announcement of any inquiry, indication of interest, proposal or
offer that constitutes, or could reasonably be expected to lead to, an
Acquisition Proposal, (b) enter into, participate in, maintain or continue
any communications (except solely to provide written notice as to the
existence of these provisions) or negotiations regarding, or deliver or make
available to any Person any non-public information with respect to, or
knowingly take any other action regarding, any inquiry, indication of
interest, proposal or offer that constitutes, or could reasonably be expected
to lead to, an Acquisition Proposal, (c) agree to, accept, approve, endorse or
recommend (or publicly propose or announce any intention or desire to agree
to, accept, approve, endorse or recommend) any Acquisition Proposal, (d) in
the case of the Purchaser, fail to include the Purchaser Board Recommendation
in (or remove from) the Registration Statement, (e) enter into any agreement
in principle, letter of intent, term sheet or any other agreement,
understanding or contract (whether binding or not) contemplating or otherwise
relating to any Acquisition Proposal, (f) submit any Acquisition Proposal to
the vote of any securityholders of the Purchaser, the Company or any of its
Subsidiaries (as applicable), (g) withhold, withdraw, qualify, amend or
modify (or publicly propose or announce any intention or desire to withhold,
withdraw, qualify, amend or modify), in a manner adverse to the other Party,
the approval of such Party's board of directors of this Agreement and/or any
of the Transactions, or, in the case of the Purchaser, the Purchaser Board
Recommendation, (h) approve any transaction, or any third party becoming an
"interested stockholder", under applicable Laws or (i) resolve, propose or
agree to do any of the foregoing (any of the actions described in clauses
(c)-(i), a " _Change of Recommendation_ "). Both the Company and the
Purchaser and Merger Sub shall, and shall cause their respective
Representatives to, immediately cease any and all existing activities,
discussions or negotiations with any Persons conducted prior to or on the date
of this Agreement with respect to any Acquisition Proposal. Each of the
Purchaser and the Company shall notify the other Party within 48 hours of the
receipt by such Party or any of its Representatives of any bona fide
inquiries, proposals or offers, requests for information or requests for
discussions or negotiations that constitutes or could reasonably be expected
to constitute an Acquisition Proposal, including a correct and complete copy
thereof if in writing or a written summary of the material terms thereof if it
is not in writing, and the identity of the party making such inquiry,
proposal, offer or request for information. If a Representative of either
Party, whether in his, her or its capacity as such or in any other capacity,
takes any action that such Party is obligated pursuant to this _Section 6.7_
not to take, then such Party shall be deemed for all purposes of this
Agreement to have breached this _Section 6.7_.

  



  

6.8 _Tax Matters_.

  



  

(a) All Transfer Taxes that may become due and payable as a result of the
Transactions, levied on the Purchaser or the Company, shall be paid fifty
percent (50%) by the Purchaser and fifty percent (50%) by the Company. The
Purchaser will file all necessary Tax Returns and other documentation with
respect to all such Transfer Taxes and any expenses incurred in connection
with the filing of such Tax Returns or other documentation shall be paid
(50%) by the Purchaser and fifty percent (50%) by the Company. If required by
applicable Law, the Company will join the Purchaser in the execution of any
such Tax Return and other documentation.

  



  

   

66

 



    



  

(b) The parties intend that, for United States federal income tax purposes,
the Merger will qualify as a "reorganization" within the meaning of Section
368(a) of the Code and the Treasury Regulations to which each of the
Purchaser and the Company are parties under Section 368(b) of the Code and
the Treasury Regulations and this Agreement is intended to be, and is adopted
as, a plan of reorganization for purposes of Sections 354, 361 and the 368 of
the Code and within the meaning of Treasury Regulations Sections 1.368-2(g)
and 1.368-3(a). The Merger shall be reported by the parties for all Tax
purposes in accordance with the foregoing, unless otherwise required by
an Authority as a result of a "determination" within the meaning of Section
1313(a) of the Code. The parties shall cooperate with each other and their
respective counsel to document and support the Tax treatment of the Merger as
a "reorganization" within the meaning of Section 368(a) of the Code and each
party shall use its reasonable best efforts to execute and deliver to counsel
of the Company and the Purchaser letters of representation customary for
transactions of this type and reasonably satisfactory to counsel of the
Company and the Purchaser, at such time or times as such counsel shall
reasonably request, including in connection with the filing and/or
effectiveness of the Registration Statement.

  



  

(c) At the Closing, the Company shall deliver to the Purchaser a certificate
on behalf of the Company, prepared in a manner consistent and in accordance
with the requirements of Treasury Regulation Sections 1.897-2(h)(2) and
1.1445-2(c)(3), certifying that no interest in the Company is, or has been
during the relevant period specified in Section 897(c)(1)(A)(ii) of the Code,
a "U.S. real property interest" within the meaning of Section 897(c) of the
Code, and a form of notice to the IRS prepared in accordance with the
provisions of Treasury Regulations Section 1.897-2(h)(2), together with
written authorization for the Purchaser to deliver such documentation to the
Internal Revenue Service on behalf of the Company after the Closing.

  



  

6.9 _Regulatory Compliance_.

  



  

(a) As promptly as practicable after execution and delivery of this
Agreement, the Purchaser and Company shall each use its reasonable best
efforts, and shall cooperate with each other, to take, or cause to be taken,
all actions, and to do, or cause to be done, all things necessary, appropriate
or desirable to consummate the Transactions, including and in no event later
than ten (10) Business Days thereafter in the case of the HSR Act, the
Purchaser and the Company shall execute and file, or join in the execution and
filing of, any application, notification (including the provision of any
required information in connection therewith) or other document that may be
required under the HSR Act, in order to obtain the authorization, approval or
consent of any Authority, or expiration or termination of the waiting periods
under such Laws, that may be reasonably required, in connection with the
consummation of the Transactions.

  



  

   

67

 



    



  

(b) The Purchaser and the Company shall cooperate with each other and shall
each use its respective reasonable best efforts to obtain promptly all
authorizations, approvals, consents, expirations or terminations of
applicable waiting periods necessary or advisable for the consummation of this
Agreement. Each of the Parties will furnish to the other Parties such
information and assistance as may be reasonably requested in connection
with the foregoing, including by: (i) timely furnishing to each other all
information required to be included in such documents; (ii) to the extent not
prohibited by such Authority and practicable, keeping each other reasonably
informed of any communication received by such Party from, or given by such
Party to, any Authority, and promptly providing each other with copies of all
written communications to or from any Authority; (iii) responding promptly to
and complying with any reasonable request for additional information
or documents; (iv) to the extent practicable, permitting the Company or the
Purchaser (as the case may be) to review in advance and consider in good
faith incorporating the other Party's reasonable comments in any communication
given by it to any Authority; and (v) to the extent there are any meetings or
substantive calls with any Authority, the Company and the Purchaser shall
each permit the other to attend such meetings or calls unless prohibited by
such Authority; _provided_ that materials required to be provided pursuant to
this _Section 6.9(b)_ may be limited to outside counsel and may be redacted
(i) to remove references to privileged information, (ii) the valuation of the
Company, and (iii) as necessary to comply with contractual arrangements.

  



  

(c) Notwithstanding the foregoing, nothing in this Section 6.9 or otherwise
in this Agreement shall require the Purchaser, any Purchaser Affiliate, or the
Company to propose, negotiate, effect or agree to, the sale, divestiture,
license or other disposition of any assets or businesses of the
Purchaser, any Purchaser Affiliate, or the Company or otherwise take any
action that limits the freedom of action with respect to, or its ability to
retain any of the businesses, product lines or assets of the Purchaser or any
Purchaser Affiliate, or the Company.

  



  

(d) All fees and payments required to be made to any Authority in accordance
with this _Section 6.9_, whether under the HSR Act, shall be paid fifty
percent (50%) by the Purchaser and fifty percent (50%) by the Company.

  



  

(e) No Party hereto shall take any action that could reasonably be expected
to adversely affect or materially delay the approval of any Authority, or the
expiration or termination of any waiting period of any required filings or
applications under any Laws relating to antitrust, including by agreeing to
merge with or acquire any other person or acquire a substantial portion of
the assets of or equity in any other person. The Parties hereto further
covenant and agree, with respect to a threatened or pending preliminary or
permanent injunction or other order, decree or ruling or statute, rule,
regulation or executive order that would adversely affect the ability of the
parties to consummate the Transactions, to use reasonable best efforts to
prevent or lift the entry, enactment or promulgation thereof, as the case
may be.

  



  

6.10 _Employment Agreements_. Prior to the Closing, the Company may enter
into employment agreements with such officers of the Company employed by the
Company as of the date of this Agreement, and on such terms as shall not be in
the aggregate, materially different from the terms of such officer's
employment (inclusive of rights of such officer under Plans and policies) as
of the date of this Agreement, as shall be reasonably determined by the
Company (provided, for the avoidance of doubt, that failure to enter into any
such employment agreements shall not be a breach of this Agreement).

  



  

6.11 _Registration Rights Agreement._ Prior to the Closing, the Company may
cause the Stockholders listed on _Schedule 6.11_ to deliver, or cause to be
delivered, to the Purchaser duly executed counterpart signature pages to the
Registration Rights Agreement.

  



  

   

68

 



    



  

Article VII _ 
 COVENANTS OF THE COMPANY AND THE PURCHASER_

  



  

The Company and the Purchaser acknowledge and agree that:

  



  

7.1 _Access to Information_. During the Interim Period, each of the Company
and the Purchaser shall (a) continue to give the other Party, its legal
counsel and other representatives reasonable access during normal business
hours to the offices, properties and Books and Records of such Party, (b)
furnish to the other Party, its legal counsel and other representatives such
information relating to the business of the Company Group and the Purchaser
as such Persons may reasonably request and (c) cause its employees, legal
counsel, accountants and representatives to cooperate with the other Party in
its investigation of such Party's business; _provided_ that no investigation
pursuant to this _Section 7.1 _(or any investigation prior to the date
hereof) shall affect any representation or warranty given by the Company or
the Purchaser and, _provided_ , _further_ , that any investigation pursuant to
this  _Section 7.1_ shall be conducted in such manner as not to interfere
unreasonably with the conduct of the business of the Company or the Purchaser
during normal business hours under the supervision of appropriate personnel of
the Company. Nothing herein shall require a Party to disclose or provide
access to any information (a) which primarily relates to the negotiation
of this Agreement or the Transactions or (b) that could be detrimental to
such Party's business or operations or if such disclosure could, in its
reasonable discretion (i) jeopardize any attorney-client or other legal
privilege (so long as such Party has reasonably cooperated with the other
Party to permit such inspection of or to disclose such information on a basis
that does not waive such privilege with respect thereto), or (ii) contravene
any applicable Law, including those related to antitrust, or binding
agreement entered into prior to the date of this Agreement (including any
confidentiality agreement to which the Company or the Purchaser is a party).

  



  

7.2 _Notices of Certain Events_. During the Interim Period, each of the
Company and the Purchaser shall promptly notify the other Party in writing
of:

  



  

(a) any notice or other communication from any Person alleging that the
consent of such Person is or may be required in connection with the
Transactions or that the Transactions might give rise to any Action or other
rights by or on behalf of such Person or result in the loss of any rights or
privileges of the Company (or the Purchaser, post-Closing) to any such Person
or create any Lien (other than Permitted Liens) on any Company Common Stock,
the Purchaser Common Stock, Merger Sub Common Stock or any of the Company
Group's or the Purchaser's or Merger Sub's assets;

  



  

(b) any notice or other communication from any Authority in connection with
the Transactions contemplated by this Agreement or the Additional Agreements;

  



  

   

69

 



    



  

(c) any Actions commenced or threatened in writing against, involving the
Company, the Purchaser, Merger Sub, the Company Common Stock, the Purchaser
Common Stock, Merger Sub Common Stock or the Company's or the Purchaser's or
Merger Sub's assets or the Business or that relate to the consummation of the
Transactions (shareholder demands or other shareholder proceedings (including
derivative claims) that relate to the consummation of the Transactions
contemplated by this Agreement or the Additional Agreements, " _Transaction
Litigation_ ") following which the Purchaser and the Company shall each (i)
keep the other reasonably informed regarding any Action, (ii) give the other
the opportunity to, at its own cost and expense, participate in the defense,
settlement and compromise of any such Action that is a Transaction Litigation
and reasonably cooperate with the other in connection with the defense,
settlement and compromise of any Transaction Litigation, (iii) consider in
good faith the other's advice with respect to any Transaction Litigation and
(iv) reasonably cooperate with each other; provided however, that the
Purchaser and the Company shall jointly control the negotiation, defense and
settlement of any Transaction Litigation;  _provided_ , _further_ , however,
that in no event shall the Purchaser, on the one hand, or the Company, on the
other hand, settle or compromise any Transaction Litigation without the prior
written consent of the other Party (not to be unreasonably
withheld, conditioned or delayed);

  



  

(d) the occurrence of any fact or circumstance which constitutes or results,
or is reasonably be expected to constitute or result, in a Material Adverse
Effect or Purchaser Material Adverse Effect; and

  



  

(e) the occurrence of any fact or circumstance that renders any
representation or warranty under _Article IV_ by the Company or _Article V_
by the Purchaser untrue or inaccurate such that the conditions set forth in
_Sections 9.2(b)_ or _9.3(b)_ , respectively, would not be satisfied.

  



  

No such notice shall constitute an acknowledgement or admission by the Party
providing the notice regarding whether or not any of the conditions to the
Closing have been satisfied or in determining whether or not any of the
representations, warranties or covenants contained in this Agreement have been
breached.

  



  

7.3 _Company IP Maintenance Filings and Payments_. From and after the date of
this Agreement and prior to the Closing Date, Company shall, and shall cause
each other member of the Company Group to, in good faith and with reasonable
care and diligence and at its own expense, take actions (including payment of
fees or filing of documents) that must be taken within three (3) months after
the Closing Date for the purposes of obtaining, maintaining, perfecting, or
renewing any existing rights in any Company IP.

  



  

   

70

 



    



  

Article VIII _ 
 COVENANTS OF ALL PARTIES HERETO_

  



  

The Parties hereto covenant and agree that:

  



  

8.1 _Registration Statement_.

  



  

(a) As soon as reasonably practicable after the date hereof, the Purchaser
and the Company shall prepare and the Purchaser shall file a preliminary
Registration Statement (in which a proxy statement (the " _Proxy Statement_
") shall be included as a prospectus), with the SEC for purposes of (i)
approval of the Business Combination and the other Transactions, (ii) approval
of the Purchaser Charter (the " _Purchaser Charter Amendment_ "), (iii)
approval, on a non-binding advisory basis, of certain differences between the
Purchaser's current certificate of incorporation and the Purchaser Charter in
accordance with the requirements of the SEC, (iv) approval of the issuance of
more than 20% of the issued and outstanding shares of the Purchaser Common
Stock pursuant to this Agreement, pursuant to NYSE requirements, (v) election
of directors of the Purchaser in accordance with _Section 8.12_ , (vi)
approval of the Equity Incentive Plan, (vii) approval of the Purchase Plan,
and (viii) approval of any adjournment of the Purchaser Stockholder
Meeting in the event the Purchaser does not receive the requisite vote to
approve the matter set forth in _clause (i)-(vii)_ above and (ix) any other
proposals the Parties deem necessary or desirable to consummate the
Transactions (the approvals described in foregoing clauses (i) through (ix),
collectively, the " _Purchaser Stockholder Matters_ "). Each of the Purchaser
and the Company agrees to use their respective reasonable best efforts to
cause the Registration Statement to be declared effective under the
Securities Act as soon as reasonably practicable after filing thereof. Each
of the Purchaser and the Company agrees to furnish to the other party all
information concerning itself, its Subsidiaries, officers, directors and
stockholders and such other matters as may be reasonably necessary or
advisable or as may be reasonably requested in connection with the
Registration Statement, Proxy Statement, a Current Report on Form 8-K pursuant
to the Exchange Act in connection with the Transactions, or any other
statement, filing, notice or application made by or on behalf of the
Purchaser, the Company or their respective Subsidiaries to any regulatory
authority (including the NYSE) in connection the Transactions, including the
Merger (the " _Offer Documents_ "). The Registration Statement, Proxy
Statement and any other Offer Documents shall be in a form mutually agreed by
the Purchaser and the Company. The Purchaser will advise the Company, promptly
after the Purchaser receives notice thereof, of the time when the
Registration Statement has become effective or any supplement or
amendment has been filed, of the issuance of any stop order or the suspension
of the qualification of the Purchaser Common Stock for offering or sale in
any jurisdiction, of the initiation or written threat of any proceeding for
any such purpose, or of any request by the SEC for the amendment or
supplement of the Registration Statement or for additional information. The
Purchaser shall cause the Proxy Statement to be mailed to its stockholders of
record, as of the record date to be established by the Purchaser Board and in
compliance with _Section 8.2_ , as promptly as practicable (but in no event
later than three (3) Business Days following effectiveness except as
otherwise required by applicable Law) following the Registration Statement
becoming declared effective under the Securities Act. The Purchaser will
cause all documents that it is responsible for filing with the SEC or other
regulatory authorities in connection with the Merger to (i) comply as to form
with all applicable SEC requirements and (ii) otherwise comply in all
material respects with all applicable Law.

  



  

(b) The Purchaser will notify the Company promptly of the receipt of any
comments (written or oral) from the SEC or its staff with respect to the
Registration Statement, the Proxy Statement or Offer Documents and of any
request by the SEC or its staff or any other official of any Authority for
amendments or supplements to the Registration Statements, the Proxy Statement
or Offer Documents, and will supply the Company with copies of all
correspondence between the Purchaser or any of its Representatives, on the one
hand, and the SEC, or its staff or any other official of any Authority, on
the other hand, with respect to the Registration Statements or Offer
Documents. The Purchaser shall permit the Company and its outside counsel to
participate in all material discussions and meetings with the SEC and its
staff relating to the Registration Statement, the Proxy Statement, this
Agreement or the Transactions. The Purchaser shall (i) consult with
the Company and obtain the Company's prior consent (such consent not to be
unreasonably withheld, conditioned or delayed) prior to providing a written
response to any comments or inquiries by the SEC or any other Authority with
respect to any filings related to the Merger, (ii) provide the Company and
its Representatives with reasonable opportunity to review and comment on any
such written response in advance and (iii) promptly inform the Company
whenever any event occurs that requires the filing of an amendment or
supplement to the Registration Statements, Proxy Statement or Offer Documents,
and the Purchaser shall provide the Company and its Representatives with a
reasonable opportunity to review and comment on any such amendment or
supplement in advance and obtain the Company's prior consent with respect to
such filing of an amendment or supplement to the Registration Statement or
Proxy Statement (such consent not to be unreasonably withheld, conditioned or
delayed), and shall cooperate in filing with the SEC or its staff or any
other official of any Authority, and/or mailing to the Purchaser's
stockholders, such amendment or supplement. The Company shall promptly inform
the Purchaser whenever the Company discovers any event relating to the
Purchaser or any of its Affiliates, officers or directors that is required to
be set forth in an amendment or supplement to the Registration
Statement, Proxy Statement or Offer Documents.

  



  

   

71

 



    



  

(c) In connection with any filing the Purchaser makes with the SEC that
requires information about the Transactions to be included, the Company will,
and will use reasonable best efforts to cause its Representatives, in
connection with the disclosure included in any such filing or the responses
provided to the SEC in connection with the SEC's comments to a filing, to use
reasonable best efforts to (i) cooperate with the Purchaser, (ii) respond to
questions about the Company required in any filing or requested by the SEC in
a timely fashion, and (iii) promptly provide any information requested by the
Purchaser or the Purchaser's Representatives in connection with any filing
with the SEC.

  



  

(d) If, at any time prior to the Purchaser Stockholder Meeting, there shall
be discovered any information that should be set forth in an amendment or
supplement to the Registration Statement so that the Registration Statement
would not include any misstatement of a material fact or omit to state any
material fact necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading, the Purchaser shall
promptly file an amendment or supplement to the Registration Statement
containing such information. If, at any time prior to the Closing, the
Company discovers any information, event or circumstance relating to the
Company, its business or any of its Affiliates, officers, directors or
employees that should be set forth in an amendment or a supplement to the
Registration Statement so that the Registration Statement would not include
any misstatement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, then the Company shall promptly inform
the Purchaser of such information, event or circumstance.

  



  

   

72

 



    



  

8.2 _Purchaser Stockholder Meeting; Board Recommendation_.

  



  

(a) Prior to or as soon as reasonably practicable after the Registration
Statement is declared effective under the Securities Act, the Purchaser shall,
in accordance with applicable Law, NYSE rules, the Purchaser Charter and the
Purchaser Bylaws, establish a record date for (which date shall be mutually
agreed with the Company), duly call, give notice of, convene and hold a
meeting of the Purchaser's stockholders (including any adjournment or
postponement thereof, including for the purpose of soliciting additional
proxies in favor of the adoption of this Agreement, the " _Purchaser
Stockholder Meeting_ ") to be held as soon as reasonably practicable
following the date that the Registration Statement is declared effective under
the Securities Act for the sole purpose of obtaining approval of the
Purchaser Stockholder Matters (the " _Purchaser Stockholder Approval_ ")
(which meeting shall be held not more than twenty-five (25) days after the
date on which the Purchaser mails the Proxy Statement to its stockholders
unless otherwise agreed in writing between the Parties). The Purchaser will
use its reasonable best efforts to solicit from its stockholders proxies in
favor of the adoption of this Agreement and will take all other reasonable
action necessary or advisable to obtain such proxies with respect to the
Purchaser Stockholder Approval and to secure the vote or consent of its
stockholders required by and in compliance with all applicable Law and its
certificate of incorporation and bylaws. The Purchaser shall not adjourn or
postpone the Purchaser Stockholder Meeting without the prior written consent
of Company; _provided_ that the Purchaser may adjourn or postpone the
Purchaser Stockholder Meeting (i) to the extent necessary to ensure that any
supplement or amendment to the Registration Statement that the Purchaser
reasonably determines (following consultation with Company, except with
respect to any Acquisition Proposal) is necessary to comply with applicable
Laws, is provided to the Purchaser's stockholders in advance of a vote on the
adoption of this Agreement, (ii) if, as of the time that the
Purchaser Stockholder Meeting is originally scheduled, there are insufficient
shares of the Purchaser Common Stock represented at such meeting (either in
person or by proxy) to constitute a quorum necessary to conduct the business
of the Purchaser Stockholder Meeting or (iii) if, as of the time that the
Purchaser Stockholder Meeting is originally scheduled, adjournment or
postponement of the Purchaser Stockholder Meeting is necessary to enable the
Purchaser to solicit additional proxies required to obtain the Purchaser
Stockholder Approval; _provided_ that the Purchaser may postpone or adjourn
on one (1) occasion so long as the date of the Purchaser Stockholder Meeting
is not postponed or adjourned more than an aggregate of 15 consecutive
calendar days in connection with such postponement or adjournment.

  



  

(b) (i) the Registration Statement shall include a statement to the effect
that the Purchaser Board has unanimously recommended that the Purchaser's
stockholders vote in favor of the Purchaser Stockholder Matters at the
Purchaser Stockholder Meeting and (ii) neither the Purchaser Board nor any
committee thereof shall withhold, withdraw, qualify, amend or modify, or
publicly propose or resolve to withhold, withdraw, qualify, amend or modify,
the Purchaser Board Recommendation.

  



  

8.3 _Further Assurances_. Subject to the terms and conditions of this
Agreement, each Party shall use its commercially reasonable efforts to take,
or cause to be taken, all actions and to do, or cause to be done, all things
necessary or desirable under applicable Laws to consummate and implement
expeditiously each of the Transactions. The Parties hereto shall execute and
deliver, or cause to be executed and delivered, such other documents,
certificates, agreements and other writings and take such other actions as may
be necessary or desirable in order to consummate or implement expeditiously
each of the Transactions. For the avoidance of doubt,
notwithstanding anything to the contrary in this Agreement, nothing herein
(including this _Section 8.3_ ) shall require the Company to use efforts to
cause, or attempt to cause, any purchase of any Purchaser Class A Common Stock
pursuant to the terms of any Subscription Agreement.

  



  

8.4 _Company Stockholder Approval_. Unless this Agreement has been terminated
in accordance with _Article 9.3(g)_ , upon the terms set forth in this
Agreement, the Company shall seek the irrevocable written consent, in form and
substance reasonably acceptable to the Purchaser, of Stockholders sufficient
to approve the adoption of this Agreement, the Merger and the other
Transactions in favor of the approval and adoption of this Agreement, the
Merger and the other Transactions (the " _Written Consent_ ") no later
than five (5) Business Days after the Registration Statement has been
declared effective by the SEC.

  



  

   

73

 



    



  

8.5 _Compliance with SPAC Agreements_. The Purchaser shall comply with each
of the agreements entered into in connection with the IPO.

  



  

8.6 _Confidentiality_. The Purchaser and the Company acknowledge that they
are parties to the Confidentiality Agreement, the terms of which are
incorporated herein by reference. Except as necessary to complete the
Registration Statement or the PIPE Investment, the Company, on the one hand,
and the Purchaser and Merger Sub, on the other hand, shall hold and shall
cause their respective representatives to hold in strict confidence, unless
compelled to disclose by judicial or administrative process or by other
requirements of Law, all documents and information concerning the other Party
furnished to it by such other Party or its representatives in connection with
the Transactions (except to the extent that such information can be shown to
have been (a) previously known by the Party to which it was furnished, (b) in
the public domain through no fault of such Party or (c) later lawfully
acquired from other sources on a non-confidential basis, which source is not
the agent of the other Party, by the Party to which it was furnished,
without any breach by such source of any obligation of confidentiality to the
other Party), and each Party shall not release or disclose such information
to any other person, except its representatives in connection with this
Agreement. In the event that any Party believes that it is required to
disclose any such confidential information pursuant to applicable Laws, to the
extent permitted by applicable Law, such Party shall give timely written
notice to the other Party (which, for clarity, shall in the case of
the Company be to the Purchaser and in the case of the Purchaser be to the
Company) so that such Party may have an opportunity to obtain a protective
order or other appropriate relief, and such Party shall only disclose the
minimum amount of such confidential information so required to be disclosed.
The Parties acknowledge that some previously confidential information will be
required by applicable Law to be disclosed in the Registration Statement. The
Company acknowledges that, in connection with the PIPE Investment, the
Purchaser shall be entitled to disclose, pursuant to the Exchange Act, any
information contained in any presentation to the PIPE Investors, which
information may include confidential material; provided that, the Purchaser
provides the Company with a reasonable opportunity to review and provide
comments to such presentation and the Company consents to the contents
thereof.

  



  

8.7 _Indemnification; Insurance_.

  



  

(a) From and after the Closing Date and for a period of six years thereafter,
the Purchaser shall fulfill and honor in all respects the obligations pursuant
to any indemnification agreements between the Purchaser or the Company Group,
on the one hand, and any current or former directors, officers and
employees, as the case may be, of the Purchaser, the Company Group, on the
other hand, in effect on the date hereof and as set forth on
_Schedule 8.7(a)_ , and any indemnification provisions under the Purchaser
Charter or the Purchaser Bylaws, Company Charter Documents or the comparable
charter or organizational documents of any of its Subsidiaries as in effect on
the date hereof, in each case to the maximum extent permitted by Law, and
shall not amend, repeal or otherwise modify any such provision in any manner
that would adversely affect the rights of such indemnitee thereunder for any
acts or omissions occurring prior to the Closing Date. Prior to the Closing
Date, the Company shall enter into a directors' and officers' liability
insurance policy covering the current and former directors, officers and
employees, as the case may be, of the Company (the "Company _Insured Parties_
") on customary terms that are no less favorable to the Company Insured
Parties than those of any directors' and officers' liability insurance policy
maintained by the Company covering the Insured Parties as of the date of this
Agreement (such policy, a " _Company D andO Policy_"), for a period of six
(6) years after the Closing Date. All costs and expenses related to the
Company DandO Policy, including the insurance premiums, shall be paid by the
Company.

  



  

   

74

 



    



  

(b) Prior to the Closing Date, the Purchaser shall enter into a directors'
and officers' liability insurance policy covering the current and former
directors, officers and employees, as the case may be, of the Purchaser (the
" _Purchaser Insured Parties_") on customary terms that are no less favorable
to the Purchaser Insured Parties than those of any directors' and
officers' liability insurance policy maintained by the Purchaser covering the
Purchaser Insured Parties as of the date of this Agreement (such policy, a "
_Purchaser D andO Policy_"), for a period of six (6) years after the Closing
Date. All costs and expenses related to the Purchaser DandO Policy, including
the insurance premiums, shall be paid by the Purchaser.

  



  

(c) Notwithstanding anything contained in this Agreement to the contrary,
this _Section 8.7_ shall survive the consummation of the Transactions and
shall be binding, jointly and severally, on the Purchaser, the Company Group
and all successors and assignees of the Purchaser and the Company Group. In
the event that the Purchaser or any of its respective successors or assigns
(i) consolidates with or merges into any other Person and is not the
continuing or surviving corporation or entity of such consolidation or merger
or (ii) transfers or conveys all or substantially all its properties and
assets to any Person, the Purchaser shall cause proper provisions to be made
so that the successors and assigns of the Purchaser assume the obligations
set forth in this _Section 8.7_.

  



  

(d) The obligations of the Purchaser and the Company under this _Section
8.7_ shall not be terminated or modified in such a manner as to adversely
affect any indemnitee and/or Insured Party to whom this _Section 8.7_
applies without the express written consent of such affected indemnitee and
Insured Party. It is expressly agreed that the indemnitees and/or Insured
Parties to whom this _Section 8.7_ applies shall be third-party
beneficiaries of this _Section 8.7_.

  



  

(e) The Purchaser shall assume, be jointly and severally liable for, and
shall cause its Subsidiaries to honor, in accordance with their respective
terms, each of the covenants contained herein without limit as to time. The
rights of each indemnitee and/or Insured Party hereunder shall be in addition
to, and not in limitation of, any other rights such Person may have under the
Company Charter Documents or the comparable charter or organizational
documents of any member of the Company Group, or any other indemnification
arrangement or otherwise.

  



  

(f) On the Closing Date, the Purchaser shall enter into customary
indemnification agreements reasonably satisfactory to the Company with the
directors and officers of the Purchaser individuals set forth on _Schedule
8.7(f)_ (the " _Indemnification Agreements_ "), which indemnification
agreements shall continue to be effective following the Closing.

  



  

   

75

 



    



  

8.8 _PIPE Investment_. Unless otherwise approved in writing by the Company,
the Purchaser shall not permit any amendment or modification to be made
to, any waiver (in whole or in part) or provide consent to (including consent
to termination), of any provision or remedy under, or any replacements of,
any of the Subscription Agreements (which consent or approval shall not be
unreasonably withheld, conditioned or delayed). The Purchaser shall take, or
cause to be taken, all actions and do, or cause to be done, all things
necessary, proper or advisable to consummate the transactions contemplated by
the Subscription Agreements on the terms and conditions described therein,
including maintaining in effect the Subscription Agreements and to: (a)
satisfy in all material respects on a timely basis all conditions and
covenants applicable to the Purchaser in the Subscription Agreements and
otherwise comply with its obligations thereunder; (b) in the event that all
conditions in the Subscription Agreements (other than conditions that the
Purchaser or any of its Affiliates control the satisfaction of and other than
those conditions that by their nature are to be satisfied at the Closing)
have been satisfied, consummate transactions contemplated by the Subscription
Agreements at or prior to Closing; (c) confer with the Company regarding
timing of the expected Closing Date (as defined in the Subscription
Agreements); (d) deliver notices to counterparties to the Subscription
Agreements sufficiently in advance of the Closing to cause them to fund their
obligations as far in advance of the Closing as permitted by the Subscription
Agreements; and (e) without limiting the Company's rights to enforce certain
of such Subscription Agreements in the event that all conditions in the
Subscription Agreements (other than conditions that the Purchaser or any of
its Affiliates control the satisfaction of and other than those conditions
that by their nature are to be satisfied at the Closing) have been satisfied,
to cause the applicable PIPE Investors to pay to (or as directed by) the
Purchaser the applicable portion of the PIPE Investment Amount, as applicable,
set forth in the Subscription Agreements in accordance with their terms.
Without limiting the generality of the foregoing, the Purchaser shall give the
Company, prompt written notice: (a) of any breach or default (or any event or
circumstance that, with or without notice, lapse of time or both, could give
rise to any breach or default) by any party to any Subscription Agreement
known to the Purchaser; (b) of the receipt of any written notice or other
written communication from any party to any Subscription Agreement with
respect to any actual, potential, threatened or claimed expiration, lapse,
withdrawal, breach, default, termination or repudiation by any party to
any Subscription Agreement or any provisions of any Subscription Agreement;
and (c) if the Purchaser does not expect to receive all or any portion of the
PIPE Investment Amount on the terms, in the manner or from the PIPE Investors
as contemplated by the Subscription Agreements. The Purchaser shall deliver
all notices it is required to deliver under the Subscription Agreements on a
timely basis in order to cause the PIPE Investors to consummate the PIPE
Investment concurrently with the Closing and shall take all actions required
under any Subscription Agreements with respect to the timely issuance and
delivery of any physical certificates evidencing the shares of the Purchaser
Class A Common Stock as and when required under any such Subscription
Agreements.

  



  

8.9 _Additional Purchase Right_. In the event that at Closing the Available
Closing Purchaser Cash would not be sufficient to satisfy the condition in
_Section 9.3(d)_ , then Sponsor and its Affiliates shall have the right (but
not the obligation) to purchase immediately prior to the Closing additional
shares of the Purchaser Class A Common Stock, valued at $10.00 per share for
such purpose up to the amount of such deficiency subject to, substantially
the same terms and conditions set forth in the Subscription Agreements.

  



  

   

76

 



    



  

8.10 _Equity Incentive Plan and Purchase Plan_. Prior to the effectiveness of
the Registration Statement, the Purchaser shall approve, and subject to
approval of the stockholders of the Purchaser, adopt, (a) an equity incentive
plan that provides for grant of awards to employees and other service
providers of the Surviving Corporation and its Subsidiaries, with a total pool
of awards of the Purchaser Class A Common Stock not exceeding eighteen and
one half percent (18.5)% of the Fully-Diluted Purchaser Common Stock
immediately following the Closing (inclusive of the shares available for
issuance under such plan), with an annual "evergreen" increase of not more
than four percent (4%) of the Fully-Diluted Purchaser Common Stock outstanding
as of the day prior to such increase (inclusive of the shares available for
issuance under such plan) in a form otherwise mutually agreed by Purchaser and
the Company (the " _Equity Incentive Plan_ ") and (b) an employee stock
purchase plan, that provides for grant of purchase rights with respect to the
Purchaser Class A Common Stock to employees of the Surviving Corporation and
its Subsidiaries, with a total pool of shares of the Purchaser Class A Common
Stock not exceeding two percent (2%) of the Fully-Diluted Purchaser
Common Stock immediately following the Closing (inclusive of the shares
available for issuance under the plan), with an annual "evergreen" increase
of one percent (1%) of the Fully-Diluted Purchaser Common Stok outstanding as
of the day prior to such increase (inclusive of the shares available for
issuance under the plan), in a form otherwise mutually agreed by Purchaser and
the Company (the " _Purchase Plan_ "). " _Fully-Diluted Purchaser Common
Stock_ " means the aggregate number of (i) shares of Purchaser Class A Common
Stock, (ii) shares of Purchaser Class B Common Stock, and (iii) securities
convertible into or exercisable for Purchaser Common Stock.

  



  

8.11 _Continuing Employees_.

  



  

(a) For all purposes (including purposes of vesting, eligibility to
participate and level of benefits) under any Plan of the Surviving Corporation
or any of its Subsidiaries, solely to the extent such Plan provides benefits
to any Continuing Employee after the Closing Date (including the Company
Plans) (the " _New Plans_ "), each such Continuing Employee shall be credited
with his or her years of service with the Company or any of its Subsidiaries
and their respective predecessors before the Effective Time, to the same
extent as such Continuing Employee was entitled, before the Effective Time,
to credit for such service under any Company Plan in which such Continuing
Employee participated or was eligible to participate immediately prior to the
Closing Date; _provided_ that the foregoing service credit shall not be
required to apply (i) to the extent that its application would result in a
duplication of benefits with respect to the same period of service, (ii) for
purposes of any defined benefit pension accrual under any New Plan and (iii)
for purposes of any subsidy provided for any post-employment welfare benefits
under any New Plan. In addition, and without limiting the generality of the
foregoing, (i) each Continuing Employee shall be immediately eligible to
participate, without any waiting time, in any and all New Plans to the extent
coverage under such New Plan is replacing comparable coverage under a Company
Plan in which such Continuing Employee participated immediately before the
Closing Date (such plans, collectively, the " _Old Plans_ ") and (ii) for
purposes of each New Plan providing medical, dental, pharmaceutical and/or
vision benefits to any Continuing Employee, the Surviving Corporation shall,
or shall cause any of its Subsidiaries to, use commercially reasonable best
efforts to cause (A) all pre-existing condition exclusions and actively-at-
work requirements of such New Plan to be waived for such Continuing
Employee and his or her covered dependents, to the extent such conditions
were inapplicable or waived under the comparable Old Plans of the Company or
any of its Subsidiaries in which such Continuing Employee participated
immediately prior to the Closing Date and (B) any eligible expenses incurred
by any Continuing Employee and his or her covered dependents during the
portion of the plan year of the Old Plan ending on the date such Continuing
Employee's participation in the corresponding New Plan begins to be taken
into account under such New Plan for purposes of satisfying all deductible,
coinsurance and maximum out-of-pocket requirements applicable to such
Continuing Employee and his or her covered dependents for the applicable plan
year as if such amounts had been paid in accordance with such New Plan.

  



  

   

77

 



    



  

(b) Nothing in this _Section 8.11_ shall be treated as an amendment of, or
undertaking to amend, any Company Plan or any other Plan, program, agreement
or arrangement. The provisions of this _Section 8.11_ are solely for the
benefit of the Parties, and nothing in this _Section 8.11_ , express or
implied, shall confer upon any current or former director, officer, employee
or natural person service provider of any member of the Company Group or
legal representative or beneficiary thereof, or any other Person, any rights
or remedies, including any right to employment or continued employment for
any specified period, or compensation or benefits of any nature or kind
whatsoever, under this Agreement or any rights or remedies under any Company
Plan that such employee, representative, beneficiary or other Person would
not otherwise have under the terms of that Company Plan.

  



  

8.12 _Post-Closing Directors_. The Purchaser and the Company shall take all
reasonably necessary action so that immediately after the Effective Time, the
board of directors of the Purchaser is comprised of the individuals designated
on _Schedule 8.12_.

  



  

Article IX _ 
 CONDITIONS TO CLOSING_

  



  

9.1 _Condition to the Obligations of the Parties_. The obligations of all of
the Parties to consummate the Closing are subject to the satisfaction of all
the following conditions:

  



  

(a) No provisions of any applicable Law, and no Order shall restrain or
prohibit or impose any condition on the consummation of the Closing.

  



  

(b) There shall not be any Action brought by any Authority to enjoin or
otherwise restrict or make illegal the consummation of the Closing.

  



  

(c) Any waiting period under the HSR Act shall have expired or been
terminated.

  



  

(d) After giving effect to the Transactions, including the PIPE Investment,
the Purchaser shall have at least $5,000,001 of net tangible assets (as
determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act)
remaining after the Redemptions immediately after the Effective Time.

  



  

(e) The Registration Statement shall have become effective under the
Securities Act and no stop order suspending the effectiveness of the
Registration Statement shall have been issued and no proceedings for that
purposes shall have been initiated or threatened by the SEC and not withdrawn.

  



  

   

78

 



    



  

(f) The Purchaser Stockholder Approval shall have been obtained in accordance
with the provisions of the Purchaser Charter and applicable Laws, including
the DGCL, NYSE rules and the Exchange Act.

  



  

(g) The Company Stockholder Approval shall have been duly obtained in
accordance with the DGCL and the Company's organizational documents, as
amended and in effect on the date hereof.

  



  

9.2 _Conditions to Obligations of the Purchaser_. The obligation of the
Purchaser to consummate the Merger is subject to the satisfaction, or the
waiver at the Purchaser's sole and absolute discretion, of all the following
further conditions:

  



  

(a) The Company shall have performed in all material respects its obligations
hereunder required to be performed by it pursuant to this Agreement at or
prior to the Closing Date.

  



  

(b) (x) The Fundamental Representations (other than the Fundamental
Representations in _Section 4.5_ (Capitalization)) shall: (A) if qualified by
materiality or Material Adverse Effect (i) be true, correct and complete at
and as of the date of this Agreement and (ii) be true, correct and
complete as of the Closing Date (or in the case of (i) and (ii) except to the
extent such representations and warranties expressly relate to a specified
date, and in such case, shall be true, correct and complete at and as of such
earlier date) and (B) if not qualified by materiality or Material Adverse
Effect (i) be true, correct and complete in all material respects at and as of
the date of this Agreement and (ii) be true, correct and complete in all
material respects as of the Closing Date (or in the case of (i) and
(ii) except to the extent such representations and warranties expressly
relate to a specified date, and in such case, shall be true, correct and
complete in all material respects at and as of such earlier date); provided
that the Fundamental Representations of the Company contained in _Section
4.5_ (Capitalization) shall be true, correct and complete other than _de
minimis_ inaccuracies; and (y) all other representations and warranties of
the Company set forth in _Article IV_ hereof, disregarding all
qualifications and exceptions contained therein relating to materiality or
Material Adverse Effect, shall: (1) be true, correct and complete at and as
of the date of this Agreement and (2) be true, correct and complete as of the
Closing Date (or in the case of (i) and (ii) except to the extent such
representations and warranties expressly relate to a specified date, and in
such case, at and as of such earlier date), except in each case for any
inaccuracies in such representations and warranties which, individually or in
the aggregate, has not had, and would not reasonably be expected to result
in, a Material Adverse Effect.

  



  

(c) There shall have been no event, change or occurrence that is continuing,
which, individually or together with any other event, change or occurrence,
would reasonably be expected to have a Material Adverse Effect.

  



  

(d) The Purchaser shall have received a certificate signed by the Chief
Executive Officer of the Company to the effect set forth in _clauses (a)_
through _(c)_ of this  _Section 9.2_ (the " _Company Certificate_ ").

  



  

(e) There shall be no Closing Indebtedness.

  



  

   

79

 



    



  

9.3 _Conditions to Obligations of the Company_. The obligations of the
Company to consummate the Closing is subject to the satisfaction, or the
waiver at the Company's discretion, of all of the following further
conditions:

  



  

(a) The Purchaser and Merger Sub shall have performed in all material
respects all of its obligations hereunder required to be performed by it
pursuant to this Agreement at or prior to the Closing Date.

  



  

(b) (x) The representations and warranties in _Sections 5.1_ (Corporate
Existence and Power), _5.2_ (Authorization) and _5.5_  (Finders' Fees) shall
(A) if qualified by materiality or Purchaser Material Adverse Effect (i) be
true, correct and complete in all respects at and as of the date of this
Agreement and (ii) be true, correct and complete as of the Closing Date (or
in the case of (i) and (ii) except to the extent such representations and
warranties expressly relate to a specified date, and in such case, shall be
true correct and complete as of such earlier date) and (B) if not qualified by
materiality or Purchaser Material Adverse Effect (i) be true, correct and
complete in all material respects at and as of the date of this Agreement and
(ii) be true, correct and complete in all material respects as of the Closing
Date (or in the case of (i) and (ii) except to the extent such
representations and warranties relate to a specified date, and in such case,
shall be true, correct and complete in all material respects at and as of
such earlier date), (y) the representations and warranties the Purchaser and
Merger Sub contained in _Section 5.6_ (Capitalization), shall be true, correct
and complete other than _de minimis_ inaccuracies), and (z) all other
representations and warranties of the Purchaser and Merger Sub set forth in
_Article V_ hereof, disregarding all qualification and exceptions contained
therein relating to materiality or Material Adverse Effect, shall: (1) be
true, correct and complete at and as of the date of this Agreement and (2) be
true, correct and complete as of the Closing Date (or in the case of (1) and
(2) except to the extent such representations and warranties expressly relate
to a specified date, and in such case, at and as of such earlier date) for any
inaccuracies in such representations and warranties which, individually or in
the aggregate, has not had, and would not reasonably be expected to result
in, a Purchaser Material Adverse Effect.

  



  

(c) The Company shall have received a certificate signed by an authorized
officer of the Purchaser to the foregoing effect set forth in clauses (a) and
(b) of this _Section 9.3_.

  



  

(d) Subject to _Section 8.9_ , the Available Closing Purchaser Cash shall
equal or exceed the Cash Closing Requirement.

  



  

(e) The Transaction Securities to be issued in connection with the Closing
shall be conditionally approved for listing upon the Closing on the NYSE
subject to any requirement to have a sufficient number of round lot holders
of the Purchaser Class A Common Stock.

  



  

(f) The Purchaser Charter and the Purchaser Bylaws shall be effective as of
the Closing.

  



  

(g) The persons listed on _Schedule 9.3(g)_  shall have resigned from all of
their positions and offices with the Purchaser and Merger Sub, in each case,
to be effective as of, and conditioned upon the occurrence of, the Closing.

  



  

   

80

 



    



  

(h) All conditions to the funding pursuant to the Forward Purchase Agreement,
if any shall have been satisfied, and such funding shall have been delivered
to the Purchaser least one (1) Business Day prior to the Closing Date in
accordance with the Forward Purchase Agreement, such that the funding of the
will be consummated immediately prior to the Closing in accordance with the
terms of the Forward Purchase Agreement.

  



  

Article X

  

 _TERMINATION_

  



  

10.1 _Termination Without Default_.

  



  

(a) In the event that the Closing of the Transactions has not occurred by
April 18, 2021 (the " _Outside Closing Date_ "), the Purchaser or the Company
shall have the right, at its sole option, to terminate this Agreement;
provided, however, that a Party shall not be permitted to terminate this
Agreement pursuant to this _Section 10.1(a)_ if the failure of the Closing
to occur prior to the Outside Closing Date is attributable to the failure on
the part of such Party to perform in any material respect any covenant or
obligation in this Agreement required to be performed by such Party. Such
right may be exercised by the Purchaser or the Company, as the case may be,
giving written notice to the other at any time after the Outside Closing Date;
_provided_ ,  _further_ , that to the extent a Government Shutdown prevents
the consummation of the Transactions prior to the Outside Closing Date, the
Outside Closing Date shall be automatically extended day-for-day, for each
Business Day the Government Shutdown is in effect for a maximum of thirty
(30) days unless otherwise mutually agreed by the Parties in writing.

  



  

(b) In the event that a court of competent jurisdiction or other Authority
shall have issued an order, decree or ruling, or shall have taken any other
action, having the effect of permanently restraining, enjoining or otherwise
prohibiting the Transactions, which order, decree, ruling or other
action shall be final and nonappealable, the Purchaser or the Company shall
have the right, at its sole option, to terminate this Agreement; provided,
however, that a Party shall not be permitted to terminate this Agreement
pursuant to this _Section 10.1(b)_ if such action by such court or Authority
is attributable to the failure on the part of such Party to perform in any
material respect any covenant or obligation in this Agreement required to be
performed by such Party.

  



  

(c) In the event that the Purchaser fails to receive the Purchaser
Stockholder Approval at the Purchaser Stockholder Meeting (subject to any
adjournment or recess of such special meeting pursuant to _Section 8.2(a)_),
the Purchaser or the Company shall have the right, at its sole option, to
terminate this Agreement by written notice to the other Party; _provided_ that
the Purchaser shall not be permitted to terminate this Agreement pursuant to
this _Section 10.1(c)_ if the failure to obtain such Purchaser Stockholder
Approval is proximately caused by any action or failure to act of the
Purchaser that constitutes a breach of this Agreement.

  



  

(d) In the event that the Company fails to receive the Company Stockholder
Approval within five (5) Business Days after the Registration Statement has
been declared effective by the SEC and delivered or otherwise made available
to Stockholders, the Purchaser shall have the right, at its sole option,
to terminate this Agreement; provided, however, that the Purchaser shall not
be permitted to terminate this Agreement pursuant to this _Section 10.1(a)_
if the failure to receive the Company Stockholder Approval is attributable to
any failure on the part of the Purchaser.

  



  

   

81

 



    



  

(e) This Agreement may be terminated at any time prior to the Closing by
mutual written consent of the Purchaser and the Company.

  



  

10.2 _Termination Upon Default_.

  



  

(a) The Purchaser may terminate this Agreement on or prior to the Closing
Date by giving written notice to the Company, without prejudice to any rights
or obligations the Purchaser may have, if the Company shall have materially
breached any representation, warranty, agreement or covenant contained herein
to be performed on or prior to the Closing Date, which would result in a
failure of a condition set forth in _Section 9.2(a)_ or _Section 9.2(b)_ to
be satisfied and cannot be cured by the earlier of the Outside Closing Date
and thirty (30) days following receipt by the Company of a written notice
describing in reasonable detail the nature of such breach; provided that
if such breach is curable by the Company prior to the Closing, then the
Purchaser may not terminate this Agreement under this _Section 10.2(a)_ until
the earlier of: (i) thirty (30) days after delivery of such written notice to
the Company and (ii) the Outside Closing Date; _provided_ , _further_ , that,
the Purchaser shall not have the right to terminate this Agreement
pursuant to this _Section 10.2(a)_ if the Purchaser is then in material
breach of any representation, warranty, agreement or covenant that would
result in the failure of a condition set forth in _Section 9.3(a)_ or _Section
9.3(b)_ to be satisfied if the Closing was scheduled to occur on such date or
if such breach by the Company is cured during such thirty (30) day period.

  



  

(b) The Company may terminate this Agreement on or prior to the Closing Date
by giving written notice to the Purchaser, without prejudice to any rights or
obligations the Company may have, if the Purchaser or Merger Sub shall have
materially breached any representation, warranty, agreement or covenant
contained herein to be performed on or prior to the Closing Date, which would
result in a failure of a condition set forth in _Section 9.3(a)_ or _Section
9.3(b)_ to be satisfied and cannot be cured by the earlier of the Outside
Closing Date and thirty (30) days following receipt by the Purchaser of a
written notice describing in reasonable detail the nature of such breach;
provided that if such breach is curable by the Purchaser or Merger Sub prior
to the Closing, then the Company may not terminate this Agreement under this
_Section 10.2(b)_ until the earlier of: (i) thirty (30) days after delivery
of such written notice from the Purchaser and (ii) the Outside Closing Date;
_provided_ , _further_ , that, the Company shall not have the right to
terminate this Agreement pursuant to this _Section 10.2(b)_ if the Company
is then in material breach of any representation, warranty, agreement or
covenant that would result in the failure of a condition set forth in
_Section 9.2(a)_ or _Section 9.2(b)_ to be satisfied if the Closing was
scheduled to occur on such date or if such breach by the Purchaser or Merger
Sub is cured during such thirty (30) day period.

  



  

10.3 _Termination for Triggering Event_. Either the Purchaser or the Company
may, by written notice to the other Party, terminate this Agreement on or
prior to the Closing Date, without prejudice to any rights or obligations of
such Party, if a Triggering Event with respect to the other Party shall have
occurred.

  



  

   

82

 



    



  

10.4 _Effect of Termination_. If this Agreement is terminated pursuant to
this _Article X_, this Agreement shall become void and of no effect without
liability of any Party (or any stockholder, director, officer, employee,
Affiliate, agent, consultant or representative of such Party) to any other
Party, other than liability of any Party for Fraud. The provisions of _Section
8.6_, this _Section 10.4_ and _Article XI _shall survive any termination
hereof pursuant to this _Article X_.

  



  

Article XI _ 
 MISCELLANEOUS_

  



  

11.1 _Notices_. Any notice and other communications hereunder shall be sent
in writing, addressed as specified below, and shall be deemed given: (a) if
by hand or recognized courier service, by 4:00 PM on a Business Day,
addressee's day and time, on the date of delivery, and otherwise on the first
(1st) Business Day after such delivery; (b) if by email, on the date that
transmission is confirmed electronically, if by 4:00 PM on a Business Day,
addressee's day and time, and otherwise on the first Business Day after the
date of such confirmation; or (c) five (5) days after mailing by certified or
registered mail, return receipt requested. Notices shall be addressed to the
respective parties as follows (excluding telephone numbers, which are for
convenience only), or to such other address as a Party shall specify to the
others in accordance with these notice provisions:

  



  

if to the Purchaser or Merger Sub, to:

  



  

Panacea Acquisition Corp. 
 357 Tehama Street, Floor 3 
 San Francisco, CA 
 E-mail: oleg@ecor1cap.com

  



  

with a copy to (which shall not constitute notice):

  



  

Skadden, Arps, Slate, Meagher and Flom LLP 
 525 University Avenue 
 Palo Alto, CA 94301 
 Attn: Michael J. Mies 
 E-mail: michael.mies@skadden.com

  



  

if to the Company or the Surviving Corporation to:

  



  

Nuvation Bio Inc.

  

1500 Broadway, Suite 1401 
 New York, NY 10036

  

Attn: David Hung, M.D. 
 E-mail: david.hung@nuvationbio.com

  



  

with a copy to (which shall not constitute notice):

  



  

Cooley LLP

  

101 California Street, 5th Floor

  

San Francisco, CA 94111 
 Attn: Kenneth Guernsey; John McKenna; and Rama Padmanabhan

  

E-mail: kguernsey@cooley.com; jmckenna@cooley.com; and rama@cooley.com

  



  

   

83

 



    



  

11.2 _Amendments; No Waivers; Remedies._

  



  

(a) This Agreement cannot be amended, except by a writing signed by each
Party; _provided_ _,_ _however_ that after any such adoption of this Agreement
by Company Stockholder Approval, no amendment shall be made which Law
requires further approval of the Stockholders without the further approval of
such Stockholders, and cannot be terminated orally or by course of conduct. No
provision hereof can be waived, except by a writing signed by the Party
against whom such waiver is to be enforced, and any such waiver shall apply
only in the particular instance in which such waiver shall have been given.

  



  

(b) Neither any failure or delay in exercising any right or remedy hereunder
or in requiring satisfaction of any condition herein nor any course of dealing
shall constitute a waiver of or prevent any Party from enforcing any right or
remedy or from requiring satisfaction of any condition. No notice to or
demand on a Party waives or otherwise affects any obligation of that Party or
impairs any right of the Party giving such notice or making such demand,
including any right to take any action without notice or demand not otherwise
required by this Agreement. No exercise of any right or remedy with respect
to a breach of this Agreement shall preclude exercise of any other right or
remedy, as appropriate to make the aggrieved Party whole with respect to such
breach, or subsequent exercise of any right or remedy with respect to any
other breach.

  



  

(c) Except as otherwise expressly provided herein, no statement herein of any
right or remedy shall impair any other right or remedy stated herein or that
otherwise may be available.

  



  

(d) Notwithstanding anything else contained herein, neither shall any Party
seek, nor shall any Party be liable for, diminution in value, punitive,
consequential, special, indirect, or exemplary damages, under any tort,
contract, equity, or other legal theory, with respect to any breach (or
alleged breach) of this Agreement or any provision hereof or any matter
otherwise relating hereto or arising in connection herewith.

  



  

11.3 _Arm 's Length Bargaining; No Presumption Against Drafter_. This
Agreement has been negotiated at arm's-length by Parties of equal bargaining
strength, each represented by counsel or having had but declined the
opportunity to be represented by counsel and having participated in the
drafting of this Agreement. This Agreement creates no fiduciary or other
special relationship between the Parties, and no such relationship otherwise
exists. No presumption in favor of or against any Party in the construction
or interpretation of this Agreement or any provision hereof shall be made
based upon which Person might have drafted this Agreement or such provision.

  



  

   

84

 



    



  

11.4 _Publicity_. The Parties agree that neither they nor their agents shall
issue any press release or make any other public disclosure concerning the
Transactions without the prior approval of the other Party (which, for
clarity, shall in the case of the Company be from the Purchaser and in the
case of the Purchaser and Merger Sub be from the Company). If a Party is
required to make such a disclosure as required by law, the Parties will use
their best efforts to cause a mutually agreeable release or public disclosure
to be issued. Notwithstanding the foregoing: (a) each Party may, without such
consultation or consent, make any public statement in response to questions
from the press, analysts, investors or those attending industry conferences,
make internal announcements to employees and make disclosures in the
Purchaser SEC Documents, so long as such statements are consistent with
previous press releases, public disclosures or public statements made jointly
by the Parties (or individually, if approved by the other Party); and (b)
a Party may, without the prior consent of the other Party but subject to
giving advance notice to the other Party, issue any such press release or
make any such public announcement or statement as may be required by any Law.

  



  

11.5 _Expenses_. The costs and expenses incurred by the Company and the
Purchaser in connection with this Agreement and the Transactions,
including any Transaction Expenses and the Deferred Underwriting Amount,
shall be paid by the Purchaser at the Closing; provided, for the avoidance of
doubt, that if the Closing does not take place, each Party shall bear its own
costs and expenses in connection with this Agreement and the Transactions.

  



  

11.6 _No Assignment or Delegation_. No Party may assign any right or delegate
any obligation hereunder, including by merger, consolidation, operation of
law, or otherwise, without the written consent of the other Party (which, for
clarity, shall in the case of the Company be from the Purchaser and in the
case of the Purchaser and Merger Sub be from the Company). Any purported
assignment or delegation without such consent shall be void, in addition to
constituting a material breach of this Agreement.

  



  

11.7 _Governing Law_. This Agreement shall be construed in accordance with
and governed by the laws of the State of Delaware, without giving effect to
the conflict of laws principles thereof.

  



  

11.8 _Counterparts; Signatures_. This Agreement may be executed in
counterparts, each of which shall constitute an original, but all of which
shall constitute one (1) agreement. This Agreement shall become effective
upon delivery to each Party of an executed counterpart or the earlier
delivery to each Party of original, photocopied, or electronically transmitted
signature pages that together (but need not individually) bear the signatures
of all other Parties.

  



  

11.9 _Entire Agreement_. This Agreement together with the Additional
Agreements, including the exhibits and schedules hereto and thereto, sets
forth the entire agreement of the Parties with respect to the subject matter
hereof and thereof and supersedes all prior and
contemporaneous understandings and agreements related to the subject matter
hereof and thereto (whether written or oral), all of which are merged herein.
Except as otherwise expressly stated herein or any Additional Agreement, there
is no condition precedent to the effectiveness of any provision hereof or
thereof. No Party has relied on any representation from, or warranty or
agreement of, any person in entering into this Agreement, prior hereto or
contemporaneous herewith or any Additional Agreement, except those expressly
stated herein or therein.

  



  

   

85

 



    



  

11.10 _Severability_. A determination by a court or other legal authority
that any provision that is not of the essence of this Agreement is
legally invalid shall not affect the validity or enforceability of any other
provision hereof. The Parties shall cooperate in good faith to substitute (or
cause such court or other legal authority to substitute) for any provision so
held to be invalid a valid provision, as alike in substance to such invalid
provision as is lawful.

  



  

11.11 _Construction of Certain Terms and References; Captions_. In this
Agreement:

  



  

(a) References to particular sections and subsections, schedules, and
exhibits not otherwise specified are cross-references to sections and
subsections, schedules, and exhibits of this Agreement.

  



  

(b) The words "herein," "hereof," "hereunder," and words of similar import
refer to this Agreement as a whole and not to any particular provision
of this Agreement.

  



  

(c) Any use of the singular or plural, or the masculine, feminine, or neuter
gender, includes the others, unless the context otherwise requires;
"including" means "including without limitation;" "or" means "and/or;" "any"
means "any one, more than one, or all;" and, unless otherwise specified, any
financial or accounting term has the meaning of the term under United States
generally accepted accounting principles as consistently applied heretofore by
the Company.

  



  

(d) Unless otherwise specified, any reference to any agreement (including
this Agreement), instrument, or other document includes all schedules,
exhibits, or other attachments referred to therein, and any reference to a
statute or other law includes any rule, regulation, ordinance, or the like
promulgated thereunder, in each case, as amended, restated, supplemented, or
otherwise modified from time to time. Any reference to a numbered schedule
means the same-numbered section of the Disclosure Schedule.

  



  

(e) If any action is required to be taken or notice is required to be given
within a specified number of days following a specific date or event, the day
of such date or event is not counted in determining the last day for such
action or notice. If any action is required to be taken or notice is required
to be given on or before a particular day which is not a Business Day, such
action or notice shall be considered timely if it is taken or given on or
before the next Business Day.

  



  

(f) Captions are not a part of this Agreement, but are included for
convenience, only.

  



  

(g) " _knowledge_ " with respect to an entity shall mean with respect to any
matter in question the actual knowledge of such entity's executive officers
after reasonable inquiry, and as such term is used with respect to the
Company, it shall mean such knowledge of each of the individuals listed on
_Section 11.11(g)_ of the Disclosure Schedule (each, a " _Key Company
Employee_ "). With respect to matters involving Intellectual Property Rights,
knowledge does not require that any of such entity's executive officers
conduct or have conducted or obtain or have obtained any freedom-to-
operate opinions or similar opinions of counsel or any intellectual property
clearance searches.

  



  

   

86

 



    



  

11.12 _Third Party Beneficiaries_. Except as provided in _Section 8.7 _and
_Section 11.14_, neither this Agreement nor any provision hereof confers any
benefit or right upon or may be enforced by any Person not a signatory hereto.

  



  

11.13 _Waiver_. Reference is made to the final prospectus of the Purchaser,
dated July 2, 2020 (the " _Prospectus_ "). The Company acknowledges that it
has been advised by the Purchaser that, as described in the Prospectus, the
Purchaser has established the Trust Account for the benefit of the public
stockholders of the Purchaser and the underwriters of the IPO pursuant to
the Trust Agreement and that, except for a portion of the interest earned on
the amounts held in the Trust Account, the Purchaser may disburse monies from
the Trust Account only (i) if the Purchaser completes the transactions which
constitute a Business Combination, then to those Persons and in such amounts
as described in the Prospectus; (ii) if the Purchaser fails to complete a
Business Combination within the allotted time period and liquidates, subject
to the terms of the Trust Agreement, the Purchaser's public stockholders; and
(iii) if the Purchaser holds a shareholder vote to amend the Purchaser's
amended and restated certificate of incorporation to modify the substance or
timing of the obligation to redeem one-hundred percent (100%) of the
Purchaser Common Stock if the Purchaser fails to complete a Business
Combination within the allotted time period, then for the redemption of any
Purchaser Common Stock properly tendered in connection with such vote. For and
in consideration of the Purchaser agreeing to enter into this Agreement, the
Company hereby agrees that it does not have any right, title, interest or
claim of any kind in or to any monies in the Trust Account and hereby agrees
that it will not seek recourse against the Trust Account for any claim it may
have in the future as a result of, or arising out of, any negotiations,
contracts or agreements with the Purchaser. Notwithstanding the foregoing,
(x) nothing herein shall serve to limit or prohibit the Company's right to
pursue a claim against the Purchaser for legal relief against monies or other
assets held outside the Trust Account, for specific performance or other
equitable relief in connection with the consummation of the Transactions
pursuant to _Section 11.16_ hereof (including a claim for the Purchaser to
specifically perform its obligations under this Agreement and cause the
disbursement of the balance of the cash remaining in the Trust Account after
giving effect to the redemption of the Purchaser Class A Common Stock pursuant
to the Redemptions in connection with the Closing) in accordance with the
terms of this Agreement and the Trust Agreement, or for fraud and (y)
nothing herein shall serve to limit or prohibit any claims that the Company
may have in the future against the Purchaser's assets or funds that are not
held in the Trust Account (including any funds that have been released from
the Trust Account to the Purchaser and any assets that have been purchased or
acquired with any such funds). This _Section 11.13_ shall survive
termination of this Agreement for any reason.

  



  

11.14 _Non-Recourse_. Notwithstanding any provision of this Agreement or
otherwise, the Parties to this Agreement agree on their own behalf and on
behalf of their respective Subsidiaries and Affiliates that this Agreement
may only be enforced against, and any action for breach of this Agreement may
only be made against, the Parties to this Agreement, and no Non-Recourse Party
of a Party to this Agreement shall have any liability relating to this
Agreement or any of the Transactions, except with respect to Fraud against the
person who committed such Fraud.

  



  

   

87

 



    



  

11.15 _Jurisdiction; Waiver of Trial by Jury_. Any Action based upon, arising
out of or related to this Agreement or the Transactions may be brought in
federal and state courts located in the State of Delaware, and each of the
Parties irrevocably submits to the exclusive jurisdiction of each such court
in any such Action, waives any objection it may now or hereafter have to
personal jurisdiction, manner of service of process, venue or to convenience
of forum, agrees that all claims in respect of the Action shall be heard and
determined only in any such court, and agrees not to bring any Action arising
out of or relating to this Agreement or the Transactions in any other court.
Nothing herein contained shall be deemed to affect the right of any Party to
serve process in any manner permitted by Law or to commence legal proceedings
or otherwise proceed against any other Party in any other jurisdiction, in
each case, to enforce judgments obtained in any Action brought pursuant to
this _Section 11.15_. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH
CANNOT BE WAIVED, EACH OF THE PARTIES AND ANY PERSON ASSERTING RIGHTS AS A
THIRD-PARTY BENEFICIARY HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL
BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT
OR THE TRANSACTIONS.

  



  

11.16 _Specific Performance_. Each Party acknowledges that the rights of each
Party to consummate the Transactions are unique, recognizes and affirms that
in the event of a breach of this Agreement by any Party, money damages would
be inadequate and the non-breaching Parties would not have adequate remedy at
law, and agree that irreparable damage would occur in the event that any of
the provisions of this Agreement were not performed by an applicable Party in
accordance with their specific terms or were otherwise breached. Accordingly,
each Party shall be entitled to an injunction or restraining order to prevent
breaches of this Agreement and to seek to enforce specifically the terms and
provisions hereof, without the requirement to post any bond or other security
or to prove that money damages would be inadequate, this being in addition to
any other right or remedy to which such Party may be entitled under this
Agreement, at law or in equity.

  



  

11.17 _Acknowledgement; Waiver of Conflicts; Retention of Privilege_.

  



  

(a) Each of the Parties hereto acknowledges and agrees that (i) Cooley LLP ("
_Prior Company Counsel_ ") has acted as counsel to the Company in various
matters involving a range of issues and as counsel to the Company in
connection with the negotiation of this Agreement and the Additional
Agreements, and the Transactions and (ii) Skadden, Arps, Slate, Meagher and Flom
LLP (" _Prior Purchaser Counsel_ ") has acted as counsel to the Purchaser in
various matters involving a range of issues and as counsel to the Purchaser
in connection with the negotiation of this Agreement and the Additional
Agreements and the Transactions.

  



  

   

88

 



    



  

(b) In connection with any matter or dispute under this Agreement, the
Purchaser hereby irrevocably waives and agrees not to assert, and agrees to
cause the Company Group after the Closing to irrevocably waive and agree not
to asset, any conflict of interest arising from or in connection with (i)
Prior Company Counsel's prior representation of the Company, (ii) Prior
Company Counsel's representation of any member of the Company Group
(collectively, the " _Company Advised Parties_") prior to and after the
Closing, (iii) Prior Purchaser Counsel's prior representation of the Purchaser
and (iv) Prior Purchaser Counsel's representation of the Sponsor, any
subsidiary of the Purchaser and/or any Purchaser stockholders
(collectively, the " _Purchaser Advised Parties_ ") prior to and after the
Closing.

  



  

(c) The Purchaser further agrees, on behalf of itself and, after the Closing,
on behalf of the Company Group, that all communications in any form or format
whatsoever between or among any of Prior Company Counsel, the Company, any of
the Company Advised Parties, or any of their respective Representatives that
relate in any way to the negotiation, documentation and consummation of the
Transactions or, beginning on the date of this Agreement, any dispute arising
under this Agreement (collectively, the " _Company Deal Communications_")
shall be deemed to be retained and owned collectively by the Company Advised
Parties, shall be controlled by Surviving Corporation on behalf of the
Company and shall not pass to or be claimed by the Purchaser or the
Company Group after the Closing. All Company Deal Communications that are
attorney-client privileged (the " _Privileged Company Deal Communications_ ")
shall remain privileged after the Closing and the privilege and the
expectation of client confidence relating thereto shall belong solely to
Surviving Corporation and the Company, shall be controlled by
Surviving Corporation on behalf of the Company and shall not pass to or be
claimed by the Purchaser or the Company Group after the Closing;  _provided_
, _further_ , that nothing contained herein shall be deemed to be a waiver by
the Purchaser or any of its Affiliates (including, after the Closing, the
Company Group and its Affiliates) of any applicable privileges or protections
that can or may be asserted to prevent disclosure of any such communications
to any third party.

  



  

(d) The Company further agrees, on behalf of itself and, after the Closing,
on behalf of the Company Group, that in the event of any dispute with respect
to this Agreement or the Transactions arises after the Closing between or
among (x) Sponsor, the stockholders or holder of other equity interests of
the Purchaser or Sponsor and/or any of their respective directors, members,
partners, officers employees or Affiliates on the one hand and (y) the
Surviving Corporation or any of the Company Advised Parties, on the other
hand, all legally privileged communications made prior to the Closing in any
form or format whatsoever between or among any of Prior Purchaser Counsel, the
Company, any of the Purchaser Advised Parties, or any of their respective
Representatives that relate in any way to the negotiation, documentation and
consummation of the Transactions or, beginning on the date of this Agreement,
any dispute arising under this Agreement (collectively, the " _Purchaser Deal
Communications_") shall be deemed to be retained and owned collectively by
the Purchaser Advised Parties, shall be controlled by Sponsor and shall not
pass to or be claimed by the Purchaser or the Company Group after the
Closing. All Purchaser Deal Communications that are attorney-client privileged
(the " _Privileged Purchaser Deal Communications_ ") shall remain
privileged after the Closing and the privilege and the expectation of client
confidence relating thereto shall belong solely to Sponsor, shall be
controlled by Sponsor and shall not pass to or be claimed by the Purchaser or
the Company Group after the Closing; _provided_ ,  _further_ , that nothing
contained herein shall be deemed to be a waiver by the Purchaser or any of its
Affiliates (including, after the Closing, the Company Group and its
Affiliates) of any applicable privileges or protections that can or may be
asserted to prevent disclosure of any such communications to any third party.

  



  

   

89

 



    



  

(e) Notwithstanding the foregoing, in the event that a dispute arises between
the Purchaser or the Company Group, on the one hand, and a third party other
than Sponsor, on the other hand, the Purchaser or the Company Group may
assert the attorney-client privilege to prevent the disclosure of
the Privileged Company Deal Communications or Privileged Purchaser Deal
Communications to such third party; provided, however, that neither the
Purchaser nor the Company Group may waive such privilege with respect to (i)
Privileged Company Deal Communications without the prior written consent of
Surviving Corporation or (ii) Privileged Purchaser Deal Communications without
the prior written consent of Sponsor. In the event that the Purchaser or the
Company Group is legally required by governmental order or otherwise to
access or obtain a copy of all or a portion of (i) the Privileged Company Deal
Communications, the Purchaser shall immediately (and, in any event, within
two (2) Business Days) notify Surviving Corporation in writing (including by
making specific reference to this _Section 11.17_) so that Surviving
Corporation can seek a protective order and (ii) the Privileged
Purchaser Deal Communications, the Surviving Corporation shall immediately
(and, in any event, within two (2) Business Days) notify Sponsor in writing
(including by making specific reference to this _Section 11.17_) so that
Sponsor can seek a protective order and, in either case, the Purchaser agrees
to use all commercially reasonable efforts to assist therewith.

  



  

(f) To the extent that files or other materials maintained by Prior Company
Counsel constitute property of its clients, only Surviving Corporation and the
Company Advised Parties shall hold such property rights and Prior Company
Counsel shall have no duty to reveal or disclose any such files or other
materials or any Privileged Company Deal Communications by reason of any
attorney-client relationship between Prior Company Counsel, on the one hand,
and the Company Group after the Closing, on the other hand so long as such
files or other materials would be subject to a privilege or protection if
they were being requested in a proceeding by an unrelated third party. To the
extent that files or other materials maintained by Prior Purchaser Counsel
constitute property of its clients, only Sponsor and the other
Purchaser Advised Parties shall hold such property rights and Prior Purchaser
Counsel shall have no duty to reveal or disclose any such files or other
materials or any Privileged Purchaser Deal Communications by reason of any
attorney-client relationship between Prior Purchaser Counsel, on the one
hand, and the Purchaser, on the other hand so long as such files or other
materials would be subject to a privilege or protection if they were being
requested in a proceeding by an unrelated third party.

  



  

(g) The Purchaser agrees on behalf of itself and the Company Group after the
Closing, (i) to the extent that the Purchaser or, after the Closing, the
Company Group receives or takes physical possession of any Company Deal
Communications or Purchaser Deal Communications, (a) such physical
possession or receipt shall not, in any way, be deemed a waiver by any of the
Company Advised Parties, the Purchaser Advised Parties or any other Person,
of the privileges or protections described in this _Section 11.17_ , and (b)
neither the Purchaser nor the Company Group after the Closing shall assert
any claim that any of the Company Advised Parties, the Purchaser Advised
Parties or any other Person waived the attorney-client privilege, attorney
work-product protection or any other right or expectation of client
confidence applicable to any such materials or communications, (ii) not to
access or use the Company Deal Communications or Purchaser
Deal Communications, including by way of review of any electronic data,
communications or other information, or by seeking to have
Surviving Corporation or Sponsor, as applicable, waive the attorney-client or
other privilege, or by otherwise asserting that the Purchaser or the Company
Group after the Closing has the right to waive the attorney-client or other
privilege, (iii) not to seek to obtain the Company Deal Communications from
Prior Company Counsel so long as such Company Deal Communications would be
subject to a privilege or protection if they were being requested in a
proceeding by an unrelated third party and (iv) not to seek to obtain
Purchaser Deal Communications from Prior Purchaser Counsel so long as such
Purchaser Deal Communications would be subject to a privilege or protection
if they were being requested in a proceeding by an unrelated third party.

  



  

11.18 _No Survival_. The Parties hereto, intending to modify any applicable
statute of limitations, agree that (a) the representations and warranties in
this Agreement and in any certificate delivered pursuant hereto shall
terminate effective as of the Closing and shall not survive the Closing for
any purpose, and thereafter there shall be no liability on the part of, nor
shall any claim be made by, any Party or any of their respective Affiliates
in respect thereof, and (b) after the Closing, there shall be no liability on
the part of, nor shall any claim be made by, any Party or any of their
respective Affiliates in respect of any covenant or agreement to be performed
prior to the Closing.

  



  

 _[The remainder of this page intentionally left blank; signature pages to
follow]_

  



    

90

 



    



  

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly
executed as of the day and year first above written.

  



       | Purchaser: 
---|--- 
     |   |   | 
     | PANACEA ACQUISITION CORP. 
     |   |   | 
     | By:  | /s/ Oleg Nodelman 
     |   | Name:  | Oleg Nodelman 
     |   | Title:  | Founder 
     |   |   | 
     | Merger Sub: 
     |   |   | 
     | PANACEA MERGER SUBSIDIARY CORP 
     |   |   | 
     | By:  | /s/ Sarah Marriott 
     |   | Name:   | Sarah Marriott 
     |   | Title:  | Secretary 
     |   |   | 
     | Company: 
     |   |   | 
     | NUVATION BIO INC. 
     |   |   | 
     | By:  | /s/ David Hung 
     |   | Name:  | David Hung, M.D. 
     |   | Title:  | President and Chief Executive Officer 
  



  

 _[Signature Page to Merger Agreement]_

  



  

   



 



    



 

Exhibit A

  



  

FORM OF PURCHASER CHARTER

  



  

AMENDED AND RESTATED

  

CERTIFICATE OF INCORPORATION

  

OF

  

PANACEA ACQUISITION CORP.

  



  

Panacea Acquisition Corp., a corporation organized and existing under the
laws of the State of Delaware (the " _Company_ "), does hereby certify that:

  



  

ONE: The name of the Company is "Panacea Acquisition Corp." The original
certificate of incorporation of the Company was filed with the Secretary of
State of the State of Delaware on April 24, 2020.

  



  

TWO: This Amended and Restated Certificate of Incorporation, which restates
and integrates and also further amends the provisions of the Company's
certificate of incorporation, was duly adopted by the Company's Board of
Directors and stockholders in accordance with Sections 228, 242 and 245 of
the General Corporation Law of the State of Delaware.

  



  

THREE: The Company's certificate of incorporation is hereby amended,
integrated and restated to read as follows:

  



  

I.

  



  

The name of this corporation is Nuvation Bio Inc. (the " _Company_ ").

  



  

II.

  



  

The address of the registered office of the Company in the State of Delaware
is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801
and the name of the registered agent of the Company in the State of Delaware
at such address is The Corporation Trust Company.

  



  

III.

  



  

The purpose of the Company is to engage in any lawful act or activity for
which a corporation may be organized under the General Corporation Law of the
State of Delaware (" _DGCL_ ").

  



  

IV.

  



  

A. The Company is authorized to issue three classes of stock to be
designated, respectively, "Class A Common Stock," "Class B Common Stock" and
"Preferred Stock." The total number of shares that the Company is authorized
to issue is [] shares, [] shares of which shall be Class A Common Stock
(the " _Class A Common Stock_ "), [] shares of which shall be Class B Common
Stock (the " _Class B Common Stock_ " and, together with the Class A Common
Stock, the " _Common Stock_ ") and [] shares of which shall be Preferred
Stock (the " _Preferred Stock_ "). The Common Stock shall have a par value of
$0.00001 per share, and the Preferred Stock shall have a par value of
$0.00001 per share.

  



    

A-1

 



    



  

B. The Preferred Stock may be issued from time to time in one or more series.
The Board of Directors of the Company is hereby expressly authorized by
resolution or resolutions to provide for the issue of all or any of the shares
of the Preferred Stock in one or more series, and to fix the number of shares
of such shares and to determine for each such series, such voting powers, full
or limited, or no voting powers, and such designation, preferences, and
relative, participating, optional, or other rights and such
qualifications, limitations, or restrictions thereof, as shall be stated and
expressed in the resolution or resolutions adopted by the Board of Directors
providing for the issuance of such shares and as may be permitted by the DGCL.
The Board of Directors is also expressly authorized to increase (but not
above the authorized number of shares of Preferred Stock) or decrease (but not
below the number of shares of such series then outstanding) the number of
shares of any series subsequent to the issuance of shares of that series.

  



  

C. The number of authorized shares of Class A Common Stock, Class B Common
Stock or Preferred Stock may be increased or decreased (but not below the
number of shares thereof then outstanding) by the affirmative vote of the
holders of a majority of the Voting Power of all of the outstanding shares of
stock of the Company entitled to vote thereon, without a separate vote of the
holders of the Class A Common Stock, the Class B Common Stock or the
Preferred Stock, or of any series thereof, unless a vote of any such holders
is required pursuant to the terms of any certificate of designation with
respect to any series of Preferred Stock.

  



  

D. Except as provided above, the rights, preferences, privileges,
restrictions and other matters relating to the Class A Common Stock and Class
B Common Stock are as follows:

  



  

1.  Definitions.

  



  

(a) " _Acquisition_ " means: (A) any consolidation or merger of the Company
with or into any other Entity, other than any such consolidation or merger in
which the stockholders of the Company immediately prior to such consolidation
or merger continue to hold a majority of the Voting Power of the outstanding
voting securities or interests of the surviving Entity in substantially the
same proportions (or, if the surviving Entity is a wholly owned subsidiary of
another Entity, the surviving Entity's Parent) immediately after such
consolidation, merger or reorganization; or (B) any transaction or series of
related transactions to which the Company is a party in which in excess of
50% of the Company's Voting Power is transferred or issued; provided that an
Acquisition shall not include any transaction or series of transactions
principally for bona fide equity financing purposes as determined in good
faith by the Board.

  



  

(b) " _Asset Transfer_ " means the sale, lease or exchange of all or
substantially all the assets of the Company.

  



  

(c) " _Cause_ " means the Founder's: (i) intentional and unauthorized use or
disclosure of the Company's confidential information or trade secrets, which
use or disclosure causes material harm to the Company; (ii) conviction of any
felony under the laws of the United States or any state thereof; (iii)
willful participation in a material fraud against the Company; (iv) gross
negligence or willful misconduct which causes material harm to the Company;
(v) intentional and material damage to the Company's property; (vi) sustained
and material failure to perform the duties customarily associated with his
position with the Company that has not been cured within thirty (30) days
after written notice from the Company or the Company's Board of Directors of
such failure; or (vii) material breach of any agreement with the Company that
has not been cured within thirty (30) days after written notice from the
Company or the Company's Board of Directors.

  



    

A-2

 



    



  

(d) " _Certificate of Incorporation_ " means the certificate of incorporation
of the Company, as amended and/or restated from time to time, including the
terms of any certificate of designation of any series of Preferred Stock.

  



  

(e)  " _Disability_ " means, with respect to the Founder, the inability of
the Founder to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment that can be expected to
result in death or that has lasted or can be expected to last for a
continuous period of not less than twelve (12) months, and will be determined
by the Company's Board of Directors on the basis of medical evidence deemed
relevant by the Board of Directors.

  



  

(f)  " _Entity_ " means any corporation, partnership, limited liability
company or other legal entity.

  



  

(g) " _Family Member_ " means with respect to any natural person, the spouse,
parents, grandparents, lineal descendants, siblings and lineal descendants of
siblings (in each case whether by blood relation or adoption) of such person.

  



  

(h) " _Final Conversion Date_ " means 5:00 p.m. in New York City, New York,
on the first Trading Day after the earliest to occur of the date on which (i)
the Founder and his Permitted Transferees own, in aggregate, fewer than
[] shares of Common Stock (including, for such purposes, any shares of
Common Stock issuable upon conversion or exchange of any securities that, by
their terms, are convertible into or exchangeable for shares of Common Stock),
subject to appropriate adjustment in the event of any stock dividend, stock
split, combination or other similar recapitalization with respect to the
Common Stock, (ii) the Founder no longer serves as the Chief Executive
Officer of the Company, unless the Founder is terminated from such
position by the Company without Cause, (iii) the Founder dies, or (iv) the
Company's Board of Directors determines that the Founder suffers from a
Disability.

  



  

(i) " _Founder_ " means David Hung, M.D.

  



  

(j) " _Liquidation Event_ " means (i) any Asset Transfer or Acquisition in
which cash or other property is, pursuant to the express terms of the Asset
Transfer or Acquisition, to be distributed to the stockholders in respect of
their shares of capital stock in the Company or (ii) any liquidation,
dissolution and winding up of the Company.

  



  

(k) " _Parent_ " of an Entity means any Entity that directly or indirectly
owns or controls a majority of the Voting Power of the voting securities or
interests of such Entity.

  



  

(l)  " _Permitted Transfer_ " means, and shall be restricted to, any Transfer
of a share of Class B Common Stock:

  



  

(i) by the Founder to the trustee of a Permitted Trust of the Founder
(including to the Founder in his capacity as the trustee of a Permitted Trust
of the Founder); or

  



  

(ii) by the trustee of a Permitted Trust of the Founder to the Founder or to
the trustee of any other Permitted Trust of the Founder (including to the
Founder in his capacity as the trustee of such other Permitted Trust of the
Founder).

  



  

(m) " _Permitted Transferee_ " means a transferee of shares of Class B Common
Stock received in a Transfer that constitutes a Permitted Transfer.

  



    

A-3

 



    



  

(n) " _Permitted Trust_ " means a validly created and existing trust all the
beneficiaries of which are the Founder and/or Family Members of the Founder.

  



  

(o)  " _Trading Day_ " means any day on which The Nasdaq Stock Market and the
New York Stock Exchange are open for trading.

  



  

(p) " _Transfer_ " of a share of Class B Common Stock means any sale,
assignment, transfer, conveyance, hypothecation or other transfer or
disposition of such share or any legal or beneficial interest in such share,
whether or not for value and whether voluntary or involuntary or by operation
of law, including, without limitation, a transfer of a share of Class B Common
Stock to a broker or other nominee (regardless of whether there is a
corresponding change in beneficial ownership), or the transfer of, or entering
into a binding agreement with respect to, Voting Control (as defined below)
over such share by proxy or otherwise; provided, however, that the following
shall not be considered a "Transfer" within the meaning of this Article IV:

  



  

(i) the granting of a revocable proxy to officers or directors of the Company
at the request of the Board of Directors in connection with actions to be
taken at an annual or special meeting of stockholders;

  



  

(ii) the existence of any proxy granted prior to [], 2020 or the amendment
or expiration of any such proxy;

  



  

(iii) entering into a voting trust, agreement or arrangement (with or without
granting a proxy) solely with stockholders who are holders of Class B Common
Stock that (A) is disclosed either in a Schedule 13D filed with the Securities
and Exchange Commission or in writing to the Secretary of the Company, (B)
either has a term not exceeding one year or is terminable by the holder of the
shares subject thereto at any time and (C) does not involve any payment of
cash, securities, property or other consideration to the holder of the shares
subject thereto other than the mutual promise to vote shares in a designated
manner;

  



  

(iv) the pledge of shares of Class B Common Stock by a stockholder that
creates a mere security interest in such shares pursuant to a bona fide loan
or indebtedness transaction for so long as such stockholder continues to
exercise exclusive Voting Control over such pledged shares; provided,
however, that a foreclosure on such shares or other similar action by the
pledgee shall constitute a "Transfer" unless such foreclosure or similar
action qualifies as a "Permitted Transfer"; or

  



  

(v) entering into, or reaching an agreement, arrangement or understanding
regarding, a support or similar voting or tender agreement (with or without
granting a proxy) in connection with a Liquidation Event, Asset Transfer or
Acquisition that has been approved by the Board of Directors.

  



  

A " _Transfer_ " shall also be deemed to have occurred with respect to a
share of Class B Common Stock beneficially held by a Permitted Transferee on
the date that such Permitted Transferee ceases to meet the qualifications to
be a Permitted Transferee of the Founder.

  



  

(q) " _Voting Control_ " means, with respect to a share of Class B Common
Stock, the power (whether exclusive or shared) to vote or direct the voting
of such share by proxy, voting agreement or otherwise.

  



  

(r) " _Voting Power,_ " when determined with respect to the Class B Common
Stock, means the voting power of the Class B Common Stock on the basis of one
vote per share.

  



    

A-4

 



    



  

2. Rights Relating To Dividends, Subdivisions and Combinations.

  



  

(a) Subject to the rights of holders of any Preferred Stock at the time
outstanding having prior rights as to dividends, the holders of the Class A
Common Stock and Class B Common Stock shall be entitled to receive, when, as
and if declared by the Board of Directors, out of any assets of the Company
legally available therefor, such dividends as may be declared from time to
time by the Board of Directors. Except as permitted in Section 2(b), any
dividends paid to the holders of shares of Class A Common Stock and Class
B Common Stock shall be paid pro rata, on an equal priority, pari passu
basis, unless different treatment of the shares of each such class is
approved by the affirmative vote of the holders of a majority of the
outstanding shares of Class A Common Stock and a majority of the outstanding
shares of Class B Common Stock, each voting separately as a class.

  



  

(b) The Company shall not declare or pay any dividend to the holders of Class
A Common Stock or Class B Common Stock payable in securities of the Company
unless the same dividend with the same record date and payment date shall be
declared and paid on all shares of Common Stock; provided, however, that (i)
dividends payable in shares of Class A Common Stock or rights to acquire
shares of Class A Common Stock may be declared and paid to the holders of
Class A Common Stock without the same dividend or distribution being declared
and paid to the holders of the Class B Common Stock if, and only if, a
dividend payable in shares of Class B Common Stock, or rights to acquire
shares of Class B Common Stock, as applicable, are declared and paid to the
holders of Class B Common Stock at the same rate and with the same record
date and payment date; and (ii) dividends payable in shares of Class B Common
Stock or rights to acquire shares of Class B Common Stock may be declared and
paid to the holders of Class B Common Stock without the same dividend being
declared and paid to the holders of the Class A Common Stock if, and only if,
a dividend payable in shares of Class A Common Stock, or rights to acquire
shares of Class A Common Stock, as applicable, are declared and paid to the
holders of Class A Common Stock at the same rate and with the same record
date and payment date.

  



  

(c) If the Company in any manner subdivides or combines (including by
reclassification) the outstanding shares of Class A Common Stock or Class B
Common Stock, then the outstanding shares of all Common Stock will be
subdivided or combined in the same proportion and manner.

  



  

3. Liquidation Rights. In the event of a Liquidation Event, upon the completion of the distributions required with respect to any Preferred Stock that may then be outstanding, the remaining assets of the Company legally available for distribution to stockholders, or consideration payable to the stockholders of the Company, in the case of an Acquisition constituting a Liquidation Event, shall be distributed on an equal priority, pro rata basis to the holders of Class A Common Stock and Class B Common Stock (and the holders of any Preferred Stock that may then be outstanding, to the extent required by the Certificate of Incorporation including any certificate of designation with respect to any series of Preferred Stock), unless different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock and a majority of the outstanding shares of Class B Common Stock, each voting separately as a class; _provided, however_ , for the avoidance of doubt, that compensation pursuant to any employment, consulting, severance or other compensatory arrangement to be paid to or received by a person who is also a holder of Class A Common Stock or Class B Common Stock does not constitute consideration or a "distribution to stockholders" in respect of the Class A Common Stock or Class B Common Stock.

  



    

A-5

 



    



  

4. Voting Rights.

  



  

(a) Class A Common Stock. Each holder of shares of Class A Common Stock shall
be entitled to one vote for each share thereof held.

  



  

(b) Class B Common Stock. Each holder of shares of Class B Common Stock shall
be entitled to one vote for each share thereof held.

  



  

(c) Voting Generally. Except as otherwise required by applicable law or the
Certificate of Incorporation, the holders of Preferred Stock, Class A Common
Stock and Class B Common Stock shall vote together and not as separate series
or classes. Except as otherwise required by applicable law, holders of Class
A Common Stock and Class B Common Stock, as such, shall not be entitled to
vote on any amendment to the Certificate of Incorporation that relates solely
to the terms of one or more outstanding series of Preferred Stock if the
holders of such affected series are entitled, either separately or together
with the holders of one or more other such series, to vote thereon pursuant
to the Certificate of Incorporation or applicable law.

  



  

(d) Liquidation Event. So long as any shares of Class B Common Stock are
outstanding, the Company shall not effect or approve any Liquidation Event
without, in addition to any other vote required by law or the Certificate of
Incorporation, the written consent or affirmative vote of the holders of a
majority of the outstanding shares of Class B Common Stock.

  



  

5. Optional Conversion.

  



  

(a) Optional Conversion of the Class B Common Stock.

  



  

(i) At the option of the holder thereof, each share of Class B Common Stock
shall be convertible, at any time or from time to time, into one fully paid
and nonassessable share of Class A Common Stock as provided herein.

  



  

(ii) Each holder of Class B Common Stock who elects to convert the same into
shares of Class A Common Stock shall surrender the certificate or
certificates therefor (if any), duly endorsed, at the office of the Company or
any transfer agent for the Class B Common Stock, and shall give written
notice to the Company at such office that such holder elects to convert the
same and shall state therein the number of shares of Class B Common Stock
being converted. Such conversion shall be deemed to have been made immediately
prior to the close of business on the date of such surrender of the
certificate or certificates representing the shares of Class B Common Stock
to be converted, or, if the shares are uncertificated, immediately prior to
the close of business on the date that the holder delivers notice of such
conversion to the Company's transfer agent and the person entitled to receive
the shares of Class A Common Stock issuable upon such conversion shall be
treated for all purposes as the record holder of such shares of Class A
Common Stock at such time.

  



  

6. Automatic Conversion.

  



  

(a) Automatic Conversion of the Class B Common Stock. Each share of Class B
Common Stock shall automatically be converted into one fully paid and
nonassessable share of Class A Common Stock upon a Transfer, other than a
Permitted Transfer, of such share of Class B Common Stock. Such conversion
shall occur automatically without the need for any further action by the
holders of such shares and whether or not the certificates representing such
shares (if any) are surrendered to the Company or its transfer agent;
provided, however, that the Company shall not be obligated to issue
certificates evidencing the shares of Class A Common Stock issuable upon such
conversion unless the certificates evidencing such shares of Class B Common
Stock are either delivered to the Company or its transfer agent as provided
below, or the holder notifies the Company or its transfer agent that such
certificates have been lost, stolen or destroyed and executes an agreement
satisfactory to the Company to indemnify the Company from any loss incurred by
it in connection with such certificates. Upon the occurrence of such
automatic conversion of the Class B Common Stock, the holders of Class B
Common Stock so converted shall surrender the certificates representing such
shares (if any) at the office of the Company or any transfer agent for the
Class A Common Stock.

  



    

A-6

 



    



  

(b) Final Conversion. On the Final Conversion Date, each issued share of
Class B Common Stock shall automatically, without any further action, convert
into one fully paid and nonassessable share of Class A Common Stock. Following
the Final Conversion Date, the Company shall not issue any additional shares
of Class B Common Stock. Such conversion shall occur automatically without the
need for any further action by the holders of such shares and whether or not
the certificates representing such shares (if any) are surrendered to the
Company or its transfer agent; provided, however, that the Company shall not
be obligated to issue certificates evidencing the shares of Class A Common
Stock issuable upon such conversion unless the certificates evidencing such
shares of Class B Common Stock are either delivered to the Company or its
transfer agent as provided below, or the holder notifies the Company or its
transfer agent that such certificates have been lost, stolen or destroyed and
executes an agreement satisfactory to the Company to indemnify the Company
from any loss incurred by it in connection with such certificates. Upon the
occurrence of such automatic conversion of the Class B Common Stock, the
holders of Class B Common Stock so converted shall surrender the certificates
representing such shares (if any) at the office of the Company or any
transfer agent for the Class A Common Stock.

  



  

(c) Procedures. The Company may, from time to time, establish such policies
and procedures relating to the conversion of Class B Common Stock to Class A
Common Stock and the general administration of this dual class stock
structure, including the issuance of stock certificates (or the establishment
of book-entry positions) with respect thereto, as it may deem reasonably
necessary or advisable, and may from time to time request that holders of
shares of Class B Common Stock furnish certifications, affidavits or other
proof to the Company as it deems necessary to verify the ownership of Class B
Common Stock and to confirm that a conversion to Class A Common Stock has not
occurred. A determination by the Secretary of the Company as to whether a
Transfer results in a conversion to Class A Common Stock shall be conclusive
and binding.

  



  

(d)  Immediate Effect. In the event of a conversion of shares of Class B
Common Stock to shares of Class A Common Stock pursuant to this Section 6,
such conversion(s) shall be deemed to have been made at the time that the
Transfer of shares occurred or immediately upon the Final Conversion Date, as
applicable. Upon any conversion of Class B Common Stock to Class A Common
Stock, all rights of the holder of shares of Class B Common Stock shall cease
and the person or persons in whose names or names the certificate
or certificates (or book-entry position(s)) representing the shares of Class
A Common Stock are to be issued shall be treated for all purposes as having
become the record holder or holders of such shares of Class A Common Stock.

  



  

7. Redemption. The Common Stock is not redeemable.

  



  

8. Reservation of Stock Issuable Upon Conversion. The Company shall at all times reserve and keep available out of its authorized but unissued shares of Class A Common Stock, solely for the purpose of effecting the conversion of the shares of the Class B Common Stock, as applicable, such number of its shares of Class A Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of Class B Common Stock; and if at any time the number of authorized but unissued shares of Class A Common Stock shall not be sufficient to effect the conversion of all then-outstanding shares of Class B Common Stock, as applicable, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Class A Common Stock to such numbers of shares as shall be sufficient for such purpose.

  



  

9. Prohibition on Reissuance of Shares. Shares of Class B Common Stock that are acquired by the Company for any reason (whether by repurchase, upon conversion, or otherwise) shall be retired in the manner required by law and shall not be reissued as shares of Class B Common Stock.

  



    

A-7

 



    



  

V.

  



  

For the management of the business and for the conduct of the affairs of the
Company, and in further definition, limitation and regulation of the powers of
the Company, of its directors and of its stockholders or any class thereof,
as the case may be, it is further provided that:

  



  

A. Board of Directors.

  



  

1. Generally. Except as otherwise provided in the Certificate of Incorporation or the DGCL, the business and affairs of the Company shall be managed by or under the direction of the Board of Directors. The number of directors that shall constitute the Board of Directors shall be fixed exclusively by resolutions adopted by the Board of Directors.

  



  

2. Election.

  



  

(a) So long as any shares of Class B Common Stock are outstanding, the
holders of record of the shares of Class B Common Stock, exclusively, shall
be entitled to elect three (3) directors of the Company or, if applicable,
such greater number of directors as may be provided by Subsection 2(b). If
the holders of shares of Class B Common Stock fail to elect a sufficient
number of directors to fill all directorships for which they are entitled to
elect directors, voting exclusively and as a separate class, pursuant to the
first sentence of this Subsection 2(a), then any directorship not so filled
shall remain vacant until such time as such directorship is filled in
accordance with Subsection 4(a); no such directorship may be filled by
stockholders of the Company other than by the holders of record of the shares
of Class B Common Stock, voting exclusively and as a separate class.

  



  

(b) At any time when any shares of Class B Common Stock are outstanding and
the authorized number of directors constituting the Board of Directors is
greater than seven (7), the number of directors that may be elected by the
holders of record of the shares of Class B Common Stock, exclusively (the "
_Class B Directors_ "), shall be increased to the sum of three (3) and the
smallest whole number that is at least 50% of the authorized number of
directors in excess of seven (7). By way of example, the number of Class B
Directors shall be four if the authorized number of directors is eight (8) or
nine (9) and shall be five (5) if the authorized number of directors is ten
(10) or eleven (11).

  



  

(c) Subject to the rights of the holders of any series of Preferred Stock to
elect additional directors under specified circumstances, the holders of
record of the shares of Class A Common Stock and Class B Common Stock and of
any other class or series of stock entitled to vote in the election of
directors, exclusively and voting together as a single class on an as-
converted to Class A Common Stock basis, shall be entitled to elect all
directors other than Class B Directors.

  



  

(d) Subject to the rights of the holders of any series of Preferred Stock to
elect additional directors under specified circumstances, the directors shall
be divided into three classes designated as Class I, Class II and Class III,
respectively. Each class shall consist, as nearly as possible, of one-third
of the total number of such directors. The Board of Directors is authorized to
assign members of the Board of Directors already in office to such classes at
the time the classification becomes effective. At the first annual meeting of
stockholders following the time at which such initial classification of the
Board of Directors becomes effective, the initial term of office of the Class
I directors shall expire. At the second annual meeting of stockholders
following the time at which such initial classification of the Board of
Directors becomes effective, the initial term of office of the Class II
directors shall expire. At the third annual meeting of stockholders following
the time at which such initial classification of the Board of Directors
becomes effective, the initial term of office of the Class III directors shall
expire. At each annual meeting of stockholders following the time at which
such initial classification of the Board of Directors becomes effective, the
successors of the class of directors whose term expires at that meeting shall
be elected for a term expiring at the annual meeting of stockholders held in
the third year following the year of their election.

  



    

A-8

 



    



  

(e) Notwithstanding the foregoing provisions of this section, each director
shall serve until his or her successor is duly elected and qualified or until
his or her earlier death, resignation or removal. No decrease in the number of
directors constituting the Board of Directors shall shorten the term of any
incumbent director.

  



  

(f) No stockholder entitled to vote at an election for directors may cumulate
votes.

  



  

(g) At any meeting held for the purpose of electing a director, the presence
in person or by proxy of the holders of a majority in Voting Power of the
outstanding shares of the class(es) or series entitled to elect such director
shall constitute a quorum for the purpose of electing such director.

  



  

(h) Election of directors need not be by written ballot unless the Bylaws of
the Company so provide.

  



  

3. Removal of Directors.

  



  

(a) So long as any shares of Class B Common Stock are outstanding, any or all
of the Class B Directors may be removed, without cause, by, and only by, the
affirmative vote of the holders of record of a majority of the shares Class B
Common Stock.

  



  

(b) Except as set forth in Subsection 3(a) and subject to any limitations
imposed by applicable law and the rights of any series of Preferred Stock to
remove directors elected by such series of Preferred Stock, any individual
director or the entire Board of Directors may be removed from office, but
only for cause, by the affirmative vote of the holders of at least 66 2/3% of
the voting power of all the then-outstanding shares of the capital stock of
the Corporation entitled to vote in the election of directors.

  



  

4. Vacancies.

  



  

(a)  So long as any shares of Class B Common Stock are outstanding, a vacancy
in the office of any Class B Director resulting from death, resignation,
disqualification, removal or other causes and any newly created directorships
resulting from any increase in the number of Class B Directors shall be
filled by, and only by, the holders of a majority of the outstanding shares of
Class B Common Stock or by any remaining Class B Director or Class B
Directors, although less than a quorum. Any director elected or appointed to
fill a vacancy or newly created directorship in accordance with the preceding
sentence shall hold office until the next annual meeting of stockholders to
elect the class of directors to which such director is elected or appointed
and until such director's successor shall have been elected and qualified or
until such director's earlier death, resignation or removal.

  



  

(b) Except as provided in Subsection 4(a) and subject to any limitations
imposed by applicable law and the rights of the holders of any series of
Preferred Stock, any vacancies on the Board of Directors resulting from death,
resignation, disqualification, removal or other causes and any newly created
directorships resulting from any increase in the number of directors, shall,
unless the Board of Directors determines by resolution that any such
vacancies or newly created directorships shall be filled by the stockholders
and except as otherwise provided by applicable law, be filled only by the
Board of Directors by a majority of the directors then in office, although
less than a quorum, or by the sole remaining director, and not by the
stockholders. Any director elected or appointed to fill a vacancy or newly
created directorship in accordance with the preceding sentence shall hold
office until the next annual meeting of stockholders to elect the class of
directors to which such director is elected or appointed and until such
director's successor shall have been elected and qualified or until such
director's earlier death, resignation or removal.

  



    

A-9

 



    



  

5. Preferred Directors. Notwithstanding anything herein to the contrary, during any period when the holders of any series of Preferred Stock, voting separately as a series or together with one or more series, have the right to elect additional directors, then upon commencement and for the duration of the period during which such right continues: (a) the then otherwise total authorized number of directors of the Company shall automatically be increased by such specified number of directors, and the holders of such Preferred Stock shall be entitled to elect the additional directors so provided for or fixed pursuant to said provisions; and (b) each such additional director shall serve until such director's successor shall have been duly elected and qualified, or until such director's right to hold such office terminates pursuant to said provisions, whichever occurs earlier, subject to his or her earlier death, resignation, or removal. Except as otherwise provided by the Certificate of Incorporation (including any certificate of designation with respect to any series of Preferred Stock) the Board of Directors in the resolution or resolutions establishing such series, whenever the holders of any series of Preferred Stock having such right to elect additional directors are divested of such right pursuant to the provisions of the Certificate of Incorporation (including any certificate of designation with respect to any series of Preferred Stock), the terms of office of all such additional directors elected by the holders of such stock, or elected to fill any vacancies resulting from the death, resignation or removal of such additional directors, shall forthwith terminate (in which case each such director thereupon shall cease to be qualified as, and shall cease to be, a director) and the total authorized number of directors of the Company shall be reduced accordingly.

  



  

B. Stockholder Actions. No action shall be taken by the stockholders of the
Company except at an annual or special meeting of stockholders called in
accordance with the Bylaws of the Company and no action shall be taken by the
stockholders by consent. Advance notice of stockholder nominations for the
election of directors and of business to be brought by stockholders before any
meeting of the stockholders of the Company shall be given in the manner
provided in the Bylaws of the Company.

  



  

C. Bylaws. The Board of Directors is expressly empowered to adopt, amend or
repeal the Bylaws of the Company. The stockholders shall also have power to
adopt, amend or repeal the Bylaws of the Company; _provided, however,_ that,
in addition to any vote of the holders of any class or series of stock of the
Company required by law or by the Certificate of Incorporation, such action by
stockholders shall require the affirmative vote of the holders of at least 66
2/3% of the Voting Power of all of the then-outstanding shares of the capital
stock of the Company entitled to vote in the election of directors, voting
together as a single class.

  



  

VI.

  



  

A. The liability of the directors of the Company for monetary damages for
breach of fiduciary duty as a director shall be eliminated to the fullest
extent permitted under applicable law.

  



  

B. To the fullest extent permitted by applicable law, the Company may provide
indemnification of (and advancement of expenses to) directors, officers,
employees and agents of the Company (and any other persons to which applicable
law permits the Company to provide indemnification) through Bylaw provisions,
agreements with such agents or other persons, vote of stockholders or
disinterested directors or otherwise.

  



    

A-10

 



    



  

C. Any repeal or modification of this Article VI shall only be prospective
and shall not affect the rights under this Article VI in effect at the time
of the alleged occurrence of any action or omission to act giving rise to
liability.

  



  

VII.

  



  

A. Unless the Company consents in writing to the selection of an alternative
forum, the Court of Chancery of the State of Delaware (or, if and only if the
Court of Chancery of the State of Delaware lacks subject matter jurisdiction,
any state court located within the State of Delaware or, if and only if all
such state courts lack subject matter jurisdiction, the federal district court
for the District of Delaware) and any appellate court therefrom shall be the
sole and exclusive forum for the following claims or causes of action under
Delaware statutory or common law: (A) any derivative claim or cause of action
brought on behalf of the Company; (B) any claim or cause of action for
breach of a fiduciary duty owed by any current or former director, officer or
other employee of the Company, to the Company or the Company's stockholders;
(C) any claim or cause of action against the Company or any current or former
director, officer or other employee of the Company, arising out of or pursuant
to any provision of the DGCL, the Certificate of Incorporation or the Bylaws
of the Company (as each may be amended from time to time); (D) any claim
or cause of action seeking to interpret, apply, enforce or determine the
validity of the Certificate of Incorporation or the Bylaws of the Company (as
each may be amended from time to time, including any right, obligation, or
remedy thereunder); (E) any claim or cause of action as to which the DGCL
confers jurisdiction on the Court of Chancery of the State of Delaware; and
(F) any claim or cause of action against the Company or any current or former
director, officer or other employee of the Company, governed by the internal
affairs doctrine or otherwise related to the Company's internal affairs, in
all cases to the fullest extent permitted by law and subject to the court's
having personal jurisdiction over the indispensable parties named as
defendants. This Article VII shall not apply to claims or causes of action
brought to enforce a duty or liability created by the Securities Act of 1933,
as amended, or the Securities Exchange Act of 1934, as amended, or any other
claim for which the federal courts have exclusive jurisdiction.

  



  

B. Unless the Company consents in writing to the selection of an alternative
forum, the federal district courts of the United States of America shall be
the exclusive forum for the resolution of any complaint asserting a cause of
action arising under the Securities Act of 1933, as amended.

  



  

VIII.

  



  

A. Any person or Entity holding, owning or otherwise acquiring any interest
in shares of capital stock of the Company shall be deemed to have notice of
and to have consented to the provisions of the Certificate of Incorporation.

  



  

B. The Company reserves the right to amend, alter, change or repeal any
provision contained in the Certificate of Incorporation, in the manner now or
hereafter prescribed by statute, except as provided in paragraph C. of this
Article VIII, and all rights conferred upon the stockholders herein are
granted subject to this reservation.

  



  

C. Notwithstanding any other provisions of the Certificate of Incorporation
or any provision of law that might otherwise permit a lesser vote or no vote,
but in addition to any affirmative vote required by law or by the Certificate
of Incorporation, (i) the affirmative vote of the holders of at least 66 2/3%
of the Voting Power of all of the then-outstanding shares of capital stock of
the Company entitled to vote in the election of directors, voting together as
a single class, shall be required to alter, amend or repeal, or adopt any
provision inconsistent with, Articles V, VI, VII and VIII and (ii) so long as
any shares of Class B Common Stock are outstanding, the affirmative vote of
the holders of a majority of the then-outstanding shares of Class B Common
Stock shall be required to adopt, amend, alter, waive or repeal any provision
of the Certificate of Incorporation in a manner that adversely affects the
powers, preferences or rights of the Class B Common Stock or the holders
thereof in respect of such shares.

  

   

 _[Signature Page Follows]_

  

 _ _

    

A-11

 



    

 _ _

  

IN WITNESS WHEREOF, Panacea Acquisition Corp. has caused this Amended and
Restated Certificate to be duly executed and acknowledged in its name and on
its behalf by an authorized officer as of this [] day of [], 2020.

  



       | Panacea Acquisition Corp. 
---|--- 
  



       | By:  | 
---|---|--- 
     |   | [] 
     |   | [] 
  



  

   

A-12

 



    



 

Exhibit B

  



  



  



  

FORM OF PURCHASER BYLAWS

  



  



  



  



  



  



  

AMENDED AND RESTATED

  



  

BYLAWS 
  
 OF 
  
 Nuvation bio inc.

  



  

(A DELAWARE CORPORATION)

  



  



  



  



  



  



  



  



  



  



  



  



  



    

B-1

 



    



  

AMENDED AND RESTATED BYLAWS 
  
 OF 
  
 nuvation bio inc. 
 (A DELAWARE CORPORATION)

  



  

ARTICLE I 
  
 Offices

  



  

Section 1. Registered Office. The registered office of the corporation in the
State of Delaware shall be as set forth in the Amended and Restated
Certificate of Incorporation of the corporation (the "Certificate of
Incorporation").

  



  

Section 2. Other Offices. The corporation may also have and maintain an
office or principal place of business at such place as may be fixed by the
Board of Directors of the corporation (the "Board of Directors"), and may also
have offices at such other places, both within and without the State of
Delaware as the Board of Directors may from time to time determine or the
business of the corporation may require.

  



  

ARTICLE II 
  
 Corporate Seal

  



  

Section 3. Corporate Seal. The Board of Directors may adopt a corporate seal.
If adopted, the corporate seal shall consist of the name of the corporation
and the inscription, "Corporate Seal-Delaware." Said seal may be used by
causing it or a facsimile thereof to be impressed or affixed or reproduced or
otherwise.

  



  

ARTICLE III 
  
 Stockholders' Meetings

  



  

Section 4. Place of Meetings. Meetings of the stockholders of the corporation
may be held at such place, if any, either within or without the State of
Delaware, as may be determined from time to time by the Board of Directors.
The Board of Directors may, in its sole discretion, determine that the
meeting shall not be held at any place, but may instead be held solely by
means of remote communication as provided under the General Corporation Law
of the State of Delaware ("DGCL") and Section 14 below.

  



  

   

B-2

 



    



  

Section 5. Annual Meetings.

  



  

(a) The annual meeting of the stockholders of the corporation, for the
purpose of election of directors and for such other business as may properly
come before it, shall be held on such date and at such time as may be
designated from time to time by the Board of Directors. The corporation may
postpone, reschedule or cancel any annual meeting of stockholders previously
scheduled by the Board of Directors. Nominations of persons for election to
the Board of Directors of the corporation and proposals of business to
be considered by the stockholders may be made at an annual meeting of
stockholders: (i) pursuant to the corporation's notice of meeting of
stockholders; (ii) by or at the direction of the Board of Directors or a duly
authorized committee thereof; or (iii) by any stockholder of the corporation
who was a stockholder of record (and, with respect to any beneficial owner, if
different, on whose behalf such business is proposed or such nomination or
nominations are made, only if such beneficial owner was the beneficial owner
of shares of the corporation) at the time of giving the stockholder's notice
provided for in Section 5(b) below, who is entitled to vote at the meeting
and who complied with the notice procedures set forth in this Section 5. For
the avoidance of doubt, clause (iii) above shall be the exclusive means for a
stockholder to make nominations and submit other business (other than matters
properly included in the corporation's notice of meeting of stockholders and
proxy statement under Rule 14a-8 under the Securities Exchange Act of 1934,
as amended, and the rules and regulations thereunder (the "1934 Act")) before
an annual meeting of stockholders.

  



  

(b) At an annual meeting of the stockholders, only such business shall be
conducted as is a proper matter for stockholder action under Delaware law,
the Certificate of Incorporation and these Bylaws, and only such nominations
shall be made and such business shall be conducted as shall have been
properly brought before the meeting in accordance with the procedures below.

  



  

(i) For nominations for the election to the Board of Directors to be properly
brought before an annual meeting by a stockholder pursuant to clause (iii) of
Section 5(a), the stockholder must deliver written notice to the Secretary at
the principal executive offices of the corporation on a timely basis as set
forth in Section 5(b)(iii) and must update and supplement such written
notice on a timely basis as set forth in Section 5(c). Such stockholder's
notice shall set forth: (A) as to each nominee such stockholder proposes to
nominate at the meeting: (1) the name, age, business address and residence
address of such nominee, (2) the principal occupation or employment of such
nominee, (3) the class or series and number of shares of each class or series
of capital stock of the corporation that are owned of record and beneficially
by such nominee, (4) the date or dates on which such shares were acquired and
the investment intent of such acquisition, and (5) all other information
concerning such nominee as would be required to be disclosed in a proxy
statement soliciting proxies for the election of such nominee as a director in
an election contest (even if an election contest is not involved and whether
or not proxies are being or will be solicited), or that is otherwise required
to be disclosed pursuant to Section 14 of the 1934 Act (including such
person's written consent to being named in the corporation's proxy statement
and associated proxy card as a nominee of the stockholder and to serving as a
director if elected); and (B) all of the information required by Section
5(b)(iv). The corporation may require any proposed nominee to furnish such
other information as it may reasonably require to determine the eligibility of
such proposed nominee to serve as an independent director of the corporation
(as such term is used in any applicable stock exchange listing requirements or
applicable law) or on any committee or sub-committee of the Board of
Directors under any applicable stock exchange listing requirements
or applicable law, or that could be material to a reasonable stockholder's
understanding of the independence, or lack thereof, of such proposed nominee.
The number of nominees a stockholder may nominate for election at the annual
meeting (or in the case of a stockholder giving the notice on behalf of a
beneficial owner, the number of nominees a stockholder may nominate for
election at the annual meeting on behalf of such beneficial owner) shall not
exceed the number of directors to be elected at such annual meeting.

  



  

(ii) Other than proposals sought to be included in the corporation's proxy
materials pursuant to Rule 14a-8 under the 1934 Act, for business other than
nominations for the election to the Board of Directors to be properly brought
before an annual meeting by a stockholder pursuant to clause (iii) of Section
5(a), the stockholder must deliver written notice to the Secretary at
the principal executive offices of the corporation on a timely basis as set
forth in Section 5(b)(iii), and must update and supplement such written
notice on a timely basis as set forth in Section 5(c). Such stockholder's
notice shall set forth: (A) as to each matter such stockholder proposes to
bring before the meeting, a brief description of the business desired to be
brought before the meeting, the text of the proposal or business (including
the text of any resolutions proposed for consideration and in the event that
such business includes a proposal to amend these Bylaws, the language of the
proposed amendment), the reasons for conducting such business at the meeting,
and any material interest (including any anticipated benefit of such business
to any Proponent (as defined below) other than solely as a result of its
ownership of the corporation's capital stock, that is material to
any Proponent individually, or to the Proponents in the aggregate) in such
business of any Proponent; and (B) the information required by Section
5(b)(iv).

  



  

   

B-3

 



    



  

(iii) To be timely, the written notice required by Section 5(b)(i) or
5(b)(ii) must be received by the Secretary at the principal executive offices
of the corporation not later than the close of business on the 90th day, nor
earlier than the close of business on the 120th day, prior to the first
anniversary of the immediately preceding year's annual meeting;
_provided, however,_ that, subject to the last sentence of this Section
5(b)(iii), in the event that (A) the date of the annual meeting is advanced
more than 30 days prior to or delayed by more than 30 days after the
anniversary of the preceding year's annual meeting, notice by the stockholder
to be timely must be so received not earlier than the close of business on the
120th day prior to such annual meeting and not later than the close of
business on the later of the 90th day prior to such annual meeting or the
tenth day following the day on which public announcement of the date of such
meeting is first made by the corporation or (B) the corporation did not have
an annual meeting in the preceding year, notice by the stockholder to be
timely must be so received not later than the tenth day following the day on
which public announcement of the date of such meeting is first made. In no
event shall an adjournment or postponement of an annual meeting for which
notice has been given, or the public announcement thereof has been made,
commence a new time period (or extend any time period) for the giving of a
stockholder's notice as described above.

  



  

(iv) The written notice required by Sections 5(b)(i) or 5(b)(ii) shall also
set forth, as of the date of the notice and as to the stockholder giving the
notice and the beneficial owner, if any, on whose behalf the nomination or
proposal is made (each, a "Proponent" and collectively, the "Proponents"):
(A) the name and address of each Proponent, including, if applicable, such
name and address as they appear on the corporation's books and records; (B)
the class, series and number of shares of each class or series of the capital
stock of the corporation that are, directly or indirectly, owned of record or
beneficially (within the meaning of Rule 13d-3 under the 1934 Act) by each
Proponent (provided, that for purposes of this Section 5(b)(iv), such
Proponent shall in all events be deemed to beneficially own all shares of any
class or series of capital stock of the corporation as to which such
Proponent has a right to acquire beneficial ownership at any time in the
future); (C) a description of any agreement, arrangement or understanding
(whether oral or in writing) with respect to such nomination or proposal
(and/or the voting of shares of any class or series of capital stock of the
corporation) between or among any Proponent and any of its affiliates or
associates, and any others (including their names) acting in concert, or
otherwise under the agreement, arrangement or understanding, with any of the
foregoing; (D) a representation that the Proponents are holders of record or
beneficial owners, as the case may be, of shares of the corporation at the
time of giving notice, will be entitled to vote at the meeting, and intend to
appear in person or by proxy at the meeting to nominate the person or persons
specified in the notice (with respect to a notice under Section 5(b)(i)) or
to propose the business that is specified in the notice (with respect to a
notice under Section 5(b)(ii)); (E) a representation as to whether the
Proponents intend to deliver a proxy statement and form of proxy to holders of
a sufficient number of the corporation's voting shares to elect such nominee
or nominees (with respect to a notice under Section 5(b)(i)) or to carry such
proposal (with respect to a notice under Section 5(b)(ii)); (F) to the extent
known by any Proponent, the name and address of any other
stockholder supporting the proposal on the date of such stockholder's notice;
and (G) a description of all Derivative Transactions (as defined below) by
each Proponent during the previous 12 month period, including the date of the
transactions and the class, series and number of securities involved in, and
the material economic terms of, such Derivative Transactions.

  



  

   

B-4

 



    



  

(c) A stockholder providing the written notice required by Section 5(b)(i) or
(ii) shall update and supplement such notice in writing, if necessary, so
that the information provided or required to be provided in such notice is
true and correct in all material respects as of (i) the record date for the
determination of stockholders entitled to notice of the meeting and (ii) the
date that is five Business Days (as defined below) prior to the meeting and,
in the event of any adjournment or postponement thereof, five Business Days
prior to such adjourned or postponed meeting. In the case of an update and
supplement pursuant to clause (i) of this Section 5(c), such update and
supplement shall be received by the Secretary at the principal executive
offices of the corporation not later than five Business Days after the later
of the record date for the determination of stockholders entitled to notice of
the meeting or the public announcement of such record date. In the case of an
update and supplement pursuant to clause (ii) of this Section 5(c), such
update and supplement shall be received by the Secretary at the principal
executive offices of the corporation not later than two Business Days prior
to the date for the meeting, and, in the event of any adjournment or
postponement thereof, two Business Days prior to such adjourned or postponed
meeting.

  



  

(d) Notwithstanding anything in Section 5(b)(iii) to the contrary, in the
event that the number of directors in an Expiring Class (as defined below) to
be elected to the Board of Directors at the annual meeting is increased
effective after the time period for which nominations would otherwise be due
under Section 5(b)(iii) and there is no public announcement by the corporation
naming the nominees for the additional directorships at least 100 days before
the first anniversary of the preceding year's annual meeting, a
stockholder's notice required by this Section 5 and that complies with the
requirements in Section 5(b)(i), other than the timing requirements in
Section 5(b)(iii), shall also be considered timely, but only with respect to
nominees for the additional directorships in such Expiring Class, if it shall
be received by the Secretary at the principal executive offices of the
corporation not later than the close of business on the tenth day following
the day on which such public announcement is first made by the corporation.
For purposes of this section, an "Expiring Class" shall mean a class of
directors whose term shall expire at the annual meeting of stockholders.

  



  

(e) A person shall not be eligible for election or re-election as a director
at an annual meeting, unless the person is nominated in accordance with
either clause (ii) or (iii) of Section 5(a) and in accordance with the
procedures set forth in Section 5(b), Section 5(c), and Section 5(d), as
applicable. Only such business shall be conducted at any annual meeting of the
stockholders of the corporation as shall have been brought before the meeting
in accordance with clauses (i), (ii), or (iii) of Section 5(a) and
in accordance with the procedures set forth in Section 5(b) and Section 5(c),
as applicable. Except as otherwise required by applicable law, the
chairperson of the meeting shall have the power and duty to determine whether
a nomination or any business proposed to be brought before the meeting was
made, or proposed, as the case may be, in accordance with the procedures set
forth in these Bylaws and, if any proposed nomination or business is not in
compliance with these Bylaws, or the Proponent does not act in
accordance with the representations in Sections 5(b)(iv)(D) and 5(b)(iv)(E),
to declare that such proposal or nomination shall not be presented for
stockholder action at the meeting and shall be disregarded, or that such
business shall not be transacted, notwithstanding that proxies in respect of
such nomination or such business may have been solicited or received.
Notwithstanding the foregoing provisions of this Section 5, unless otherwise
required by law, if the stockholder (or a qualified representative of the
stockholder) does not appear at the annual meeting of stockholders of the
corporation to present a nomination or proposed business, such
nomination shall be disregarded and such proposed business shall not be
transacted, notwithstanding that proxies in respect of such vote may have
been received by the corporation. For purposes of this Section 5, to be
considered a qualified representative of the stockholder, a person must be a
duly authorized officer, manager or partner of such stockholder or must be
authorized by a writing executed by such stockholder or an electronic
transmission delivered by such stockholder to act for such stockholder as
proxy at the meeting of stockholders and such person must produce such
writing or electronic transmission, or a reliable reproduction of the writing
or electronic transmission, at the meeting of stockholders.

  



  

   

B-5

 



    



  

(f) Notwithstanding the foregoing provisions of this Section 5, in order to
include information with respect to a stockholder proposal in the proxy
statement and form of proxy for a stockholders' meeting, a stockholder must
also comply with all applicable requirements of the 1934 Act and the rules
and regulations thereunder. Nothing in these Bylaws shall be deemed to affect
any rights of stockholders to request inclusion of proposals in the
corporation's proxy statement pursuant to Rule 14a-8 under the 1934 Act;
_provided, however,_ that any references in these Bylaws to the 1934 Act or
the rules and regulations thereunder are not intended to and shall not limit
the requirements applicable to proposals and/or nominations to be considered
pursuant to Section 5(a)(iii). Nothing in these Bylaws shall be deemed to
affect any rights of holders of any class or series of preferred stock to
nominate and elect directors pursuant to and to the extent provided in any
applicable provision of the Certificate of Incorporation.

  



  

(g) For purposes of Sections 5 and 6,

  



  

(i) "affiliates" and "associates" shall have the meanings set forth in Rule
405 under the Securities Act of 1933, as amended (the "1933 Act");

  



  

(ii) "Business Day" means any day other than Saturday, Sunday or a day on
which banks are closed in New York City, New York;

  



  

(iii) "close of business" means 6:00 p.m. local time at the principal
executive offices of the corporation on any calendar day, whether or not the
day is a Business Day;

  



  

(iv) "Derivative Transaction" means any agreement, arrangement, interest or
understanding entered into by, or on behalf or for the benefit of, any
Proponent or any of its affiliates or associates, whether record or
beneficial:

  



  

(A) the value of which is derived in whole or in part from the value of any
class or series of shares or other securities of the corporation;

  



  

(B) that otherwise provides any direct or indirect opportunity to gain or
share in any gain derived from a change in the value of securities of the
corporation;

  



  

(C) the effect or intent of which is to mitigate loss, manage risk or benefit
from changes in value or price with respect to any securities of the
corporation; or

  



  

(D) that provides the right to vote or increase or decrease the voting power
of, such Proponent, or any of its affiliates or associates, directly or
indirectly, with respect to any securities of the corporation,

  



  

which agreement, arrangement, interest or understanding may include, without
limitation, any option, warrant, debt position, note, bond, convertible
security, swap, stock appreciation or similar right, short position, profit
interest, hedge, right to dividends, voting agreement, performance-related
fee or arrangement to borrow or lend shares (whether or not subject to
payment, settlement, exercise or conversion in any such class or series), and
any proportionate interest of such Proponent in the securities of the
corporation held by any general or limited partnership, or any limited
liability company, of which such Proponent is, directly or indirectly, a
general partner or managing member; and

  



  

   

B-6

 



    



  

(v) "public announcement" shall mean disclosure in a press release reported
by the Dow Jones News Service, Associated Press or comparable national news
service or in a document publicly filed by the corporation with the Securities
and Exchange Commission pursuant to Section 13, 14 or 15(d) of the 1934 Act
or by such other means reasonably designed to inform the public or security
holders in general of such information, including, without limitation,
posting on the corporation's investor relations website.

  



  

Section 6. Special Meetings.

  



  

(a) Special meetings of the stockholders of the corporation may be called,
for any purpose as is a proper matter for stockholder action under Delaware
law, by (i) the Chairperson of the Board of Directors, (ii) the Chief
Executive Officer, or (iii) the Board of Directors. The corporation may
postpone, reschedule or cancel any special meeting of stockholders previously
scheduled by the Board of Directors.

  



  

(b) The Board of Directors shall determine the time and place, if any, of
such special meeting. Upon determination of the time and place, if any, of
the meeting, the Secretary shall cause a notice of meeting to be given to the
stockholders entitled to vote, in accordance with the provisions of Section
7\. No business may be transacted at such special meeting otherwise than
specified in the notice of meeting.

  



  

(c) Only such business shall be conducted at a special meeting of
stockholders as shall have been brought before the meeting pursuant to the
corporation's notice of meeting. Nominations of persons for election to the
Board of Directors may be made at a special meeting of stockholders at which
directors are to be elected (i) by or at the direction of the Board of
Directors or a duly authorized committee thereof or (ii) provided that the
Board of Directors has determined that directors shall be elected at such
meeting, by any stockholder of the corporation who is a stockholder of record
(and, with respect to any beneficial owner, if different, on whose behalf
such nomination or nominations are made, only if such beneficial owner was the
beneficial owner of shares of the corporation) at the time of giving notice
provided for in this paragraph, who is entitled to vote at the meeting and who
delivers written notice to the Secretary of the corporation setting forth the
information required by Sections 5(b)(i) and 5(b)(iv). The number of nominees
a stockholder may nominate for election at the special meeting (or in the case
of a stockholder giving the notice on behalf of a beneficial owner, the
number of nominees a stockholder may nominate for election at the special
meeting on behalf of such beneficial owner) shall not exceed the number of
directors to be elected at such special meeting. In the event the corporation
calls a special meeting of stockholders for the purpose of electing one or
more directors to the Board of Directors, any such stockholder of record may
nominate a person or persons (as the case may be), for election to such
position(s) as specified in the corporation's notice of meeting, if written
notice setting forth the information required by Sections 5(b)(i)
and 5(b)(iv) shall be received by the Secretary at the principal executive
offices of the corporation not earlier than 120 days prior to such special
meeting and not later than the close of business on the later of the 90th day
prior to such meeting or the tenth day following the day on which the
corporation first makes a public announcement of the date of the special
meeting and of the nominees proposed by the Board of Directors to be elected
at such meeting. The stockholder shall also update and supplement such
information as required under Section 5(c). In no event shall an adjournment
or a postponement of a special meeting for which notice has been given, or
the public announcement thereof has been made, commence a new time period (or
extend any time period) for the giving of a stockholder's notice as described
above.

  



  

   

B-7

 



    



  

A person shall not be eligible for election or re-election as a director at
the special meeting unless the person is nominated either in accordance with
clause (i) or clause (ii) of this Section 6(c). Except as otherwise required
by applicable law, the chairperson of the meeting shall have the power and
duty to determine whether a nomination was made in accordance with the
procedures set forth in these Bylaws and, if any proposed nomination or
business is not in compliance with these Bylaws, or if the Proponent does not
act in accordance with the representations in Sections 5(b)(iv)(D) and
5(b)(iv)(E), to declare that such nomination shall not be presented for
stockholder action at the meeting and shall be disregarded, notwithstanding
that proxies in respect of such nomination may have been solicited or
received. Notwithstanding the foregoing provisions of this Section 6, unless
otherwise required by law, if the stockholder (or a qualified representative
of the stockholder (as defined in Section 5(e))) does not appear at the
special meeting of stockholders of the corporation to present a nomination,
such nomination shall be disregarded, notwithstanding that proxies in respect
of such vote may have been received by the corporation.

  



  

(d) Notwithstanding the foregoing provisions of this Section 6, a stockholder
must also comply with all applicable requirements of the 1934 Act and the
rules and regulations thereunder with respect to matters set forth in this
Section 6. Nothing in these Bylaws shall be deemed to affect any rights of
stockholders to request inclusion of proposals in the corporation's proxy
statement pursuant to Rule 14a-8 under the 1934 Act; _provided, however,_
that any references in these Bylaws to the 1934 Act or the rules
and regulations thereunder are not intended to and shall not limit the
requirements applicable to nominations for the election to the Board of
Directors to be considered pursuant to Section 6 (c).

  



  

Section 7. Notice of Meetings. Except as otherwise provided by applicable
law, notice, given in writing or by electronic transmission, of each meeting
of stockholders shall be given not less than ten nor more than 60 days before
the date of the meeting to each stockholder entitled to vote at such meeting.
Such notice shall specify the place, if any, date, hour and in the case of
special meetings, the purpose or purposes of the meeting, the record date for
determining stockholders entitled to vote at the meeting, if such record date
is different from the record date for determining stockholders entitled to
notice of the meeting, and the means of remote communications, if any, by
which stockholders and proxyholders may be deemed to be present in person and
vote at any such meeting. If mailed, notice is given when deposited in the
United States mail, postage prepaid, directed to the stockholder at such
stockholder's address as it appears on the records of the corporation. If
delivered by courier service, the notice is given on the earlier of when the
notice is received or left at the stockholder's address. If given via
electronic mail, notice is given when directed to such stockholder's
electronic mail address in accordance with applicable law unless (a) the
stockholder has notified the corporation in writing or by electronic
transmission of an objection to receiving notice by electronic mail or (b)
electronic transmission of such notice is prohibited by applicable law. Notice
of the time, place, if any, and purpose of any meeting of stockholders (to
the extent required) may be waived in writing, signed by the person entitled
to notice thereof, or by electronic transmission by such person, either
before or after such meeting, and will be waived by any stockholder by his or
her attendance thereat in person, by remote communication, if applicable, or
by proxy, except when the stockholder attends a meeting for the express
purpose of objecting, at the beginning of the meeting, to the transaction of
any business because the meeting is not lawfully called or convened. Any
stockholder so waiving notice of such meeting shall be bound by the
proceedings of any such meeting in all respects as if due notice thereof had
been given.

  



  

Section 8. Quorum and Vote Required. At all meetings of stockholders, except
where otherwise provided by statute or by the Certificate of Incorporation,
or by these Bylaws, the presence, in person, by remote communication, if
applicable, or by proxy duly authorized, of the holders of a majority of the
voting power of the outstanding shares of stock entitled to vote at the
meeting shall constitute a quorum for the transaction of business. In the
absence of a quorum, any meeting of stockholders may be adjourned, from
time to time, either by the chairperson of the meeting or by vote of the
holders of a majority of the voting power of the shares represented thereat
and entitled to vote thereon, but no other business shall be transacted at
such meeting. The stockholders present at a duly called or convened meeting,
at which a quorum is present, may continue to transact business until
adjournment, notwithstanding the withdrawal of enough stockholders to leave
less than a quorum.

  



  

   

B-8

 



    



  

Except as otherwise provided by statute or by applicable stock exchange
rules, or by the Certificate of Incorporation or these Bylaws, in all matters
other than the election of directors, the affirmative vote of the holders of a
majority of the voting power of the shares present in person, by remote
communication, if applicable, or represented by proxy duly authorized at the
meeting and voting affirmatively or negatively (excluding abstentions and
broker non-votes) on such matter shall be the act of the stockholders. Except
as otherwise provided by statute, the Certificate of Incorporation or these
Bylaws, directors shall be elected by a plurality of the votes of the shares
present in person, by remote communication, if applicable, or represented by
proxy duly authorized at the meeting and entitled to vote in the election of
directors. Where a separate vote by a class or classes or series is
required, except where otherwise provided by statute or by the Certificate of
Incorporation or these Bylaws or any applicable stock exchange rules, the
holders of a majority of the voting power of the outstanding shares of such
class or classes or series, present in person, by remote communication, if
applicable, or represented by proxy duly authorized, shall constitute a quorum
entitled to take action with respect to that vote on that matter. Except
where otherwise provided by statute or by the Certificate of Incorporation or
these Bylaws or any applicable stock exchange rules, the affirmative vote of
the holders of a majority (plurality, in the case of the election of
directors) of the voting power of the shares of such class or classes or
series present in person, by remote communication, if applicable, or
represented by proxy at the meeting and voting affirmatively or negatively
(excluding abstention and broker non-votes) on such matter shall be the act
of such class or classes or series.

  



  

Section 9. Adjournment and Notice of Adjourned Meetings. Any meeting of
stockholders, whether annual or special, may be adjourned from time to time
either by the chairperson of the meeting or by the vote of the holders of a
majority of the voting power of the shares present in person, by remote
communication, if applicable, or represented by proxy duly authorized at the
meeting and entitled to vote thereon. When a meeting is adjourned to another
time or place, if any, notice need not be given of the adjourned meeting if
the time and place, if any, thereof and the means of remote communication, if
any, by which stockholders and proxyholders may be deemed present in person
and may vote at such meeting are announced at the meeting at which the
adjournment is taken. At the adjourned meeting, the corporation may transact
any business that might have been transacted at the original meeting. If
the adjournment is for more than 30 days or if after the adjournment a new
record date is fixed for the adjourned meeting, a notice of the adjourned
meeting shall be given to each stockholder of record entitled to vote at the
meeting. If after the adjournment a new record date for determination of
stockholders entitled to vote is fixed for the adjourned meeting, the Board of
Directors shall fix as the record date for determining stockholders entitled
to notice of such adjourned meeting the same or an earlier date as that fixed
for determination of stockholders entitled to vote at the adjourned meeting,
and shall give notice of the adjourned meeting to each stockholder of record
as of the record date so fixed for notice of such adjourned meeting.

  



  

Section 10. Voting Rights. For the purpose of determining those stockholders
entitled to vote at any meeting of the stockholders or adjournment thereof,
except as otherwise provided by applicable law, only persons in whose names
shares stand on the stock records of the corporation on the record date shall
be entitled to vote at any meeting of stockholders. Every person entitled to
vote shall have the right to do so either in person, by remote communication,
if applicable, or by an agent or agents authorized by a proxy granted in
accordance with Delaware law. An agent so appointed need not be a stockholder.
No proxy shall be voted after three years from its date of creation unless
the proxy provides for a longer period. A proxy shall be irrevocable if it
states that it is irrevocable and if, and only as long as, it is coupled with
an interest sufficient in law to support an irrevocable power. A stockholder
may revoke any proxy which is not irrevocable by attending the meeting and
voting in person or by delivering to the Secretary of the corporation a
revocation of the proxy or a new proxy bearing a later date. Voting at
meetings of stockholders need not be by written ballot.

  



  

   

B-9

 



    



  

Section 11. Joint Owners of Stock. If shares or other securities having
voting power stand of record in the names of two or more persons, whether
fiduciaries, members of a partnership, joint tenants, tenants in common,
tenants by the entirety, or otherwise, or if two or more persons have the
same fiduciary relationship respecting the same shares, unless the Secretary
is given written notice to the contrary and is furnished with a copy of the
instrument or order appointing them or creating the relationship wherein it
is so provided, their acts with respect to voting shall have the following
effect: (a) if only one votes, his or her act binds all; (b) if more than one
votes, the act of the majority so voting binds all; (c) if more than one
votes, but the vote is evenly split on any particular matter, each faction
may vote the securities in question proportionally, or may apply to the
Delaware Court of Chancery for relief as provided in Section 217(b) of the
DGCL. If the instrument filed with the Secretary shows that any such tenancy
is held in unequal interests, a majority or even-split for the purpose of
subsection (c) shall be a majority or even-split in interest.

  



  

Section 12. List of Stockholders. The corporation shall prepare, at least ten
days before every meeting of stockholders, a complete list of the
stockholders entitled to vote at said meeting, arranged in alphabetical order,
showing the address of each stockholder and the number and class of shares
registered in the name of each stockholder; provided, however, if the record
date for determining the stockholders entitled to vote is less than ten days
before the meeting date, the list shall reflect all of the
stockholders entitled to vote as of the tenth day before the meeting date.
Such list shall be open to the examination of any stockholder, for any
purpose germane to the meeting, (a) on a reasonably accessible electronic
network, provided that the information required to gain access to such list
is provided with the notice of the meeting, or (b) during ordinary business
hours, at the principal place of business of the corporation. In the event
that the corporation determines to make the list available on an
electronic network, the corporation may take reasonable steps to ensure that
such information is available only to stockholders of the corporation. The
list shall be open to examination of any stockholder during the time of the
meeting as provided by applicable law.

  



  

Section 13. Action without Meeting. No action shall be taken by the
stockholders of the corporation except at an annual or special meeting of
stockholders duly called in accordance with these Bylaws, and no action shall
be taken by the stockholders by consent.

  



  

Section 14. Remote Communication. For the purposes of these Bylaws, if
authorized by the Board of Directors in its sole discretion, and subject to
such guidelines and procedures as the Board of Directors may adopt,
stockholders and proxyholders may, by means of remote communication:

  



  

(a) participate in a meeting of stockholders; and

  



  

(b) be deemed present in person and vote at a meeting of stockholders whether
such meeting is to be held at a designated place or solely by means of remote
communication, provided that (i) the corporation shall implement reasonable
measures to verify that each person deemed present and permitted to vote at
the meeting by means of remote communication is a stockholder or proxyholder,
(ii) the corporation shall implement reasonable measures to provide such
stockholders and proxyholders a reasonable opportunity to participate in the
meeting and to vote on matters submitted to the stockholders, including an
opportunity to read or hear the proceedings of the meeting substantially
concurrently with such proceedings, and (iii) if any stockholder or
proxyholder votes or takes other action at the meeting by means of remote
communication, a record of such vote or other action shall be maintained by
the corporation.

  



  

   

B-10

 



    



  

Section 15. Organization.

  



  

(a) At every meeting of stockholders, the Chairperson of the Board of
Directors, or, if a Chairperson has not been appointed, is absent or refuses
to act, the Chief Executive Officer, or if no Chief Executive Officer is then
serving or the Chief Executive Officer is absent or refuses to act, the
President, or, if the President is absent or refuses to act, a chairperson of
the meeting designated by the Board of Directors, or, if the Board of
Directors does not designate such chairperson, a chairperson of the meeting
chosen by a majority of the voting power of the stockholders entitled to
vote, present in person or by proxy duly authorized, shall act as chairperson
of the meeting of stockholders. The Chairperson of the Board of Directors may
appoint the Chief Executive Officer as chairperson of the meeting. The
Secretary, or, in his or her absence, an Assistant Secretary or other officer
or other person directed to do so by the chairperson of the meeting, shall
act as secretary of the meeting.

  



  

(b) The Board of Directors shall be entitled to make such rules or
regulations for the conduct of meetings of stockholders as it shall deem
necessary, appropriate or convenient. Subject to such rules and regulations of
the Board of Directors, if any, the chairperson of the meeting shall have the
right and authority to convene and (for any or no reason) to recess and/or
adjourn the meeting, to prescribe such rules, regulations and procedures and
to do all such acts as, in the judgment of such chairperson, are
necessary, appropriate or convenient for the proper conduct of the meeting,
including, without limitation, establishing an agenda or order of business
for the meeting, rules and procedures for maintaining order at the meeting and
the safety of those present, limitations on participation in such meeting to
stockholders of record of the corporation and their duly authorized and
constituted proxies and such other persons as the chairperson shall permit,
restrictions on entry to the meeting after the time fixed for the
commencement thereof, limitations on the time allotted to questions or
comments by participants and regulation of the opening and closing of the
polls for balloting on matters that are to be voted on by ballot. The date and
time of the opening and closing of the polls for each matter upon which the
stockholders will vote at the meeting shall be announced at the meeting.
Unless and to the extent determined by the Board of Directors or the
chairperson of the meeting, meetings of stockholders shall not be required to
be held in accordance with rules of parliamentary procedure.

  



  

Section 15A. Delivery to the corporation. Whenever this Article III requires
one or more persons (including a record or beneficial owner of stock) to
deliver a document or information to the corporation or any officer, employee
or agent thereof (including any notice, request, questionnaire, revocation,
representation or other document or agreement), such document or information
shall be in writing exclusively (and not in an electronic transmission) and
shall be delivered exclusively by hand (including, without limitation,
overnight courier service) or by certified or registered mail, return receipt
requested and the corporation shall not be required to accept delivery of any
document not in such written form or so delivered. For the avoidance of
doubt, with respect to any notice from any stockholder of record or
beneficial owner of the corporation's capital stock under the Certificate of
Incorporation, these Bylaws or the DGCL, to the fullest extent permitted by
law, the corporation expressly opts out of Section 116 of the DGCL.

  



  

   

B-11

 



    



  

ARTICLE IV 
  
 Directors

  



  

Section 16. Number and Term of Office. The authorized number of directors of
the corporation shall be fixed in accordance with the Certificate of
Incorporation. Directors need not be stockholders unless so required by the
Certificate of Incorporation. If for any cause, the directors shall not have
been elected at an annual meeting, they may be elected as soon thereafter as
convenient at a special meeting of the stockholders called for that purpose
in the manner provided in these Bylaws.

  



  

Section 17. Powers. The business and affairs of the corporation shall be
managed by or under the direction of the Board of Directors, except as may be
otherwise provided by the Certificate of Incorporation.

  



  

Section 18. Terms of Directors. The terms of directors shall be as set forth
in the Certificate of Incorporation.

  



  

Section 19. Vacancies. Vacancies and newly created directorships on the Board
of Directors shall be filled as set forth in the Certificate of
Incorporation.

  



  

Section 20. Resignation. Any director may resign at any time by delivering
his or her notice in writing or by electronic transmission to the Board of
Directors or the Secretary. Such resignation shall take effect at the time of
delivery of the notice or at any later time specified therein. Acceptance of
such resignation shall not be necessary to make it effective. When one or more
directors shall resign from the Board of Directors, effective at a future
date, a majority of the directors then in office, including those who have so
resigned, shall have power to fill such vacancy or vacancies, the vote thereon
to take effect when such resignation or resignations shall become effective,
and each director so chosen shall hold office for the unexpired portion of the
term of the director whose place shall be vacated and until his or her
successor shall have been duly elected and qualified or until his or her
earlier death, resignation or removal.

  



  

Section 21. Removal. Directors shall be removed as set forth in the
Certificate of Incorporation.

  



  

Section 22. Meetings.

  



  

(a) Regular Meetings. Unless otherwise restricted by the Certificate of
Incorporation, regular meetings of the Board of Directors may be held at any
time or date and at any place within or without the State of Delaware that has
been designated by the Board of Directors and publicized among all directors,
either orally or in writing, by telephone, including a voice-messaging system
or other system designed to record and communicate messages, or by electronic
mail or other electronic means. No further notice shall be required for
regular meetings of the Board of Directors.

  



  

(b) Special Meetings. Unless otherwise restricted by the Certificate of
Incorporation, special meetings of the Board of Directors may be held at any
time and place within or without the State of Delaware as designated and
called by the Chairperson of the Board of Directors, the Chief Executive
Officer or the Board of Directors.

  



  

(c) Meetings by Electronic Communications Equipment. Any member of the Board
of Directors, or of any committee thereof, may participate in a meeting by
means of conference telephone or other communications equipment by means of
which all persons participating in the meeting can hear each other, and
participation in a meeting by such means shall constitute presence in person
at such meeting.

  



  

   

B-12

 



    



  

(d) Notice of Special Meetings. Notice of the time and place, if any, of all
special meetings of the Board of Directors shall be transmitted orally or in
writing, by telephone, including a voice messaging system or other system or
technology designed to record and communicate messages, or by electronic mail
or other electronic means, during normal business hours, at least 24 hours
before the meeting. If notice is sent by U.S. mail, it shall be sent by first
class mail, postage prepaid, at least three days before the meeting.

  



  

(e) Waiver of Notice. Notice of any meeting of the Board of Directors may be
waived in writing, or by electronic transmission, at any time before or after
the meeting and will be waived by any director by attendance thereat, except
when the director attends the meeting for the express purpose of objecting,
at the beginning of the meeting, to the transaction of any business because
the meeting is not lawfully called or convened. The transaction of all
business at any meeting of the Board of Directors, or any committee thereof,
however called or noticed, or wherever held, shall be as valid as though it
had been transacted at a meeting duly held after regular call and notice, if
a quorum be present and if, either before or after the meeting, each of the
directors not present who did not receive notice shall sign a written waiver
of notice or shall waive notice by electronic transmission. All such
waivers shall be filed with the corporate records or made a part of the
minutes of the meeting.

  



  

Section 23. Quorum and Voting.

  



  

(a) Unless the Certificate of Incorporation requires a greater number, and
except with respect to questions related to indemnification arising under
Section 46 for which a quorum shall be one-third of the authorized number of
directors fixed from time to time by the Board of Directors in accordance
with the Certificate of Incorporation, a quorum of the Board of Directors
shall consist of a majority of the total number of directors then serving on
the Board of Directors or, if greater, one-third of the authorized number
of directors fixed from time to time by the Board of Directors in accordance
with the Certificate of Incorporation. At any meeting whether a quorum be
present or otherwise, a majority of the directors present may adjourn from
time to time, without notice other than by announcement at the meeting.

  



  

(b) At each meeting of the Board of Directors at which a quorum is present,
all questions and business shall be determined by the affirmative vote of a
majority of the directors present, unless a different vote be required by
applicable law, the Certificate of Incorporation or these Bylaws.

  



  

Section 24. Action without Meeting. Unless otherwise restricted by the
Certificate of Incorporation or these Bylaws, any action required or
permitted to be taken at any meeting of the Board of Directors or of any
committee thereof may be taken without a meeting, if all members of the Board
of Directors or committee, as the case may be, consent thereto in writing or
by electronic transmission. After an action is taken, such consent or
consents shall be filed with the minutes of proceedings of the Board
of Directors or committee. Such filing shall be in paper form if the minutes
are maintained in paper form and shall be in electronic form if the minutes
are maintained in electronic form.

  



  

(a) Fees and Compensation. Directors shall be entitled to such compensation
for their services on the Board of Directors or any committee thereof as may
be approved by the Board of Directors, or a committee thereof to which the
Board of Directors has delegated such responsibility and authority,
including, if so approved, by resolution of the Board of Directors or a
committee thereof to which the Board of Directors has delegated such
responsibility and authority, including, without limitation, a fixed sum and
reimbursement of expenses incurred, if any, for attendance at each regular or
special meeting of the Board of Directors and at any meeting of a committee
of the Board of Directors, as well as reimbursement for other reasonable
expenses incurred with respect to duties as a member of the Board of
Directors or any committee thereof. Nothing herein contained shall be
construed to preclude any director from serving the corporation in any other
capacity as an officer, agent, employee, or otherwise and receiving
compensation therefor.

  



  

   

B-13

 



    



  

Section 25. Committees.

  



  

(a) Executive Committee. The Board of Directors may appoint an Executive
Committee to consist of one or more members of the Board of Directors. The
Executive Committee, to the extent permitted by applicable law and provided in
the resolution of the Board of Directors shall have and may exercise all the
powers and authority of the Board of Directors in the management of the
business and affairs of the corporation, and may authorize the seal of the
corporation to be affixed to all papers that may require it; but no such
committee shall have the power or authority in reference to (i) approving or
adopting, or recommending to the stockholders, any action or matter (other
than the election or removal of directors) expressly required by the DGCL to
be submitted to stockholders for approval, or (ii) adopting, amending or
repealing any Bylaw of the corporation.

  



  

(b) Other Committees. The Board of Directors may, from time to time, appoint
such other committees as may be permitted by applicable law. Such other
committees appointed by the Board of Directors shall consist of one or more
members of the Board of Directors and shall have such powers and perform such
duties as may be prescribed by the resolution or resolutions creating such
committees, but in no event shall any such committee have the powers denied
to the Executive Committee in these Bylaws.

  



  

(c) Term. The Board of Directors, subject to any requirements of any
outstanding series of preferred stock and the provisions of subsections
(a) or (b) of this Section 25, may at any time increase or decrease the
number of members of a committee or terminate the existence of a committee.
The membership of a committee member shall terminate on the date of his or her
death or voluntary resignation from the committee or from the Board of
Directors. The Board of Directors may at any time for any reason remove any
individual committee member and the Board of Directors may fill any committee
vacancy created by death, resignation, removal or increase in the number of
members of the committee. The Board of Directors may designate one or more
directors as alternate members of any committee, who may replace any absent
or disqualified member at any meeting of the committee, and, in addition, in
the absence or disqualification of any member of a committee, the member or
members thereof present at any meeting and not disqualified from voting,
whether or not such member or members constitute a quorum, may unanimously
appoint another member of the Board of Directors to act at the meeting in the
place of any such absent or disqualified member.

  



  

(d) Meetings. Unless the Board of Directors shall otherwise provide, regular
meetings of the Executive Committee or any other committee appointed pursuant
to this Section 25 shall be held at such times and places, if any, as are
determined by the Board of Directors, or by any such committee, and when
notice thereof has been given to each member of such committee, no further
notice of such regular meetings need be given thereafter. Special meetings of
any such committee may be held at such place, if any, that has been
determined from time to time by such committee, and may be called by any
director who is a member of such committee, upon notice to the members of
such committee of the time and place, if any, of such special meeting given in
the manner provided for the giving of notice to members of the Board of
Directors of the time and place, if any, of special meetings of the Board of
Directors. Notice of any meeting of any committee may be waived in writing or
by electronic transmission at any time before or after the meeting and
will be waived by any director by attendance thereat, except when the
director attends such meeting for the express purpose of objecting, at the
beginning of the meeting, to the transaction of any business because the
meeting is not lawfully called or convened. Unless otherwise provided by the
Board of Directors in the resolutions authorizing the creation of the
committee, a majority of the authorized number of members of any such
committee shall constitute a quorum for the transaction of business, and the
act of a majority of those present at any meeting at which a quorum is
present shall be the act of such committee.

  



  

   

B-14

 



    



  

Section 26. Duties of Chairperson of the Board of Directors. The Chairperson
of the Board of Directors, when present, shall preside at all meetings of the
stockholders and the Board of Directors. The Chairperson of the Board of
Directors shall perform such other duties customarily associated with the
office and shall also perform such other duties and have such other powers, as
the Board of Directors shall designate from time to time.

  



  

Section 27. Lead Independent Director. The Chairperson of the Board of
Directors, or if the Chairperson is not an independent director, one of the
independent directors, may be designated by the Board of Directors as lead
independent director to serve until replaced by the Board of Directors ("Lead
Independent Director"). The Lead Independent Director will preside over
meetings of the independent directors and perform such other duties as may be
established or delegated by the Board of Directors and perform such other
duties as may be established or delegated by the Chairperson of the Board of
Directors.

  



  

Section 28. Organization. At every meeting of the directors, the Chairperson
of the Board of Directors, or, if a Chairperson has not been appointed or is
absent, the Lead Independent Director, or, if the Lead Independent Director
has not been appointed or is absent, the Chief Executive Officer (if a
director), or, if a Chief Executive Officer is absent, the President (if a
director), or if the President is absent, the most senior Vice President (if
a director), or, in the absence of any such person, a chairperson of the
meeting chosen by a majority of the directors present, shall preside over the
meeting. The Secretary, or in his or her absence, any Assistant Secretary or
other officer, director or other person directed to do so by the person
presiding over the meeting, shall act as secretary of the meeting.

  



  

ARTICLE V 
  
 Officers

  



  

Section 29. Officers Designated. The officers of the corporation shall
include, if and when designated by the Board of Directors, the Chief
Executive Officer, the President, one or more Vice Presidents, the Secretary,
the Chief Financial Officer and the Treasurer. The Board of Directors may
also appoint one or more Assistant Secretaries and Assistant Treasurers and
such other officers and agents with such powers and duties as it shall deem
appropriate or necessary. The Board of Directors may assign such
additional titles to one or more of the officers as it shall deem
appropriate. Any one person may hold any number of offices of the
corporation at any one time unless specifically prohibited therefrom by
applicable law, the Certificate of Incorporation or these Bylaws. The
salaries and other compensation of the officers of the corporation shall be
fixed by or in the manner designated by the Board of Directors or by a
committee thereof to which the Board of Directors has delegated such
responsibility.

  



  

Section 30. Tenure and Duties of Officers.

  



  

(a) General. All officers shall hold office at the pleasure of the Board of
Directors and until their successors shall have been duly elected and
qualified, subject to such officer's earlier death, resignation or removal. If
the office of any officer becomes vacant for any reason, the vacancy may be
filled by the Board of Directors or by a committee thereof to which the Board
of Directors has delegated such responsibility or, if so authorized by the
Board of Directors, by the Chief Executive Officer or another officer of the
corporation.

  



  

   

B-15

 



    



  

(b) Duties of Chief Executive Officer. The Chief Executive Officer shall be
the chief executive officer of the corporation and, subject to the
supervision, direction and control of the Board of Directors, shall have the
general powers and duties of supervision, direction, management and control
of the business and officers of the corporation as are customarily associated
with the position of Chief Executive Officer. To the extent that a Chief
Executive Officer has been appointed and no President has been appointed, all
references in these Bylaws to the President shall be deemed references to the
Chief Executive Officer. The Chief Executive Officer shall perform other
duties customarily associated with the office and shall also perform such
other duties and have such other powers, as the Board of Directors shall
designate from time to time.

  



  

(c) Duties of President. Unless another officer has been appointed Chief
Executive Officer of the corporation, the President shall be the chief
executive officer of the corporation and, subject to the supervision,
direction and control of the Board of Directors, shall have the general
powers and duties of supervision, direction, management and control of the
business and officers of the corporation as are customarily associated with
the position of President. The President shall perform other duties
customarily associated with the office and shall also perform such other
duties and have such other powers as the Board of Directors (or the Chief
Executive Officer, if the Chief Executive Officer and President are not the
same person and the Board of Directors has delegated the designation of the
President's duties to the Chief Executive Officer) shall designate from time
to time.

  



  

(d) Duties of Vice Presidents. A Vice President may assume and perform the
duties of the President in the absence or disability of the President or
whenever the office of President is vacant (unless the duties of the President
are being filled by the Chief Executive Officer). A Vice President shall
perform other duties customarily associated with the office and shall also
perform such other duties and have such other powers as the Board of
Directors or the Chief Executive Officer, or, if the Chief Executive
Officer has not been appointed or is absent, the President shall designate
from time to time.

  



  

(e) Duties of Secretary and Assistant Secretary. The Secretary shall attend
all meetings of the stockholders and of the Board of Directors and shall
record all acts, votes and proceedings thereof in the minute books of the
corporation. The Secretary shall give notice in conformity with these Bylaws
of all meetings of the stockholders and of all meetings of the Board of
Directors and any committee thereof requiring notice. The Secretary shall
perform all other duties provided for in these Bylaws and other duties
customarily associated with the office and shall also perform such other
duties and have such other powers, as the Board of Directors or the Chief
Executive Officer, or if no Chief Executive Officer is then serving, the
President shall designate from time to time. The Chief Executive Officer, or
if no Chief Executive Officer is then serving, the President may direct any
Assistant Secretary or other officer to assume and perform the duties of the
Secretary in the absence or disability of the Secretary, and each
Assistant Secretary shall perform other duties customarily associated with
the office and shall also perform such other duties and have such other
powers as the Board of Directors or the Chief Executive Officer, or if no
Chief Executive Officer is then serving, the President shall designate from
time to time.

  



  

(f) Duties of Chief Financial Officer. The Chief Financial Officer shall keep
or cause to be kept the books of account of the corporation in a thorough and
proper manner and shall render statements of the financial affairs of the
corporation in such form and as often as required by the Board of Directors,
the Chief Executive Officer, or the President. The Chief Financial Officer,
subject to the order of the Board of Directors, shall have the custody of all
funds and securities of the corporation. The Chief Financial Officer shall
perform other duties customarily associated with the office and shall also
perform such other duties and have such other powers as the Board of
Directors or the Chief Executive Officer, or if no Chief Executive Officer is
then serving, the President shall designate from time to time. To the extent
that a Chief Financial Officer has been appointed and no Treasurer has been
appointed, all references in these Bylaws to the Treasurer shall be deemed
references to the Chief Financial Officer. The President may direct the
Treasurer, if any, or any Assistant Treasurer to assume and perform the duties
of the Chief Financial Officer in the absence or disability of the Chief
Financial Officer.

  



  

   

B-16

 



    



  

(g) Duties of Treasurer and Assistant Treasurer. Unless another officer has
been appointed Chief Financial Officer of the corporation, the Treasurer
shall be the chief financial officer of the corporation, shall keep or cause
to be kept the books of account of the corporation in a thorough and proper
manner and shall render statements of the financial affairs of the corporation
in such form and as often as required by the Board of Directors, the Chief
Executive Officer or the President. Unless another officer has been appointed
Chief Financial Officer of the corporation, the Treasurer, subject to the
order of the Board of Directors, shall have the custody of all funds and
securities of the corporation. The Treasurer shall perform other duties
customarily associated with the office and shall also perform such other
duties and have such other powers as the Board of Directors or the Chief
Executive Officer, or if no Chief Executive Officer is then serving, the
President shall designate from time to time. The Chief Executive Officer, or
if no Chief Executive Officer is then serving, the President may direct any
Assistant Treasurer or other officer to assume and perform the duties of the
Treasurer in the absence or disability of the Treasurer, and each Assistant
Treasurer shall perform other duties commonly incident to the office and
shall also perform such other duties and have such other powers as the Board
of Directors or the Chief Executive Officer, or if no Chief Executive Officer
is then serving, the President shall designate from time to time.

  



  

Section 31. Delegation of Authority. The Board of Directors may from time to
time delegate the powers or duties of any officer to any other officer or
agent, notwithstanding any provision hereof.

  



  

Section 32. Resignations. Any officer may resign at any time by giving notice
in writing or by electronic transmission to the Board of Directors, the
Chairperson of the Board of Directors, the Chief Executive Officer, the
President or the Secretary. Any such resignation shall be effective when
received by the person or persons to whom such notice is given, unless a later
time is specified therein, in which event the resignation shall become
effective at such later time. Unless otherwise specified in such notice, the
acceptance of any such resignation shall not be necessary to make it
effective. Any resignation shall be without prejudice to the rights, if any,
of the corporation under any contract with the resigning officer.

  



  

Section 33. Removal. Any officer may be removed from office at any time,
either with or without cause, by the Board of Directors, or by any duly
authorized committee thereof or any superior officer upon whom such power of
removal may have been conferred by the Board of Directors.

  



  

   

B-17

 



    



  

ARTICLE VI 
  
 Execution Of Corporate Instruments And Voting Of Securities Owned By The
Corporation

  



  

Section 34. Execution of Corporate Instruments. The Board of Directors may,
in its discretion, determine the method and designate the signatory officer
or officers, or other person or persons, to execute, sign or endorse on behalf
of the corporation any corporate instrument or document, or to sign on behalf
of the corporation the corporate name without limitation, or to enter into
contracts on behalf of the corporation, except where otherwise provided by
applicable law or these Bylaws, and such execution or signature shall be
binding upon the corporation.

  



  

All checks and drafts drawn on banks or other depositaries on funds to the
credit of the corporation or in special accounts of the corporation shall be
signed by such person or persons as the Board of Directors shall from time to
time authorize so to do.

  



  

Unless otherwise specifically determined by the Board of Directors or
otherwise required by applicable law, the execution, signing or endorsement
of any corporate instrument or document by or on behalf of the corporation may
be effected manually, by facsimile or (to the extent permitted by applicable
law and subject to such policies and procedures as the corporation may have in
effect from time to time) by electronic signature.

  



  

Unless authorized or ratified by the Board of Directors or within the agency
power of an officer, no officer, agent or employee shall have any power or
authority to bind the corporation by any contract or engagement or to pledge
its credit or to render it liable for any purpose or for any amount.

  



  

Section 35. Voting of Securities Owned by the Corporation. All stock and
other securities of or interests in other corporations or entities owned or
held by the corporation for itself, or for other parties in any capacity,
shall be voted, and all proxies with respect thereto shall be executed, by
the person authorized so to do by resolution of the Board of Directors, or, in
the absence of such authorization, by the Chairperson of the Board of
Directors, the Chief Executive Officer, the President, or any Vice President.

  



  

ARTICLE VII 
  
 Shares Of Stock

  



  

Section 36. Form and Execution of Certificates. The shares of the corporation
shall be represented by certificates, or shall be uncertificated if so
provided by resolution or resolutions of the Board of Directors. Certificates
for the shares of stock, if any, shall be in such form as is consistent with
the Certificate of Incorporation and applicable law. Every holder of stock
in the corporation represented by certificates shall be entitled to have a
certificate signed by or in the name of the corporation by any two authorized
officers of the corporation (it being understood that each of the Chairperson
of the Board of Directors, the Chief Executive Officer, the President, any
Vice President, the Treasurer, any Assistant Treasurer, the Secretary and
any Assistant Secretary shall be an authorized officer for such purpose),
certifying the number, and the class or series, of shares owned by such
holder in the corporation. Any or all of the signatures on the certificate may
be facsimiles. In case any officer, transfer agent, or registrar who has
signed or whose facsimile signature has been placed upon a certificate shall
have ceased to be such officer, transfer agent, or registrar before such
certificate is issued, it may be issued with the same effect as if he were
such officer, transfer agent, or registrar at the date of issue.

  



  

Section 37. Lost Certificates. A new certificate or certificates shall be
issued in place of any certificate or certificates theretofore issued by the
corporation alleged to have been lost, stolen, or destroyed, upon the making
of an affidavit of that fact by the person claiming the certificate of stock
to be lost, stolen, or destroyed. The corporation may require, as a condition
precedent to the issuance of a new certificate or certificates, the owner of
such lost, stolen, or destroyed certificate or certificates, or the owner's
legal representative, to agree to indemnify the corporation in such manner as
it shall require or to give the corporation a surety bond in such form and
amount as it may direct as indemnity against any claim that may be made
against the corporation with respect to the certificate alleged to have been
lost, stolen, or destroyed.

  



  

   

B-18

 



    



  

Section 38. Transfers.

  



  

(a) Transfers of record of shares of stock of the corporation shall be made
only upon its books by the holders thereof, in person or by attorney duly
authorized, and, in the case of stock represented by certificate, upon the
surrender of a properly endorsed certificate or certificates for a like
number of shares.

  



  

(b) The corporation shall have power to enter into and perform any agreement
with any number of stockholders of any one or more classes or series of stock
of the corporation to restrict the transfer of shares of stock of the
corporation of any one or more classes or series owned by such stockholders
in any manner not prohibited by the DGCL.

  



  

Section 39. Fixing Record Dates.

  



  

(a) In order that the corporation may determine the stockholders entitled to
notice of or to vote at any meeting of stockholders or any adjournment
thereof, the Board of Directors may fix a record date, which record date shall
not precede the date upon which the resolution fixing the record date is
adopted by the Board of Directors, and which record date shall, subject to
applicable law, not be more than 60 nor less than ten days before the date of
such meeting. If the Board of Directors so fixes a record date
for determining the stockholders entitled to notice of any meeting of
stockholders, such date shall also be the record date for determining the
stockholders entitled to vote at such meeting, unless the Board of Directors
determines, at the time it fixes the record date for determining the
stockholders entitled to notice of such meeting, that a later date on or
before the date of the meeting shall be the record date for determining the
stockholders entitled to vote at such meeting. If no record date is fixed by
the Board of Directors, the record date for determining stockholders entitled
to notice of or to vote at a meeting of stockholders shall be at the close of
business on the day immediately preceding the day on which notice is given, or
if notice is waived, at the close of business on the day immediately
preceding the day on which the meeting is held. A determination of
stockholders of record entitled to notice of or to vote at a meeting of
stockholders shall apply to any adjournment of the meeting; _provided,
however, _ that the Board of Directors may fix a new record date for the
adjourned meeting in accordance with the provisions of this Section 39(a).

  



  

(b) In order that the corporation may determine the stockholders entitled to
receive payment of any dividend or other distribution or allotment of any
rights or the stockholders entitled to exercise any rights in respect of any
change, conversion or exchange of stock, or for the purpose of any other
lawful action, the Board of Directors may fix, in advance, a record date,
which record date shall not precede the date upon which the resolution fixing
the record date is adopted, and which record date shall be not more than 60
days prior to such action. If no record date is fixed, the record date for
determining stockholders for any such purpose shall be at the close of
business on the day on which the Board of Directors adopts the resolution
relating thereto.

  



  

Section 40. Registered Stockholders. The corporation shall be entitled to
recognize the exclusive right of a person registered on its books as the
owner of shares to receive dividends, and to vote as such owner, and shall not
be bound to recognize any equitable or other claim to or interest in such
share or shares on the part of any other person whether or not it shall have
express or other notice thereof, except as otherwise provided by the laws of
Delaware.

  



  

Section 41. Additional Powers of the Board. In addition to, and without
limiting, the powers set forth in these Bylaws, the Board of Directors shall
have power and authority to make all such rules and regulations as it shall
deem expedient concerning the issue, transfer, and registration of
certificates for shares of stock of the corporation, including the use of
uncertificated shares of stock, subject to the provisions of the DGCL, other
applicable law, the Certificate of Incorporation and these Bylaws. The Board
of Directors may appoint and remove transfer agents and registrars of
transfers, and may require all stock certificates to bear the signature of
any such transfer agent and/or any such registrar of transfers.

  



  

   

B-19

 



    



  

ARTICLE VIII 
  
 Other Securities Of The Corporation

  



  

Section 42. Execution of Other Securities. All bonds, debentures and other
corporate securities of the corporation, other than stock certificates
(covered in Section 36), may be signed by the Chairperson of the Board of
Directors, the Chief Executive Officer, the President or any Vice President,
or such other person as may be authorized by the Board of Directors;
_provided, however,_ that where any such bond, debenture or other corporate
security shall be authenticated by the manual signature, or where permissible
facsimile signature, of a trustee under an indenture pursuant to which such
bond, debenture or other corporate security shall be issued, the signatures
of the persons signing and attesting the corporate seal on such bond,
debenture or other corporate security may be the imprinted facsimile of the
signatures of such persons. Interest coupons appertaining to any such bond,
debenture or other corporate security, authenticated by a trustee as
aforesaid, shall be signed by the Treasurer or an Assistant Treasurer of the
corporation or such other person as may be authorized by the Board of
Directors, or bear imprinted thereon the facsimile signature of such person.
In case any officer who shall have signed or attested any bond, debenture or
other corporate security, or whose facsimile signature shall appear thereon
or on any such interest coupon, shall have ceased to be such officer before
the bond, debenture or other corporate security so signed or attested shall
have been delivered, such bond, debenture or other corporate security
nevertheless may be adopted by the corporation and issued and delivered as
though the person who signed the same or whose facsimile signature shall have
been used thereon had not ceased to be such officer of the corporation.

  



  

ARTICLE IX 
  
 Dividends

  



  

Section 43. Declaration of Dividends. Dividends upon the capital stock of the
corporation, subject to the provisions of the Certificate of Incorporation
and applicable law, if any, may be declared by the Board of Directors.
Dividends may be paid in cash, in property, or in shares of the capital
stock, subject to the provisions of the Certificate of Incorporation and
applicable law.

  



  

Section 44. Dividend Reserve. Before payment of any dividend, there may be
set aside out of any funds of the corporation available for dividends such
sum or sums as the Board of Directors from time to time, in its absolute
discretion, determines proper as a reserve or reserves to meet contingencies,
or for equalizing dividends, or for repairing or maintaining any property of
the corporation, or for such other purpose or purposes as the Board of
Directors shall determine to be conducive to the interests of the
corporation, and the Board of Directors may modify or abolish any such
reserve in the manner in which it was created.

  



  

   

B-20

 



    



  

ARTICLE X 
  
 Fiscal Year

  



  

Section 45. Fiscal Year. The fiscal year of the corporation shall be fixed by
resolution of the Board of Directors.

  



  

ARTICLE XI 
  
 Indemnification

  



  

Section 46. Indemnification of Directors, Executive Officers, Employees and
Agents.

  



  

(a) Directors and Executive Officers. The corporation shall indemnify to the
full extent permitted under and in any manner permitted under the DGCL or any
other applicable law, any person who is made or threatened to be made a party
to or is otherwise involved (as a witness or otherwise) in any threatened,
pending, or completed action, suit, or proceeding, whether civil, criminal,
administrative, or investigative (hereinafter, a "Proceeding"), by reason of
the fact that such person is or was a director or executive officer (for the
purposes of this Article XI, "executive officers" shall be those persons
designated by the corporation as (a) executive officers for purposes of the
disclosures required in the corporation's proxy and periodic reports or (b)
officers for purposes of Section 16 of the 1934 Act) of the corporation, or
while serving as a director or executive officer of the corporation, is or was
serving at the request of the corporation as a director, officer, employee,
or agent of another corporation, partnership, joint venture, trust, or other
enterprise, including service with respect to an employee benefit plan
(collectively, "Another Enterprise"), against expenses (including attorneys'
fees), judgments, fines (including ERISA excise taxes or penalties) and
amounts paid in settlement actually and reasonably incurred by him or her in
connection with such Proceeding; _provided, however,_ that the corporation
shall not be required to indemnify any director or executive officer in
connection with any proceeding (or part thereof) initiated by such person
unless (i) such indemnification is expressly required to be made by applicable
law, (ii) the proceeding was authorized in the specific case by the Board of
Directors of the corporation, (iii) such indemnification is provided by the
corporation, in its sole discretion, pursuant to the powers vested in the
corporation under the DGCL or any other applicable law or (iv)
such indemnification is required to be made under subsection (d) of this
Section 46.

  



  

(b) Other Officers, Employees and Other Agents. The corporation shall have
power to indemnify (including the power to advance expenses in a manner
consistent with subsection (c) of this Section 46) its other officers,
employees and agents as set forth in the DGCL or any other applicable law.
The Board of Directors shall have the power to delegate the determination of
whether indemnification shall be given to any such person to such officers or
other persons as the Board of Directors shall determine.

  



  

(c) Expenses. The corporation shall, to the full extent permitted under and
in any manner permitted under the DGCL or any other applicable law, pay the
expenses (including attorney's fees) incurred by a director or executive
officer in defending any Proceeding in advance of its final disposition,
provided, however, that if the DGCL requires, an advancement of expenses
incurred by a director or executive officer in his or her capacity as a
director or executive officer (and not in any other capacity in which
service was or is rendered by such indemnitee, including, without limitation,
service to an employee benefit plan) shall be made only upon delivery to the
corporation of an undertaking (hereinafter an "undertaking"), by or on behalf
of such indemnitee, to repay all amounts so advanced if it shall ultimately
be determined by final judicial decision from which there is no further right
to appeal (hereinafter a "final adjudication") that such indemnitee is not
entitled to be indemnified for such expenses under this Section 46 or
otherwise.

  



  

   

B-21

 



    



  

(d) Enforcement. Without the necessity of entering into an express contract,
all rights to indemnification and advances to directors and
executive officers under this Section 46 shall be deemed to be contractual
rights, shall vest when the person becomes a director or executive officer of
the corporation, shall continue as vested contract rights even if such person
ceases to be a director or executive officer of the corporation, and shall be
effective to the same extent and as if provided for in a contract between the
corporation and the director or executive officer. Any right to
indemnification or advances granted by this Section 46 to a director or
executive officer shall be enforceable by or on behalf of the person holding
such right in any court of competent jurisdiction if (i) the claim for
indemnification or advances is denied, in whole or in part, or (ii) no
disposition of such claim is made within 90 days of request therefor. To the
fullest extent permitted by applicable law, the claimant in such enforcement
action, if successful in whole or in part, shall be entitled to be paid also
the expense of prosecuting the claim. In connection with any claim
for indemnification, the corporation shall be entitled to raise as a defense
to any such action that the claimant has not met the standards of conduct
that make it permissible under the DGCL or any other applicable law for the
corporation to indemnify the claimant for the amount claimed. Neither the
failure of the corporation (including its Board of Directors, independent
legal counsel or its stockholders) to have made a determination prior to the
commencement of such action that indemnification of the claimant is proper in
the circumstances because he or she has met the applicable standard of conduct
set forth in the DGCL or any other applicable law, nor an actual
determination by the corporation (including its Board of Directors,
independent legal counsel or its stockholders) that the claimant has not met
such applicable standard of conduct, shall be a defense to the action or
create a presumption that claimant has not met the applicable standard of
conduct. In any suit brought by a director or executive officer to enforce a
right to indemnification or to an advancement of expenses hereunder, the
burden of proving that the director or executive officer is not entitled to
be indemnified, or to such advancement of expenses, under this Section 46 or
otherwise shall be on the corporation.

  



  

(e) Non-Exclusivity of Rights. The rights conferred on any person by this
Section 46 shall not be exclusive of any other right that such person may
have or hereafter acquire under any applicable statute, provision of the
Certificate of Incorporation, Bylaws, agreement, vote of stockholders or
disinterested directors or otherwise, both as to action in his or her official
capacity and as to action in another capacity while holding office. The
corporation is specifically authorized to enter into individual contracts with
any or all of its directors, officers, employees or agents respecting
indemnification and advances, to the fullest extent not prohibited by the
DGCL, or by any other applicable law.

  



  

(f) Survival of Rights. The rights conferred on any person by this Bylaw
shall continue as to a person who has ceased to be a director or executive
officer, employee or other agent and shall inure to the benefit of the heirs,
executors and administrators of such a person.

  



  

(g) Insurance. To the fullest extent permitted by the DGCL or any other
applicable law, the corporation, upon approval by the Board of Directors, may
purchase and maintain insurance on behalf of any person required or permitted
to be indemnified pursuant to this Section 46.

  



  

(h) Amendments. Any repeal or modification of this Section 46 shall only be
prospective and shall not affect the rights under this Section 46 as in
effect at the time of the alleged occurrence of any action or omission to act
that is the cause of any Proceeding against any agent of the corporation.

  



  

(i) Saving Clause. If this Article XI or any portion hereof shall be
invalidated on any ground by any court of competent jurisdiction, then the
corporation shall nevertheless indemnify each director and executive officer
to the full extent not prohibited by any applicable portion of this Article
XI that shall not have been invalidated, or by any other applicable law. If
this Article XI shall be invalid due to the application of the
indemnification provisions of another jurisdiction, then the corporation
shall indemnify each director and executive officer to the full extent
permitted under any other applicable law.

  



  

   

B-22

 



    



  

(j) Certain Definitions and Construction of Terms. For the purposes of
Article XI of these Bylaws, the following definitions and rules of
construction shall apply:

  



  

(i) The term " _Proceeding_ " shall be broadly construed and shall include,
without limitation, the investigation, preparation, prosecution, defense,
settlement, arbitration and appeal of, and the giving of testimony in, any
threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative.

  



  

(ii) The term " _expenses_ " shall be broadly construed and shall include,
without limitation, court costs, attorneys' fees, witness fees, fines,
amounts paid in settlement or judgment and any other costs and expenses of any
nature or kind incurred in connection with any Proceeding.

  



  

(iii) The term the " _corporation_ " shall include, in addition to the
resulting corporation, any constituent corporation (including any constituent
of a constituent) absorbed in a consolidation or merger that, if its separate
existence had continued, would have had power and authority to indemnify its
directors, officers, and employees or agents, so that any person who is
or was a director, officer, employee or agent of such constituent
corporation, or is or was serving at the request of such
constituent corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, shall
stand in the same position under the provisions of this Section 46 with
respect to the resulting or surviving corporation as he would have with
respect to such constituent corporation if its separate existence had
continued.

  



  

(iv) References to a " _director_ ," " _executive officer_ ," " _officer_
," " _employee_ ," or " _agent_ " of the corporation shall include, without
limitation, situations where such person is serving at the request of the
corporation as, respectively, a director, executive officer,
officer, employee, trustee or agent of another corporation, partnership,
joint venture, trust or other enterprise.

  



  

(v) References to " _Another Enterprise_ " shall include employee benefit
plans; references to "fines" shall include any excise taxes assessed on a
person with respect to an employee benefit plan; and references to "serving at
the request of the corporation" shall include any service as a director,
officer, employee or agent of the corporation that imposes duties on, or
involves services by, such director, officer, employee, or agent with respect
to an employee benefit plan, its participants, or beneficiaries; and a person
who acted in good faith and in a manner such person reasonably believed to
be in the interest of the participants and beneficiaries of an employee
benefit plan shall be deemed to have acted in a manner "not opposed to the
best interests of the corporation" as referred to in this Section 46.

  



  

ARTICLE XII 
  
 Notices

  



  

Section 47. Notices.

  



  

(a) Notice to Stockholders. Notice to stockholders of stockholder meetings
shall be given as provided in Section 7. Without limiting the manner by which
notice may otherwise be given effectively to stockholders under any agreement
or contract with such stockholder, and except as otherwise required by
applicable law, written notice to stockholders for purposes other than
stockholder meetings may be sent by U.S. mail or nationally recognized
overnight courier, or by electronic mail or other electronic means.

  



  

   

B-23

 



    



  

(b) Notice to Directors. Any notice required to be given to any director may
be given by the method stated in subsection (a), as otherwise provided in
these Bylaws (including by any of the means specified in Section 22(d)), or by
overnight delivery service. Any notice sent by overnight delivery service or
U.S. mail shall be sent to such address as such director shall have filed
in writing with the Secretary, or, in the absence of such filing, to the last
known post office address of such director.

  



  

(c) Affidavit of Mailing. An affidavit of mailing, executed by a duly
authorized and competent employee of the corporation or its transfer agent
appointed with respect to the class of stock affected, or other agent,
specifying the name and address or the names and addresses of the stockholder
or stockholders, or director or directors, to whom any such notice or notices
was or were given, and the time and method of giving the same, shall in the
absence of fraud, be prima facie evidence of the facts therein contained.

  



  

(d) Methods of Notice. It shall not be necessary that the same method of
giving notice be employed in respect of all recipients of notice, but one
permissible method may be employed in respect of any one or more, and any
other permissible method or methods may be employed in respect of any other
or others.

  



  

(e) Notice to Person with Whom Communication is Unlawful. Whenever notice is
required to be given, under applicable law or any provision of the
Certificate of Incorporation or Bylaws of the corporation, to any person with
whom communication is unlawful, the giving of such notice to such person
shall not be required and there shall be no duty to apply to any governmental
authority or agency for a license or permit to give such notice to such
person. Any action or meeting which shall be taken or held without notice to
any such person with whom communication is unlawful shall have the same force
and effect as if such notice had been duly given. In the event that the
action taken by the corporation is such as to require the filing of a
certificate under any provision of the DGCL, the certificate shall state, if
such is the fact and if notice is required, that notice was given to all
persons entitled to receive notice except such persons with whom
communication is unlawful.

  



  

(f) Notice to Stockholders Sharing an Address. Except as otherwise prohibited
under the DGCL, any notice given under the provisions of the DGCL, the
Certificate of Incorporation or these Bylaws shall be effective if given by a
single written notice to stockholders who share an address if consented to by
the stockholders at that address to whom such notice is given. Such consent
shall have been deemed to have been given if such stockholder fails to object
in writing to the corporation within 60 days of having been given notice by
the corporation of its intention to send the single notice. Any consent shall
be revocable by the stockholder by written notice to the corporation.

  



  

ARTICLE XIII 
  
 Amendments

  



  

Section 48. Amendments. The Board of Directors is expressly empowered to
adopt, amend or repeal the Bylaws of the corporation. The stockholders also
shall have power to adopt, amend or repeal the Bylaws of the corporation;
_provided, however,_ that, in addition to any vote of the holders of any
class or series of stock of the corporation required by applicable law or by
the Certificate of Incorporation, such action by stockholders shall require
the affirmative vote of the holders of at least 66-2/3% of the voting power
of all of the then-outstanding shares of the capital stock of the corporation
entitled to vote in the election of directors, voting together as a single
class.

  



  

   

B-24

 



    



  

ARTICLE XIV 
  
 Loans To Officers

  



  

Section 49. Loans to Officers. Except as otherwise prohibited by applicable
law, the corporation may lend money to, or guarantee any obligation of, or
otherwise assist any officer or other employee of the corporation or of its
subsidiaries, including any officer or employee who is a director of the
corporation or its subsidiaries, whenever, in the judgment of the Board of
Directors, such loan, guarantee or assistance may reasonably be expected to
benefit the corporation. The loan, guarantee or other assistance may be with
or without interest and may be unsecured, or secured in such manner as the
Board of Directors shall approve, including, without limitation, a pledge of
shares of stock of the corporation. Nothing in these Bylaws shall be deemed to
deny, limit or restrict the powers of guaranty or warranty of the corporation
at common law or under any statute.

  



  

   

B-25

 



    

    



 

Exhibit C

  



  

 _Execution Version_

  



  

FORM OF STOCKHOLDER SUPPORT AGREEMENT

  



  

THIS STOCKHOLDER SUPPORT AGREEMENT (this " _Support Agreement_ ") is made and
entered into as of October 20, 2020, by and between Panacea Acquisition
Corp., a Delaware corporation (" _Purchaser_ "), and the individual person or
entity identified on the signature page hereto (" _Securityholder_ ").

  



  

Recitals

  



  

WHEREAS, Purchaser, Panacea Merger Subsidiary Corp., a Delaware corporation
and a direct, wholly owned subsidiary of Purchaser (" _Merger Sub_ ") and
Nuvation Bio Inc., a Delaware corporation (the " _Company_ ") have entered
into an Agreement and Plan of Merger as of October 20, 2020 (the " _Merger
Agreement_ "), which provides (upon the terms and subject to the
conditions set forth therein) for a business combination transaction by which
Merger Sub will merge with and into the Company (the " _Merger_ "), with the
Company being the surviving entity of the Merger (the Company, in its capacity
as the surviving corporation of the Merger, is sometimes referred to as the "
_Surviving Corporation_ ").

  



  

WHEREAS, in connection with the Merger, upon the terms and subject to the
conditions of the Merger Agreement, all shares of each class and series of
Company Common Stock and Company Preferred Stock (collectively, " _Company
Capital Stock_ ") and each option to purchase Company Common Stock (each, a "
_Company Option_ ") will be converted into the right to receive the
consideration set forth in _Section 3.1_ of the Merger Agreement.

  



  

NOW, THEREFORE, in consideration of the covenants, promises and
representations set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto, intending to be legally bound, agree as follows:

  



  

Agreement

  



  

Section 1. Certain Definitions

  



  

For purposes of this Support Agreement:

  



  

(a) Capitalized terms used but not otherwise defined in this Support
Agreement have the meanings assigned to such terms in the Merger Agreement.

  



  

(b) " _Action_ " means any legal action, suit, claim, investigation, hearing
or proceeding, including any audit, claim or assessment for Taxes
or otherwise, by or before any Authority.

  



  

(c) " _Associated Parties_ " shall mean (i) Securityholder's predecessors,
successors, executors, administrators, trusts, spouse, heirs and estate; (ii)
Securityholder's past, present and future assigns; (iii) each entity that
Securityholder has the power to bind (by Securityholder's acts or signature)
or over which Securityholder directly or indirectly exercises control; and
(iv) each entity of which Securityholder owns, directly or indirectly, at
least a majority of the outstanding equity, beneficial, proprietary,
ownership or voting interests.

  



  

(d) " _Authority_ " means any governmental, quasi-governmental, regulatory or
administrative body, agency, instrumentality, department or authority, any
court, tribunal, judicial authority, administrative hearing body, arbitrator,
commission or other similar dispute-resolving panel or body, or any public,
private or industry regulatory authority, whether international, national,
Federal, state, or local.

  



  

   

C-1

 



    



  

(e) " _Business Day_ " means any day other than a Saturday, Sunday or a legal
holiday on which commercial banking institutions in Wilmington, Delaware, New
York, New York, or San Francisco, California are authorized to close for
business.

  



  

(f)  " _Consent_ " shall mean any consent, approval, authorization, permit or
notice.

  



  

(g) " _Expiration Date_ " shall mean the earliest of: (i) the date on which
the Merger Agreement is validly terminated in accordance with its terms or
(ii) the time the Merger becomes effective (the " _Effective Time_ ").

  



  

(h) " _Law_ " means any domestic or foreign, federal, state, municipality or
local law, statute, ordinance, code, rule, regulation, legislation, principle
of common law, edict, decree, treaty, or Order that is or has been issued,
enacted, adopted, passed, approved, promulgated, made, implemented or
otherwise put into effect by or under the authority of any Authority.

  



  

(i) " _Liens_ " means, with respect to any property or asset, any mortgages,
liens, pledges, charges, security interests or encumbrances of any kind in
respect of such property or asset, and any conditional sale or voting
agreements or proxies, including any agreements to give any of the foregoing.

  



  

(j) " _Order_ " means any decree, order, judgment, writ, award, injunction,
rule or consent of or by an Authority.

  



  

(k) " _Person_ " means an individual, corporation, partnership (including a
general partnership, limited partnership or limited liability
partnership), limited liability company, association, trust or other entity
or organization, including a government, domestic or foreign, or political
subdivision thereof, or an agency or instrumentality thereof.

  



  

(l) " _Representatives_ " means, collectively, with respect to any Person,
such Person's officers, directors, Affiliates, employees, agents or
advisors, including any investment banker, broker, attorney, accountant,
consultant or other authorized representative of such Person.

  



  

(m) " _Voting Period_ " shall mean the period commencing on (and including)
the date of this Support Agreement and ending on (and including) the
Expiration Date.

  



  

Section 2. Support

  



  

2.1 Transfer of Securities. Securityholder agrees not to, directly or
indirectly, at any time during the Voting Period, other than as may be
required by a court Order or other Law, (a) sell, assign, transfer (including
by operation of law), pledge, dispose of or otherwise encumber or otherwise
agree to do any of the foregoing (each, a " _Transfer_ ") with respect to any
of the Subject Securities, (b) deposit any Subject Securities into a voting
trust or enter into a voting agreement or arrangement or grant any proxy or
power of attorney with respect thereto that is inconsistent with this Support
Agreement, (c) enter into any Contract, option or other arrangement or
undertaking with respect to the direct or indirect sale, assignment,
transfer (including by operation of law) or other disposition by
Securityholder of any Subject Securities, or (d) take any action that
would make any representation or warranty of Securityholder herein untrue or
incorrect in any material respect or have the effect of preventing or
disabling Securityholder from performing Securityholder's obligations
hereunder; _provided_ , that (i) if a Securityholder is an individual,
Securityholder may Transfer any such Subject Securities (A) to any member of
such Securityholder's immediate family, or to a trust for the benefit of
Securityholder or any member of such Securityholder's immediate family, the
sole trustees of which are Securityholder or any member of Securityholder's
immediate family or (B) by will, other testamentary document or under the
laws of intestacy upon the death of such Securityholder; or (ii) if a
Securityholder is an entity, Securityholder may Transfer any Subject
Securities to any partner, member, or affiliate of Securityholder; _provided
further_ , that in each case such transferee of such Subject Securities
evidences in a writing such transferee's agreement to be bound by and
subject to the terms and provisions hereof to the same effect as such
transferring Securityholder. Any Transfer or attempted Transfer of any
Subject Securities in violation of any provision of this Support Agreement
shall be void ab initio and of no force or effect.

  



  

   

C-2

 



    



  

2.2 Voting Covenant. Securityholder hereby agrees that, during the Voting
Period, at any meeting of the holders of Company Capital Stock (the "
_Equityholders_ ") (whether annual or special and whether or not adjourned or
postponed), however called, and in any action by written consent of the
Equityholders, at which the Merger Agreement and other related agreements (or
any amended versions thereof) or such other related actions, are submitted for
the consideration and vote of the Company Capital Stock, unless otherwise
directed in writing by Purchaser, Securityholder shall cause the
Subject Securities to be voted:

  



  

(a) in favor of (i) the Merger and the adoption and approval of the Merger
Agreement and the terms thereof, (ii) each of the other actions contemplated
by the Merger Agreement and (iii) any action in furtherance of any of the
foregoing;

  



  

(b) against any action, proposal, agreement or transaction that, to the
knowledge of Securityholder, would reasonably be expected to result in a
material breach of any representation, warranty, covenant or obligation of the
Company in the Merger Agreement; and

  



  

(c) against the following actions (other than pursuant to, or in furtherance
of, the Merger and the other Transactions (as defined in the
Merger Agreement), including the Pre-Closing Recapitalization): (i) any
extraordinary corporate transaction, such as a merger, consolidation or other
business combination involving the Company; (ii) any Acquisition Proposal (as
defined in the Merger Agreement), including any reorganization,
recapitalization, dissolution or liquidation of the Company; (iii) any change
in a majority of the board of directors of the Company; (iv) any amendment to
the Company's Governing Documents; (iv) any change in the capitalization of
the Company or the Company's corporate structure (other than as contemplated
in or permitted by the Merger Agreement); and (v) any other action, proposal,
agreement or transaction or proposed transaction (including any possible
Acquisition Proposal) which is intended, or would reasonably be expected, to
impede, interfere with, delay, postpone, discourage or adversely affect the
Merger or any of the other Transactions;

  

 _ _

  

 _provided_ ,  _however_ , such Securityholder shall not vote or provide
consent with respect to any of its Subject Securities that are not held by
the Company's directors, officers, affiliates or greater than 5% shareholders
of the Company, or take any other action, in each case to the extent any such
vote, consent or other action would preclude Purchaser from filing with the
SEC a registration statement on Form S-4 as contemplated by the Merger
Agreement; _provided_ , _further_ , that as of the effective date of the
Merger, no amendment, modification or waiver of the Merger Agreement shall
have occurred that would reasonably be expected to adversely affect the
economic benefits that Securityholder would reasonably expect to receive
pursuant to the Merger.

  



  

Notwithstanding anything to the contrary in this _Section 2.2_ , (i) this
_Section 2.2_ shall not apply to any proposal submitted to any of
the Equityholders holding the number of shares of Company Capital Stock
required by the terms of Section 280G(b)(5)(B) of the Code, whether at a
meeting or in an action by written consent, to render the parachute payment
provisions of Section 280G inapplicable to any and all payments or benefits
provided pursuant to Plan or other Company Contracts that might result,
separately or in the aggregate, in the payment of any amount or the provision
of any benefit that would not be deductible by reason of Section 280G or that
would be subject to an excise tax under Section 4999 of the Code.

  



  

   

C-3

 



    



  

2.3 Other Voting Agreements. During the Voting Period, Securityholder shall
not enter into any agreement or understanding with any Person to vote or give
instructions in any manner inconsistent with _Section 2.2_.

  



  

Section 3. Binding Terms of Merger Agreement

  



  

Securityholder hereby agrees to be bound by, observe and comply with the
following terms and provisions of the Merger Agreement: Article II (The
Merger), Sections 3.2 (Exchange of Certificates) (including the requirement,
if Securityholder holds any Certificates, to provide a Letter of Transmittal
in accordance with Section 3.2(b) in order to be entitled to any portion of
the Per Share Merger Consideration), 11.13 (Waiver), and 11.14 (Non-
Recourse), as if Securityholder were an original signatory to the Merger
Agreement with respect to such provisions; p _rovided_ , _however_ , that as
of the effective date of the Merger, no amendment, modification or waiver of
the Merger Agreement shall have occurred that would reasonably be expected to
adversely affect the economic benefits that Securityholder would reasonably
expect to receive pursuant to the Merger.

  



  

Section 4. Waiver of Appraisal Rights

  



  

Securityholder hereby irrevocably and unconditionally waives, and agrees to
cause to be waived and to prevent the exercise of, any rights of
appraisal, any dissenters' rights and any similar rights (including any
notice requirements related thereto) relating to the Merger that
Securityholder or any other Person may have by virtue of, or with respect to,
any shares of Company Capital Stock owned by Securityholder (including all
rights under Section 262 of the DGCL).

  



  

Section 5. Representations and Warranties of Securityholder

  



  

Securityholder hereby represents and warrants to Purchaser as follows:

  



  

5.1 Authorization, etc. Securityholder has the power, authority and capacity
to execute and deliver this Support Agreement and to perform Securityholder's
obligations hereunder. This Support Agreement has been duly executed
and delivered by Securityholder and constitutes a legal, valid and binding
obligation of Securityholder, enforceable against Securityholder in
accordance with its terms, subject only to: (a) laws of general application
relating to bankruptcy, insolvency and the relief of debtors; and (b) rules
of law governing specific performance, injunctive relief and other equitable
remedies. To the extent that Securityholder is a natural person who is
married and is a resident in a community property state, Securityholder
represents and warrants that Securityholder has the absolute and unrestricted
power, authority and capacity to execute and deliver this Support Agreement
and to perform Securityholder's obligations hereunder, notwithstanding any
laws related to community property. To the extent that Securityholder is not
a natural person, including if Securityholder is a trust, Securityholder
hereby further represents and warrants that: (i) Securityholder is duly
organized, validly existing and in good standing under the laws of
the jurisdiction in which it was organized; (ii) Securityholder has the power
to execute, deliver and perform this Support Agreement and the undersigned
has the power to execute and deliver this Support Agreement on behalf of
Securityholder; (iii) Securityholder has taken all necessary action to
authorize the execution, delivery and performance of this Support Agreement;
and (iv) the execution, delivery and performance of this Support Agreement by
Securityholder will not violate any provision of Securityholder's
Governing Documents. Securityholder has read and understood this Support
Agreement, including the waiver of jury trial contained herein, has
consulted, or had the opportunity to consult, with Securityholder's legal
counsel or other advisors with respect thereto, has knowingly and voluntarily
elected to sign and accept this Support Agreement, and has not relied upon any
promise, statement, or representation that is not set forth explicitly herein
in deciding to sign and accept this Support Agreement.

  



  

   

C-4

 



    



  

5.2 No Conflicts or Consents.

  



  

(a) The execution and delivery of this Support Agreement by Securityholder
does not, and the performance of this Support Agreement by
Securityholder will not: (i) conflict with or violate any Law or Order
applicable to Securityholder or by which Securityholder or any of
Securityholder's assets is or may be bound or affected; or (ii) result in or
constitute (with or without notice or lapse of time) any breach of or default
under, or give to any other Person (with or without notice or lapse of time)
any right of termination, amendment, acceleration or cancellation of, or
result (with or without notice or lapse of time) in the creation of any Lien
on any of the securities of the Company owned by Securityholder pursuant to,
any Contract to which Securityholder is a party or by which Securityholder
or any of Securityholder's assets is or may be bound or affected except, in
the case of clause (i) or (ii), as would not reasonably be expected, either
individually or in the aggregate, to materially impair the ability of
Securityholder to perform its obligations hereunder or to consummate the
transactions contemplated hereby.

  



  

(b) With the exception of any notification or approval that the Company or
Securityholder is required to provide under the terms of any applicable Laws,
the execution and delivery of this Support Agreement by Securityholder does
not, and the performance of this Support Agreement by Securityholder will
not, require any Consent of any Person.

  



  

(c) There is no Action by or before any Governmental Entity pending or, to
the best of the knowledge of Securityholder, threatened
against Securityholder or any of its Associated Parties that challenges or
would challenge the execution and delivery of this Support Agreement or the
taking of any of the actions required to be taken by Securityholder under this
Support Agreement.

  



  

5.3 Title to Securities. As of the date of this Support Agreement: (a)
Securityholder has good and valid title to and holds of record (free and
clear of any Liens other than those arising under applicable securities laws
or as would not otherwise restrict the performance of Securityholder's
obligations pursuant to this Support Agreement) the number, class and series
of shares of Company Capital Stock set forth under the headings "Class of
Shares Held of Record" and "Number of Shares Held of Record" on the signature
page hereof; (b) Securityholder holds (free and clear of any Liens) the
options and other rights to acquire shares of Company Capital Stock set forth
on the signature page hereof; (c) Securityholder has a right and an
obligation to acquire (free and clear of any Liens other than those arising
under applicable securities laws or as would not otherwise restrict the
performance of Securityholder's obligations pursuant to this Support
Agreement) the number, class and series of shares of Company Capital Stock,
if any, set forth under the headings "Class of Shares To Be Acquired" and
"Additional Number of Shares To Be Acquired" on the signature page hereof; and
(d) Securityholder does not own any shares of Company Capital Stock or other
securities of the Company, or any option, warrant, convertible
note, outstanding agreement or other right to acquire (by purchase,
conversion or otherwise) any shares of Company Capital Stock or
other securities of the Company, other than as set forth on the signature
page hereof (such securities set forth under the headings "Class of Shares
Held of Record" and "Number of Shares Held of Record", "Class of Shares To Be
Acquired" and "Additional Number of Shares To Be Acquired", "Company Options
Held of Record" and "Number and Type of Other Rights Held of Record" and all
additional securities of the Company (including any securities convertible
into or exchangeable or exercisable for securities of the Company) of which
Securityholder acquires ownership of record or the power to vote during the
Voting Period, and all other securities issued in any distribution in respect
of any of the foregoing with respect to which the Securityholder has the
power to vote, the " _Subject Securities_ ").

  



  

   

C-5

 



    



  

Section 6. Alternative Acquisition Proposals. From the date hereof until the
Expiration Date, Securityholder agrees that such Person shall not, and shall
not authorize or permit its Representatives to, directly or indirectly, (i)
solicit, initiate or knowingly encourage, support, facilitate or induce
the making, submission or public announcement of any inquiry, indication of
interest, proposal or offer that constitutes, or could reasonably be expected
to lead to, an Acquisition Proposal, (ii) enter into, participate in, maintain
or continue any communications (except solely to provide written notice as to
the existence of these provisions) or negotiations regarding, or deliver or
make available to any Person any non-public information with respect to, or
knowingly take any other action regarding, any inquiry, indication of
interest, proposal or offer that constitutes, or could reasonably be expected
to lead to, an Acquisition Proposal, (iii) enter into any agreement in
principle, letter of intent, term sheet or any other agreement, understanding
or contract (whether binding or not) contemplating or otherwise relating to
any Acquisition Proposal, (iv) agree to, accept, approve, endorse or
recommend (or publicly propose or announce any intention or desire to agree
to, accept, approve, endorse or recommend) any Acquisition Proposal, (v)
withhold, withdraw, qualify, amend or modify (or publicly propose or announce
any intention or desire to withhold, withdraw, qualify, amend or modify), in
a manner adverse to the Purchaser, the approval of Securityholder's board of
directors (if any) of this Agreement or (vi) resolve, propose or agree to do
any of the following. In addition, Securityholder shall, and shall cause its
subsidiaries (if applicable) to, and each shall cause their respective
Representatives to, immediately cease any and all existing discussions or
negotiations with any Person conducted prior to or on the date of
this Agreement with respect to any Acquisition Proposal. Securityholder
agrees that such Person shall promptly inform such Person's Representatives
of the obligations undertaken in this _Section 6_.

  



  

Section 7. Miscellaneous.

  



  

7.1 Termination. The obligations of Securityholder under this Support
Agreement (other than the provisions of this _Section 7_ ) shall
terminate and be of no further force or effect upon the termination of the
Merger Agreement prior to the Closing in accordance with its terms. Nothing
in this _Section 7.1_ shall relieve any party of liability for any willful and
material breach of this Support Agreement.

  



  

7.2 Further Assurances. From time to time and without additional
consideration, Securityholder shall execute and deliver, or cause to be
executed and delivered, such additional transfers, assignments, endorsements,
Consents and other instruments, and shall take such further actions, as
Purchaser may reasonably request for the purpose of carrying out
and furthering the intent of this Support Agreement and the Merger Agreement.

  



  

7.3 Notices. Any notice and other communications hereunder shall be sent in
writing, addressed as specified below, and shall be deemed given: (a) if by
hand or recognized courier service, by 4:00 PM on a Business Day, addressee's
day and time, on the date of delivery, and otherwise on the first Business
Day after such delivery; (b) if by email, on the date that transmission is
confirmed electronically, if by 4:00 PM on a Business Day, addressee's day
and time, and otherwise on the first Business Day after the date of
such confirmation; or (c) five days after mailing by certified or registered
mail, return receipt requested. notices shall be addressed to the respective
parties as follows (excluding telephone numbers, which are for convenience
only), or to such other address as a party shall specify to the others in
accordance with these notice provisions:

  



  

   

C-6

 



    



  

if to Purchaser, to:

  



  

Panacea Acquisition Corp. 
 357 Tehama Street, Floor 3 
 San Francisco, CA 94103 
 Attention: Oleg Nodelman 
 Email: oleg@ecor1cap.com

  



  

with a copy (which shall not constitute notice) to:

  



  

Skadden, Arps, Slate, Meagher and Flom LLP 
 525 University Avenue, Suite #1400 
 Palo Alto, CA 94301 
 Attention: Michael J. Mies 
 Email: michael.mies@skadden.com

  



  

if to the Company, to:

  



  

Nuvation Bio Inc. 
 1500 Broadway, Suite 1401 
 New York, NY 10036 
 Attention: David Hung, M.D. 
 Email: david.hung@nuvationbio.com

  



  

with copies (which shall not constitute notice) to:

  



  

Cooley LLP 
 101 California Street, 5th Floor 
 San Francisco, CA 94111 
 Attention: Kenneth Guernsey 
 Email: kguernsey@cooley.com

  



  

if to Securityholder, to the address or email address of such person set
forth beneath the name of such Person on the applicable signature page hereto.

  



  

7.4 Severability. A determination by a court or other legal authority that
any provision that is not of the essence of this Support Agreement is legally
invalid shall not affect the validity or enforceability of any other provision
hereof. The parties shall cooperate in good faith to substitute (or cause
such court or other legal authority to substitute) for any provision so held
to be invalid a valid provision, as alike in substance to such invalid
provision as is lawful.

  



  

7.5 Entire Agreement. This Support Agreement, together with the Additional
Agreements to which Securityholder is a party sets forth the entire agreement
of the parties with respect to the subject matter hereof and thereof and
supersedes all prior and contemporaneous understandings and agreements
related to the subject matter hereof and thereto (whether written or oral),
all of which are merged herein. Except as otherwise expressly stated herein,
there is no condition precedent to the effectiveness of any provision hereof
or thereof. No party has relied on any representation from, or warranty or
agreement of, any Person in entering into this Support Agreement, prior
hereto or contemporaneous herewith, except those expressly stated herein or
therein. 

  



  

   

C-7

 



    



  

7.6 Amendment. This Support Agreement cannot be amended, except by a writing
signed by each party, and cannot be terminated orally or by course of
conduct.

  



  

7.7 Assignment; Binding Effect. Neither this Support Agreement nor any of the
rights, interests or obligations hereunder may be assigned or delegated by
Securityholder, and any attempted or purported assignment or delegation of any
of such interests or obligations shall be null and void. Subject to the
preceding sentence, this Support Agreement shall be binding upon each of the
parties hereto, their respective heirs, estates, executors and personal
representatives (if applicable) and their respective successors and assigns,
and shall inure to the benefit of each of the parties hereto and their
respective successors and assigns.

  



  

7.8 Third-Party Beneficiaries. Neither this Support Agreement nor any
provision hereof confers any benefit or right upon or may be enforced by any
Person not a signatory hereto.

  



  

7.9 Specific Performance. The parties hereto acknowledge that the rights of
each party contemplated hereby are unique, recognize and affirm that in the
event of a breach of this Support Agreement by any party, money damages
would be inadequate and the non-breaching parties would not have adequate
remedy at law, and agree that irreparable damage would occur in the event
that any of the provisions of this Support Agreement were not performed by an
applicable party in accordance with their specific terms or were otherwise
breached. Accordingly, each party shall be entitled to an injunction or
restraining order to prevent breaches of this Support Agreement and to seek
to enforce specifically the terms and provisions hereof, without
the requirement to post any bond or other security or to prove that money
damages would be inadequate, this being in addition to any other right or
remedy to which such party may be entitled under this Support Agreement, at
law or in equity.

  



  

7.10 Governing Law. This Support Agreement shall be construed in accordance
with and governed by the laws of the State of Delaware, without giving effect
to the conflict of laws principles thereof.

  



  

7.11 Consent to Jurisdiction; Waiver of Trial by Jury. Any Action based upon,
arising out of or related to this Support Agreement or the transactions
contemplated hereby may be brought in federal and state courts located in the
State of Delaware, and each of the parties irrevocably submits to the
exclusive jurisdiction of each such court in any such Action, waives any
objection it may now or hereafter have to personal jurisdiction, venue or to
convenience of forum, agrees that all claims in respect of the Action shall
be heard and determined only in any such court, and agrees not to bring any
Action arising out of or relating to this Support Agreement or the
transactions contemplated hereby in any other court. Nothing herein contained
shall be deemed to affect the right of any party to serve process in any
manner permitted by Law or to commence legal proceedings or otherwise proceed
against any other party in any other jurisdiction, in each case, to enforce
judgments obtained in any Action brought pursuant to this _Section 7.11_.
EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS SUPPORT
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

  



  

7.12 Attorneys' Fees. If any Action, suit or other Action relating to this
Support Agreement or the enforcement of any provision of this Support
Agreement is brought against Securityholder, the prevailing party in such
Action as determined in a final, non-appealable decision by a court of
competent jurisdiction, suit or other Action shall be entitled to receive
the costs incurred by such party in conducting the suit, Action or
proceeding, including reasonable attorneys' fees and expenses and court costs
(in addition to any other relief to which such prevailing party may be
entitled).

  



  

   

C-8

 



    



  

7.13 Counterparts; Electronic Signatures. This Support Agreement may be
executed in counterparts, each of which shall constitute an original, but all
of which shall constitute one agreement. This Support Agreement shall become
effective upon delivery to each party of an executed counterpart or the
earlier delivery to each party of original, photocopied, or
electronically transmitted signature pages that together (but need not
individually) bear the signatures of all other parties.

  



  

7.14 No Ownership Interest. Nothing contained in this Agreement shall be
deemed to vest in Purchaser any direct or indirect ownership or incidence of
ownership of or with respect to any Subject Securities.

  



  

7.15 Directors and Officers. Nothing in this Agreement shall be construed to
impose any obligation or limitation on votes or actions taken by any
director, officer, employee, agent, designee or other representative of any
Securityholder or by any Securityholder that is a natural person, in each
case, in his or her capacity as a director or officer of the Company. Each
Securityholder is executing this Agreement solely in such capacity as a record
or beneficial holder of Company Capital Stock.

  



  

7.16 Headings. The headings used in this Support Agreement have been inserted
for convenience of reference only and do not define or limit the provisions
hereof.

  



  

7.17 Extension; Waiver. At any time prior to the Closing, Purchaser (on
behalf of itself and Merger Sub), on the one hand, and Securityholder, on the
other hand, may, to the extent not prohibited by applicable Laws: (i) extend
the time for the performance of any of the obligations or other acts of the
other parties hereto; (ii) waive any inaccuracies in the representations and
warranties made to the other parties hereto contained herein or in any
document delivered pursuant hereto; and (iii) waive compliance with any of
the agreements or conditions for the benefit of such party contained herein.
Any agreement on the part of a party hereto to any such extension or waiver
shall be valid only if set forth in an instrument in writing signed on behalf
of such party. No failure or delay on the part of either party to exercise
any power, right, privilege or remedy under this Support Agreement shall
operate as a waiver of such power, right, privilege or remedy; and no single
or partial exercise of any such power, right, privilege or remedy shall
preclude any other or further exercise thereof or of any other power, right,
privilege or remedy. Neither party shall be deemed to have waived any claim
available to such party arising out of this Support Agreement, or any
power, right, privilege or remedy under this Support Agreement, unless the
waiver of such claim, power, right, privilege or remedy is expressly set
forth in a written instrument duly executed and delivered on behalf of such
waiving party; and any such waiver shall not be applicable or have any effect
except in the specific instance in which it is given.

  



  

7.18 Independence of Obligations. The covenants and obligations of
Securityholder set forth in this Support Agreement shall be construed as
independent of any other Contract between Securityholder, on the one hand, and
the Company or Purchaser, on the other hand. The existence of any claim or
cause of action by Securityholder against the Company or Purchaser shall not
constitute a defense to the enforcement of any of such covenants or
obligations against Securityholder. Nothing in this Support Agreement shall
limit any of the rights or remedies of Purchaser under the Merger Agreement,
or any of the rights or remedies of Purchaser or any of the obligations of
Securityholder under any agreement between such Person and Purchaser or any
certificate or instrument executed by such Person in favor of Purchaser; and
nothing in the Merger Agreement or in any other such agreement,
certificate or instrument, shall limit any of the rights or remedies of
Purchaser or any of the obligations of Securityholder under this
Support Agreement.

  



  

   

C-9

 



    



  

7.19 Construction of Certain Terms and References; Captions. In this Support
Agreement:

  



  

(a) The words "herein," "hereof," "hereunder," and words of similar import
refer to this Support Agreement as a whole and not to any particular
provision of this Support Agreement.

  



  

(b) Any use of the singular or plural, or the masculine, feminine, or neuter
gender, includes the others, unless the context otherwise requires;
"including" means "including without limitation;" "or" means "and/or;" "any"
means "any one, more than one, or all,"

  



  

(c) Unless otherwise specified, any reference to any agreement (including
this Support Agreement), instrument, or other document includes all
schedules, exhibits, or other attachments referred to therein, and any
reference to a statute or other Law includes any rule, regulation, ordinance,
or the like promulgated thereunder, in each case, as amended, restated,
supplemented, or otherwise modified from time to time.

  



  

(d) If any action is required to be taken or notice is required to be given
within a specified number of days following a specific date or event, the day
of such date or event is not counted in determining the last day for such
action or notice. If any action is required to be taken or notice is required
to be given on or before a particular day which is not a Business Day, such
action or notice shall be considered timely if it is taken or given on or
before the next Business Day.

  



  

(e) Captions are not a part of this Support Agreement, but are included for
convenience, only.

  



  

(f) " _knowledge_ " with respect to an entity shall mean with respect to any
matter in question the actual knowledge of such entity's executive officers
after reasonable inquiry.

  

 _ _

  

 _[Remainder of page intentionally left blank.]_

  



    

C-10

 



    



  

In Witness Whereof, the parties have caused this Support Agreement to be
executed as of the date first written above.

  



       | Panacea Acquisition Corp. 
---|--- 
     | 
     | By:  | 
     |   | Name:   | 
     |   | Title:  | 
  

 _ _

  

 _Signature Page to Support Agreement_

  



    

C-11

 



    



  

In Witness Whereof, the parties have caused this Support Agreement to be
executed as of the date first written above.

  



       | Securityholder: 
---|--- 
     | 
     | 
     | Signature 
     | 
     | 
     | Printed Name 
     | 
     | Address: 
     | 
     | 
     | 
     | 
     | 
     | 
     | 
     | Email:   | 
  



      Class of Shares Held of Record  | 
---|--- 
   Number of Shares Held of Record  | 
   Class of Shares To Be Acquired  | 
   Additional Number of Shares To Be Acquired  | 
   Company Options Held of Record  | 
   Number and Type of Other Rights Held of Record  | 
   



  



  

 _Signature Page to Support Agreement_

  



  

   

C-12

 



    

    

  



 

Exhibit D

  



  

 _Execution Version_

  



  

FORM OF SPONSOR SUPPORT AGREEMENT

  



  

THIS SPONSOR SUPPORT AGREEMENT (this " _Support Agreement_ ") is made and
entered into as of October 20, 2020, by and between Panacea Acquisition
Corp., a Delaware corporation (" _Purchaser_ "), Nuvation Bio, Inc., a
Delaware corporation (the " _Company_ "), EcoR1 Panacea Holdings, LLC ("
_Sponsor_ ") and PA Co-Investment LLC (along with Sponsor a " _Supporting
Party_ " and, collectively, the " _Supporting Parties_ "). Capitalized terms
used but not otherwise defined herein shall have the meanings ascribed to them
in the Merger Agreement (as defined below).

  



  

Recitals

  



  

WHEREAS, Purchaser, Panacea Merger Subsidiary Corp., a Delaware corporation
and a direct, wholly owned subsidiary of Purchaser (" _Merger Sub_ ") and the
Company are entering into an Agreement and Plan of Merger of even date
herewith (the " _Merger Agreement_ "), which provides (upon the terms and
subject to the conditions set forth therein) for a business combination
transaction by which Merger Sub will merge with and into the Company (the "
_Merger_ "), with the Company being the surviving entity of the Merger (the
Company, in its capacity as the surviving corporation of the Merger, is
sometimes referred to as the " _Surviving Corporation_ ").

  



  

WHEREAS, the Supporting Parties are entering into this Support Agreement in
order to induce the Company to enter into the Merger Agreement and cause
the Merger to be consummated.

  



  

NOW, THEREFORE, in consideration of the covenants, promises and
representations set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto, intending to be legally bound, agree as follows:

  



  

Agreement

  



  

Section 1. Certain Definitions

  



  

For purposes of this Support Agreement:

  



  

(a) Capitalized terms used but not otherwise defined in this Support
Agreement have the meanings assigned to such terms in the Merger Agreement.

  



  

(b) " _Action_ " means any legal action, suit, claim, investigation, hearing
or proceeding, including any audit, claim or assessment for Taxes
or otherwise, by or before any Authority.

  



  

(c) " _Associated Parties_ " shall mean (i) each Supporting Party's
predecessors, successors, executors, administrators, trusts, spouse, heirs
and estate; (ii) each Supporting Party's past, present and future assigns;
(iii) each entity that each Supporting Party has the power to bind (by such
Supporting Party's acts or signature) or over which each Supporting Party
directly or indirectly exercises control; and (iv) each entity of which each
Supporting Party owns, directly or indirectly, at least a majority of the
outstanding equity, beneficial, proprietary, ownership or voting interests.

  



  

(d) " _Authority_ " means any governmental, quasi-governmental, regulatory or
administrative body, agency, instrumentality, department or authority, any
court, tribunal, judicial authority, administrative hearing body, arbitrator,
commission or other similar dispute-resolving panel or body, or any public,
private or industry regulatory authority, whether international, national,
Federal, state, or local.

  



  

   

D-1

 



    



  

(e) " _Business Day_ " means any day other than a Saturday, Sunday or a legal
holiday on which commercial banking institutions in Wilmington, Delaware, New
York, New York, or San Francisco, California are authorized to close for
business.

  



  

(f) " _Consent_ " shall mean any consent, approval, authorization, permit or
notice.

  



  

(g) " _Expiration Date_ " shall mean the earliest of: (i) the date on which
the Merger Agreement is validly terminated in accordance with its terms or
(ii) the time the Merger becomes effective (the " _Effective Time_ ").

  



  

(h) " _Law_ " means any domestic or foreign, federal, state, municipality or
local law, statute, ordinance, code, rule, regulation, legislation, principle
of common law, edict, decree, treaty, or Order that is or has been issued,
enacted, adopted, passed, approved, promulgated, made, implemented or
otherwise put into effect by or under the authority of any Authority.

  



  

(i) " _Liens_ " means, with respect to any property or asset, any mortgages,
liens, pledges, charges, security interests or encumbrances of any kind in
respect of such property or asset, and any conditional sale or voting
agreements or proxies, including any agreements to give any of the foregoing.

  



  

(j) " _New Subject Securities_ " means, with respect to each Supporting
Party, any equity securities of Purchaser that it purchases or otherwise
hereafter acquires (including as a result of a stock dividend, subdivision,
reclassification, recapitalization, split, combination or exchange of shares,
or any similar event) or with respect to which it otherwise acquires sole or
shared voting power after the execution of this Support Agreement and prior
to the Expiration Date.

  



  

(k) " _Order_ " means any decree, order, judgment, writ, award, injunction,
rule or consent of or by an Authority.

  



  

(l) " _Permitted Transferee_ " shall mean any Affiliate or equityholder of
such Supporting Party.

  



  

(m) " _Person_ " means an individual, corporation, partnership (including a
general partnership, limited partnership or limited liability
partnership), limited liability company, association, trust or other entity
or organization, including a government, domestic or foreign, or political
subdivision thereof, or an agency or instrumentality thereof.

  



  

(n) " _Representatives_ " means, collectively, with respect to any Person,
such Person's officers, directors, Affiliates, employees, agents or
advisors, including any investment banker, broker, attorney, accountant,
consultant or other authorized representative of such Person.

  



  

(o) " _Subject Securities_ " means, such number and type of Purchaser equity
securities as are indicated next to each Supporting Party's name on _Schedule
A_, together with any New Subject Securities.

  



  

(p) " _Voting Period_ " shall mean the period commencing on (and including)
the date of this Support Agreement and ending on (and including) the
Expiration Date.

  



  

   

D-2

 



    



  

Section 2. Support

  



  

2.1 Transfer of Securities. Each Supporting Party agrees not to, directly or
indirectly, at any time during the Voting Period, other than as may be
required by a court Order or other Law, (a) sell, assign, transfer (including
by operation of law), pledge, dispose of or otherwise encumber or otherwise
agree to do any of the foregoing (each, a " _Transfer_ ") with respect to any
of the Subject Securities, (b) deposit any Subject Securities into a voting
trust or enter into a voting agreement or arrangement or grant any proxy or
power of attorney with respect thereto that is inconsistent with this Support
Agreement, (c) enter into any Contract, option or other arrangement or
undertaking with respect to the direct or indirect sale, assignment,
transfer (including by operation of law) or other disposition by such
Supporting Party of any Subject Securities, or (d) take any action that would
make any representation or warranty of such Supporting Party herein untrue or
incorrect in any material respect or have the effect of preventing or
disabling such Supporting Party from performing such Supporting Party's
obligations hereunder;  _provided_ , that Supporting Party may Transfer any
Subject Securities to a Permitted Transferee; _provided further_ , that such
transferee of such Subject Securities evidences in a writing such transferee's
agreement to be bound by and subject to the terms and provisions hereof to
the same effect as such transferring Supporting Party. Any Transfer or
attempted Transfer of any Subject Securities in violation of any provision of
this Support Agreement shall be void ab initio and of no force or effect.

  



  

2.2 Voting Covenant. Each Supporting Party hereby agrees that, during the
Voting Period, at any meeting of the stockholders of Purchaser (whether
annual or special and whether or not adjourned or postponed), however called,
and in any action by written consent of the stockholders of Purchaser, at
which the Merger Agreement and other related agreements (or any amended
versions thereof) or such other related actions, are submitted for the
consideration and vote of the stockholders of Purchaser, such Supporting
Party shall appear at each such meeting or otherwise cause all Subject
Securities beneficially owned which such Supporting Party has a right to vote
or owned of record by such Supporting Party to be counted as present thereat
for purposes of calculating a quorum and shall cause the Subject Securities
to be voted:

  



  

(a) in favor of (i) the Merger and the approval of the Merger Agreement and
the terms thereof, (ii) the proposals set forth in the Proxy Statement, (iii)
each of the Purchaser Stockholder Matters; (iv) each of the other actions,
including the Transactions contemplated by the Merger Agreement and (v) any
action in furtherance of any of the foregoing;

  



  

(b) against any action, proposal, agreement or transaction that, to the
knowledge of each Supporting Party, would reasonably be expected to result in
a material breach of any representation, warranty, covenant or obligation of
the Purchaser in the Merger Agreement; and

  



  

(c) against the following actions (other than pursuant to, or in furtherance
of, the Merger and the other Transactions: (i) any extraordinary corporate
transaction, such as a merger, consolidation or other business combination
involving the Purchaser; (ii) any Acquisition Proposal, including any
reorganization, recapitalization, dissolution or liquidation of Purchaser;
(iii) any change in a majority of the board of directors of Purchaser; (iv)
any amendment to the Purchaser's governing documents; (v) any change in
the capitalization of Purchaser or Purchaser's corporate structure; and (vi)
any other action, proposal, agreement or transaction or proposed transaction
(including any possible Acquisition Proposal) which is intended, or would
reasonably be expected, to (1) impede, interfere with, delay, postpone,
discourage or (2) adversely affect the Merger or any of the other
Transactions.

  



  

2.3 Other Voting Agreements. During the Voting Period, no Supporting Party
shall enter into any agreement or understanding with any Person to vote or
give instructions in any manner inconsistent with _Section 2.3_.

  



  

2.4 No Redemption. Each Supporting Party irrevocably and unconditionally
agrees that, during the Voting Period, such Supporting Party shall not elect
to cause Purchaser to redeem any Subject Securities beneficially owned or
owned of record by such Supporting Party, or submit any of its Subject
Securities for redemption, in connection with the transactions contemplated by
the Merger Agreement or otherwise.

  



  

   

D-3

 



    



  

2.5 Waiver of Anti-dilution Protection. Each Supporting Party hereby waives,
to the fullest extent permitted by law, the ability to adjust the Initial
Conversion Ratio (as defined in the certificate of incorporation of the
Purchaser) pursuant to Section 4.3(b)(ii) of the certificate of incorporation
of the Purchaser in connection with the issuance of additional Purchaser Class
A Common Stock in the Transactions. This waiver shall be applicable only in
connection with the Transactions and this Support Agreement (and
any Purchaser Class A Common Stock issued in connection with the
Transactions) and shall be void and of no force and effect following the
Expiration Date.

  



  

Section 3. Binding Terms of Merger Agreement

  



  

Each Supporting Party hereby agrees to be bound by, observe and comply with
Section 11.14 (Non-Recourse) of the Merger Agreement, as if such
Supporting Party was an original signatory to the Merger Agreement with
respect to such provision.

  



  

Section 4. Representations and Warranties of the Supporting Parties

  



  

Each of the Supporting Parties represents and warrants (severally and not
jointly) to Parent and the Company as follows:

  



  

4.1 Authorization, etc. Such Supporting Party has the power, authority and
capacity to execute and deliver this Support Agreement and to perform such
Supporting Party's obligations hereunder. This Support Agreement has been
duly executed and delivered by such Supporting Party and constitutes a legal,
valid and binding obligation of such Supporting Party, enforceable against
such Supporting Party in accordance with its terms, subject only to: (a) laws
of general application relating to bankruptcy, insolvency and the relief of
debtors; and (b) rules of law governing specific performance, injunctive
relief and other equitable remedies. Such Supporting Party hereby further
represents and warrants that: (i) such Supporting Party is duly organized,
validly existing and in good standing under the laws of the jurisdiction in
which it was organized; (ii) such Supporting Party has the power to execute,
deliver and perform this Support Agreement and the undersigned has the power
to execute and deliver this Support Agreement on behalf of such Supporting
Party; (iii) such Supporting Party has taken all necessary action to
authorize the execution, delivery and performance of this Support Agreement;
and (iv) the execution, delivery and performance of this Support Agreement by
such Supporting Party will not violate any provision of such Supporting
Party's governing documents. Such Supporting Party has read and understood
this Support Agreement, including the waiver of jury trial contained herein,
has consulted, or had the opportunity to consult, with such Supporting
Party's legal counsel or other advisors with respect thereto, has
knowingly and voluntarily elected to sign and accept this Support Agreement,
and has not relied upon any promise, statement, or representation that is not
set forth explicitly herein in deciding to sign and accept this Support
Agreement.

  



  

4.2 No Conflicts or Consents.

  



  

(a) The execution and delivery of this Support Agreement by such Supporting
Party does not, and the performance of this Support Agreement by such
Supporting Party will not: (i) conflict with or violate any Law or Order
applicable to such Supporting Party or by which such Supporting Party or any
of such Supporting Party's assets is or may be bound or affected; or (ii)
result in or constitute (with or without notice or lapse of time) any breach
of or default under, or give to any other Person (with or without notice
or lapse of time) any right of termination, amendment, acceleration or
cancellation of, or result (with or without notice or lapse of time) in the
creation of any Lien on any of the securities of Purchaser owned by such
Supporting Party pursuant to, any Contract to which such Supporting Party is
a party or by which such Supporting Party or any of such Supporting Party's
Affiliates or assets is or may be bound or affected, except, in the case of
clause (i) or (ii), as would not reasonably be expected, either individually
or in the aggregate, to materially impair the ability of such Supporting Party
to perform its obligations hereunder or to consummate the transactions
contemplated hereby.

  



  

   

D-4

 



    



  

(b) With the exception of any notification or approval that the Company,
Purchaser or a Supporting Party is required to provide under the terms of any
applicable Laws, the execution and delivery of this Support Agreement by such
Supporting Party does not, and the performance of this Support Agreement by
such Supporting Party will not, require any Consent of any Person.

  



  

(c) There is no Action by or before any Governmental Entity pending or, to
the best of the knowledge of such Supporting Party, threatened against such
Supporting Party or any of its Associated Parties that challenges or would
challenge the execution and delivery of this Support Agreement or the taking
of any of the actions required to be taken by such Supporting Party under this
Support Agreement.

  



  

4.3 Title to Securities. As of the date of this Support Agreement: (i) such
Supporting Party has good and valid title to and holds of record (free and
clear of any Liens other than those arising under applicable securities
laws or as would not otherwise restrict the performance of such Supporting
Party's obligations pursuant to this Support Agreement) the number, class and
series of shares of Subject Securities set forth next to such Supporting
Party's name on _Schedule A_ and (ii) such Supporting Party does not own any
shares of capital stock or other securities of Parent or any option,
warrant, convertible note or other right to acquire (by purchase, conversion
or otherwise) any shares of capital stock or other securities of Parent,
other than as set forth on _Schedule A_.

  



  

Section 5. Alternative Acquisition Proposals

  



  

From the date hereof until the Expiration Date, each Supporting Party agrees
that such Person shall not, and shall not authorize or permit its
Representatives to, directly or indirectly, (i) solicit, initiate or
knowingly encourage, support, facilitate or induce the making, submission or
public announcement of any inquiry, indication of interest, proposal or offer
that constitutes, or could reasonably be expected to lead to, an Acquisition
Proposal, (ii) enter into, participate in, maintain or continue any
communications (except solely to provide written notice as to the existence
of these provisions) or negotiations regarding, or deliver or make available
to any Person any non-public information with respect to, or knowingly take
any other action regarding, any inquiry, indication of interest, proposal or
offer that constitutes, or could reasonably be expected to lead to, an
Acquisition Proposal; (iii) enter into any agreement in principle, letter of
intent, term sheet or any other agreement, understanding or contract (whether
binding or not) contemplating or otherwise relating to any Acquisition
Proposal; (iv) agree to, accept, approve, endorse or recommend (or publicly
propose or announce any intention or desire to agree to, accept, approve,
endorse or recommend) any Acquisition Proposal, (v) withhold,
withdraw, qualify, amend or modify (or publicly propose or announce any
intention or desire to withhold, withdraw, qualify, amend or modify), in a
manner adverse to the Purchaser, the approval of such Supporting Party's board
of directors (if any) of this Agreement or (vi) resolve, propose or agree to
do any of the following. In addition, each Supporting Party shall, and shall
cause its subsidiaries (if applicable) to, and each shall cause their
respective Representatives to, immediately cease any and all existing
discussions or negotiations with any Person, conducted prior to or on the
date of this Agreement, with respect to any Acquisition Proposal. Each
Supporting Party agrees that such Person shall promptly inform such Person's
Representatives of the obligations undertaken in this _Section 5_.

  



  

   

D-5

 



    



  

Section 6. Miscellaneous

  



  

6.1 Termination. The obligations of each Supporting Party under this Support
Agreement (other than the provisions of this _Section 6_ ) shall terminate
and be of no further force or effect upon the termination of the Merger
Agreement prior to the Closing in accordance with its terms. Nothing in this
_Section 6.1_ shall relieve any party of liability for any willful and
material breach of this Support Agreement.

  



  

6.2 Further Assurances. From time to time and without additional
consideration, each Supporting Party shall execute and deliver, or cause to
be executed and delivered, such additional transfers, assignments,
endorsements, Consents and other instruments, and shall take such further
actions, as Purchaser may reasonably request for the purpose of carrying
out and furthering the intent of this Support Agreement and the Merger
Agreement.

  



  

6.3 Notices. Any notice and other communications hereunder shall be sent in
writing, addressed as specified below, and shall be deemed given: (a) if by
hand or recognized courier service, by 4:00 PM on a Business Day, addressee's
day and time, on the date of delivery, and otherwise on the first Business
Day after such delivery; (b) if by email, on the date that transmission is
confirmed electronically, if by 4:00 PM on a Business Day, addressee's day
and time, and otherwise on the first Business Day after the date of
such confirmation; or (c) five days after mailing by certified or registered
mail, return receipt requested. notices shall be addressed to the respective
parties as follows (excluding telephone numbers, which are for convenience
only), or to such other address as a party shall specify to the others in
accordance with these notice provisions:

  



  

if to Purchaser, to:

  



  

Panacea Acquisition Corp. 
 357 Tehama Street, Floor 3 
 San Francisco, CA 94103 
 Attention: Oleg Nodelman 
 Email: oleg@ecor1cap.com

  



  

with a copy (which shall not constitute notice) to:

  



  

Skadden, Arps, Slate, Meagher and Flom LLP 
 525 University Avenue, Suite #1400 
 Palo Alto, CA 94301 
 Attention: Michael J. Mies 
 Email: michael.mies@skadden.com

  



  

if to the Company, to:

  



  

Nuvation Bio Inc. 
 1500 Broadway, Suite 1401 
 New York, NY 10036 
 Attention: David Hung, M.D. 
 Email: david.hung@nuvationbio.com

  



  

   

D-6

 



    



  

with copies (which shall not constitute notice) to:

  



  

Cooley LLP 
 101 California Street, 5th Floor 
 San Francisco, CA 94111 
 Attention: Kenneth Guernsey 
 Email: kguernsey@cooley.com

  



  

if to a Supporting Party, to the address or email address of such Person set
forth next to the name of such Person on _Schedule A_.

  



  

6.4 Severability. A determination by a court or other legal authority that
any provision that is not of the essence of this Support Agreement is legally
invalid shall not affect the validity or enforceability of any other provision
hereof. The parties shall cooperate in good faith to substitute (or cause
such court or other legal authority to substitute) for any provision so held
to be invalid a valid provision, as alike in substance to such invalid
provision as is lawful.

  



  

6.5 Entire Agreement. This Support Agreement, together with the Additional
Agreements to which the Supporting Parties are parties sets forth the entire
agreement of the parties with respect to the subject matter hereof and
thereof and supersedes all prior and contemporaneous understandings and
agreements related to the subject matter hereof and thereto (whether written
or oral), all of which are merged herein. Except as otherwise expressly stated
herein, there is no condition precedent to the effectiveness of any provision
hereof or thereof. No party has relied on any representation from, or warranty
or agreement of, any Person in entering into this Support Agreement, prior
hereto or contemporaneous herewith, except those expressly stated herein or
therein.

  



  

6.6 Amendment. This Support Agreement cannot be amended, except by a writing
signed by each party, and cannot be terminated orally or by course of
conduct.

  



  

6.7 Assignment; Binding Effect. Neither this Support Agreement nor any of the
rights, interests or obligations hereunder may be assigned or delegated by
any Supporting Party, and any attempted or purported assignment or delegation
of any of such interests or obligations shall be null and void. Subject to
the preceding sentence, this Support Agreement shall be binding upon each of
the parties hereto, their respective heirs, estates, executors and personal
representatives (if applicable) and their respective successors and assigns,
and shall inure to the benefit of each of the parties hereto and their
respective successors and assigns.

  



  

6.8 Third-Party Beneficiaries. Neither this Support Agreement nor any
provision hereof confers any benefit or right upon or may be enforced by any
Person not a signatory hereto.

  



  

6.9 Specific Performance. The parties hereto acknowledge that the rights of
each party contemplated hereby are unique, recognize and affirm that in the
event of a breach of this Support Agreement by any party, money damages
would be inadequate and the non-breaching parties would not have adequate
remedy at law, and agree that irreparable damage would occur in the event
that any of the provisions of this Support Agreement were not performed by an
applicable party in accordance with their specific terms or were otherwise
breached. Accordingly, each party shall be entitled to an injunction or
restraining order to prevent breaches of this Support Agreement and to seek
to enforce specifically the terms and provisions hereof, without
the requirement to post any bond or other security or to prove that money
damages would be inadequate, this being in addition to any other right or
remedy to which such party may be entitled under this Support Agreement, at
law or in equity.

  



  

   

D-7

 



    



  

6.10 Governing Law. This Support Agreement shall be construed in accordance
with and governed by the laws of the State of Delaware, without giving effect
to the conflict of laws principles thereof.

  



  

6.11 Consent to Jurisdiction; Waiver of Trial by Jury. Any Action based upon,
arising out of or related to this Support Agreement or the transactions
contemplated hereby may be brought in federal and state courts located in the
State of Delaware, and each of the parties irrevocably submits to the
exclusive jurisdiction of each such court in any such Action, waives any
objection it may now or hereafter have to personal jurisdiction, venue or to
convenience of forum, agrees that all claims in respect of the Action shall
be heard and determined only in any such court, and agrees not to bring any
Action arising out of or relating to this Support Agreement or the
transactions contemplated hereby in any other court. Nothing herein contained
shall be deemed to affect the right of any party to serve process in any
manner permitted by Law or to commence legal proceedings or otherwise proceed
against any other party in any other jurisdiction, in each case, to enforce
judgments obtained in any Action brought pursuant to this _Section 6.11_.
EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS SUPPORT
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

  



  

6.12 Attorneys' Fees. If any Action, suit or other Action relating to this
Support Agreement or the enforcement of any provision of this Support
Agreement is brought against any Supporting Party, the prevailing party in
such Action, as determined in a final, non-appealable decision by a court of
competent jurisdiction, suit or other Action shall be entitled to receive
the costs incurred by such party in conducting the suit, Action or
proceeding, including reasonable attorneys' fees and expenses and court costs
(in addition to any other relief to which such prevailing party may be
entitled).

  



  

6.13 Counterparts; Electronic Signatures. This Support Agreement may be
executed in counterparts, each of which shall constitute an original, but all
of which shall constitute one agreement. This Support Agreement shall become
effective upon delivery to each party of an executed counterpart or the
earlier delivery to each party of original, photocopied, or
electronically transmitted signature pages that together (but need not
individually) bear the signatures of all other parties.

  



  

6.14 Headings. The headings used in this Support Agreement have been inserted
for convenience of reference only and do not define or limit the provisions
hereof.

  



  

6.15 No Ownership Interest. Nothing contained in this Agreement shall be
deemed to vest in Purchaser any direct or indirect ownership or incidence of
ownership of or with respect to any Subject Securities.

  



  

6.16 Directors and Officers. Nothing in this Agreement shall be construed to
impose any obligation or limitation on votes or actions taken by any
director, officer, employee, agent, designee or other representative of any
Supporting Party or by any Supporting Party that is a natural person, in each
case, in his or her capacity as a director or officer of Purchaser. Each
Supporting Party is executing this Agreement solely in such capacity as a
record or beneficial holder of Purchaser equity securities.

  



  

   

D-8

 



    



  

6.17 Extension; Waiver. At any time prior to the Closing, Purchaser (on
behalf of itself and Merger Sub), the Company, and each Supporting Party,
may, to the extent not prohibited by applicable Laws: (i) extend the time for
the performance of any of the obligations or other acts of the other parties
hereto; (ii) waive any inaccuracies in the representations and
warranties made to the other parties hereto contained herein or in any
document delivered pursuant hereto; and (iii) waive compliance with any of
the agreements or conditions for the benefit of such party contained herein.
Any agreement on the part of a party hereto to any such extension or waiver
shall be valid only if set forth in an instrument in writing signed on behalf
of such party. No failure or delay on the part of either party to exercise
any power, right, privilege or remedy under this Support Agreement
shall operate as a waiver of such power, right, privilege or remedy; and no
single or partial exercise of any such power, right, privilege or remedy
shall preclude any other or further exercise thereof or of any other power,
right, privilege or remedy. Neither party shall be deemed to have waived any
claim available to such party arising out of this Support Agreement, or any
power, right, privilege or remedy under this Support Agreement, unless the
waiver of such claim, power, right, privilege or remedy is expressly set
forth in a written instrument duly executed and delivered on behalf of such
waiving party; and any such waiver shall not be applicable or have any effect
except in the specific instance in which it is given.

  



  

6.18 Independence of Obligations. The covenants and obligations of each
Supporting Party set forth in this Support Agreement shall be construed as
independent of any other Contract between such Supporting Party, on the one
hand, and the Company or Purchaser, on the other hand. The existence of any
claim or cause of action by any Supporting Party against the Company or
Purchaser shall not constitute a defense to the enforcement of any of such
covenants or obligations against such Supporting Party. Nothing in this
Support Agreement shall limit any of the rights or remedies of Purchaser or
the Company under the Merger Agreement, or any of the rights or remedies of
Purchaser or the Company or any of the obligations of any Supporting Party
under any agreement between such Person and Purchaser or the Company or any
certificate or instrument executed by such Person in favor of Purchaser or
the Company; and nothing in the Merger Agreement or in any other such
agreement, certificate or instrument, shall limit any of the rights or
remedies of Purchaser or the Company or any of the obligations of any
Supporting Party under this Support Agreement.

  



  

6.19 Construction of Certain Terms and References; Captions. In this Support
Agreement:

  



  

(a) The words "herein," "hereof," "hereunder," and words of similar import
refer to this Support Agreement as a whole and not to any particular
provision of this Support Agreement.

  



  

(b) Any use of the singular or plural, or the masculine, feminine, or neuter
gender, includes the others, unless the context otherwise requires;
"including" means "including without limitation;" "or" means "and/or;" "any"
means "any one, more than one, or all,"

  



  

(c) Unless otherwise specified, any reference to any agreement (including
this Support Agreement), instrument, or other document includes all
schedules, exhibits, or other attachments referred to therein, and any
reference to a statute or other Law includes any rule, regulation, ordinance,
or the like promulgated thereunder, in each case, as amended, restated,
supplemented, or otherwise modified from time to time.

  



  

(d) If any action is required to be taken or notice is required to be given
within a specified number of days following a specific date or event, the day
of such date or event is not counted in determining the last day for such
action or notice. If any action is required to be taken or notice is required
to be given on or before a particular day which is not a Business Day, such
action or notice shall be considered timely if it is taken or given on or
before the next Business Day.

  



  

(e) Captions are not a part of this Support Agreement, but are included for
convenience, only.

  



  

(f) " _knowledge_ " with respect to an entity shall mean with respect to any
matter in question the actual knowledge of such entity's executive officers
after reasonable inquiry.

  

 _ _

  

 _[Remainder of page intentionally left blank.]_

  



    

D-9

 



    



  

In Witness Whereof, the parties have caused this Support Agreement to be
executed as of the date first written above.

  



       | Panacea Acquisition Corp. 
---|--- 
     | 
     | By:  | 
     |   | Name:   | 
     |   | Title:  | 
  

 _ _

  

 _Signature Page to Support Agreement_

  



    

D-10

 



    



  

In Witness Whereof, the parties have caused this Support Agreement to be
executed as of the date first written above.

  



       | Nuvation Bio, Inc. 
---|--- 
     | 
     | By:  | 
     |   | Name:   | 
     |   | Title:  | 
  

 _ _

  

 _Signature Page to Support Agreement_

  



    

D-11

 



    



  

In Witness Whereof, the parties have caused this Support Agreement to be
executed as of the date first written above.

  



       | SPONSOR: 
---|--- 
     | 
     | ECO R1 PANACEA HOLDINGS, LLC 
     | 
     | By:  | 
     |   | Name:   | 
     |   | Title:  | 
  



  

 _Signature Page to Support Agreement_

  



    

D-12

 



    



  

In Witness Whereof, the parties have caused this Support Agreement to be
executed as of the date first written above.

  



       | SUPPORTING PARTY: 
---|--- 
     | 
     | PA Co-Investment LLC 
     | 
     | By:  | 
     |   | Name:   | 
     |   | Title:  | 
   



  

 _Signature Page to Support Agreement_

  



    

D-13

 



    



  

 _SCHEDULE A_ 1

  



     Name|   | Notice Address|   | Class A 
  Stock| |   | Class B 
  Stock| |   | Warrants| 
---|---|---|---|---|---|---|---|---|---|---|--- 
   EcoR1 Panacea Holdings, LLC|   | c/o Panacea Acquisition Corp., 357
Tehama Street, Floor 3, San Francisco, CA 94103|   | | 390,000| 2|   | |
2,875,000| |   | | 130,000| 2 
   PA Co-Investment LLC|   | 599 Lexington Avenue, 20th Floor, New York,
NY 10022|   | | 97,500| 3|   | | 718,750| |   | | 32,500| 3 
    



   | _1_| Table excludes forward purchase securities that will only be
issued, if at all, at the time of our initial business combination.  
---|---|--- 
   | _2_| Class A Stock and Warrants held as part of 390,000 Units (each
of which consists of one share of Class A Stock and 1/3 of one warrant).  
---|---|--- 
   | _3_| Class A Stock and Warrants held as part of 97,500 Units (each
of which consists of one share of Class A Stock and 1/3 of one warrant).  
---|---|--- 
  



  

   

D-14

 



    

    



  

 

Exhibit E

  



  

 _Execution Version_

  

 _ _

  

FORM OF SPONSOR AND FOUNDER LOCK-UP AGREEMENT

  



  

October 20, 2020

  



  

Panacea Acquisition Corp.

  

357 Tehama Street

  

Floor 3

  

San Francisco, CA 94103

  



  

Re: Lock-Up Agreement for EcoR1 Panacea Holdings, LLC and PA Co-Investment
LLC

  



  

Ladies and Gentlemen:

  



  

This letter (this " _Letter Agreement_ ") is being delivered to you in
accordance with the Agreement and Plan of Merger (the " _MA_ ") entered into
by and among Panacea Acquisition Corp., a Delaware corporation (the "
_Company_ "), Panacea Merger Subsidiary Corp., a Delaware corporation ("
_Merger Sub_ ") and Nuvation Bio Inc., a Delaware corporation (" _Nuvation_
"), pursuant to which, among other things, Merger Sub will be merged with and
into Nuvation on the date hereof (the " _Merger_ "), with Nuvation surviving
the Merger as a wholly owned subsidiary of the Company.

  



  

In order to induce the Company to proceed with the Merger and for other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned (the " _Securityholder_ ") hereby agrees with
the Company as follows:

  



  

1. Subject to the exceptions set forth herein, the Securityholder agrees not to, without the prior written consent of the board of directors of the Company, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option, right or warrant to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the " _Exchange Act_ "), and the rules and regulations of the Securities and Exchange Commission promulgated thereunder, any currently outstanding Class B Common Stock, par value $0.0001 per share, of the Company (the " _Existing Class B Common Stock_ ") issued in connection with the public offering of the Company (or shares of Class A Common Stock, par value $0.0001 per share, of the Company (the " _Class A Common Stock_ ") issuable upon conversion of the Existing Class B Common Stock) held by it immediately after the effective time of the Merger (the " _Lock-up Shares_ "), (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Lock-up Shares, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii) (the actions specified in clauses (i)-(iii), collectively, " _Transfer_ ") until 365 days after the closing date of the Merger (the " _Lock-Up Period_ "), subject to the early release provisions set forth in Section 3 below.

  



  

2. The restrictions set forth in paragraph 1 shall not apply to:

  



   | (i)| in the case of an entity, (A) to another entity that is an
affiliate (as defined in Rule 405 promulgated under the Securities Act of
1933, as amended) of the undersigned, or to any investment fund or other
entity controlling, controlled by, managing or managed by or under common
control with the undersigned or affiliates of the undersigned or who shares a
common investment advisor with the undersigned or (B) as part of a
distribution to members, partners or shareholders of the undersigned; 
---|---|--- 
  



  

   

E-1

 



    



   | (ii)| in the case of an individual, Transfers by gift to members of
the individual's immediate family (as defined below) or to a trust, the
beneficiary of which is a member of one of the individual's immediate
family, an affiliate of such person or to a charitable organization; 
---|---|--- 
  



   | (iii)| in the case of an individual, Transfers by virtue of laws of
descent and distribution upon death of the individual; 
---|---|--- 
  



   | (iv)| in the case of an individual, Transfers by operation of law or
pursuant to a court order, such as a qualified domestic relations order,
divorce decree or separation agreement; 
---|---|--- 
  



   | (v)| in the case of an individual, Transfers to a partnership, limited
liability company or other entity of which the undersigned and/or the
immediate family (as defined below) of the undersigned are the legal and
beneficial owner of all of the outstanding equity securities or similar
interests; 
---|---|--- 
  



   | (vi)| in the case of an entity that is a trust, to a trustor or
beneficiary of the trust or to the estate of a beneficiary of such trust; 
---|---|--- 
  



   | (vii)| in the case of an entity, Transfers by virtue of the laws of
the state of the entity's organization and the entity's organizational
documents upon dissolution of the entity; 
---|---|--- 
  



   | (viii)| Transfers of any shares of Class A Common Stock or Class B
Common Stock, par value $0.001 per share of the Company with such rights and
characteristics as are described in the certificate of incorporation of the
Company as in effect immediately following the Merger (the " _Class B Common
Stock_ " and together with the Class A Common Stock, the " _Common Stock_ ")
or other securities acquired as part of the PIPE (as defined in the MA) or
issued in exchange for, or on conversion or exercise of, any securities
issued as part of the PIPE; 
---|---|--- 
  



   | (ix)| transactions relating to Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock acquired in
open market transactions after the effective time of the Merger, _provided_
that no such transaction is required to be, or is, publicly announced
(whether on Form 4, Form 5 or otherwise, other than a required filing on
Schedule 13F, 13G or 13G/A) during the Lock-Up Period; 
---|---|--- 
  



   | (x)| the exercise of stock options or warrants to purchase shares of
Common Stock or the vesting of stock awards of Common Stock and any related
transfer of shares of Common Stock to the Company in connection therewith (x)
deemed to occur upon the "cashless" or "net" exercise of such options or
warrants or (y) for the purpose of paying the exercise price of such options
or warrants or for paying taxes due as a result of the exercise of such
options or warrants, the vesting of such options, warrants or stock awards,
or as a result of the vesting of such shares of Common Stock, it being
understood that all shares of Common Stock received upon such exercise,
vesting or transfer will remain subject to the restrictions of this Letter
Agreement during the Lock-Up Period; 
---|---|--- 
  



   | (xi)| Transfers to the Company pursuant to any contractual arrangement
in effect at the effective time of the Merger that provides for the
repurchase by the Company or forfeiture of Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock in
connection with the termination of the Securityholder's service to
the Company; 
---|---|--- 
  



  

   

E-2

 



    



   | (xii)| the entry, by the Securityholder, at any time after the
effective time of the Merger, of any trading plan providing for the sale of
shares of Common Stock by the Securityholder, which trading plan meets the
requirements of Rule 10b5-1(c) under the Exchange Act, _provided_ , _however_
, that such plan does not provide for, or permit, the sale of any shares of
Common Stock during the Lock-Up Period and no public announcement or filing is
voluntarily made or required regarding such plan during the Lock-Up Period; 
---|---|--- 
  



   | (xiii)| transactions in the event of completion of a liquidation,
merger, stock exchange or other similar transaction which results in all of
the Company's securityholders having the right to exchange their shares of
Common Stock for cash, securities or other property; and 
---|---|--- 
  



   | (xiv)| transactions to satisfy any U.S. federal, state, or local
income tax obligations of the Securityholder (or its direct or indirect
owners) arising from a change in the U.S. Internal Revenue Code of 1986, as
amended (the " _Code_ "), or the U.S. Treasury Regulations promulgated
thereunder (the " _Regulations_ ") after the date on which the MA was
executed by the parties, and such change prevents the Merger from qualifying
as a "reorganization" pursuant to Section 368 of the Code (and the Merger
does not qualify for similar tax-free treatment pursuant to any successor or
other provision of the Code or Regulations taking into account such changes),
in each case solely and to the extent necessary to cover any tax liability as
a direct result of the transaction. 
---|---|--- 
  

 _ _

  

 _provided, however_ , that (A) in the case of clauses (i) through (vii),
these permitted transferees must enter into a written agreement, in
substantially the form of this Letter Agreement (it being understood that any
references to "immediate family" in the agreement executed by such transferee
shall expressly refer only to the immediate family of the Securityholder and
not to the immediate family of the transferee), agreeing to be bound by these
Transfer restrictions. For purposes of this paragraph, "immediate family"
shall mean a spouse, domestic partner, child (including by adoption), father,
mother, brother or sister of the undersigned, and lineal
descendant (including by adoption) of the undersigned or of any of the
foregoing persons; and "affiliate" shall have the meaning set forth in Rule
405 under the Securities Act of 1933, as amended.

  



  

3. In the event that the Company releases or waives, in full or in part, any party from a lock-up agreement entered into in connection with the closing of the Merger, then the same percentage of Lock-up Shares held by the undersigned as the percentage of Lock-up Shares (or such equivalent term as defined in such lock-up agreement) held by such released party to such party's aggregate number of Lock-up Shares that are the subject of such waiver or release shall be immediately and fully released on the same terms from the applicable prohibition(s) set forth herein. The foregoing provisions of this paragraph will not apply if the release or waiver is granted to a holder of Common Stock in connection with a follow-on public offering of Common Stock pursuant to a registration statement filed with the SEC, whether or not such offering or sale is wholly or partially a secondary offering of the Common Stock, and the undersigned, only to the extent the undersigned has a contractual right to demand or require the registration of the undersigned's Common Stock or "piggyback" on a registration statement filed by the Company for the offer and sale of its Common Stock, has been given an opportunity to participate on a basis consistent with such contractual rights in such follow-on offering. In the event that the Company changes, amends, modifies or waives (other than to correct a typographical error) any particular provision of any other lock-up agreement entered into in connection with the closing of the Merger, then the undersigned shall be offered the option (but not the requirement) to make a corresponding change, amendment, modification or waiver to this Letter Agreement.

  



  

   

E-3

 



    



  

4. The Lock-Up Period shall terminate upon the earlier of (i) 365 days after the closing date of the Merger, (ii) the closing of a merger, liquidation, stock exchange, reorganization or other similar transaction after the closing date of the Merger that results in all of the public stockholders of the Company having the right to exchange their shares of Common Stock for cash securities or other property, or (iii) the day after the date on which the closing price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the closing date of the Merger.

  



  

5. In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described therein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.

  



  

6. This Letter Agreement replaces Section 7(a) of that certain Letter Agreement, dated June 30, 2020, among the Company, the Sponsor, Cowen Investments and the Company's officers and directors, which Section 7(a) shall be terminated and of no further effect with respect to Securityholder upon the Closing of the Merger, and constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by the undersigned (i) Securityholder and (ii) the Company.

  



  

7. No party hereto may assign either this Letter Agreement or any of its rights, interests or obligations hereunder without the prior written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Securityholder and each of its respective successors, heirs and assigns and permitted transferees.

  



  

8. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the Delaware Chancery Court, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

  



  

9. This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Period and (ii) the liquidation of the Company.

  

 _ _

  

 _[remainder of page intentionally left blank]_

  



    

E-4

 



    



       | Very truly yours, 
---|--- 
     | 
     | _If stockholder is an individual:_ 
     | 
     | Signature:  | 
     |   | 
     | Print Name:  | 
     |   | 
     | _If stockholder is an entity:_ 
     |   | 
     | Name of Stockholder:   | 
     |   | 
     | Signature:  | 
     |   | 
     | Name:  | 
     |   | 
     | Title:   | 
  



     Agreed and Acknowledged:  | 
---|--- 
     |   | 
   Panacea Acquisition Corp  | 
     |   | 
   By:  | / _s_ /  | 
     |   |   | 
     | Name:   |   | 
     |   |   | 
     | Title:  |   | 
  



  



  

 _[Signature Page to Lock-Up Agreement]_

  



  

   

E-5

 



    



  

 

Exhibit F

  



  

 _Execution Version_

  



  

FORM OF FPA LOCK-UP AGREEMENT

  



  

October 20, 2020

  



  

Panacea Acquisition Corp.

  

357 Tehama Street

  

Floor 3

  

San Francisco, CA 94103

  



  

Re: Lock-Up Agreement for Forward Purchase Agreement Purchasers

  



  

Ladies and Gentlemen:

  



  

This letter (this " _Letter Agreement_ ") is being delivered to you in
accordance with the Agreement and Plan of Merger (the " _MA_ ") entered into
by and among Panacea Acquisition Corp., a Delaware corporation (the "
_Company_ "), Panacea Merger Subsidiary Corp., a Delaware corporation ("
_Merger Sub_ ") and Nuvation Bio Inc., a Delaware corporation (" _Nuvation_
"), pursuant to which, among other things, Merger Sub will be merged with and
into Nuvation on the date hereof (the " _Merger_ "), with Nuvation surviving
the Merger as a wholly owned subsidiary of the Company.

  



  

In order to induce the Company to proceed with the Merger and for other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned (the " _Securityholder_ ") hereby agrees with
the Company as follows:

  



  

1. Subject to the exceptions set forth herein, the Securityholder agrees not to, without the prior written consent of the board of directors of the Company, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option, right or warrant to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the " _Exchange Act_ "), and the rules and regulations of the Securities and Exchange Commission promulgated thereunder, any shares of (A) Class A Common Stock, par value $0.0001 per share, of the Company (the " _Class A Common Stock_ ") or (B) Class B Common Stock, par value $0.0001 per share, of the Company (the " _Class B Common Stock_ " and together with the Class A Common Stock, the " _Common Stock_ ") purchased by it pursuant to that certain Forward Purchase Agreement, dated June 30, 2020, between the Company, EcoR1 Panacea Holdings, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. (the " _Lock-up Shares_ "), (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Lock-up Shares, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii) (the actions specified in clauses (i)-(iii), collectively, " _Transfer_ ") until 365 days after the closing date of the Merger (the " _Lock-Up Period_ "), subject to the early release provisions set forth in Section 3 below.

  



  

2. The restrictions set forth in paragraph 1 shall not apply to:

  



   | (i)| in the case of an entity, (A) to another entity that is an
affiliate (as defined in Rule 405 promulgated under the Securities Act of
1933, as amended) of the undersigned, or to any investment fund or other
entity controlling, controlled by, managing or managed by or under common
control with the undersigned or affiliates of the undersigned or who shares a
common investment advisor with the undersigned or (B) as part of a
distribution to members, partners or shareholders of the undersigned; 
---|---|--- 
  



  

   

F-1

 



    



   | (ii)| in the case of an individual, Transfers by gift to members of
the individual's immediate family (as defined below) or to a trust, the
beneficiary of which is a member of one of the individual's immediate
family, an affiliate of such person or to a charitable organization; 
---|---|--- 
  



   | (iii)| in the case of an individual, Transfers by virtue of laws of
descent and distribution upon death of the individual; 
---|---|--- 
  



   | (iv)| in the case of an individual, Transfers by operation of law or
pursuant to a court order, such as a qualified domestic relations order,
divorce decree or separation agreement; 
---|---|--- 
  



   | (v)| in the case of an individual, Transfers to a partnership, limited
liability company or other entity of which the undersigned and/or the
immediate family (as defined below) of the undersigned are the legal and
beneficial owner of all of the outstanding equity securities or similar
interests; 
---|---|--- 
  



   | (vi)| in the case of an entity that is a trust, to a trustor or
beneficiary of the trust or to the estate of a beneficiary of such trust; 
---|---|--- 
  



   | (vii)| in the case of an entity, Transfers by virtue of the laws of
the state of the entity's organization and the entity's organizational
documents upon dissolution of the entity; 
---|---|--- 
  



   | (viii)| Transfers of any shares of Common Stock or other securities
acquired as part of the PIPE (as defined in the MA) or issued in exchange
for, or on conversion or exercise of, any securities issued as part of the
PIPE; 
---|---|--- 
  



   | (ix)| transactions relating to Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock acquired in
open market transactions after the effective time of the Merger, _provided_
that no such transaction is required to be, or is, publicly announced
(whether on Form 4, Form 5 or otherwise, other than a required filing on
Schedule 13F, 13G or 13G/A) during the Lock-Up Period; 
---|---|--- 
  



   | (x)| the exercise of stock options or warrants to purchase shares of
Common Stock or the vesting of stock awards of Common Stock and any related
transfer of shares of Common Stock to the Company in connection therewith (x)
deemed to occur upon the "cashless" or "net" exercise of such options or
warrants or (y) for the purpose of paying the exercise price of such options
or warrants or for paying taxes due as a result of the exercise of such
options or warrants, the vesting of such options, warrants or stock awards,
or as a result of the vesting of such shares of Common Stock, it being
understood that all shares of Common Stock received upon such exercise,
vesting or transfer will remain subject to the restrictions of this Letter
Agreement during the Lock-Up Period; 
---|---|--- 
  



   | (xi)| Transfers to the Company pursuant to any contractual arrangement
in effect at the effective time of the Merger that provides for the
repurchase by the Company or forfeiture of Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock in
connection with the termination of the Securityholder's service to
the Company; 
---|---|--- 
  



  

   

F-2

 



    



   | (xii)| the entry, by the Securityholder, at any time after the
effective time of the Merger, of any trading plan providing for the sale of
shares of Common Stock by the Securityholder, which trading plan meets the
requirements of Rule 10b5-1(c) under the Exchange Act, _provided_ , _however_
, that such plan does not provide for, or permit, the sale of any shares of
Common Stock during the Lock-Up Period and no public announcement or filing is
voluntarily made or required regarding such plan during the Lock-Up Period; 
---|---|--- 
  



   | (xiii)| transactions in the event of completion of a liquidation,
merger, stock exchange or other similar transaction which results in all of
the Company's securityholders having the right to exchange their shares of
Common Stock for cash, securities or other property; and 
---|---|--- 
  



   | (xiv)| transactions to satisfy any U.S. federal, state, or local
income tax obligations of the Securityholder (or its direct or indirect
owners) arising from a change in the U.S. Internal Revenue Code of 1986, as
amended (the " _Code_ "), or the U.S. Treasury Regulations promulgated
thereunder (the " _Regulations_ ") after the date on which the MA was
executed by the parties, and such change prevents the Merger from qualifying
as a "reorganization" pursuant to Section 368 of the Code (and the Merger
does not qualify for similar tax-free treatment pursuant to any successor or
other provision of the Code or Regulations taking into account such changes),
in each case solely and to the extent necessary to cover any tax liability as
a direct result of the transaction. 
---|---|--- 
  

 _ _

  

 _provided, however_ , that (A) in the case of clauses (i) through (vii),
these permitted transferees must enter into a written agreement, in
substantially the form of this Letter Agreement (it being understood that any
references to "immediate family" in the agreement executed by such transferee
shall expressly refer only to the immediate family of the Securityholder and
not to the immediate family of the transferee), agreeing to be bound by these
Transfer restrictions. For purposes of this paragraph, "immediate family"
shall mean a spouse, domestic partner, child (including by adoption), father,
mother, brother or sister of the undersigned, and lineal
descendant (including by adoption) of the undersigned or of any of the
foregoing persons; and "affiliate" shall have the meaning set forth in Rule
405 under the Securities Act of 1933, as amended.

  



  

3. In the event that the Company releases or waives, in full or in part, any party from a lock-up agreement entered into in connection with the closing of the Merger, then the same percentage of Lock-up Shares held by the undersigned as the percentage of Lock-up Shares (or such equivalent term as defined in such lock-up agreement) held by such released party to such party's aggregate number of Lock-up Shares that are the subject of such waiver or release shall be immediately and fully released on the same terms from the applicable prohibition(s) set forth herein. The foregoing provisions of this paragraph will not apply if the release or waiver is granted to a holder of Common Stock in connection with a follow-on public offering of Common Stock pursuant to a registration statement filed with the SEC, whether or not such offering or sale is wholly or partially a secondary offering of the Common Stock, and the undersigned, only to the extent the undersigned has a contractual right to demand or require the registration of the undersigned's Common Stock or "piggyback" on a registration statement filed by the Company for the offer and sale of its Common Stock, has been given an opportunity to participate on a basis consistent with such contractual rights in such follow-on offering. In the event that the Company changes, amends, modifies or waives (other than to correct a typographical error) any particular provision of any other lock-up agreement entered into in connection with the closing of the Merger, then the undersigned shall be offered the option (but not the requirement) to make a corresponding change, amendment, modification or waiver to this Letter Agreement.

  



  

   

F-3

 



    



  

4. The Lock-Up Period shall terminate upon the earlier of (i) 365 days after the closing date of the Merger, (ii) the closing of a merger, liquidation, stock exchange, reorganization or other similar transaction after the closing date of the Merger that results in all of the public stockholders of the Company having the right to exchange their shares of Common Stock for cash securities or other property, or (iii) the day after the date on which the closing price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the closing date of the Merger.

  



  

5. In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described therein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.

  



  

6. This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by the undersigned (i) Securityholder and (ii) the Company.

  



  

7. No party hereto may assign either this Letter Agreement or any of its rights, interests or obligations hereunder without the prior written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Securityholder and each of its respective successors, heirs and assigns and permitted transferees.

  



  

8. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the Delaware Chancery Court, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

  



  

9. This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Period and (ii) the liquidation of the Company.

  

 _ _

  

 _[remainder of page intentionally left blank]_

  



  

   

F-4

 



    



          | Very truly yours, 
---|--- 
     | 
     | _If stockholder is an individual:_ 
     | 
     | Signature:  | 
     |   | 
     | Print Name:   | 
   



       | _If stockholder is an entity:_ 
---|--- 
     |   | 
     | Name of Stockholder:   | 
   



       | Signature:   | 
---|---|--- 
     |   | 
     | Name:  | 
     |   | 
     | Title:   | 
  



  

 _[Signature Page to Lock-Up Agreement]_

  



  

   

F-5

 



    

    



  

Exhibit G

  



  

 _Execution Version_

  

 _ _

  

October 20, 2020

  



  

Panacea Acquisition Corp.

  

357 Tehama Street

  

Floor 3

  

San Francisco, CA 94103

  



  

Re: Lock-Up Agreement for Company Stockholders

  



  

Ladies and Gentlemen:

  



  

This letter (this " _Letter Agreement_ ") is being delivered to you in
accordance with the Agreement and Plan of Merger (the " _MA_ ") entered into
by and among Panacea Acquisition Corp., a Delaware corporation (the "
_Company_ "), Panacea Merger Subsidiary Corp., a Delaware corporation ("
_Merger Sub_ ") and Nuvation Bio Inc., a Delaware corporation (" _Nuvation_
"), pursuant to which, among other things, Merger Sub will be merged with and
into Nuvation on the date hereof (the " _Merger_ "), with Nuvation surviving
the Merger as a wholly owned subsidiary of the Company.

  



  

In order to induce the Company to proceed with the Merger and for other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the undersigned (the " _Securityholder_ ") hereby agrees with
the Company as follows:

  



  

1. Subject to the exceptions set forth herein, the Securityholder agrees not to, without the prior written consent of the board of directors of the Company, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option, right or warrant to purchase or otherwise transfer, dispose of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the " _Exchange Act_ "), and the rules and regulations of the Securities and Exchange Commission promulgated thereunder, any shares of (A) Class A Common Stock, par value $0.0001 per share, of the Company (the " _Class A Common Stock_ ") or (B) Class B Common Stock, par value $0.0001 per share, of the Company (the " _Class B Common Stock_ " and together with the Class A Common Stock, the " _Common Stock_ ") held by it immediately after the effective time of the Merger, any shares of Common Stock issuable upon the exercise of options to purchase shares of Common Stock held by it immediately after the effective time of the Merger, or any securities convertible into or exercisable or exchangeable for Common Stock held by it immediately after the effective time of the Merger (the " _Lock-up Shares_ "), (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Lock-up Shares, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii) (the actions specified in clauses (i)-(iii), collectively, " _Transfer_ ") until 180 days after the closing date of the Merger (the " _Lock-Up Period_ "), subject to the early release provisions set forth in Section 3 below.

  



  

2. The restrictions set forth in paragraph 1 shall not apply to:

  



   | (i)| in the case of an entity, (A) to another entity that is an
affiliate (as defined in Rule 405 promulgated under the Securities Act of
1933, as amended) of the undersigned, or to any investment fund or other
entity controlling, controlled by, managing or managed by or under common
control with the undersigned or affiliates of the undersigned or who shares a
common investment advisor with the undersigned or (B) as part of a
distribution to members, partners or shareholders of the undersigned; 
---|---|--- 
  



  

   

G-1

 



    



   | (ii)| in the case of an individual, Transfers by gift to members of
the individual's immediate family (as defined below) or to a trust, the
beneficiary of which is a member of one of the individual's immediate
family, an affiliate of such person or to a charitable organization; 
---|---|--- 
  



   | (iii)| in the case of an individual, Transfers by virtue of laws of
descent and distribution upon death of the individual; 
---|---|--- 
  



   | (iv)| in the case of an individual, Transfers by operation of law or
pursuant to a court order, such as a qualified domestic relations order,
divorce decree or separation agreement; 
---|---|--- 
  



   | (v)| in the case of an individual, Transfers to a partnership, limited
liability company or other entity of which the undersigned and/or the
immediate family (as defined below) of the undersigned are the legal and
beneficial owner of all of the outstanding equity securities or similar
interests; 
---|---|--- 
  



   | (vi)| in the case of an entity that is a trust, to a trustor or
beneficiary of the trust or to the estate of a beneficiary of such trust; 
---|---|--- 
  



   | (vii)| in the case of an entity, Transfers by virtue of the laws of
the state of the entity's organization and the entity's organizational
documents upon dissolution of the entity; 
---|---|--- 
  



   | (viii)| Transfers of any shares of Common Stock or other securities
acquired as part of the PIPE (as defined in the MA) or issued in exchange
for, or on conversion or exercise of, any securities issued as part of the
PIPE; 
---|---|--- 
  



   | (ix)| transactions relating to Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock acquired in
open market transactions after the effective time of the Merger, _provided_
that no such transaction is required to be, or is, publicly announced
(whether on Form 4, Form 5 or otherwise, other than a required filing on
Schedule 13F, 13G or 13G/A) during the Lock-Up Period; 
---|---|--- 
  



   | (x)| the exercise of stock options or warrants to purchase shares of
Common Stock or the vesting of stock awards of Common Stock and any related
transfer of shares of Common Stock to the Company in connection therewith (x)
deemed to occur upon the "cashless" or "net" exercise of such options or
warrants or (y) for the purpose of paying the exercise price of such options
or warrants or for paying taxes due as a result of the exercise of such
options or warrants, the vesting of such options, warrants or stock awards,
or as a result of the vesting of such shares of Common Stock, it being
understood that all shares of Common Stock received upon such exercise,
vesting or transfer will remain subject to the restrictions of this Letter
Agreement during the Lock-Up Period; 
---|---|--- 
  



   | (xi)| Transfers to the Company pursuant to any contractual arrangement
in effect at the effective time of the Merger that provides for the
repurchase by the Company or forfeiture of Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock in
connection with the termination of the Securityholder's service to
the Company; 
---|---|--- 
  



  

   

G-2

 



    



   | (xii)| the entry, by the Securityholder, at any time after the
effective time of the Merger, of any trading plan providing for the sale of
shares of Common Stock by the Securityholder, which trading plan meets the
requirements of Rule 10b5-1(c) under the Exchange Act, _provided_ , _however_
, that such plan does not provide for, or permit, the sale of any shares of
Common Stock during the Lock-Up Period and no public announcement or filing is
voluntarily made or required regarding such plan during the Lock-Up Period; 
---|---|--- 
  



   | (xiii)| transactions in the event of completion of a liquidation,
merger, stock exchange or other similar transaction which results in all of
the Company's securityholders having the right to exchange their shares of
Common Stock for cash, securities or other property; and 
---|---|--- 
  



   | (xiv)| transactions to satisfy any U.S. federal, state, or local
income tax obligations of the Securityholder (or its direct or indirect
owners) arising from a change in the U.S. Internal Revenue Code of 1986, as
amended (the " _Code_ "), or the U.S. Treasury Regulations promulgated
thereunder (the " _Regulations_ ") after the date on which the MA was
executed by the parties, and such change prevents the Merger from qualifying
as a "reorganization" pursuant to Section 368 of the Code (and the Merger
does not qualify for similar tax-free treatment pursuant to any successor or
other provision of the Code or Regulations taking into account such changes),
in each case solely and to the extent necessary to cover any tax liability as
a direct result of the transaction. 
---|---|--- 
  

 _ _

  

 _provided, however_ , that (A) in the case of clauses (i) through (vii),
these permitted transferees must enter into a written agreement, in
substantially the form of this Letter Agreement (it being understood that any
references to "immediate family" in the agreement executed by such transferee
shall expressly refer only to the immediate family of the Securityholder and
not to the immediate family of the transferee), agreeing to be bound by these
Transfer restrictions. For purposes of this paragraph, "immediate family"
shall mean a spouse, domestic partner, child (including by adoption), father,
mother, brother or sister of the undersigned, and lineal
descendant (including by adoption) of the undersigned or of any of the
foregoing persons; and "affiliate" shall have the meaning set forth in Rule
405 under the Securities Act of 1933, as amended.

  



  

3. In the event that the Company releases or waives, in full or in part, any party from a lock-up agreement entered into in connection with the closing of the Merger, then the same percentage of Lock-up Shares held by the undersigned as the percentage of Lock-up Shares (or such equivalent term as defined in such lock-up agreement) held by such released party to such party's aggregate number of Lock-up Shares that are the subject of such waiver or release shall be immediately and fully released on the same terms from the applicable prohibition(s) set forth herein. The foregoing provisions of this paragraph will not apply if the release or waiver is granted to a holder of Common Stock in connection with a follow-on public offering of Common Stock pursuant to a registration statement filed with the SEC, whether or not such offering or sale is wholly or partially a secondary offering of the Common Stock, and the undersigned, only to the extent the undersigned has a contractual right to demand or require the registration of the undersigned's Common Stock or "piggyback" on a registration statement filed by the Company for the offer and sale of its Common Stock, has been given an opportunity to participate on a basis consistent with such contractual rights in such follow-on offering. In the event that the Company changes, amends, modifies or waives (other than to correct a typographical error) any particular provision of any other lock-up agreement entered into in connection with the closing of the Merger, then the undersigned shall be offered the option (but not the requirement) to make a corresponding change, amendment, modification or waiver to this Letter Agreement.

  



  

   

G-3

 



    



  

4. The Lock-Up Period shall terminate upon the earlier of (i) 180 days after the closing date of the Merger, (ii) the closing of a merger, liquidation, stock exchange, reorganization or other similar transaction after the closing date of the Merger that results in all of the public stockholders of the Company having the right to exchange their shares of Common Stock for cash securities or other property, or (iii) the day after the date on which the closing price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the closing date of the Merger.

  



  

5. In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described therein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.

  



  

6. This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by the undersigned (i) Securityholder and (ii) the Company.

  



  

7. No party hereto may assign either this Letter Agreement or any of its rights, interests or obligations hereunder without the prior written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Securityholder and each of its respective successors, heirs and assigns and permitted transferees.

  



  

8. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the Delaware Chancery Court, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

  



  

9. This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Period and (ii) the liquidation of the Company.

  

 _ _

  

 _[remainder of page intentionally left blank]_

  



    

G-4

 



    



  

       | Very truly yours, 
---|--- 
     | 
     | _If stockholder is an individual:_ 
     | 
     | Signature:  | 
     |   | 
     | Print Name:  | 
     |   | 
     | _If stockholder is an entity:_ 
     |   | 
     | Name of Stockholder:   | 
     |   | 
     | Signature:  | 
     |   | 
     | Name:  | 
     |   | 
     | Title:   | 
  



  

 _[Signature Page to Lock-Up Agreement]_

  



  

   

G-5

 



    



  

Exhibit H

  



  

FORM OF CERTIFICATE OF MERGER

  



  

CERTIFICATE OF MERGER

  


 OF

  


 PANACEA MERGER SUBSIDIARY CORP

  


 WITH AND INTO

  


 NUVATION BIO INC.

  



  

Pursuant to Section 251 of the 
 General Corporation Law of the State of Delaware

  



  

Pursuant to Section 251 of the General Corporation Law of the State of
Delaware (" _DGCL_ "), the undersigned corporation, Nuvation Bio Inc., a
Delaware corporation (" _Nuvation_ "), does hereby certify the following
information relating to the merger of Panacea Merger Subsidiary Corp ("
_Merger Sub_ "), a Delaware corporation, with and into Nuvation (the "
_Merger_ "):

  



  

FIRST: The names and states of incorporation of the constituent corporations
to this Merger (the " _Constituent Corporations_ ") are as follows:

  



     Name  |   | State of Incorporation 
---|---|--- 
     |   | 
   Nuvation Bio Inc.  |   | Delaware 
     |   | 
   Panacea Merger Subsidiary Corp  |   | Delaware 
  



  

SECOND: An Agreement and Plan of Merger, dated as of October 20, 2020, by and
among Panacea Acquisition Corp., a Delaware corporation, Merger Sub
and Nuvation (the " _Merger Agreement_ "), has been approved, adopted,
executed and acknowledged by each of the Constituent Corporations in
accordance with Sections 251 and 228 of the DGCL.

  



  

THIRD: Nuvation will be the surviving corporation in the Merger. The name of
the corporation surviving the Merger is "Nuvation Bio Inc." (the " _Surviving
Corporation_ ").

  



  

FOURTH: Upon the effectiveness of the Merger in accordance with Section 251
of the DGCL, the amended and restated certificate of incorporation of Nuvation
as in effect immediately prior to the Merger shall be amended and restated in
its entirety at the effective time of the Merger as set forth in Exhibit A
attached hereto and, as so amended and restated, shall be the certificate of
incorporation of the Surviving Corporation until thereafter amended as
provided therein or by applicable law.

  



  

   

H-1

 



    



  

FIFTH: The executed Merger Agreement is on file at an office of the Surviving
Corporation at the following address:

  



  

357 Tehama St

  

Floor 3

  

San Francisco, CA 94103

  



  

SIXTH: A copy of the Merger Agreement will be provided by the Surviving
Corporation, upon request and without cost, to any stockholder of either
Constituent Corporation.

  



  

SEVENTH: The Merger shall become effective upon the filing of this
Certificate of Merger with the Secretary of State of the State of Delaware.

  



  

[ _Signature Page Follows_ ]

  



    

H-2

 



    



  

IN WITNESS WHEREOF, Nuvation Bio Inc. has caused this Certificate of Merger
to be executed in its corporate name this 20th day of October 2020.

  



       | NUVATION BIO INC. 
---|--- 
     |   | 
     | By:  | 
     | Name:   | 
     | Title:  | 
  



  

   

H-3

 



    



  

  

Exhibit I

  



  

FORM OF NEW COMPANY CERTIFICATE OF INCORPORATION

  



  

AMENDED AND RESTATED

  

CERTIFICATE OF INCORPORATION

  

OF

  

NUVATION BIO INC.

  



  

(Pursuant to Sections 242 and 245 of the

  

General Corporation Law of the State of Delaware)

  



  

Nuvation Bio Inc., a corporation organized and existing under and by virtue
of the provisions of the General Corporation Law of the State of
Delaware (the "General Corporation Law"),

  



  

DOES HEREBY CERTIFY:

  



  

1. That the name of this corporation is Nuvation Bio Inc., and that this corporation was originally incorporated pursuant to the General Corporation Law on March 20, 2018 under the name RePharmation Inc.

  



  

2. That the Board of Directors duly adopted resolutions proposing to amend and restate the Certificate of Incorporation of this corporation, declaring said amendment and restatement to be advisable and in the best interests of this corporation and its stockholders, and authorizing the appropriate officers of this corporation to solicit the consent of the stockholders therefor, which resolution setting forth the proposed amendment and restatement is as follows:

  



  

RESOLVED, that the Certificate of Incorporation of this corporation be
amended and restated in its entirety to read as follows:

  



  

FIRST: The name of this corporation is Nuvation Bio Inc. (the "Corporation").

  



  

SECOND: The address of the registered office of the Corporation in the State
of Delaware is 1209 Orange Street, in the City of Wilmington, County of New
Castle, 19801, and the name of its registered agent at such address is The
Corporation Trust Company.

  



  

THIRD: The nature of the business or purposes to be conducted or promoted is
to engage in any lawful act or activity for which corporations may be
organized under the General Corporation Law.

  



  

   

I-1

 



    



  

FOURTH: A. The Company is authorized to issue three classes of stock to be
designated, respectively, "Class A Common Stock," "Class B Common Stock" and
"Preferred Stock." The total number of shares of all classes of stock which
the Corporation shall have authority to issue is 1,534,594,678 comprised of
(i) 880,000,000 shares of Class A Common Stock, $0.0001 par value per share
("Class A Common Stock"), (ii) 294,094,678 shares of Class B Common Stock,
$0.0001 par value per share ("Class B Common Stock" and, together with the
Class A Common Stock, the "Common Stock") and (ii) 360,500,000 shares of
Preferred Stock, $0.0001 par value per share ("Preferred Stock").
Immediately upon the filing and effectiveness of this Amended and Restated
Certificate of Incorporation with the Secretary of State of the State of
Delaware (the "Effective Time"), automatically and without further action on
the part of the Company or the holders of capital stock of the Company, each
share of common stock, par value $0.0001 per share, of the Company ("Pre-
Exchange Stock") issued and outstanding or held by the Company as treasury
stock immediately prior to the Effective Time shall automatically be
reclassified as and become one validly issued, fully paid and non-assessable
share of Class A Common Stock (the "Reclassification"). Certificates
representing shares of Pre-Exchange Stock immediately prior to the
Effective Time shall, from and after the Effective Time, no longer represent
shares of Pre-Exchange Stock and shall represent only the number of shares of
Class A Common Stock into which the shares of Pre-Exchange Stock previously
represented by such certificate were reclassified pursuant hereto. The
Reclassification shall also apply to any outstanding securities or rights
convertible into, or exchangeable or exercisable for, Pre-Exchange Stock, and
all references to the Pre-Exchange Stock in agreements, arrangements,
documents and plans relating thereto or any option or right to purchase or
acquire shares of Pre-Exchange Stock shall be deemed to be references to the
Class A Common Stock or options or rights to purchase or acquire shares of
Class A Common Stock, as the case may be.

  



  

The following is a statement of the designations and the powers, privileges
and rights, and the qualifications, limitations or restrictions thereof in
respect of each class of capital stock of the Corporation.

  



  

A. COMMON STOCK

  



  

1\. Definitions.

  



  

1.1 " _Cause_ " means the Founder's: (i) intentional and unauthorized use or
disclosure of the Company's confidential information or trade secrets, which
use or disclosure causes material harm to the Company; (ii) conviction of any
felony under the laws of the United States or any state thereof; (iii)
willful participation in a material fraud against the Company; (iv) gross
negligence or willful misconduct which causes material harm to the Company;
(v) intentional and material damage to the Company's property; (vi) sustained
and material failure to perform the duties customarily associated with his
position with the Company that has not been cured within thirty (30) days
after written notice from the Company or the Company's Board of Directors of
such failure; or (vii) material breach of any agreement with the Company that
has not been cured within thirty (30) days after written notice from the
Company or the Company's Board of Directors.

  



  

1.2 " _Disability_ " means, with respect to the Founder, the inability of the
Founder to engage in any substantial gainful activity by reason of
any medically determinable physical or mental impairment that can be expected
to result in death or that has lasted or can be expected to last for a
continuous period of not less than twelve (12) months, and will be determined
by the Company's Board of Directors on the basis of medical evidence deemed
relevant by the Board of Directors.

  



  

   

I-2

 



    



  

1.3 " _Family Member_ " means, with respect to any natural person, the spouse
or registered domestic partner, parents, grandparents, lineal descendants,
siblings and lineal descendants of siblings (in each case whether by blood
relation or adoption) of such person.

  



  

1.4 " _Final Conversion Date_ " means 5:00 p.m. in New York City, New York,
on the first Trading Day after the earliest to occur of the date on which (i)
the Founder and his Permitted Transferees own, in aggregate, fewer than
220,571,000 shares of Common Stock (including, for such purposes, any shares
of Common Stock issuable upon conversion or exchange of any securities that,
by their terms, are convertible into or exchangeable for shares of Common
Stock), subject to appropriate adjustment in the event of any stock dividend,
stock split, combination or other similar recapitalization with respect to the
Common Stock, (ii) the Founder no longer serves as the Chief Executive
Officer of the Corporation, unless the Founder is terminated from such
position by the Company without Cause, (iii) the Founder dies, or (iv) the
Company's Board of Directors determines that the Founder suffers from a
Disability.

  



  

1.5 " _Founder_ " means David T. Hung, M.D.

  



  

1.6 " _Permitted Transfer_ " means, and shall be restricted to, any Transfer
of a share of Class B Common Stock:

  



  

1.6.1 by the Founder to the trustee of a Permitted Trust of the Founder
(including to the Founder in his capacity as the trustee of a Permitted
Trust of the Founder); or

  



  

1.6.2 by the trustee of a Permitted Trust of the Founder to the Founder or to
the trustee of any other Permitted Trust of the Founder (including to the
Founder in his capacity as the trustee of such other Permitted Trust of the
Founder).

  



  

1.7 " _Permitted Transferee_ " means a transferee of shares of Class B Common
Stock received in a Transfer that constitutes a Permitted Transfer.

  



  

1.8 " _Permitted Trust_ " means a validly created and existing trust all the
beneficiaries of which are the Founder and/or Family Members of the Founder.

  



  

1.9 " _Trading Day_ " means any day on which both the New York Stock Exchange
and The Nasdaq Stock Market are open for trading.

  



  

   

I-3

 



    



  

1.10 " _Transfer_ " of a share of Class B Common Stock means any sale,
assignment, transfer, conveyance, hypothecation or other transfer or
disposition of such share or any legal or beneficial interest in such share,
whether or not for value and whether voluntary or involuntary or by operation
of law, including, without limitation, a transfer of a share of Class B Common
Stock to a broker or other nominee (regardless of whether there is a
corresponding change in beneficial ownership), or the transfer of, or entering
into a binding agreement with respect to, Voting Control (as defined below)
over such share by proxy or otherwise; provided, however, that the following
shall not be considered a "Transfer" within the meaning of this _Subsection
1.9_ :

  



  

1.10.1 the granting of a revocable proxy to officers or directors of the
Company at the request of the Board of Directors in connection with actions
to be taken at an annual or special meeting of stockholders;

  



  

1.10.2 the existence of any proxy granted prior to the Effective Time or the
amendment or expiration of any such proxy;

  



  

1.10.3 entering into a voting trust, agreement or arrangement (with or
without granting a proxy) solely with stockholders who are holders of Class
B Common Stock that (A) is disclosed either in a Schedule 13D filed with the
Securities and Exchange Commission or in writing to the Secretary of the
Company, (B) either has a term not exceeding one year or is terminable by the
holder of the shares subject thereto at any time and (C) does not involve any
payment of cash, securities, property or other consideration to the holder
of the shares subject thereto other than the mutual promise to vote shares in
a designated manner;

  



  

1.10.4 the pledge of shares of Class B Common Stock by a stockholder that
creates a mere security interest in such shares pursuant to a bona fide
loan or indebtedness transaction for so long as such stockholder continues to
exercise exclusive Voting Control over such pledged shares; provided,
however, that a foreclosure on such shares or other similar action by the
pledgee shall constitute a "Transfer" unless such foreclosure or similar
action qualifies as a "Permitted Transfer"; or

  



  

1.10.5 entering into, or reaching an agreement, arrangement or understanding
regarding, a support or similar voting or tender agreement (with or
without granting a proxy) in connection with a Deemed Liquidation Event (as
defined below).

  



  

A " _Transfer_ " shall also be deemed to have occurred with respect to a
share of Class B Common Stock beneficially held by a Permitted Transferee on
the date that such Permitted Transferee ceases to meet the qualifications to
be a Permitted Transferee of the Founder.

  



  

1.11 " _Voting Control_ " means, with respect to a share of Class B Common
Stock, the power (whether exclusive or shared) to vote or direct the voting
of such share by proxy, voting agreement or otherwise.

  



  

2. _General_. The voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights, powers and preferences of the holders of the Preferred Stock set forth herein. Except as otherwise provided in this Amended and Restated Certificate of Incorporation or required by applicable law, shares of Class A Common Stock and Class B Common Stock shall have the same rights, privileges and powers, rank equally (including as to dividends and distributions, and upon any liquidation, dissolution, distribution of assets or winding up of the Corporation), share ratably and be identical in all respects and as to all matters.

  



  

   

I-4

 



    



  

3.  _Voting_.

  



  

3.1 Except as otherwise provided herein or required by law, the holders of
the Class A Common Stock and Class B Common Stock are entitled to one vote
for each share held thereof at all meetings of stockholders (and written
actions in lieu of meetings).

  



  

3.2 Notwithstanding anything to the contrary contained herein, the holders of
Class B Common Stock are entitled to ten votes for each share held thereof on
any matter submitted to stockholders of the Corporation, whether at a meeting
of stockholders or via written action in lieu of a meeting, requesting
approval of any merger, consolidation or any other Deemed Liquidation Event,
including, for the avoidance of doubt, any vote, consent or action related to
whether an event is considered a Deemed Liquidation Event as provided in
_Article Fourth, Section B.2.3_.

  



  

3.3 There shall be no cumulative voting. The number of authorized shares of
Class A Common Stock and Class B Common Stock may be increased or
decreased (but not below the number of shares thereof then outstanding) by
(in addition to any vote of the holders of one or more series of Preferred
Stock that may be required by the terms of this Amended and Restated
Certificate of Incorporation) the affirmative vote of the holders of shares
of capital stock of the Corporation representing a majority of the votes
represented by all outstanding shares of capital stock of the Corporation
entitled to vote, irrespective of the provisions of Section 242(b)(2) of the
General Corporation Law. In addition, prior to the date on which the first
share of Class B Common Stock is issued, the Corporation shall not effect or
approve any Deemed Liquidation Event (as defined below) without (in addition
to any other vote required by law or this Amended and Restated Certificate of
Incorporation) the written consent or affirmative vote of the holders of a
majority of the outstanding shares of Class A Common Stock.

  



  

4.  _Optional Conversion_.

  



  

4.1 Optional Conversion of the Class B Common Stock.

  



  

4.1.1 At the option of the holder thereof, each share of Class B Common Stock
shall be convertible, at any time or from time to time, into one fully
paid and nonassessable share of Class A Common Stock as provided herein.

  



  

4.1.2 Each holder of Class B Common Stock who elects to convert the same into
shares of Class A Common Stock shall surrender the certificate or
certificates therefor (if any), duly endorsed, at the office of the Company
or any transfer agent for the Class B Common Stock, and shall give written
notice to the Company at such office that such holder elects to convert the
same and shall state therein the number of shares of Class B Common Stock
being converted. Such conversion shall be deemed to have been made immediately
prior to the close of business on the date of such surrender of the
certificate or certificates representing the shares of Class B Common Stock
to be converted, or, if the shares are uncertificated, immediately prior to
the close of business on the date that the holder delivers notice of such
conversion to the Company's transfer agent and the person entitled to receive
the shares of Class A Common Stock issuable upon such conversion shall be
treated for all purposes as the record holder of such shares of Class A Common
Stock at such time.

  



  

   

I-5

 



    



  

5.  _Automatic Conversion_.

  



  

5.1 _Automatic Conversion of the Class B Common Stock_. Each share of Class B
Common Stock shall automatically be converted into one fully paid and
nonassessable share of Class A Common Stock upon a Transfer, other than a
Permitted Transfer, of such share of Class B Common Stock. Such
conversion shall occur automatically without the need for any further action
by the holders of such shares and whether or not the
certificates representing such shares (if any) are surrendered to the Company
or its transfer agent; provided, however, that the Company shall not be
obligated to issue certificates evidencing the shares of Class A Common Stock
issuable upon such conversion unless the certificates evidencing such shares
of Class B Common Stock are either delivered to the Company or its transfer
agent as provided below, or the holder notifies the Company or its transfer
agent that such certificates have been lost, stolen or destroyed and executes
an agreement satisfactory to the Company to indemnify the Company from any
loss incurred by it in connection with such certificates. Upon the occurrence
of such automatic conversion of the Class B Common Stock, the holders of Class
B Common Stock so converted shall surrender the certificates representing
such shares (if any) at the office of the Company or any transfer agent for
the Class A Common Stock.

  



  

5.2 _Final Conversion_. On the Final Conversion Date, each issued share of
Class B Common Stock shall automatically, without any further action,
convert into one fully paid and nonassessable share of Class A Common Stock.
Following the Final Conversion Date, the Company shall not issue any
additional shares of Class B Common Stock. Such conversion shall occur
automatically without the need for any further action by the holders of such
shares and whether or not the certificates representing such shares (if any)
are surrendered to the Company or its transfer agent; provided, however, that
the Company shall not be obligated to issue certificates evidencing
the shares of Class A Common Stock issuable upon such conversion unless the
certificates evidencing such shares of Class B Common Stock are either
delivered to the Company or its transfer agent as provided below, or the
holder notifies the Company or its transfer agent that such certificates have
been lost, stolen or destroyed and executes an agreement satisfactory to the
Company to indemnify the Company from any loss incurred by it in connection
with such certificates. Upon the occurrence of such automatic conversion of
the Class B Common Stock, the holders of Class B Common Stock so converted
shall surrender the certificates representing such shares (if any) at the
office of the Company or any transfer agent for the Class A Common Stock.

  



  

5.3 _Procedures_. The Company may, from time to time, establish such policies
and procedures relating to the conversion of Class B Common Stock to Class A
Common Stock and the general administration of this dual class stock
structure, including the issuance of stock certificates (or the establishment
of book-entry positions) with respect thereto, as it may deem reasonably
necessary or advisable, and may from time to time request that holders of
shares of Class B Common Stock furnish certifications, affidavits or other
proof to the Corporation as it deems necessary to verify the ownership of
Class B Common Stock and to confirm that a conversion to Class A Common Stock
has not occurred. A determination by the Secretary of the Company as to
whether a Transfer results in a conversion to Class A Common Stock shall be
conclusive and binding.

  



  

   

I-6

 



    



  

5.4 _Immediate Effect_. In the event of a conversion of shares of Class B
Common Stock to shares of Class A Common Stock pursuant to this _Section 5_
, such conversion(s) shall be deemed to have been made at the time that the
Transfer of shares occurred or immediately upon the Final Conversion Date, as
applicable. Upon any conversion of Class B Common Stock to Class A Common
Stock, all rights of the holder of shares of Class B Common Stock shall cease
and the person or persons in whose names or names the certificate or
certificates (or book-entry position(s)) representing the shares of Class A
Common Stock are to be issued shall be treated for all purposes as
having become the record holder or holders of such shares of Class A Common
Stock.

  



  

6.  _Redemption_. The Common Stock is not redeemable.

  



  

7. _Reservation of Stock Issuable Upon Conversion_. The Company shall at all times reserve and keep available out of its authorized but unissued shares of Class A Common Stock, solely for the purpose of effecting the conversion of the shares of the Class B Common Stock, as applicable, such number of its shares of Class A Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of Class B Common Stock; and if at any time the number of authorized but unissued shares of Class A Common Stock shall not be sufficient to effect the conversion of all then-outstanding shares of Class B Common Stock, as applicable, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Class A Common Stock to such numbers of shares as shall be sufficient for such purpose including, without limitation, engaging in best efforts to obtain the requisite stockholder approval of any necessary amendment to this Certificate of Incorporation.

  



  

8. _Prohibition on Reissuance of Shares_. Shares of Class B Common Stock that are acquired by the Company for any reason (whether by repurchase, upon conversion, or otherwise) shall be retired in the manner required by law and shall not be reissued as shares of Class B Common Stock.

  



  

B. PREFERRED STOCK

  



  

360,500,000 shares of the authorized and unissued Preferred Stock of the
Corporation are hereby designated "Series A Preferred Stock" with the
following rights, preferences, powers, privileges and restrictions,
qualifications and limitations. Unless otherwise indicated, references to
"sections" or "subsections" in this _Part B_ of this _Article Fourth_  refer
to sections and subsections of _Part B_ of this _Article Fourth_.

  



  

   

I-7

 



    



  

1.  _Dividends_.

  



  

The Corporation shall not declare, pay or set aside any dividends on shares
of any other class or series of capital stock of the Corporation (other
than dividends on shares of Common Stock payable in shares of Common Stock)
unless (in addition to the obtaining of any consents required elsewhere in
this Amended and Restated Certificate of Incorporation) the holders of the
Series A Preferred Stock then outstanding shall simultaneously receive, a
dividend on each outstanding share of Series A Preferred Stock in an amount at
least equal to (i) in the case of a dividend on Common Stock or any class or
series that is convertible into Common Stock, that dividend per share of
Series A Preferred Stock as would equal the product of (A) the dividend
payable on each share of such class or series determined, if applicable, as
if all shares of such class or series had been converted into Common Stock and
(B) the number of shares of Common Stock issuable upon conversion of a share
of Series A Preferred Stock, without giving effect to the limitations set
forth in _Subsection 4.2.3_ , in each case calculated on the record date for
determination of holders entitled to receive such dividend or (ii) in the
case of a dividend on any class or series that is not convertible into Common
Stock, at a rate per share of Series A Preferred Stock determined by (A)
dividing the amount of the dividend payable on each share of such class or
series of capital stock by the original issuance price of such class or
series of capital stock (subject to appropriate adjustment in the event of any
stock dividend, stock split, combination or other similar recapitalization
with respect to such class or series) and (B) multiplying such fraction by an
amount equal to the Series A Original Issue Price (as defined below);
_provided_ that, if the Corporation declares, pays or sets aside, on the same
date, a dividend on shares of more than one class or series of capital stock
of the Corporation, the dividend payable to the holders of Series A Preferred
Stock pursuant to this _Section 1_ shall be calculated based upon the
dividend on the class or series of capital stock that would result in the
highest Series A Preferred Stock dividend. The "Series A Original Issue
Price" shall mean $0.77138 per share, subject to appropriate adjustment in the
event of any stock dividend, stock split, combination or other similar
recapitalization with respect to the Series A Preferred Stock.

  



  

2.  _Liquidation, Dissolution or Winding Up; Certain Mergers, Consolidations
and Asset Sales_.

  



  

2.1 _Preferential Payments to Holders of Series A Preferred Stock_. In the
event of any voluntary or involuntary liquidation, dissolution or winding up
of the Corporation, the holders of shares of Series A Preferred Stock then
outstanding shall be entitled to be paid out of the assets of the Corporation
available for distribution to its stockholders, and in the event of a Deemed
Liquidation Event (as defined below), the holders of shares of Series A
Preferred Stock then outstanding shall be entitled to be paid out of the
consideration payable to stockholders in such Deemed Liquidation Event or out
of the Available Proceeds (as defined below), as applicable, before any
payment shall be made to the holders of Common Stock by reason of their
ownership thereof, an amount per share equal to the greater of (i) the Series
A Original Issue Price, plus any dividends declared but unpaid thereon, or
(ii) such amount per share as would have been payable had all shares of
Series A Preferred Stock been converted into Common Stock pursuant to _Section
4_  immediately prior to such liquidation, dissolution, winding up or Deemed
Liquidation Event (the amount payable pursuant to this sentence is
hereinafter referred to as the "Series A Liquidation Amount"). If upon any
such liquidation, dissolution or winding up of the Corporation or Deemed
Liquidation Event, the assets of the Corporation available for distribution to
its stockholders shall be insufficient to pay the holders of shares of Series
A Preferred Stock the full amount to which they shall be entitled under this
_Subsection 2.1_ , the holders of shares of Series A Preferred Stock shall
share ratably in any distribution of the assets available for distribution in
proportion to the respective amounts which would otherwise be payable in
respect of the shares of Series A Preferred Stock held by them upon such
distribution if all amounts payable on or with respect to such shares were
paid in full.

  



  

   

I-8

 



    



  

2.2 _Payments to Holders of Common Stock_. In the event of any voluntary or
involuntary liquidation, dissolution or winding up of the Corporation, after
the payment in full of all Series A Liquidation Amounts required to be paid to
the holders of shares of Series A Preferred Stock, the remaining assets of
the Corporation available for distribution to its stockholders or, in the case
of a Deemed Liquidation Event, the consideration not payable to the holders
of shares of Series A Preferred Stock pursuant to _Subsection 2.1_ or the
remaining Available Proceeds, as the case may be, shall be distributed among
the holders of shares of Class A Common Stock and Class B Common Stock, pro
rata based on the number of shares held by each such holder; _provided_ that
shares of Class A Common Stock and Class B Common Stock may receive, or have
the right to elect to receive, different or disproportionate consideration in
connection with a Deemed Liquidation Event if the only differences in the per
share consideration to the holders of the Class A Common Stock and Class B
Common Stock are that any securities distributed to the holders of, or
issuable upon the conversion of, a share of Class B Common Stock (i) have ten
times the voting power of any securities distributed to the holders of, or
issuable upon the conversion of, a share of Class A Common Stock with respect
to any merger, consolidation, sale of all or substantially all of the assets,
or similar transaction of the surviving or resulting corporation of such
Deemed Liquidation Event and (ii) have the right to elect, exclusively and as
a separate class, directors of the surviving or resulting corporation of such
Deemed Liquidation Event.

  



  

2.3 _Deemed Liquidation Events_.

  



  

2.3.1 _Definition_. Each of the following events shall be considered a
"Deemed Liquidation Event" unless the holders of a majority of the
outstanding shares of Series A Preferred Stock, which majority must include
the Lead Investor (as defined in the Investors' Rights Agreement, dated June
17, 2019, by and among the Corporation and the other parties thereto, as such
agreement may be amended from time to time (the "Investors' Rights
Agreement")) so long as neither the Lead Investor nor any of its Affiliates
(as defined in the Purchase Agreement (as defined below) is a Defaulting
Holder (as defined below) (the "Requisite Holders"), and the holders of a
majority of the outstanding shares of Class A Common Stock and Class B Common
Stock, voting together as a single class, elect otherwise by written notice
sent to the Corporation at least five (5) days prior to the effective date of
any such event:

  



   | (a)| a merger or consolidation in which 
---|---|--- 
  



   | (i)| the Corporation is a constituent party or 
---|---|--- 
  



   | (ii)| a subsidiary of the Corporation is a constituent party and the
Corporation issues shares of its capital stock pursuant to such merger or
consolidation, 
---|---|--- 
  



  

   

I-9

 



    



  

except any such merger or consolidation involving the Corporation or a
subsidiary in which the shares of capital stock of the Corporation outstanding
immediately prior to such merger or consolidation continue to represent, or
are converted into or exchanged for shares of capital stock that
represent, immediately following such merger or consolidation, a majority, by
voting power, of the capital stock, with substantially the
same properties/rights, of (1) the surviving or resulting corporation; or (2)
if the surviving or resulting corporation is a wholly owned subsidiary of
another corporation immediately following such merger or consolidation, the
parent corporation of such surviving or resulting corporation; or

  



  

(b) (1) the sale, lease, transfer, exclusive license or other disposition, in
a single transaction or series of related transactions, by the Corporation or
any subsidiary of the Corporation of all or substantially all the assets of
the Corporation and its subsidiaries taken as a whole, or (2) the sale or
disposition (whether by merger, consolidation or otherwise, and whether in a
single transaction or a series of related transactions) of one or more
subsidiaries of the Corporation if substantially all of the assets of the
Corporation and its subsidiaries taken as a whole are held by such subsidiary
or subsidiaries, except where such sale, lease, transfer, exclusive license
or other disposition is to a wholly owned subsidiary of the Corporation.

  



  

2.3.2 _Effecting a Deemed Liquidation Event_.

  



  

(a) The Corporation shall not have the power to effect a Deemed Liquidation
Event referred to in _Subsection 2.3.1(a)(i)_ unless the agreement or plan of
merger or consolidation for such transaction (the "Merger Agreement") provides
that the consideration payable to the stockholders of the Corporation in such
Deemed Liquidation Event shall be paid to the holders of capital stock of the
Corporation in accordance with _Subsections 2.1_ and _2.2_.

  



  

(b) In the event of a Deemed Liquidation Event referred to in _Subsection
2.3.1(a)(ii)_ or _2.3.1(b)_ , if the Corporation does not effect a
dissolution of the Corporation under the General Corporation Law within ninety
(90) days after such Deemed Liquidation Event, then (i) the Corporation shall
send a written notice to each holder of Series A Preferred Stock no later than
the ninetieth (90th) day after the Deemed Liquidation Event advising such
holders of their right (and the requirements to be met to secure such right)
pursuant to the terms of the following clause (ii) to request the non-
redemption of such shares of Series A Preferred Stock, and (ii) unless the
Requisite Holders request otherwise in a written instrument delivered to the
Corporation not later than one hundred twenty (120) days after such Deemed
Liquidation Event, the Corporation shall use the consideration received by the
Corporation for such Deemed Liquidation Event (net of any retained
liabilities associated with the assets sold or technology licensed, as
determined in good faith by the Board of Directors of the Corporation),
together with any other assets of the Corporation available for
distribution to its stockholders, all to the extent permitted by Delaware law
governing distributions to stockholders (the "Available Proceeds"), on the
one hundred fiftieth (150th) day after such Deemed Liquidation Event, to
redeem all outstanding shares of Series A Preferred Stock at a price per
share equal to the Series A Liquidation Amount. Notwithstanding the foregoing,
in the event of a redemption pursuant to the preceding sentence, if the
Available Proceeds are not sufficient to redeem all outstanding shares of
Series A Preferred Stock, the Corporation shall redeem a pro rata portion of
each holder's shares of Series A Preferred Stock to the fullest extent of
such Available Proceeds, based on the respective amounts which would otherwise
be payable in respect of the shares to be redeemed if the Available Proceeds
were sufficient to redeem all such shares, and shall redeem the
remaining shares as soon as it may lawfully do so under Delaware law
governing distributions to stockholders. Prior to the distribution
or redemption provided for in this _Subsection 2.3.2(b)_ , the Corporation
shall not expend or dissipate the consideration received for such Deemed
Liquidation Event, except to discharge expenses incurred in connection with
such Deemed Liquidation Event.

  



  

   

I-10

 



    



  

2.3.3 _Amount Deemed Paid or Distributed_. The amount deemed paid or
distributed to the holders of capital stock of the Corporation upon any
such merger, consolidation, sale, transfer, exclusive license, other
disposition or redemption shall be the cash or the value of the property,
rights or securities to be paid or distributed to such holders pursuant to
such Deemed Liquidation Event. The value of such property, rights or
securities shall be mutually agreed by the Board of Directors of the
Corporation, including the approval of Lead Series A Director (as defined in
the Voting Agreement, dated June 17, 2019, by and among the Corporation and
the other parties thereto, as such agreement may be amended from time to
time) (the "Lead Series A Director"), and the Requisite Holders. If the
Requisite Holders and the Board of Directors are not able to agree on the
valuation amount within a reasonable period of time (not to exceed twenty
(20) days), the valuation amount shall be determined by an investment banking
firm of national recognition, which firm shall be unaffiliated with each of
the Corporation and the Requisite Holders and shall be reasonably
acceptable to the Board of Directors and the Requisite Holders. If the Board
of Directors and the Requisite Holders are unable to agree upon an acceptable
investment banking firm within ten (10) days after the date either party
proposed that one be selected, the investment banking firm will be selected
by an arbitrator located in New York, New York, selected by the American
Arbitration Association (or if such organization ceases to exist, the
arbitrator shall be chosen by a court of competent jurisdiction). The
arbitrator shall select the investment banking firm (within ten (10) days of
his appointment) from a list, jointly prepared by the Requisite Holders and
the Board of Directors, of not more than six (6) investment banking firms of
national standing in the United States, of which no more than three (3) may
be named by the Board of Directors and no more than three (3) may be named by
the Requisite Holders. The arbitrator may consider, within the ten (10) day
period allotted, arguments from the parties regarding which
investment banking firm to choose, but the selection by the arbitrator shall
be made in its sole discretion from the list of six (6). The Board of
Directors and the Requisite Holders shall submit their respective valuations
and other relevant data to the investment banking firm, and the investment
banking firm shall as soon as practicable thereafter make its own
determination of the valuation amount. The final valuation amount for
purposes hereof shall be the average of the two valuation amounts closest
together, as determined by the investment banking firm, from among the
valuation amounts submitted by the Corporation and the Requisite Holders and
the valuation amount calculated by the investment banking firm. The
determination of the final valuation amount by such investment banking firm
shall be final and binding upon the parties. The Corporation shall pay the
fees and expenses of the investment banking firm and arbitrator (if any) used
to determine the valuation amount. If required by any such investment banking
firm or arbitrator, the Corporation shall execute a retainer and engagement
letter containing reasonable terms and conditions, including, without
limitation, customary provisions concerning the rights of indemnification and
contribution by the Corporation in favor of such investment banking firm or
arbitrator and its officers, directors, partners, employees, agents and
affiliates. If the valuation amount is for Common Stock of the Corporation,
the valuation amount shall not include a discount for minority ownership or
illiquidity or a control premium.

  



  

   

I-11

 



    



  

2.3.4 _Allocation of Escrow and Contingent Consideration_. In the event of a
Deemed Liquidation Event pursuant to _Subsection 2.3.1(a)(i)_ , if any
portion of the consideration payable to the stockholders of the Corporation is
payable only upon satisfaction of contingencies (the "Additional
Consideration"), the Merger Agreement shall provide that (a) the portion of
such consideration that is not Additional Consideration (such portion, the
"Initial Consideration") shall be allocated among the holders of capital
stock of the Corporation in accordance with _Subsections 2.1_ and _2.2_ as if
the Initial Consideration were the only consideration payable in connection
with such Deemed Liquidation Event; and (b) any Additional Consideration
which becomes payable to the stockholders of the Corporation upon
satisfaction of such contingencies shall be allocated among the holders of
capital stock of the Corporation in accordance with _Subsections 2.1_ and
_2.2_ after taking into account the previous payment of the Initial
Consideration as part of the same transaction. For the purposes of this
_Subsection 2.3.4_ , consideration placed into escrow or retained as a
holdback to be available for satisfaction of indemnification or similar
obligations in connection with such Deemed Liquidation Event shall be deemed
to be Additional Consideration.

  



  

3.  _Voting_.

  



  

3.1 _General_. On any matter presented to the stockholders of the Corporation
for their action or consideration at any meeting of stockholders of the
Corporation (or by written consent of stockholders in lieu of meeting), each
holder of outstanding shares of Series A Preferred Stock shall be entitled to
cast the number of votes equal to the number of whole shares of Class A Common
Stock into which the shares of Series A Preferred Stock held by such holder
are convertible as of the record date for determining stockholders
entitled to vote on such matter, without giving effect to the limitations set
forth in _Subsection 4.2.3_. Except as provided by law or by the other
provisions of this Amended and Restated Certificate of Incorporation, holders
of Series A Preferred Stock shall vote together with the holders of Class A
Common Stock and Class B Common Stock as a single class and on an as-converted
to Class A Common Stock basis, without giving effect to the limitations set
forth in _Subsection 4.2.3_.

  



  

3.2 _Election of Directors_.

  



  

3.2.1 The holders of record of the shares of Series A Preferred Stock,
exclusively and as a separate class, shall be entitled to elect three (3)
directors of the Corporation and the holders of record of the shares of Class
A Common Stock and Class B Common Stock, exclusively and voting together as a
single class, shall be entitled to elect three (3) directors of the
Corporation or, if applicable, such greater number of directors as may be
provided by _Subsection 3.2.2_. Any director elected as provided in the
preceding sentence may be removed without cause by, and only by, the
affirmative vote of the holders of the shares of the class or series of
capital stock entitled to elect such director or directors, given either at a
special meeting of such stockholders duly called for that purpose or
pursuant to a written consent of stockholders. If the holders of shares of
Series A Preferred Stock or Class A Common Stock and Class B Common Stock, as
the case may be, fail to elect a sufficient number of directors to fill all
directorships for which they are entitled to elect directors, voting
exclusively and as a separate class, pursuant to the first sentence of this
_Subsection 3.2.1_ , then any directorship not so filled shall remain vacant
until such time as the holders of the Series A Preferred Stock or Class A
Common Stock and Class B Common Stock, as the case may be, elect a person to
fill such directorship by vote or written consent in lieu of a meeting; and
no such directorship may be filled by stockholders of the Corporation other
than by the stockholders of the Corporation that are entitled to elect a
person to fill such directorship, voting exclusively and as a separate class.
The holders of record of the shares of Class A Common Stock and Class B
Common Stock and of any other class or series of voting stock (including the
Series A Preferred Stock), exclusively and voting together as a single class
on an as-converted to Class A Common Stock basis, shall be entitled to elect
the balance of the total number of directors.

  



  

   

I-12

 



    



  

3.2.2 At any time when the authorized number of directors constituting the
Board of Directors is greater than seven (7), the number of directors
that may be elected by the holders of record of the shares of Class A Common
Stock and Class B Common Stock, exclusively and voting together as a single
class (the "Common Directors"), shall be increased to the sum of three (3) and
the smallest whole number that is at least 50% of the authorized number of
directors in excess of seven (7). By way of example, the number of Common
Directors shall be four if the authorized number of directors is eight (8) or
nine (9) and shall be five (5) if the authorized number of directors is ten
(10) or eleven (11).

  



  

3.2.3 At any meeting held for the purpose of electing a director, the
presence in person or by proxy of the holders of a majority in voting power
of the outstanding shares of the class or series entitled to elect such
director shall constitute a quorum for the purpose of electing such director.
Except as otherwise provided in this _Subsection 3.2_ , a vacancy in any
directorship filled by the holders of any class or series shall be filled
only by vote or consent in lieu of a meeting of the holders of such class or
series or by any remaining director or directors elected by the holders of
such class or series pursuant to this _Subsection 3.2_.

  



  

3.3 _Series A Preferred Stock Protective Provisions_. At any time when shares
of Series A Preferred Stock are outstanding, the Corporation shall
not, either directly or indirectly by amendment, merger, consolidation or
otherwise, do any of the following without (in addition to any other vote
required by law or this Amended and Restated Certificate of Incorporation) the
written consent or affirmative vote of the Requisite Holders given in writing
or by vote at a meeting, consenting or voting (as the case may be) separately
as a class, and any such act or transaction entered into without such consent
or vote shall be null and void _ab initio_ , and of no force or effect.

  



  

3.3.1 liquidate, dissolve or wind-up the business and affairs of the
Corporation, effect any merger or consolidation or any other Deemed
Liquidation Event, or consent to any of the foregoing;

  



  

3.3.2 amend, alter, waive or repeal any provision of this Amended and
Restated Certificate of Incorporation or Bylaws of the Corporation in a manner
that adversely affects the powers, preferences or rights of the Series A
Preferred Stock or the holders thereof in respect of such shares, or effect a
reclassification, reorganization or recapitalization of the outstanding equity
interests in the Company;

  



  

   

I-13

 



    



  

3.3.3 create, or authorize the creation of, or issue or obligate itself to
issue shares of, any additional class or series of capital stock, or increase
the authorized number of shares of Series A Preferred Stock or increase the
authorized number of shares of any additional class or series of capital
stock of the Corporation;

  



  

3.3.4 (i) reclassify, alter or amend any existing security of the Corporation
that is pari passu with the Series A Preferred Stock in respect of
the distribution of assets on the liquidation, dissolution or winding up of
the Corporation, the payment of dividends or rights of redemption, if such
reclassification, alteration or amendment would render such other security
senior to the Series A Preferred Stock in respect of any such right,
preference, or privilege or (ii) reclassify, alter or amend any existing
security of the Corporation that is junior to the Series A Preferred Stock in
respect of the distribution of assets on the liquidation, dissolution or
winding up of the Corporation, the payment of dividends or rights of
redemption, if such reclassification, alteration or amendment would render
such other security senior to or pari passu with the Series A Preferred Stock
in respect of any such right, preference or privilege;

  



  

3.3.5 purchase or redeem (or permit any subsidiary to purchase or redeem) or
pay or declare any dividend, or make any distribution on, any shares of
capital stock of the Corporation other than (i) redemptions of or dividends
or distributions on the Series A Preferred Stock as expressly authorized
herein, (ii) dividends or other distributions payable on the Common Stock
solely in the form of additional shares of Common Stock and (iii) repurchases
of stock from former employees, officers, directors, consultants or other
persons who performed services for the Corporation or any subsidiary in
connection with the cessation of such employment or service at the lower of
the original purchase price or the then-current fair market value thereof as
approved by the Board of Directors, including the approval of at least one
Series A Director;

  



  

3.3.6 create, or hold capital stock in, any subsidiary that is not wholly
owned (either directly or through one or more other subsidiaries) by the
Corporation, or permit any subsidiary to create, or authorize the creation
of, or issue or obligate itself to issue, any shares of any class or series
of capital stock, or sell, transfer or otherwise dispose of any capital stock
of any direct or indirect subsidiary of the Corporation, or permit any direct
or indirect subsidiary to sell, lease, transfer, exclusively license or
otherwise dispose (in a single transaction or series of related transactions)
of all or substantially all of the assets of such subsidiary;

  



  

3.3.7 increase or decrease the authorized number of directors constituting
the Board of Directors of the Corporation; or

  



  

3.3.8 permit any direct or indirect subsidiary of the Corporation to take any
of the above actions under _Subsections 3.3.1_ through _3.3.7_.

  



  

   

I-14

 



    



  

4.  _Optional Conversion_.

  



  

The holders of the Series A Preferred Stock shall have conversion rights as
follows (the "Conversion Rights"):

  



  

4.1 _Right to Convert_. Other than as indicated in _Subsection 4.2_ herein,
each share of Series A Preferred Stock shall be convertible, at the option of
the holder thereof, at any time and from time to time, and without the payment
of additional consideration by the holder thereof, into such number of fully
paid and non-assessable shares of Class A Common Stock as is determined by
dividing the Series A Original Issue Price by the Series A Conversion Price
(as defined below) in effect at the time of conversion. The "Series A
Conversion Price" shall initially be equal to $0.77138. Such initial Series A
Conversion Price, and the rate at which shares of Series A Preferred Stock
may be converted into shares of Class A Common Stock, shall be subject to
adjustment as provided below.

  



  

4.2 _Special Mandatory Conversion_.

  



  

4.2.1 If, at any time after June 17, 2019, a Second Tranche Closing (as
defined in that certain Series A Preferred Stock Purchase Agreement, dated
June 17, 2019, by and among the Company and the purchasers of Series A
Preferred Stock named therein, as such agreement is amended from time to time
(the "Purchase Agreement")), occurs pursuant to Section 1.3 of the Purchase
Agreement, then each share of Series A Preferred Stock held by a holder who
(together with such holder's Affiliates (as defined in the
Purchase Agreement)) is required under the Purchase Agreement to purchase
Second Tranche Closing Shares (as defined in the Purchase Agreement) at the
Second Tranche Closing and does not purchase at the Second Tranche Closing, or
within five (5) business days thereafter, at least the number of Second
Tranche Closing Shares set forth opposite such holder's name on _Schedule A_
attached to the Purchase Agreement under the heading "Second Tranche
Closing," taking into account any Second Tranche Elective Closing Shares
previously acquired by such Purchaser (a "Defaulting Holder") or by any
transferee, assignee or pledgee of any shares of Series A Preferred Stock
originally purchased by such Defaulting Holder shall be automatically
and without further action on the part of such holder converted into shares
of Class A Common Stock at a ratio of 10 shares of Series A Preferred Stock
for 1 share of Class A Common Stock (such conversion, a "Mandatory Conversion
Upon Default"), effective immediately prior to the consummation of the Second
Tranche Closing (the "Second Tranche Offering Date").

  



  

4.2.2 Without limiting or delaying any Mandatory Conversion Upon Default, the
Defaulting Holders holding shares of Series A Preferred Stock
converted pursuant to _Subsection 4.2.1_ shall, if the Series A Preferred
Stock is certificated, deliver to the Company at the office of the Company or
any transfer agent for the Series A Preferred Stock or at such other place as
may be designated by the Company, the certificate or certificates for the
shares so converted, duly endorsed or assigned in blank or to the Company. As
promptly as practicable thereafter, if the Series A Preferred Stock is
certificated, the Company shall issue and deliver to such holder, at the
place designated by such holder, a certificate or certificates for the full
number of shares of Class A Common Stock to which such holder is entitled.
The person in whose name such shares of Class A Common Stock are to be issued
shall be deemed to have become a stockholder of record of such shares of
Class A Common Stock on the Second Tranche Offering Date unless the
transfer books of the Company are closed on that date, in which event such
person shall be deemed to have become a stockholder of record on the next
succeeding date on which the transfer books are open. Failure by a Defaulting
Holder to deliver its certificate(s) for shares of Series A Preferred Stock
shall not affect the Mandatory Conversion Upon Default, and any such
certificate(s) shall only represent the right to receive shares of Class A
Common Stock at a ratio of 1 share of Class A Common Stock for each 10
shares of Series A Preferred Stock so converted.

  



  

   

I-15

 



    



  

4.2.3 Notwithstanding anything contained in _Subsection 4.1_ above to the
contrary, no shares of Series A Preferred Stock shall be convertible
into shares of Class A Common Stock at the election of any holder pursuant to
_Subsection 4.1_ during the period beginning on June 17, 2019 and ending
immediately following the earlier to occur of the sixth (6th) business day
following the Second Tranche Closing and the Second Tranche Closing
Termination Date (as defined in the Purchase Agreement); _provided_ that,
notwithstanding the foregoing, in the event of a firmly underwritten initial
public offering of the Company's securities pursuant to the Securities Act of
1933, as amended (an "IPO"), or a Deemed Liquidation Event, the Company shall
provide each holder of Series A Preferred Stock written notice at least
twenty (20) days' prior to the consummation of such IPO or Deemed Liquidation
Event and, upon delivery of such notice, each holder of Series A Preferred
Stock shall be entitled to convert such holder's shares of Series A Preferred
Stock into shares of Class A Common Stock in accordance with _Subsection 4.1_
 hereof. Any conversion effected or attempted to be effected in contravention
of this _Subsection 4.2.3_ shall be null and void; _provided_ that any such
conversion or attempted conversion shall be effective if, in a resolution duly
approved by the disinterested members of the Company's Board of Directors,
such conversion is approved and is designated by the disinterested members of
the Company's Board of Directors as being exempt from a Second Tranche
Closing.

  



  

4.3 _Fractional Shares_. No fractional shares of Class A Common Stock shall
be issued upon conversion of the Series A Preferred Stock. In lieu of any
fractional shares to which the holder would otherwise be entitled, the
Corporation shall pay cash equal to such fraction multiplied by the fair
market value of a share of Class A Common Stock as determined in good faith by
the Board of Directors of the Corporation;  _provided_ , _however_ , that in
lieu of any fractional shares to which the holder would otherwise be entitled
pursuant to _Subsection 4.2_ above, the Company shall pay the Original Issue
Price of such fractional share. Whether or not fractional shares would be
issuable upon such conversion shall be determined on the basis of the total
number of shares of Series A Preferred Stock the holder is at the time
converting into Class A Common Stock and the aggregate number of shares of
Class A Common Stock issuable upon such conversion.

  



  

   

I-16

 



    



  

4.4 _Mechanics of Conversion_.

  



  

4.4.1 _Notice of Conversion_. In order for a holder of Series A Preferred
Stock to voluntarily convert shares of Series A Preferred Stock into shares of
Class A Common Stock pursuant to _Subsection 4.1_ , such holder shall (a)
provide written notice to the Corporation's transfer agent at the office of
the transfer agent for the Series A Preferred Stock (or at the principal
office of the Corporation if the Corporation serves as its own transfer
agent) that such holder elects to convert all or any number of such holder's
shares of Series A Preferred Stock and, if applicable, any event on which
such conversion is contingent and (b), if such holder's shares are
certificated, surrender the certificate or certificates for such shares of
Series A Preferred Stock (or, if such registered holder alleges that such
certificate has been lost, stolen or destroyed, a lost certificate affidavit
and agreement reasonably acceptable to the Corporation to indemnify the
Corporation against any claim that may be made against the Corporation on
account of the alleged loss, theft or destruction of such certificate), at
the office of the transfer agent for the Series A Preferred Stock (or at the
principal office of the Corporation if the Corporation serves as its own
transfer agent). Such notice shall state such holder's name or the names of
the nominees in which such holder wishes the shares of Class A Common Stock to
be issued. If required by the Corporation, any certificates surrendered for
conversion shall be endorsed or accompanied by a written instrument or
instruments of transfer, in form satisfactory to the Corporation, duly
executed by the registered holder or his, her or its attorney duly authorized
in writing. The close of business on the date of receipt by the transfer agent
(or by the Corporation if the Corporation serves as its own transfer agent)
of such notice and, if applicable, certificates (or lost certificate
affidavit and agreement) shall be the time of conversion (the "Conversion
Time"), and the shares of Class A Common Stock issuable upon conversion of
the specified shares shall be deemed to be outstanding of record as of such
date. The Corporation shall, as soon as practicable after the Conversion Time
(i) issue and deliver to such holder of Series A Preferred Stock, or to his,
her or its nominees, a certificate or certificates for the number of full
shares of Class A Common Stock issuable upon such conversion in accordance
with the provisions hereof and a certificate for the number (if any) of the
shares of Series A Preferred Stock represented by the surrendered certificate
that were not converted into Class A Common Stock, (ii) pay in cash such
amount as provided in _Subsection 4.2_ in lieu of any fraction of a share of
Class A Common Stock otherwise issuable upon such conversion and (iii) pay all
declared but unpaid dividends on the shares of Series A Preferred Stock
converted.

  



  

4.4.2 _Reservation of Shares_. The Corporation shall at all times when the
Series A Preferred Stock shall be outstanding, reserve and keep available out
of its authorized but unissued capital stock, for the purpose of effecting the
conversion of the Series A Preferred Stock, such number of its duly
authorized shares of Class A Common Stock as shall from time to time be
sufficient to effect the conversion of all outstanding Series A Preferred
Stock; and if at any time the number of authorized but unissued shares of
Class A Common Stock shall not be sufficient to effect the conversion of all
then outstanding shares of the Series A Preferred Stock, the
Corporation shall take such corporate action as may be necessary to increase
its authorized but unissued shares of Class A Common Stock to such number of
shares as shall be sufficient for such purposes, including, without
limitation, engaging in best efforts to obtain the requisite stockholder
approval of any necessary amendment to this Amended and Restated Certificate
of Incorporation. Before taking any action which would cause an adjustment
reducing the Series A Conversion Price below the then par value of the
shares of Class A Common Stock issuable upon conversion of the Series A
Preferred Stock, the Corporation will take any corporate action which may, in
the opinion of its counsel, be necessary in order that the Corporation may
validly and legally issue fully paid and non-assessable shares of Class A
Common Stock at such adjusted Series A Conversion Price.

  



  

4.4.3 _Effect of Conversion_. All shares of Series A Preferred Stock which
shall have been surrendered for conversion as herein provided shall no longer
be deemed to be outstanding and all rights with respect to such shares shall
immediately cease and terminate at the Conversion Time, except only the right
of the holders thereof to receive shares of Class A Common Stock in exchange
therefor, to receive payment in lieu of any fraction of a share otherwise
issuable upon such conversion as provided in _Subsection 4.2_ and to receive
payment of any dividends declared but unpaid thereon. Any shares of Series A
Preferred Stock so converted shall be retired and cancelled and may not be
reissued as shares of such series, and the Corporation may thereafter take
such appropriate action (without the need for stockholder action) as may be
necessary to reduce the authorized number of shares of Series A Preferred
Stock accordingly.

  



  

   

I-17

 



    



  

4.4.4 _No Further Adjustment_. Upon any such conversion, no adjustment to the
Series A Conversion Price shall be made for any declared but unpaid dividends
on the Series A Preferred Stock surrendered for conversion or on the Class A
Common Stock delivered upon conversion.

  



  

4.4.5 _Taxes_. The Corporation shall pay any and all issue and other similar
taxes that may be payable in respect of any issuance or delivery of shares of
Class A Common Stock upon conversion of shares of Series A Preferred Stock
pursuant to this _Section 4_. The Corporation shall not, however, be required
to pay any tax which may be payable in respect of any transfer involved in the
issuance and delivery of shares of Class A Common Stock in a name other than
that in which the shares of Series A Preferred Stock so converted were
registered, and no such issuance or delivery shall be made unless and until
the person or entity requesting such issuance has paid to the Corporation the
amount of any such tax or has established, to the satisfaction of the
Corporation, that such tax has been paid.

  



  

4.5 _Adjustments to Series A Conversion Price for Diluting Issues_.

  



  

4.5.1 _Special Definitions_. For purposes of this Article Fourth, the
following definitions shall apply:

  



  

(a) "Option" shall mean rights, options or warrants to subscribe for,
purchase or otherwise acquire Class A Common Stock or Convertible Securities.

  



  

(b) "Series A Original Issue Date" shall mean the date on which the first
share of Series A Preferred Stock was issued.

  



  

(c) "Convertible Securities" shall mean any evidences of indebtedness, shares
or other securities directly or indirectly convertible into or exchangeable
for Class A Common Stock, but excluding Class B Common Stock and Options.

  



  

(d) "EIP" shall mean the Corporation's 2019 Equity Incentive Plan, as in
effect on the Original Issue Date, or any amended version of such plan or
successor plan approved by the Board of Directors of the Corporation,
including the approval of the Lead Series A Director.

  



  

   

I-18

 



    



  

(e) "Additional Shares of Class A Common Stock" shall mean all shares of
Common Stock issued (or, pursuant to _Subsection 4.5.3_  below, deemed to be
issued) by the Corporation after the Series A Original Issue Date, other than
(1) the following shares of Class A Common Stock and (2) shares of Class A
Common Stock deemed issued pursuant to the following Options and Convertible
Securities (clauses (1) and (2), collectively, "Exempted Securities"):

  



   | (i)| shares of Class A Common Stock, Options or Convertible Securities
issued pro rata as a dividend or distribution on Series A Preferred Stock; 
---|---|--- 
  



   | (ii)| shares of Class A Common Stock, Options or Convertible
Securities issued by reason of a dividend, stock split, split-up or other
distribution on shares of Common Stock that is covered by _Subsection 4.6_ ,
_4.7_ , _4.8_  or _4.9_ ; 
---|---|--- 
  



   | (iii)| shares of Class A Common Stock or Options issued to employees
or directors of, or consultants or advisors to, the Corporation or any of its
subsidiaries pursuant to the EIP or pursuant to any other plan, agreement or
arrangement approved by the Board of Directors of the Corporation, including
the approval of the Lead Series A Director; 
---|---|--- 
  



   | (iv)| shares of Class A Common Stock or Convertible Securities
actually issued upon the exercise of Options or shares of Common Stock
actually issued upon the conversion or exchange of Convertible Securities, in
each case provided such issuance is pursuant to the terms of such Option or
Convertible Security; 
---|---|--- 
  



   | (v)| shares of Class A Common Stock, Options or Convertible Securities
issued to banks, equipment lessors or other financial institutions, or to
real property lessors, pursuant to a debt financing, equipment leasing or real
property leasing transaction approved by the Board of Directors of the
Corporation, including the approval of the Lead Series A Director; 
---|---|--- 
  



   | (vi)| shares of Class A Common Stock, Options or Convertible
Securities issued to suppliers or third-party service providers as
consideration in connection with the provision of goods or services (and for
purposes other than equity financing) pursuant to transactions approved by
the Board of Directors of the Corporation, including the approval of the Lead
Series A Director; 
---|---|--- 
  



  

   

I-19

 



    



   | (vii)| shares of Class A Common Stock, Options or Convertible
Securities issued as acquisition consideration pursuant to the acquisition of
another corporation by the Corporation by merger, purchase of substantially
all of the assets or other reorganization or to a joint venture agreement,
_provided_ that such issuances are approved by the Board of Directors of the
Corporation, including the approval of the Lead Series A Director; 
---|---|--- 
  



   | (viii)| shares of Class A Common Stock, Options or Convertible
Securities issued as consideration in connection with sponsored research,
collaboration, technology license, development, OEM, marketing or other
similar agreements or strategic partnerships (and for purposes other than
equity financing) approved by the Board of Directors of the Corporation,
including the approval of the Lead Series A Director; or 
---|---|--- 
  



   | (ix)| the issuance of any Series A Preferred Stock sold pursuant to
the Purchase Agreement. 
---|---|--- 
  



  

4.5.2 _No Adjustment of Series A Conversion Price_. No adjustment in the
Series A Conversion Price shall be made as the result of the issuance
or deemed issuance of Additional Shares of Class A Common Stock if the
Corporation receives written notice from the Requisite Holders agreeing that
no such adjustment shall be made as the result of the issuance or deemed
issuance of such Additional Shares of Class A Common Stock.

  



  

4.5.3 _Deemed Issue of Additional Shares of Class A Common Stock_.

  



  

(a) If the Corporation at any time or from time to time after the Series A
Original Issue Date shall issue any Options or Convertible Securities
(excluding Options or Convertible Securities which are themselves Exempted
Securities) or shall fix a record date for the determination of holders of
any class of securities entitled to receive any such Options or Convertible
Securities, then the maximum number of shares of Class A Common Stock (as set
forth in the instrument relating thereto, assuming the satisfaction of any
conditions to exercisability, convertibility or exchangeability but without
regard to any provision contained therein for a subsequent adjustment of such
number) issuable upon the exercise of such Options or, in the case of
Convertible Securities and Options therefor, the conversion or exchange of
such Convertible Securities, shall be deemed to be Additional Shares of Class
A Common Stock issued as of the time of such issue or, in case such a record
date shall have been fixed, as of the close of business on such record date.

  



  

   

I-20

 



    



  

(b) If the terms of any Option or Convertible Security, the issuance of which
resulted in an adjustment to the Series A Conversion Price pursuant to the
terms of _Subsection 4.5.4_ , are revised as a result of an amendment to such
terms or any other adjustment pursuant to the provisions of such Option or
Convertible Security (but excluding automatic adjustments to such terms
pursuant to anti-dilution or similar provisions of such Option or Convertible
Security) to provide for either (1) any increase or decrease in the number of
shares of Class A Common Stock issuable upon the exercise, conversion and/or
exchange of any such Option or Convertible Security or (2) any increase or
decrease in the consideration payable to the Corporation upon such exercise,
conversion and/or exchange, then, effective upon such increase or decrease
becoming effective, the Series A Conversion Price computed upon the
original issue of such Option or Convertible Security (or upon the occurrence
of a record date with respect thereto) shall be readjusted to such Series A
Conversion Price as would have obtained had such revised terms been in effect
upon the original date of issuance of such Option or Convertible Security.
Notwithstanding the foregoing, no readjustment pursuant to this clause (b)
shall have the effect of increasing the Series A Conversion Price to an
amount which exceeds the lower of (i) the Series A Conversion Price in effect
immediately prior to the original adjustment made as a result of the issuance
of such Option or Convertible Security, or (ii) the Series A Conversion Price
that would have resulted from any issuances of Additional Shares of Class A
Common Stock (other than deemed issuances of Additional Shares of Class A
Common Stock as a result of the issuance of such Option or Convertible
Security) between the original adjustment date and such readjustment date.

  



  

(c) If the terms of any Option or Convertible Security (excluding Options or
Convertible Securities which are themselves Exempted Securities), the
issuance of which did not result in an adjustment to the Series A Conversion
Price pursuant to the terms of _Subsection 4.5.4_  (either because the
consideration per share (determined pursuant to _Subsection 4.5.5_ ) of the
Additional Shares of Class A Common Stock subject thereto was equal to or
greater than the Series A Conversion Price then in effect, or because such
Option or Convertible Security was issued before the Series A Original Issue
Date), are revised after the Series A Original Issue Date as a result of an
amendment to such terms or any other adjustment pursuant to the provisions of
such Option or Convertible Security (but excluding automatic adjustments to
such terms pursuant to anti-dilution or similar provisions of such Option or
Convertible Security) to provide for either (1) any increase in the number of
shares of Class A Common Stock issuable upon the exercise, conversion or
exchange of any such Option or Convertible Security or (2) any decrease in the
consideration payable to the Corporation upon such exercise, conversion or
exchange, then such Option or Convertible Security, as so amended or adjusted,
and the Additional Shares of Class A Common Stock subject thereto (determined
in the manner provided in _Subsection 4.5.3(a)_ shall be deemed to have been
issued effective upon such increase or decrease becoming effective.

  



  

(d) Upon the expiration or termination of any unexercised Option or
unconverted or unexchanged Convertible Security (or portion thereof) which
resulted (either upon its original issuance or upon a revision of its terms)
in an adjustment to the Series A Conversion Price pursuant to the terms of
_Subsection 4.5.4_ , the Series A Conversion Price shall be readjusted to such
Series A Conversion Price as would have obtained had such Option or
Convertible Security (or portion thereof) never been issued.

  



  

   

I-21

 



    



  

(e) If the number of shares of Class A Common Stock issuable upon the
exercise, conversion and/or exchange of any Option or Convertible Security,
or the consideration payable to the Corporation upon such exercise, conversion
and/or exchange, is calculable at the time such Option or Convertible
Security is issued or amended but is subject to adjustment based upon
subsequent events, any adjustment to the Series A Conversion Price provided
for in this _Subsection 4.5.3_ shall be effected at the time of such issuance
or amendment based on such number of shares or amount of consideration
without regard to any provisions for subsequent adjustments (and any
subsequent adjustments shall be treated as provided in clauses (b) and (c) of
this _Subsection 4.5.3_ ). If the number of shares of Class A Common Stock
issuable upon the exercise, conversion and/or exchange of any Option or
Convertible Security, or the consideration payable to the Corporation upon
such exercise, conversion and/or exchange, cannot be calculated at all at the
time such Option or Convertible Security is issued or amended, any adjustment
to the Series A Conversion Price that would result under the terms of this
_Subsection 4.5.3_ at the time of such issuance or amendment shall instead be
effected at the time such number of shares and/or amount of consideration is
first calculable (even if subject to subsequent adjustments), assuming for
purposes of calculating such adjustment to the Series A Conversion Price that
such issuance or amendment took place at the time such calculation can first
be made.

  



  

4.5.4 _Adjustment of Series A Conversion Price Upon Issuance of Additional
Shares of Class A Common Stock_. In the event the Corporation shall at any
time after the Series A Original Issue Date issue Additional Shares of Class A
Common Stock (including Additional Shares of Class A Common Stock deemed to
be issued pursuant to _Subsection 4.5.3_ ), without consideration or for a
consideration per share less than the Series A Conversion Price in effect
immediately prior to such issuance or deemed issuance, then the Series A
Conversion Price shall be reduced, concurrently with such issue, to a price
(calculated to the nearest one-hundredth of a cent) determined in accordance
with the following formula:

  



  

CP2 = CP1* (A + B)  (A + C).

  



  

For purposes of the foregoing formula, the following definitions shall apply:

  



  

(a) "CP2" shall mean the Series A Conversion Price in effect immediately
after such issuance or deemed issuance of Additional Shares of Class A Common
Stock

  



  

(b) "CP1" shall mean the Series A Conversion Price in effect immediately
prior to such issuance or deemed issuance of Additional Shares of Class A
Common Stock;

  



  

(c) "A" shall mean the number of shares of Class A Common Stock outstanding
immediately prior to such issuance or deemed issuance of Additional Shares of
Class A Common Stock (treating for this purpose as outstanding all shares of
Class A Common Stock issuable upon exercise of Options outstanding
immediately prior to such issuance or deemed issuance or upon conversion or
exchange of Convertible Securities (including the Series A Preferred Stock)
outstanding (assuming exercise of any outstanding Options therefor)
immediately prior to such issue);

  



  

   

I-22

 



    



  

(d) "B" shall mean the number of shares of Class A Common Stock that would
have been issued if such Additional Shares of Class A Common Stock had been
issued or deemed issued at a price per share equal to CP1 (determined by
dividing the aggregate consideration received by the Corporation in respect
of such issue by CP1); and

  



  

(e) "C" shall mean the number of such Additional Shares of Class A Common
Stock issued in such transaction.

  



  

4.5.5 _Determination of Consideration_. For purposes of this _Subsection 4.5_
, the consideration received by the Corporation for the issuance or deemed
issuance of any Additional Shares of Class A Common Stock shall be computed as
follows:

  



   | (a)| _Cash and Property_ : Such consideration shall: 
---|---|--- 
  



   | (i)| insofar as it consists of cash, be computed at the aggregate
amount of cash received by the Corporation, excluding amounts paid or payable
for accrued interest; 
---|---|--- 
  



   | (ii)| insofar as it consists of property other than cash, be computed
at the fair market value thereof at the time of such issue, as determined in
good faith by the Board of Directors of the Corporation; and 
---|---|--- 
  



   | (iii)| in the event Additional Shares of Class A Common Stock are
issued together with other shares or securities or other assets of the
Corporation for consideration which covers both, be the proportion of such
consideration so received, computed as provided in clauses (i) and (ii)
above, as determined in good faith by the Board of Directors of the
Corporation. 
---|---|--- 
  



  

   

I-23

 



    



  

(b) _Options and Convertible Securities_. The consideration per share
received by the Corporation for Additional Shares of Class A Common Stock
deemed to have been issued pursuant to _Subsection 4.5.3_ , relating to
Options and Convertible Securities, shall be determined by dividing:

  



   | (i)| The total amount, if any, received or receivable by the
Corporation as consideration for the issue of such Options or Convertible
Securities, plus the minimum aggregate amount of additional consideration (as
set forth in the instruments relating thereto, without regard to any
provision contained therein for a subsequent adjustment of such consideration)
payable to the Corporation upon the exercise of such Options or the
conversion or exchange of such Convertible Securities, or in the case of
Options for Convertible Securities, the exercise of such Options for
Convertible Securities and the conversion or exchange of such Convertible
Securities, by 
---|---|--- 
  



   | (ii)| the maximum number of shares of Common Stock (as set forth in
the instruments relating thereto, without regard to any provision contained
therein for a subsequent adjustment of such number) issuable upon the exercise
of such Options or the conversion or exchange of such Convertible Securities,
or in the case of Options for Convertible Securities, the exercise of such
Options for Convertible Securities and the conversion or exchange of such
Convertible Securities. 
---|---|--- 
  



  

4.5.6 _Multiple Closing Dates_. In the event the Corporation shall issue on
more than one date Additional Shares of Class A Common Stock that are a part
of one transaction or a series of related transactions and that would result
in an adjustment to the Series A Conversion Price pursuant to the terms of
_Subsection 4.5.4_ , then, upon the final such issuance, the Series A
Conversion Price shall be readjusted to give effect to all such issuances as
if they occurred on the date of the first such issuance (and without giving
effect to any additional adjustments as a result of any such subsequent
issuances within such period).

  



  

4.6 _Adjustment for Stock Splits and Combinations_. If the Corporation shall
at any time or from time to time after the Series A Original Issue Date
effect a subdivision of the outstanding Class A Common Stock, the Series A
Conversion Price in effect immediately before that subdivision shall be
proportionately decreased so that the number of shares of Class A Common Stock
issuable on conversion of each share of such series shall be increased in
proportion to such increase in the aggregate number of shares of Class A
Common Stock outstanding. If the Corporation shall at any time or from time
to time after the Series A Original Issue Date combine the outstanding shares
of Class A Common Stock, the Series A Conversion Price in effect immediately
before the combination shall be proportionately increased so that the number
of shares of Class A Common Stock issuable on conversion of each share of such
series shall be decreased in proportion to such decrease in the aggregate
number of shares of Class A Common Stock outstanding. Any adjustment under
this subsection shall become effective at the close of business on the date
the subdivision or combination becomes effective.

  



  

   

I-24

 



    



  

4.7 _Adjustment for Certain Dividends and Distributions_. In the event the
Corporation at any time or from time to time after the Series A
Original Issue Date shall make or issue, or fix a record date for the
determination of holders of Common Stock entitled to receive, a dividend or
other distribution payable on the Class A Common Stock in Additional Shares of
Class A Common Stock, then and in each such event the Series A Conversion
Price in effect immediately before such event shall be decreased as of the
time of such issuance or, in the event such a record date shall have been
fixed, as of the close of business on such record date, by multiplying the
Series A Conversion Price then in effect by a fraction:

  



  

(1) the numerator of which shall be the total number of shares of Class A
Common Stock issued and outstanding immediately prior to the time of such
issuance or the close of business on such record date, and

  



  

(2) the denominator of which shall be the total number of shares of Class A
Common Stock issued and outstanding immediately prior to the time of such
issuance or the close of business on such record date plus the number of
shares of Class A Common Stock issuable in payment of such dividend or
distribution.

  



  

Notwithstanding the foregoing (a) if such record date shall have been fixed
and such dividend is not fully paid or if such distribution is not fully made
on the date fixed therefor, the Series A Conversion Price shall be recomputed
accordingly as of the close of business on such record date and
thereafter the Series A Conversion Price shall be adjusted pursuant to this
subsection as of the time of actual payment of such dividends or
distributions; and (b) that no such adjustment shall be made if the holders of
Series A Preferred Stock simultaneously receive a dividend or other
distribution of shares of Class A Common Stock in a number equal to the number
of shares of Class A Common Stock as they would have received if all
outstanding shares of Series A Preferred Stock had been converted into Class A
Common Stock on the date of such event.

  



  

4.8 _Adjustments for Other Dividends and Distributions_. In the event the
Corporation at any time or from time to time after the Series A
Original Issue Date shall make or issue, or fix a record date for the
determination of holders of Common Stock entitled to receive, a dividend or
other distribution payable in securities of the Corporation (other than a
distribution of shares of Class A Common Stock in respect of outstanding
shares of Common Stock) or in other property and the provisions of _Section 1_
do not apply to such dividend or distribution, then and in each such event
the holders of Series A Preferred Stock shall receive, simultaneously
with the distribution to the holders of Class A Common Stock, a dividend or
other distribution of such securities or other property in an amount equal to
the amount of such securities or other property as they would have received if
all outstanding shares of Series A Preferred Stock had been converted into
Class A Common Stock on the date of such event.

  



  

   

I-25

 



    



  

4.9 _Adjustment for Merger or Reorganization, etc_. Subject to the provisions
of _Subsection 2.3_ , if there shall occur any
reorganization, recapitalization, reclassification, consolidation or merger
involving the Corporation in which the Class A Common Stock (but not the
Series A Preferred Stock) is converted into or exchanged for securities, cash
or other property (other than a transaction covered by _Subsections 4.4_ ,
_4.6_ or _4.7_ ), then, following any such reorganization, recapitalization,
reclassification, consolidation or merger, each share of Series A Preferred
Stock shall thereafter be convertible in lieu of the Class A Common
Stock into which it was convertible prior to such event into the kind and
amount of securities, cash or other property which a holder of the number of
shares of Class A Common Stock of the Corporation issuable upon conversion of
one share of Series A Preferred Stock immediately prior to such
reorganization, recapitalization, reclassification, consolidation or merger
would have been entitled to receive pursuant to such transaction; and, in
such case, appropriate adjustment (as determined in good faith by the Board
of Directors of the Corporation) shall be made in the application of the
provisions in this _Section 4_ with respect to the rights and interests
thereafter of the holders of the Series A Preferred Stock, to the end that the
provisions set forth in this _Section 4_ (including provisions with respect
to changes in and other adjustments of the Series A Conversion Price) shall
thereafter be applicable, as nearly as reasonably may be, in relation to any
securities or other property thereafter deliverable upon the conversion of
the Series A Preferred Stock.

  



  

4.10 _Certificate as to Adjustments_. Upon the occurrence of each adjustment
or readjustment of the Series A Conversion Price pursuant to this  _Section
4_ , the Corporation at its expense shall, as promptly as reasonably
practicable but in any event not later than ten (10) days thereafter, compute
such adjustment or readjustment in accordance with the terms hereof and
furnish to each holder of Series A Preferred Stock a certificate setting
forth such adjustment or readjustment (including the kind and amount of
securities, cash or other property into which the Series A Preferred Stock is
convertible) and showing in detail the facts upon which such adjustment or
readjustment is based. The Corporation shall, as promptly as reasonably
practicable after the written request at any time of any holder of Series A
Preferred Stock (but in any event not later than ten (10) days thereafter),
furnish or cause to be furnished to such holder a certificate setting forth
(i) the Series A Conversion Price then in effect, and (ii) the number of
shares of Class A Common Stock and the amount, if any, of other securities,
cash or property which then would be received upon the conversion of Series A
Preferred Stock.

  



  

4.11 _Notice of Record Date_. In the event:

  



  

(a) the Corporation shall take a record of the holders of its Class A Common
Stock (or other capital stock or securities at the time issuable upon
conversion of the Series A Preferred Stock) for the purpose of entitling or
enabling them to receive any dividend or other distribution, or to receive
any right to subscribe for or purchase any shares of capital stock of any
class or any other securities, or to receive any other security; or

  



  

(b) of any capital reorganization of the Corporation, any reclassification of
the Class A Common Stock of the Corporation, or any Deemed Liquidation Event;
or

  



  

(c) of the voluntary or involuntary dissolution, liquidation or winding-up of
the Corporation,

  



  

   

I-26

 



    



  

then, and in each such case, the Corporation will send or cause to be sent to
the holders of the Series A Preferred Stock a notice specifying, as the case
may be, (i) the record date for such dividend, distribution or right, and the
amount and character of such dividend, distribution or right, or (ii)
the effective date on which such reorganization, reclassification,
consolidation, merger, transfer, dissolution, liquidation or winding-up is
proposed to take place, and the time, if any is to be fixed, as of which the
holders of record of Class A Common Stock (or such other capital stock or
securities at the time issuable upon the conversion of the Series A Preferred
Stock) shall be entitled to exchange their shares of Class A Common Stock (or
such other capital stock or securities) for securities or other property
deliverable upon such reorganization, reclassification, consolidation,
merger, transfer, dissolution, liquidation or winding-up, and the amount per
share and character of such exchange applicable to the Series A Preferred
Stock and the Class A Common Stock. Such notice shall be sent at least ten
(10) days prior to the record date or effective date for the event specified
in such notice.

  



  

5.  _Mandatory Conversion_.

  



  

5.1 _Trigger Events_. Upon either (a) the closing of the sale of shares of
Common Stock to the public in a firm-commitment underwritten public
offering at a price per share of at least $1.15707 (subject to appropriate
adjustment in the event of any stock dividend, stock split, combination or
other similar recapitalization with respect to the Common Stock), or such
lesser price as may be approved by the Requisite Holders, pursuant to an
effective registration statement under the Securities Act of 1933, as amended,
resulting in at least $100,000,000 of proceeds, net of the underwriting
discount and commissions to the Corporation and in connection with such
offering the Common Stock is listed for trading on the Nasdaq Stock Market\'s
National Market, the New York Stock Exchange or another exchange or
marketplace approved the Board of Directors, including the approval of the
Lead Series A Director or (b) the date and time, or the occurrence of an
event, specified by vote or written consent of the Requisite Holders (the time
of such closing or the date and time specified or the time of the event
specified in such vote or written consent is referred to herein as the
"Mandatory Conversion Time"), then (i) all outstanding shares of Series A
Preferred Stock shall automatically be converted into shares of Class A
Common Stock, at the then effective conversion rate as calculated pursuant to
_Subsection 4.1.1_ and (ii) such shares may not be reissued by the
Corporation.

  



  

5.2 _Procedural Requirements_. All holders of record of shares of Series A
Preferred Stock shall be sent written notice of the Mandatory Conversion Time
and the place designated for mandatory conversion of all such shares of
Series A Preferred Stock pursuant to this _Section 5_. Such notice need not
be sent in advance of the occurrence of the Mandatory Conversion Time. Upon
receipt of such notice, each holder of shares of Series A Preferred Stock in
certificated form shall surrender his, her or its certificate or certificates
for all such shares (or, if such holder alleges that such certificate has
been lost, stolen or destroyed, a lost certificate affidavit and agreement
reasonably acceptable to the Corporation to indemnify the Corporation against
any claim that may be made against the Corporation on account of the alleged
loss, theft or destruction of such certificate) to the Corporation at the
place designated in such notice. If so required by the Corporation, any
certificates surrendered for conversion shall be endorsed or accompanied by
written instrument or instruments of transfer, in form satisfactory to the
Corporation, duly executed by the registered holder or by his, her or its
attorney duly authorized in writing. All rights with respect to the Series A
Preferred Stock converted pursuant to _Subsection 5.1_ , including the
rights, if any, to receive notices and vote (other than as a holder of Class A
Common Stock), will terminate at the Mandatory Conversion Time
(notwithstanding the failure of the holder or holders thereof to surrender
any certificates at or prior to such time), except only the rights of the
holders thereof, upon surrender of any certificate or certificates of such
holders (or lost certificate affidavit and agreement) therefor, to receive the
items provided for in the next sentence of this _Subsection 5.2_. As soon as
practicable after the Mandatory Conversion Time and, if applicable, the
surrender of any certificate or certificates (or lost certificate affidavit
and agreement) for Series A Preferred Stock, the Corporation shall (a) issue
and deliver to such holder, or to his, her or its nominees, a certificate or
certificates for the number of full shares of Class A Common Stock issuable
on such conversion in accordance with the provisions hereof and (b) pay cash
as provided in _Subsection 4.2_ in lieu of any fraction of a share of Class A
Common Stock otherwise issuable upon such conversion and the payment of
any declared but unpaid dividends on the shares of Series A Preferred Stock
converted. Such converted Series A Preferred Stock shall be retired and
cancelled and may not be reissued as shares of such series, and the
Corporation may thereafter take such appropriate action (without the need for
stockholder action) as may be necessary to reduce the authorized number of
shares of Series A Preferred Stock accordingly.

  



  

   

I-27

 



    



  

6.  _Redemption_.

  



  

6.1 _General_. Unless prohibited by Delaware law governing distributions to
stockholders, shares of Series A Preferred Stock shall be redeemed by the
Corporation at a price equal to the greater of (A) the Series A Original Issue
Price per share, plus all declared but unpaid dividends thereon and (B) the
Fair Market Value (determined in the manner set forth below) of a single share
of Series A Preferred Stock as of the date of the Corporation's receipt of
the Redemption Request (the "Redemption Price"), in three (3) annual
installments commencing not more than sixty (60) days after receipt by the
Corporation at any time on or after the Third-Party Transfer Rights
Expiration Date (as defined in the Investors' Rights Agreement) from the
holders of at least eighty percent (80%) of the outstanding shares of Series
A Preferred Stock, which holders must include the Lead Investor so long as
neither the Lead Investor nor any of its Affiliates is a Defaulting Holder, of
written notice requesting redemption of all shares of Series A Preferred
Stock (the "Redemption Request"). Upon receipt of a Redemption Request, the
Corporation shall apply all of its assets to any such redemption, and to no
other corporate purpose, except to the extent prohibited by Delaware law
governing distributions to stockholders. For purposes of this _Subsection 6.1_
, the Fair Market Value of a single share of Series A Preferred Stock shall
be the value of a single share of Series A Preferred Stock as mutually
determined by (x) the holders of a majority of the outstanding shares of
Series A Preferred Stock (which holders must include the Lead Investor so
long as neither the Lead Investor nor any of its Affiliates is a Defaulting
Holder) and (y) the holders of a majority of the outstanding shares of Class
A Common Stock and Class B Common Stock, voting together as a single class,
and, in the event that they are unable to reach agreement, by a third-party
appraiser selected by the Board of Directors of the Corporation, including the
approval of Lead Series A Director. The date of each such installment
provided in the Redemption Notice (as defined below) shall be referred to as
a "Redemption Date." On each Redemption Date, the Corporation shall redeem, on
a pro rata basis in accordance with the number of shares of Series A
Preferred Stock owned by each holder, that number of outstanding shares of
Series A Preferred Stock determined by dividing (i) the total number of
shares of Series A Preferred Stock outstanding immediately prior to
such Redemption Date by (ii) the number of remaining Redemption Dates
(including the Redemption Date to which such calculation applies); 
_provided_ , _however_ , that Excluded Shares (as such term is defined in
_Subsection 6.2_ ) shall not be redeemed and shall be excluded from the
calculations set forth in this sentence. If on any Redemption Date, Delaware
law governing distributions to stockholders prevents the Corporation from
redeeming all shares of Series A Preferred Stock to be redeemed, the
Corporation shall ratably redeem the maximum number of shares that it may
redeem consistent with such law, and shall redeem the remaining shares as
soon as it may lawfully do so under such law.

  



  

   

I-28

 



    



  

6.2 _Redemption Notice_. The Corporation shall send written notice of the
mandatory redemption (the "Redemption Notice") to each holder of record of
Series A Preferred Stock not less than forty (40) days prior to each
Redemption Date. Each Redemption Notice shall state:

  



  

(a) the number of shares of Series A Preferred Stock held by the holder that
the Corporation shall redeem on the Redemption Date specified in the
Redemption Notice;

  



  

(b) the Redemption Date and the Redemption Price;

  



  

(c) the date upon which the holder's right to convert such shares terminates
(as determined in accordance with _Subsection 4.1_ ); and

  



  

(d) for holders of shares in certificated form, which the holder is to
surrender to the Corporation, in the manner and at the place designated, his,
her or its certificate or certificates representing the shares of Series A
Preferred Stock to be redeemed.

  



  

If the Corporation receives, on or prior to the twentieth (20th ) day after
the date of delivery of the Redemption Notice to a holder of Series A
Preferred Stock, written notice from such holder that such holder elects to
be excluded from the redemption provided in this _Section 6_ , then the
shares of Series A Preferred Stock registered on the books of the Corporation
in the name of such holder at the time of the Corporation's receipt of such
notice shall thereafter be "Excluded Shares." Excluded Shares shall not be
redeemed or redeemable pursuant to this _Section 6_ , whether on such
Redemption Date or thereafter.

  



  

6.3 _Surrender of Certificates; Payment_. On or before the applicable
Redemption Date, each holder of shares of Series A Preferred Stock to
be redeemed on such Redemption Date, unless such holder has exercised his,
her or its right to convert such shares as provided in  _Section 4_ , shall,
if a holder of shares in certificated form, surrender the certificate or
certificates representing such shares (or, if such registered holder alleges
that such certificate has been lost, stolen or destroyed, a lost certificate
affidavit and agreement reasonably acceptable to the Corporation to indemnify
the Corporation against any claim that may be made against the Corporation on
account of the alleged loss, theft or destruction of such certificate) to the
Corporation, in the manner and at the place designated in the Redemption
Notice, and thereupon the Redemption Price for such shares shall be payable to
the order of the person whose name appears on such certificate or
certificates as the owner thereof. In the event less than all of the
shares of Series A Preferred Stock represented by a certificate are redeemed,
a new certificate, instrument, or book entry representing the unredeemed
shares of Series A Preferred Stock shall promptly be issued to such holder.

  



  

   

I-29

 



    



  

6.4 _Interest_. If any shares of Preferred Stock are not redeemed for any
reason on any Redemption Date, all such unredeemed shares shall
remain outstanding and entitled to all the rights and preferences provided
herein, and the Corporation shall pay interest on the Redemption Price
applicable to such unredeemed shares at an aggregate per annum rate equal to
the prime rate, from time to time in effect, as published in The Wall Street
Journal, with such interest to accrue daily in arrears and be compounded
annually; _provided_ ,  _however_ , that in no event shall such interest
exceed the maximum permitted rate of interest under applicable law (the
"Maximum Permitted Rate"), _provided_ , _however_ , that the Corporation
shall take all such actions as may be necessary, including without
limitation, making any applicable governmental filings, to cause the Maximum
Permitted Rate to be the highest possible rate. In the event any provision
hereof would result in the rate of interest payable hereunder being in excess
of the Maximum Permitted Rate, the amount of interest required to be paid
hereunder shall automatically be reduced to eliminate such excess; 
_provided_ , _however_ , that any subsequent increase in the Maximum Permitted
Rate shall be retroactively effective to the applicable Redemption Date to
the extent permitted by law.

  



  

6.5 _Rights Subsequent to Redemption_. If the Redemption Notice shall have
been duly given, and if on the applicable Redemption Date the
Redemption Price payable upon redemption of the shares of Series A Preferred
Stock to be redeemed on such Redemption Date is paid or tendered for payment
or deposited with an independent payment agent so as to be available therefor
in a timely manner, then notwithstanding that any certificates evidencing any
of the shares of Series A Preferred Stock so called for redemption shall not
have been surrendered, dividends with respect to such shares of Series A
Preferred Stock shall cease to accrue after such Redemption Date and all
rights with respect to such shares shall forthwith after the Redemption Date
terminate, except only the right of the holders to receive the Redemption
Price without interest upon surrender of any such certificate or certificates
therefor.

  



  

7. _Redeemed or Otherwise Acquired Shares_. Any shares of Series A Preferred Stock that are redeemed or otherwise acquired by the Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or transferred. Neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted to the holders of Series A Preferred Stock following redemption.

  



  

8. _Waiver_. Any of the rights, powers, preferences and other terms of the Series A Preferred Stock set forth herein may be waived on behalf of all holders of Series A Preferred Stock by the affirmative written consent or vote of the Requisite Holders.

  



  

9. _Notices_. Any notice required or permitted by the provisions of this Article Fourth to be given to a holder of shares of Series A Preferred Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic communication in compliance with the provisions of the General Corporation Law, and shall be deemed sent upon such mailing or electronic transmission.

  



  

   

I-30

 



    



  

FIFTH: Subject to any additional vote required by this Amended and Restated
Certificate of Incorporation or Bylaws, in furtherance and not in limitation
of the powers conferred by statute, the Board of Directors is expressly
authorized to make, repeal, alter, amend and rescind any or all of the Bylaws
of the Corporation.

  



  

SIXTH: Subject to any additional vote required by this Amended and Restated
Certificate of Incorporation, the number of directors of the
Corporation shall be determined in the manner set forth in the Bylaws of the
Corporation. Each director shall be entitled to one vote on each matter
presented to the Board of Directors; _provided_ , _however_ , that, so long as
the holders of Series A Preferred Stock are entitled to elect a Series A
Director, the affirmative vote of the Lead Series A Director shall be required
for the authorization by the Board of Directors of any of the matters set
forth in Section 5.4 of the Investors' Rights Agreement.

  



  

SEVENTH: Elections of directors need not be by written ballot unless the
Bylaws of the Corporation shall so provide.

  



  

EIGHTH: Meetings of stockholders may be held within or without the State of
Delaware, as the Bylaws of the Corporation may provide. The books of the
Corporation may be kept outside the State of Delaware at such place or places
as may be designated from time to time by the Board of Directors or in the
Bylaws of the Corporation.

  



  

NINTH: To the fullest extent permitted by law, a director of the Corporation
shall not be personally liable to the Corporation or its stockholders for
monetary damages for breach of fiduciary duty as a director. If the General
Corporation Law or any other law of the State of Delaware is amended after
approval by the stockholders of this Article Ninth to authorize corporate
action further eliminating or limiting the personal liability of directors,
then the liability of a director of the Corporation shall be eliminated or
limited to the fullest extent permitted by the General Corporation Law as so
amended.

  



  

Any repeal or modification of the foregoing provisions of this Article Ninth
by the stockholders of the Corporation shall not adversely affect any right
or protection of a director of the Corporation existing at the time of, or
increase the liability of any director of the Corporation with respect to any
acts or omissions of such director occurring prior to, such repeal or
modification.

  



  

TENTH: To the fullest extent permitted by applicable law, the Corporation is
authorized to provide indemnification of (and advancement of expenses to)
directors, officers and agents of the Corporation (and any other persons to
which General Corporation Law permits the Corporation to provide
indemnification) through Bylaw provisions, agreements with such agents or
other persons, vote of stockholders or disinterested directors or otherwise,
in excess of the indemnification and advancement otherwise permitted by
Section 145 of the General Corporation Law.

  



  

Any amendment, repeal or modification of the foregoing provisions of this
Article Tenth shall not (a) adversely affect any right or protection of
any director, officer or other agent of the Corporation existing at the time
of such amendment, repeal or modification or (b) increase the liability of
any director of the Corporation with respect to any acts or omissions of such
director, officer or agent occurring prior to, such amendment, repeal or
modification.

  



  

   

I-31

 



    



  

ELEVENTH: The Corporation renounces, to the fullest extent permitted by law,
any interest or expectancy of the Corporation in, or in being offered an
opportunity to participate in, any Excluded Opportunity. An "Excluded
Opportunity" is any matter, transaction or interest that is presented to, or
acquired, created or developed by, or which otherwise comes into the
possession of (i) any director of the Corporation who is not an employee of
the Corporation or any of its subsidiaries, or (ii) any holder of Series A
Preferred Stock or any partner, member, director, stockholder, employee,
affiliate or agent of any such holder, other than someone who is an employee
of the Corporation or any of its subsidiaries (collectively, the persons
referred to in clauses (i) and (ii) are "Covered Persons"), unless such
matter, transaction or interest is presented to, or acquired, created or
developed by, or otherwise comes into the possession of, a Covered Person
expressly and solely in such Covered Person's capacity as a director of the
Corporation while such Covered Person is performing services in such capacity.
Any repeal or modification of this Article Eleventh will only be prospective
and will not affect the rights under this Article Eleventh in effect at the
time of the occurrence of any actions or omissions to act giving rise to
liability. Notwithstanding anything to the contrary contained elsewhere in
this Amended and Restated Certificate of Incorporation, the affirmative vote
of the Requisite Holders, will be required to amend or repeal, or to adopt
any provisions inconsistent with this Article Eleventh.

     

3. That the foregoing amendment and restatement was approved by the holders of the requisite number of shares of this corporation in accordance with Section 228 of the General Corporation Law.

  



  

4. That this Certificate of Incorporation, which restates and integrates and further amends the provisions of this Corporation's Certificate of Incorporation, has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law.

  



  

IN WITNESS WHEREOF, this Amended and Restated Certificate of Incorporation
has been executed by a duly authorized officer of this corporation on this
[] day of [], 2020.

  



       | By:  | 
---|---|--- 
     |   | President 
  



  

   

I-32

 



    



 

Exhibit J

  



  

SHARE EXCHANGE AGREEMENT

  



  

by and between

  



  

NUVATION BIO INC.

  



  

and

  



  

DAVID HUNG, M.D.

  



  

Dated as of October 5, 2020

  



  

This Share Exchange Agreement (this " _Agreement_ ") is made and entered
into as of October 5, 2020 by and between Nuvation Bio Inc., a Delaware
Corporation (" _Nuvation Bio_ "), and David Hung, M.D. (the " _Founder_ ").

  



  

RECITALS

  



  

Whereas, Panacea Acquisition Corp., a Delaware corporation (" _Panacea_
"), Nuvation Bio, the Founder and Omega Venture Fund V, L.P. have executed a
letter of intent dated September 4, 2020 (the " _LOI_ ") describing the
parties' intent to enter into a definitive merger agreement pursuant to which
Panacea will acquire all of the issued and outstanding shares of preferred
and common stock and all outstanding options to acquire common stock
of Nuvation Bio via a merger transaction (the " _Merger_ "), such that, upon
consummation of the Merger, Nuvation Bio will be a wholly-owned subsidiary of
Panacea; and

  



  

Whereas, pursuant to the LOI, Nuvation Bio intends to effect the Company
Recapitalization prior to the Closing (as such terms are defined in the LOI),
pursuant to which (a) the certificate of incorporation of Nuvation Bio will
be amended and restated (the " _New Certificate_ "), among other things, (i)
to provide that all shares of Nuvation Bio's common stock the, par value
$0.0001 per share (" _Existing Common Stock_ "), will be reclassified into
the same number of shares of Class A common stock, par value $0.0001 per
share, having the same rights, preferences and privileges as the Existing
Common Stock and (ii) to create a new class of stock called Class B Common
Stock, and (b) following the filing and effectiveness of the New Certificate,
the Founder will exchange 281,130,898 shares of Class A common stock (the "
_Founder Existing Class A Common_ ") and 12,963,780 shares of Series A
Preferred Stock (together with the Founder Existing Class A Common, the "
_Founder Existing Shares_ ") for 294,094,678 shares of newly issued Class B
common stock, par value $0.0001 per share (the " _New Class B Shares_
"), having (i) ten votes per share on certain proposed change in control
transactions, (ii) one vote per share on all other matters, and (iii) the
right (voting together with the Class A Common Stock with one vote per share)
to elect and remove (without cause) three directors (including the seat
occupied by the Founder) plus at least 50% of any directors beyond the
initial seven, on the terms and subject to the conditions set forth herein
(the " _Share Exchange_ "); and

  



  

Whereas, Nuvation Bio's Board of Directors has unanimously (with the Founder
abstaining) approved and declared advisable (i) the New Certificate, (ii)
Nuvation Bio's entry into this Agreement, and (iii) the Share Exchange.

  



    

J-1

 



    



  

AGREEMENT

  



  

Now, Therefore, in consideration of the foregoing premises and for other
good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the undersigned parties hereby agree as follows:

  



  

1\. The Share Exchange.

    



  

1.1 Share Exchange. Upon the terms and subject to the conditions of this
Agreement, at the Share Exchange Closing (as defined below), Nuvation
Bio shall issue the New Class B Shares to the Founder and, in exchange
therefor, the Founder shall deliver to Nuvation Bio the Founder Existing
Shares.

  



  

1.2 Share Exchange Closing. The closing of the Share Exchange (the "
_Share Exchange Closing_ "), at which Nuvation Bio will deliver to the
Founder evidence of the issuance of the New Class B Shares registered in the
name of the Founder and the Founder will deliver to Nuvation Bio evidence of
his surrender to Nuvation Bio of the Founder Existing Shares, shall take place
on such date as Nuvation Bio and the Founder may mutually select, provided
that such date shall in any event be (i) following the filing and
effectiveness of the New Certificate, (ii) after the satisfaction or waiver
of the conditions set forth in Section 4 of this Agreement and (iii) prior to
the closing of the Merger.

  



  

1.3 Stock Restriction Agreement. The Founder acknowledges that (i) certain
shares of Existing Common Stock currently held by the Founder are subject to
a repurchase option in favor of Nuvation Bio pursuant to that certain Stock
Restriction Agreement dated June 17, 2019 between Nuvation Bio and the
Founder (the " _Stock Restriction Agreement_ "), and (ii) by the terms of the
Stock Restriction Agreement, such repurchase option will continue to apply to
an equal number of shares of Founder Existing Class A Common from and after
the date on which the New Certificate is filed with the Delaware Secretary of
State. The Founder hereby agrees that the Stock Restriction Agreement and the
repurchase option set forth therein shall apply, from and after the Share
Exchange Closing, to an equal number of New Class B Shares received in
exchange for the Founder Existing Class A Common. The Founder intends to
make a new election pursuant to Section 83(b) of the Internal Revenue
Code of 1986, as amended (the " _Code_ "), with respect to the New Class B
Shares.

  



  

1.4 Tax Reporting. Nuvation Bio agrees to treat and report the Share Exchange
as a tax-free "reorganization" within the meaning of Section 368(a)(1)(E) of
the Code and corresponding provisions of applicable state and local law.
Nuvation Bio shall not report any income to or with respect to the Founder in
respect of the Share Exchange or the issuance of the New Class B Shares for
tax purposes. Neither Nuvation Bio nor the Founder shall take any position
inconsistent with the foregoing two sentences, including on any financial
statement or tax return or in any administrative or judicial action or
proceeding unless otherwise required pursuant to a determination as defined
in Section 1313 of the Code. The parties hereto adopt this Agreement as a
"plan of reorganization" within the meaning of Sections 1.368-2(g) and
1.368-3(a) of the United States Treasury Regulations.

  



  

2. Representations and Warranties of Nuvation Bio. Nuvation Bio represents
and warrants to the Founder as of the date hereof that:

  



  

2.1 Existence and Power. Nuvation Bio is a corporation duly incorporated,
validly existing and in good standing under the laws of the State
of Delaware. Nuvation Bio has the requisite corporate power and authority to
own or lease all of its properties and assets and to carry on its business as
it is now being conducted, and is duly licensed or qualified to do business in
each jurisdiction in which the nature of the business conducted by it or the
character or location of the properties and assets owned or leased by it
makes such licensing or qualification necessary.

  



    

J-2

 



    



  

2.2 Authorization. The execution, delivery and performance of this Agreement
has been duly authorized by all necessary action on the part of Nuvation Bio,
and this Agreement is a valid and binding obligation of Nuvation Bio,
enforceable against it in accordance with its terms.

  



  

2.3 Approvals. The transactions contemplated by this Agreement, including
without limitation the issuance of the New Class B Shares and the
compliance with the terms of this Agreement, have been duly and validly
authorized by all necessary corporate consents and authorizations on the part
of Nuvation Bio, and no other corporate actions on the part of Nuvation Bio
are necessary to authorize the execution and delivery by Nuvation Bio of this
Agreement.

  



  

2.4 Valid Issuance. Upon their issuance, the New Class B Shares will have
been duly authorized by all necessary corporate action and will be
validly issued, fully paid and non-assessable, will not subject the holders
thereof to personal liability and will not be subject to any preemptive or
similar rights. The voting rights provided for in the terms of the New Class B
Shares as set forth in the New Certificate are validly authorized.

  



  

2.5 Non-Contravention. The execution, delivery and performance of this
Agreement, and the consummation by Nuvation Bio of the transactions
contemplated hereby, will not (i) violate or result in a breach of any
provision of law to which Nuvation Bio is subject; (ii) conflict
with, violate or result in a breach of any provision of, or constitute a
default (or an event which, with notice or lapse of time or both would
constitute a default) under, any provision of the New Certificate or the
bylaws of Nuvation Bio; or

  



  

(iii) violate or result in a violation of, conflict with or constitute
or result in a default (whether after the giving of notice, lapse of time or
both) under, accelerate any obligation under, or give rise to a right of
termination of, the LOI.

  



  

3. Representations and Warranties of the Founder. The Founder represents and
warrants to Nuvation Bio as of the date hereof that:

  



  

3.1 Authorization. The Founder has all requisite power and authority to enter
into, deliver and perform his obligations under this Agreement.
The execution, delivery and performance of this Agreement has been duly
authorized by all necessary action on the part of the Founder, and this
Agreement is a valid and binding obligation of the Founder, enforceable
against the Founder in accordance with its terms.

  



  

3.2 Non-Contravention. The execution, delivery and performance of this
Agreement, and the consummation by the Founder of the transactions
contemplated hereby, will not (i) violate or result in a breach of any
provision of law to which the Founder is subject; (ii) violate or result in a
violation of, conflict with or constitute or result in a default (whether
after the giving of notice, lapse of time or both) under, accelerate any
obligation under, or give rise to a right of termination of, any contract,
permit, license, authorization, agreement or any other instrument to which
the Founder is a party or by which the Founder is bound; or (iii) result in
the creation or imposition of any liens on any of the Founder Existing
shares.

  



  

3.3 Title to Interests. The Founder is the sole beneficial owner of the
Founder Existing Shares and has good title to the Founder Existing
Shares, free and clear of any liens, other than restrictions under applicable
securities laws or as set forth under the New Certificate and the Stock
Restriction Agreement. The Founder is not a party to any option, warrant,
purchase right or other contract or commitment that could require the Founder
to sell, transfer, or otherwise dispose of any Founder Existing Shares (other
than this Agreement).

  



    

J-3

 



    



  

3.4 Acquisition for Own Account. The Founder is acquiring the New Class B
Shares for his own account and not with a view to the distribution thereof in
violation of the Securities Act of 1933, as amended, and the rules and
regulations of the Securities and Exchange Commission promulgated thereunder
(the " _Securities Act_ ").

  



  

3.5 No Registration. (a) The Founder understands that (i) the New Class B
Shares have not been registered under the Securities Act or any
state securities laws, and are being issued in a transaction exempt from the
registration requirements thereof and (ii) the New Class B Shares may not be
sold unless such disposition is registered under the Securities Act and
applicable state securities laws or is exempt from registration thereunder.

  



  

4. Conditions to Share Exchange Closing. The respective obligations of the
parties hereunder to effect the Share Exchange shall be subject to the
following conditions:

  



  

4.1 No Injunctions or Restraints; Illegality. No order, injunction or decree
issued by any court or agency of competent jurisdiction or other law
preventing or making illegal the consummation of the Share Exchange shall be
in effect.

  



  

4.2 Filing of New Certificate. The New Certificate shall have been duly
approved by Nuvation Bio's stockholders and filed with the Delaware Secretary
of State.

  



  

5\. Miscellaneous.

    



  

5.1 Notices. All notices, requests, claims, demands and other communications
hereunder shall be in writing and shall be deemed given, delivered and/or
provided (a) when delivered personally, (b) when sent by facsimile (which is
confirmed by a printed confirmation produced by the sending machine) or (c)
when delivered when dispatched for overnight delivery by Federal Express or a
similar courier, in either case, to the parties at the following addresses
(or at such other address for a party as shall be specified by like notice):

  



   | (a)| if to Nuvation Bio, to: 
---|---|--- 
  



  

Nuvation Bio Inc.

  

1500 Broadway, Suite 1401

  

New York, NY 10036

  

Attention: Daniel G. Welch

  



  

with copies to:

  



  

Cooley LLP

  



  

101 California Street, 5th Floor

  

San Francisco, CA 94111

  

Attention: Kenneth L. Guernsey and

  



    

J-4

 



    



  

Goodwin Procter LP

  

100 Northern Avenue

  

Boston, MA 02210

  

United States

  

Attention: Joseph C. Theis, Jr.

  



   | (b)| if to the Founder, to: 
---|---|--- 
  

  

David Hung, M.D.

  

c/o Nuvation Bio Inc.

  

1500 Broadway, Suite 1401

  

New York, NY 10036

  



  

5.2 Further Assurances. Each party hereto shall do and perform or cause to be
done and performed all further acts and shall execute and deliver all other
agreements, certificates, instruments and documents as any other party hereto
reasonably may request in order to carry out the intent and accomplish the
purposes of this Agreement and the consummation of the transactions
contemplated hereby.

  



  

5.3 Amendment and Waivers. Any provision of this Agreement may be amended or
waived if, and only if, such amendment or waiver is in writing and is duly
executed and delivered by Nuvation Bio and the Founder. No failure or delay by
any party in exercising any right, power or privilege hereunder shall operate
as a waiver thereof nor shall any single or partial exercise thereof preclude
any other or further exercise thereof or the exercise of any other right,
power or privilege. The rights and remedies herein provided shall be
cumulative and not exclusive of any rights or remedies provided by law.

  



  

5.4 Fees and Expenses. Each party hereto shall pay all of its own fees and
expenses (including attorneys' fees) incurred in connection with this
Agreement and the transactions contemplated hereby.

  



  

5.5 Successors and Assigns. The provisions of this Agreement shall be binding
upon and inure to the benefit of the parties hereto and their
respective successors and assigns, _provided_ that neither party may assign,
delegate or otherwise transfer any of its rights or obligations under this
Agreement without the consent of the other party hereto, such consent not to
be unreasonably withheld or delayed.

  



  

5.6 Governing Law. This Agreement shall be governed by, and construed in
accordance with, the Laws of the State of New York, regardless of the laws
that might otherwise govern under applicable principles of conflicts of laws
thereof. The parties hereto agree that any suit, action or proceeding brought
by either party to enforce any provision of, or based on any matter arising
out of or in connection with, this Agreement or the transactions contemplated
hereby shall be brought in New York state court located in New York City, or
if such court lacks jurisdiction, any other federal or state court located in
the State of New York. Each of the parties hereto submits to the jurisdiction
of any such court in any suit, action or proceeding seeking to enforce any
provision of, or based on any matter arising out of, or in connection with,
this Agreement or the transactions contemplated hereby and hereby
irrevocably waives the benefit of jurisdiction derived from present or future
domicile or otherwise in such action or proceeding. Each party hereto
irrevocably waives, to the fullest extent permitted by law, any objection that
it may now or hereafter have to the laying of venue of any such suit, action
or proceeding in any such court or that any such suit, action or proceeding
brought in any such court has been brought in an inconvenient forum.

  



  

   

J-5

 



    



  

5.7 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY
AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN
RESPECT OF ANY LEGAL ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS. EACH PARTY TO THIS AGREEMENT CERTIFIES
AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER PARTY HAS
REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO
ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION, (B) SUCH PARTY
HAS CONSIDERED AND UNDERSTANDS THE IMPLICATIONS OF THIS WAIVER, (C) SUCH
PARTY MAKES THIS WAIVER VOLUNTARILY AND (D) SUCH PARTY HAS BEEN INDUCED TO
ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS SECTION 5.7.

  



  

5.8 Entire Agreement. This Agreement constitutes the entire agreement between
the parties with respect to the subject matter of this Agreement, and this
Agreement supersedes all prior agreements and understandings, both oral and
written, between the parties and/or their affiliates with respect to the
subject matter of this Agreement.

  



  

5.9 Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision shall be deemed amended to
achieve an effect that is as near as possible to that provided by the original
provision and the legality, validity and enforceability of the remaining
provisions of this Agreement shall not be affected and this Agreement shall be
enforceable in accordance with its terms.

  



  

5.10 Counterparts; Third Party Beneficiaries. This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original and
all of which together shall constitute one instrument. Counterparts may be
delivered via facsimile, electronic mail (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
www.docusign.com) or other transmission method and any counterpart so
delivered shall be deemed to have been duly and validly delivered and be
valid and effective for all purposes. No provision of this Agreement shall
confer upon any person other than the parties hereto any rights or remedies
hereunder.

  



  

5.11 Specific Performance. Unless this Agreement has been terminated, each
party to this Agreement acknowledges and agrees that any breach by it of this
Agreement shall cause one or more of the other parties irreparable harm which
may not be adequately compensable by money damages. Accordingly, except in
the case of termination, in the event of a breach or threatened breach by a
party of any provision of this Agreement, each party shall be entitled to
seek the remedies of specific performance, injunction or other preliminary or
equitable relief, without having to prove irreparable harm or actual damages.
The foregoing right shall be in addition to such other rights or remedies as
may be available to any party for such breach or threatened breach, including
but not limited to the recovery of money damages.

  



  

In Witness Whereof, the parties hereto have caused this Agreement to be duly
executed as of the date first written above.

     



       | NUVATION BIO INC 
---|--- 
     |   | 
     | By:  | /s/ Daniel G. Welch 
     |   | Daniel G. Welch 
     |   | Chair of the Board 
     |   | 
     | /s/ DAVID HUNG 
     |

DAVID HUNG, M.D. 

  



  



  

J-6

  



  

      '

